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1 Introduction and goals 
Although fluorine is the most abundant halogen atom in the earth’s crust, only 13 natural products 
incorporating fluorine have been discovered so far.1 The first fluorinated natural product to be discovered 
was fluoroacetate 1, isolated from Dichapetalum cymosum, also known as Gifblaar or Poison leaf  
(Figure 1). The name of this South African shrub indicates its toxicity, which is due to the high levels of 
fluoroacetate 1 in its leafs. The only amino acid among the 13 fluorinated natural products is 
4-fluorothreonine 2 which is produced in the actinomycete Streptomyces cattleya (Figure 1).2 
 
Figure 1 
The introduction of fluorine in organic compounds is very popular in medicinal chemistry. This can be 
attributed to its unique chemical, biological and physical properties.3 The high electronegativity of fluorine 
(χpauling = 4) and the excellent overlap between the 2s and 2p orbitals of fluorine with the corresponding 
orbitals of carbon lead to a highly polarized, very strong and short carbon-fluorine bond. In addition, this 
bond has a low polarizability, which often leads to an increase in lipophilicity of fluorinated compounds, 
especially in the case of aromatic fluorination and fluorination adjacent to atoms with π-bonds. Since the 
lipophilicity of a compound has a profound effect on its passive transport in the body, this is a very 
important property of orally administered drugs. Another result of the electron-withdrawing character of 
fluorine is the pronounced effect of fluorine substitution on the acidity of adjacent functional groups. This 
in turn is an important feature in the solubility and bioavailability of pharmaceuticals. Furthermore, the 
introduction of fluorine in molecules can enhance their metabolic stability. As such, metabolically labile 
sites can be blocked by the introduction of fluorine. Another important feature of fluorine substitution is 
its effect on the conformation of molecules. Because of the fact that the van der Waals radius of fluorine 
(1.47 Å) is situated in between that of hydrogen (1.20 Å) and oxygen (1.57 Å), the replacement of one of 
these two elements by fluorine does not have a pronounced effect on steric grounds. However, the 
electronic properties of fluorine can lead to a conformational change in fluorinated molecules. For 
example, 1,2-difluoroethane 3 adopts a gauche conformation due to the stabilizing effect of 
hyperconjugative (σ -> σ*) interactions. 
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Figure 2 
These unique properties of fluorine have led to an increasing number of fluorinated pharmaceuticals, with 
2% of fluorine-containing drugs in 1970 and about 25% of fluorinated drugs nowadays.4 In 2013, seven of 
the 30 best-selling drugs incorporated at least one fluorine atom in their structure. The cholesterol-
lowering drug Crestor® (rosuvastatin) 4 occupied the fourth place in this list and Advair Diskus®  
(a combination drug of fluticasone propionate 5 and salmeterol), which is used for the treatment of 
asthma, was the sixth best-selling drug in 2013 (Figure 3). In 2011, the cholesterol lowering drug Lipitor® 
(atorvastatin) 6 was the best-selling drug worldwide. Another important example of a fluorinated drug is 
the well-known antidepressant Prozac® (fluoxetine) 7. 
 
 
Figure 3 
The above-mentioned drugs are members of the class of ‘small molecule’ drugs, with a molecular weight 
generally less than 500 Da. The biggest advantage of these drugs is that they can be administered orally. 
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However, some disadvantages are associated with this class of drugs, for example a reduced target 
selectivity, which can lead to the occurrence of side-effects. Another class of drugs comprises the 
biopharmaceuticals, such as proteins. The biggest advantage of this class is their high site-specificity due 
to the higher amount of interactions with the appropriate receptors. However, due to the high molecular 
weight of these compounds, oral administration is not possible and these drugs need to be administered 
by injection, which is probably the major drawback of this type of drugs. Another disadvantage is their low 
metabolic stability. Nevertheless, biopharmaceuticals are also represented in the list of top-selling 
blockbuster drugs in 2013, with four protein drugs in the top 10. For example, adalimumab (Humira®), an 
anti-inflammatory drug, is a monoclonal antibody consisting of 1330 amino acids and was listed as the 
third best-selling drug in 2013. 
Peptides can be mentioned as a third class of pharmaceuticals, with a molecular weight situated between 
that of ‘small molecule’ drugs and biopharmaceuticals.5 An example of a synthetic therapeutic peptide is 
exenatide (Byetta®), which is used for the treatment of diabetes mellitus type 2. The biggest drawback of 
peptides is their limited metabolic stability since they are readily degraded by proteolytic enzymes. In 
order to reduce the biodegradation of peptides, different strategies have been developed. For example, 
since the β-peptide bond is stable toward proteases,6 it is useful to consider β-amino acids as building 
blocks for more stable peptides.7 Furthermore, the use of conformationally restricted β-amino acids 
increases the conformational stability and rigidity of peptides.8 Thus, less β-amino acid residues are 
required for the formation of secondary structures, as compared to α-amino acids.9 The use of fluorine in 
peptide chemistry is also an emerging area10 and the influence of fluorine substitution on the formation 
of secondary structures has been described.11 One of the main limitations for the synthesis of fluorinated 
peptides is now the accessibility of the appropriate building blocks, namely fluorinated amino acids. 
The first part of this PhD thesis will focus on the synthesis of carbocyclic β-amino acid analogues, as new 
building blocks for β-peptides. In previous research at our department, the synthesis of various analogues 
of β-aminocyclopropanecarboxylic acid has already been developed.12 The synthesis of one enantiomer of 
trans-2-(diphenylmethylideneamino)cyclopropanecarboxylate (1R,2R)-8 starting from (S)-β-benzyl N-
(tert-butoxycarbonyl)aspartate has already been developed in a previous Master thesis.13 In this work, this 
synthesis will be optimized and the synthesis of the other enantiomer (1S,2S)-8 is envisaged, as well as the 
saponification of both enantiomers 8 toward the corresponding carboxylic acids 9. Furthermore, coupling 
of these cyclopropanecarboxylic acids 9 with amino acids should lead to dipeptides 10 (Scheme 1). 
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Scheme 1 
2-Aminocyclobutanecarboxylates are another class of conformationally restricted β-amino acids. In a 
previous Master thesis,13 the synthesis of dialkyl β-aminocyclobutane-1,1-dicarboxylates 13 was described 
via a Michael Induced Ring Closure (MIRC) reaction. In that reaction, Michael-type addition of 
diphenylmethylideneamine 12 across halogenated propylidenemalonates 11 is followed by intramolecular 
substitution of the leaving group X, leading to ring closure. However, this reaction suffered from low yields 
(28-38%) and therefore, in this PhD thesis, it will be tried to optimize the synthesis of 
β-aminocyclobutanecarboxylates 13 (Scheme 2). 
 
Scheme 2 
In the second part of this PhD thesis, the focus will lie on the synthesis of fluorinated conformationally 
restricted amino acids. As a first example, the synthesis of fluorinated 2-aminocyclopropanecarboxylates 
17 will be attempted. This would be the first example of the synthesis of ring fluorinated 
β-aminocyclopropanecarboxylates. In analogy with the synthesis of cyclobutanes 13, the synthesis of 
cyclopropanes 17 is envisaged via the MIRC reaction starting from the appropriate fluorinated Michael 
acceptors 16 and various nitrogen nucleophiles. The synthesis of ethylidenemalonates 16 should proceed 
starting from ethyl bromodifluoroacetate 14 via reduction toward the corresponding aldehyde and 
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subsequent Knoevenagel condensation with malonates 15 (Scheme 3). Having fluorinated β-ACC 
derivatives 17 hopefully in hand, their reactivity will be studied. 
 
Scheme 3 
As a second class of fluorinated conformationally restricted amino acids, the synthesis of mono- and 
difluorinated azetidine-2-carboxylates 22 will be attempted. Based on the work of Couty, which describes 
the synthesis of azetidine-2-carboxylates,14 the synthesis of azetidines 22 is envisaged via the base-induced 
ring closure of fluorinated N-protected amino esters 21. Precursors 21 should be accessible via the 
condensation of amino esters 19 with fluorinated building blocks 18 leading to amides 20, followed by 
selective reduction of the amide bond and protection of the amine function. In case of the 
monofluorinated azetidines, the stereoselectivity of the ring closure will also be evaluated (Scheme 4). 
 
Scheme 4 
The third part of this PhD thesis will be devoted to the synthesis of fluorinated heterocycles, because there 
is a profound interest from medicinal chemistry in this type of compounds. The use of fluorinated building 
blocks in the synthesis of fluorinated heterocyclic compounds avoids the need for a late-stage fluorination 
step, which often has a low functional group compatibility. In this work, the synthesis of a new building 
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block 25 is envisaged, followed by its application in the synthesis of fluorinated heterocycles. 
Transformation of ethyl bromodifluoroacetate 14 into amines 23 has already been described in the 
literature.15 Protection of the amine could give compounds 24, which should be transformed into 
enamides 25 (PG = acyl, sulfonyl) upon treatment with base (Scheme 5). 
 
Scheme 5 
The presence of two fluorine atoms at the β-carbon atom of enamides 25, in combination with an electron-
withdrawing acyl or sulfonyl group (PG) at nitrogen, could lead to a highly polarized double bond and an 
electron-deficient difluorinated carbon atom. If this effect could predominate the electron-donating effect 
of the enamide nitrogen atom, enamides 25 would be an example of electrophilic enamides readily 
reacting with nucleophiles. Thus, when having enamides 25 in hand, their reactivity toward nucleophiles 
will be investigated, possibly leading to the formation of fluorinated enamides 26. By incorporating the 
nucleophile in the same molecule as the enamide moiety, this method should give rise to the formation of 
fluorinated heterocycles 27 (Scheme 6). 
 
Scheme 6 
In the last part of this PhD thesis, the synthesis of fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones 31 is envisioned (Scheme 7). Non-fluorinated derivatives of 31 have already 
been synthesized in our research group and they have been tested for activity against Mycobacterium 
tuberculosis. However, these compounds showed a low specificity since they are also active against gram 
positive bacteria. Therefore, the synthesis of fluorinated derivatives 31 will be attempted starting from 
aldehyde 28, via sequential reductive amination, mesylation, ring closure and oxidation steps. These 
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fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-diones 31 will also be tested 
for activity against M. tuberculosis. 
 
Scheme 7
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2 Literature overview 
In recent decades, much attention has been devoted to the synthesis of fluorinated amino acids, as can 
be seen in a number of reviews that have been published in this area.16 However, there has been no 
general representation on the synthesis of small-membered ring-containing fluorinated amino acids. So, 
the objective of this literature overview is to give a short summary of the synthetic routes toward amino 
acid derivatives with a cyclopropane, cyclobutane, aziridine or azetidine core, containing one or more 
fluorine atoms directly attached to the carbo- or heterocyclic ring. Carbo- or heterocyclic amino acids 
incorporating the fluorine atoms in a trifluoromethyl group or on a side chain will not be discussed here, 
just like the higher homologues, i.e. amino acids containing a five- or six-membered ring as a core structure 
and oxa- and thiaheterocyclic compounds. 
2.1 Synthesis of ring fluorinated 1-amino- and 2-aminocyclopropanecarboxylic 
acid derivatives 
1-Aminocyclopropanecarboxylic acid (α-ACC), the precursor of the plant hormone ethylene, and 
2-aminocyclopropanecarboxylic acid (β-ACC) are the two carbocyclic amino acids possessing the most 
severe ring strain. In the first part of this literature overview, the synthesis of ring fluorinated analogues 
of α-ACC 32 and β-ACC 33 will be discussed (Figure 4). 
 
Figure 4 
The first synthesis of a ring fluorinated 1-aminocyclopropanecarboxylic acid was reported in 1997  
(Scheme 8).17 In the first step of this reaction sequence, treatment of acrylate 3418 with diazomethane 
(CH2N2) afforded the corresponding pyrazoline, which underwent photochemical expulsion of dinitrogen, 
leading to the formation of cyclopropanes 35 (trans/cis 3/1). Subsequently, this diastereomeric mixture 
35 was converted into hydrazides 36 in excellent yield by treatment with hydrazine monohydrate in 
ethanol. Curtius rearrangement of hydrazines 36 toward carbamates 37 was performed by addition of 
NaNO2 in the presence of HCl, followed by heating at reflux temperature using the corresponding alcohol 
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as solvent. In the next step, the oxidation of the aromatic moiety of cyclopropanes 37 was studied. A first 
method (method A) comprised the oxidation by means of RuO4, prepared in situ from RuCl3, in the 
presence of NaIO4 as a co-oxidant. However, ozonolysis followed by an oxidative work-up in H2O2 proved 
to be a more suitable route toward acids 38b (R = Et, method B). For the synthesis of tert-butyl esters 38a, 
ozonolysis over dry silica gel gave the best results (method C). No yields were reported for this oxidation 
step. In a last step, removal of the Boc-protecting group of carbamates 38a proceeded smoothly in the 
presence of 3M HCl in EtOAc to afford fluorinated ACC derivatives 41, as a mixture of two isomers. In case 
of derivatives 38b, the carboxylic acids were first converted into the corresponding methyl esters 39 by 
treatment with CH2N2. Hydrolysis of carbamates 39 was achieved in a solution of HBr in HOAc under reflux 
conditions, affording the corresponding hydrobromic acids which were subjected to ion exchange 
chromatography over Dowex® using 1M HCl as the eluent, leading to hydrochloric acids 41, or using NH4OH 
as the eluent, which led to the formation of the free amino acids 40. No yields were reported for this last 
step. The trans-isomer trans-41 was obtained in pure form applying the same reaction sequence on 
hydrazide trans-36, which precipitated upon concentration of the solution after conversion of esters 35 
into hydrazides 36. 1-Aminocyclopropanecarboxylic acid (α-ACC) is a potent glycine agonist on the 
N-methyl-D-aspartate (NMDA) receptor ion chanel,19 a very important receptor involved in the process of 
learning and memory.20 The activity of 1-amino-2-fluorocyclopropanecarboxylic acid 40 was also tested in 
this regard, and it proved to be comparable to α-ACC itself. 
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Scheme 817 
An enantioselective synthetic pathway toward gem-difluorinated 1-aminocyclopropanecarboxylic acids 
(S)-46 and (R)-46 has also been developed, starting from diacetoxy alkene 42 (Scheme 9, Scheme 10).21 
Cyclopropanation of alkene 42 by addition of difluorocarbene, derived from sodium chlorodifluoroacetate, 
led to the formation of fluorinated cyclopropane 43, which was hydrolyzed toward diol 44 using potassium 
carbonate in a methanol/water mixture (1/1). A lipase-catalysed (Amano PS from Pseudomonas cepacia) 
desymmetrization of prochiral precursors 43 and 44 led to the formation of monoacetates (S)-45 and  
(R)-45, respectively, which were converted into 2,2-difluoro-1-aminocyclopropanecarboxylic acids (S)-46 
and (R)-46 in five steps (Scheme 9).  
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Scheme 921 
The synthesis of carboxylic acid (R)-46 from monoacetate (R)-45 is presented in detail in Scheme 10. Jones 
oxidation of alcohol (R)-45 toward carboxylic acid (R)-47, followed by Curtius rearrangement using 
diphenylphosphoryl azide (DPPA) in the presence of benzyl alcohol or tert-butanol afforded carbamates 
(R)-48a and (R)-48b. Removal of the acetate protecting group was achieved by stirring carbamates (R)-48 
in MeOH in the presence of K2CO3 for 30 minutes at room temperature and subsequent Jones oxidation 
afforded carboxylic acids (R)-50a and (R)-50b. While the Cbz-protecting group in compound (R)-50a could 
not be removed under various reaction conditions, deprotection of compound (R)-50b could be achieved 
upon stirring in an aqueous solution of HCl, leading to cleavage of the Boc group and the formation of the 
envisaged hydrochloric salt (R)-46. Carboxylic acid (R)-50a were converted into the corresponding methyl 
ester (R)-51 by treatment with an excess of diazomethane. 
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Scheme 1021 
Besides the synthesis of the above-mentioned mono- and difluorinated 1-aminocyclopropanecarboxylic 
acids, some examples of fluorinated derivatives of α-ACC containing extra functional groups have also 
been described. In the diastereoselective synthesis of novel fluorinated glutamic acid analogues 56-61, 
cyclopropane-1,2-dicarboxylates cis-55 and trans-55 were obtained as intermediates (Scheme 11, Scheme 
12).22 A Michael Induced Ring Closure (MIRC) reaction using N-Boc-protected methyl 2-aminoacrylate 52a 
and the Reformatsky reagent derived from ethyl dibromofluoroacetate 53, prepared using Et2Zn  
(Method A), led to the formation of cyclopropanes 54a as a mixture of two diastereomers (cis/trans 2/1). 
Alternatively, cyclopropanes 54a could also be prepared using Zn in the precense of LiCl in a total yield of 
80%, but with a lower diastereoselectivity (cis/trans 3/2).23 In the preparation of the corresponding tert-
butyl esters 54b, a higher diastereomeric ratio (cis/trans 8/2) was observed, due to presence of the bulky 
tert-butyl group. The two diastereomers cis-54b and trans-54b were isolated in 63% and 10% yield, 
respectively. Subsequently, using the mixture of diesters 54a (cis/trans 2/1), a regio- and 
diastereoselective saponification of the ethyl ester of diester cis-54a using LiOH at 0 °C afforded a mixture 
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of carboxylic acid cis-55 and ethyl ester trans-54a, which could be separated via acid/base extraction. In a 
next step, the regioselective saponification of diester trans-54a toward carboxylic acid trans-55 was 
achieved with LiOH at room temperature. 
 
Scheme 1122 
Cyclopropanecarboxylates cis-55 and trans-55 were then converted into a variety of fluorinated 
cyclopropyl-containing glutamic acid analogues 56-61 (Scheme 12). Phosphonic acid cis-56 was prepared 
via a sequential reduction, mesylation, iodination and Arbuzov condensation, followed by a complete 
deprotection in the last step. This reaction sequence could not be applied for the synthesis of the 
corresponding trans-56. Reduction of cis-55 and trans-55 toward the corresponding alcohol, followed by 
a Mitsunobu reaction with 2-hydroxy-2-methylpropanenitrile and hydrolysis furnished dicarboxylates cis-
57 and trans-57. Furthermore, the homologated derivatives cis-58, trans-58 and cis-59 were prepared by 
transformation of the carboxylic acid of cis-55 or trans-55 into the corresponding aldehydes, followed by 
a Horner-Wadsworth-Emmons condensation, hydrogenation of the alkenes and a subsequent 
deprotection/hydrolysis step. Sulfonic acids cis-60 and trans-60 were also prepared via the corresponding 
alcohols of compounds cis-55 and trans-55, followed by a Mitsunobu reaction using thioacetic acid as the 
nucleophile and a subsequent one pot oxidation and hydrolysis step. Finally, branched phosphonic acids 
cis-61 and trans-61 were prepared by the addition of diethyl phosphite across the corresponding 
aldehydes of compounds cis-55 and trans-55, followed by hydrolysis of the protecting groups. 
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Subsequently, these compounds were tested as agonists of metabotropic glutamate receptor subtype 4 
(mGluR4), revealing a potency of phosphonic acid cis-56 which is ten times higher than that of glutamate. 
Furthermore, phosphonic acid cis-56 proved to be seven times more potent than the non-fluorinated 
analogue. 
 
Scheme 1222 
Furthermore, cyclopropanecarboxylates cis-55 and trans-55 were used as building blocks for the synthesis 
of various fluorinated cyclopropyl amino acid analogues, more specifically methionine 62, leucine 63, 
lysine 64 and arginine cis-65 analogues (Figure 5).24 
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Figure 524 
Additionally, the incorporation of fluorinated ACC derivative cis-63 in a tripeptide was reported. This was 
the first example of a tripeptide incorporating a fluorinated cyclopropane amino acid analogue (Scheme 
13).24 To this end, protected amino acid derivative cis-63 was converted into the mono N-Boc protected 
carboxylic acid cis-67 in two steps, by a selective monodeprotection of the amine using Yb(OTf)3 followed 
by hydrolysis of the ester to give the corresponding carboxylic acid. In the next step, a standard peptide-
coupling reaction was employed for the synthesis of dipeptide cis-68 which was obtained as a mixture of 
diastereomers in 57% yield. Removal of the resulting Boc group in dipeptide cis-68 was achieved by 
treatment with HCl in dioxane and MeOH, leading to hydrochloric salt cis-69 in quantitative yield. In a last 
step, coupling of this dipeptide cis-69 with Cbz-Ala-OH 70 was achieved, again using a standard peptide-
coupling technique, leading to the unprecedented fluorinated cyclopropyl-containing tripeptide cis-71 in 
76% yield, as a mixture of diastereomers. 
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Scheme 1324 
Monofluorinated ACC derivatives 73 were also synthesized in a diastereoselective way using quaternary 
ammonium salt 72 in a MIRC reaction with Michael acceptors 52 (Scheme 14).25 This reaction, which 
probably proceeds via a two-step mechanism, afforded a mixture of two isomers cis-73 and trans-73 with 
good diastereoselectivity. In case of the methyl ester 73a, the two isomers were separated and were 
obtained in a total yield of 87% (separate yields were not mentioned), while the tert-butyl derivatives 73b 
were inseparable and a combined yield of 77% was reported. The cyclopropanation of methyl acrylate 52a 
could also be effectuated in a one-pot reaction, by treatment of acrylate 52a with DABCO and 2-bromo-2-
fluoro-1-morpholinoethan-1-one in the presence of Cs2CO3. The two isomers cis-73a and trans-73a were 
obtained with a similar diastereoselectivity (cis/trans 12/88) and were isolated in 8% and 59% yield, 
respectively. Selective removal of one of the Boc protecting groups of cyclopropane trans-73a was 
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effectuated using Yb(OTf)3.H2O in dry acetonitrile leading to the formation of ACC derivative trans-74a 
which was isolated in an excellent yield of 97%.25 
 
Scheme 1425 a Sum of the yields of the isolated isomers cis-73a and trans-73a.  
b Combined yield, the isomers cis-73b and trans-73b could not be separated via column chromatography. 
Furthermore, the enantioselective version of the synthetic route toward 1-amino-2-
fluorocyclopropanecarboxylates was developed, again via a Reformatsky reaction using the combination 
of Zn and LiCl as metalating reagents for the cyclopropanation (Scheme 15).26 As a chiral auxiliary, 
dibromofluoroacetylated oxazolidinone (S)-75 was employed. The reaction proceeded smoothly, leading 
to a mixture of two diastereomers cis-76 and trans-76 with a good cis/trans ratio of 73/27 and a good 
combined yield of 78%. The major isomer cis-76 was isolated in 56% yield and showed a diastereomeric 
excess of 80%. 
 
Scheme 1526 
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Additionally, some examples of trifluoromethylated 1- or 2-aminocyclopropanecarboxylic acid derivatives 
have been reported.27 But as mentioned before, these examples will not be discussed in detail since this 
exceeds the scope of this literature overview. 
In conclusion, various mono- and difluorinated derivatives of 1-aminocyclopropanecarboxylic acid have 
been reported, while the synthesis of ring fluorinated 2-aminocyclopropanecarboxylic acid derivatives has 
been limited to cyclopropanes 55, which can be seen as α-ACC-derivatives with an extra carboxylic acid 
functionality at C2. This is probably due to the inherent instability of β-ACC caused by its 1,2-donor-
acceptor substituted cyclopropane structure. Therefore, a suitable protecting group at nitrogen is essential 
to avoid spontaneous ring opening of the cyclopropane core, which complicates the synthesis of β-ACC 
derivatives.  
2.2 Synthesis of ring fluorinated 1-amino- and 2-aminocyclobutanecarboxylic 
acid derivatives 
In the second part of this literature overview, the synthesis of the higher carbocyclic homologues, 
cyclobutanes incorporating an amino acid functionality, will be discussed. This section is divided in two 
different parts, more specifically the synthesis of ring fluorinated 1-aminocyclobutanecarboxylic acid 
analogues 77 and ring fluorinated 2-aminocyclobutanecarboxylic acids analogues 78 (Figure 6). Since no 
relevant references were found concerning the synthesis of fluorinated 3-aminocyclobutanecarboxylic 
acid derivatives 79, these will not be discussed in this section. 
 
Figure 6 
2.2.1 Ring fluorinated 1-aminocyclobutanecarboxylic acid derivatives 
An important example of a ring fluorinated cyclobutane-containing amino acid is trans-1-amino-3-
[18F]cyclobutane-1-carboxylic acid (trans-[18F]FACBC) trans-85 or [18F]fluciclovine. This unnatural 
18F-labelled amino acid is used as a tracer in Positron Emission Tomography (PET), an imaging technique.28 
PET-tracers are molecules that are labelled with a radioactive isotope, for example 18F. When this 
Literature overview  Chapter 2 
20 
 
radioactive isotope emits a positron from its nucleus, this positron will come in contact with an electron 
and annihilation will occur, a process in which two gamma-rays are produced. These gamma-rays can be 
detected, and as such the place of annihilation can be determined. 2-18F-Fluoro-2-deoxy-D-glucose 
([18F]FDG) is a commonly used PET tracer. When this compound is administered to a patient, it accumulates 
more in tumors than in normal cells, since tumors have a higher rate of glucose metabolism. As such, 
Positron Emission Tomography is a technique to detect tumors. In many tumors there is also an increased 
amino acid transport as compared to normal tissues and therefore, the use of amino acids for tumor 
imaging is also well established. Since the use of natural amino acids in which a radioisotope is 
incorporated can lead to the formation of numerous radiolabelled metabolites, research has been devoted 
to the synthesis of 18F-labelled unnatural amino acids, such as (trans-[18F]FACBC) trans-85. This PET tracer 
is currently undergoing human clinical trials phase 2 for its validation as an imaging agent for the diagnosis 
and management of cancer treatment.29 
The first synthesis of 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) labelled with fluorine-18 was 
reported in 1999 and comprised ten steps.30 In this synthetic procedure, epichlorohydrine was converted 
into hydantoin 81 in four steps. A drawback of this synthesis was the low diastereoselectivity of the 
hydantoin-synthesis and the difficult scale-up. Therefore, in 2003 an improved synthesis was reported 
(Scheme 16).31 In this pathway, hydantoin cis-81 was obtained as the major diastereomer after a modified 
Strecker synthesis (cis/trans ratio after reaction: 5/1). Hydrolysis of the hydantoin ring toward the 
corresponding α-amino acid was achieved by heating in 3M aq. NaOH. Double protection of the amino 
acid furnished methyl 3-benzyloxy-1-(tert-butoxycarbonylamino)cyclobutanecarboxylate cis-82. The 
3-benzyloxy substituent was transformed into a good leaving group by hydrogenolysis followed by 
treatment with trifluoromethanesulfonic anhydride, yielding triflate cis-83, a suitable precursor for the 
introduction of fluorine-18. In an automated radiosynthesis, triflate cis-83 was reacted with K18F which led 
to the formation of fluorinated cyclobutane trans-84. In a last step, treatment with HCl furnished the 
deprotected [18F]-1-amino-3-fluorocyclobutanecarboxylic acid trans-85. The corresponding ‘cold’ FACBC 
trans-88 was synthesized by reacting alcohol cis-86 with DAST, followed by hydrolysis using 2M aq. HCl 
(Scheme 17).30 
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Scheme 1631 
 
 
Scheme 1731 
Next to trans-1-amino-3-fluorocyclobutanecarboxylic acid trans-85, the other isomer cis-85 has also been 
synthesized and tested as a potential brain tumor imaging agent (Scheme 18).32 In this synthetic pathway, 
the two isomers cis-81 and trans-81, obtained after hydantion formation (Scheme 16) were not separated, 
but used as a diastereomeric mixture in the next steps. Thus, hydantoins 81 were converted into methyl 
cyclobutanecarboxylates 89 in three steps. After debenzylation using 10% Pd/C and oxidation of the 
resulting secondary alcohol toward cyclobutanone 90, a diastereoselective reduction of the ketone was 
established, using L-selectride in combination with zinc chloride as a chelating Lewis acid. The introduction 
of fluorine was achieved using DAST in the case of the ‘cold’ amino acid cis-88 and via triflation followed 
by treatment with K18F in case of the radiolabelled amino acid cis-85. In the last step, removal of the 
phthalimido protecting group was effectuated using hydrazine monohydrate. The biological evaluation of 
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cis-[18F]FACBC cis-85 in rodent 9L gliosarcoma brain tumor model showed comparable results as its isomer 
trans-[18F]FACBC trans-85, rendering it also a promising PET brain tumor imaging agent. 
 
Scheme 1832 
Furthermore, to test the potency of structural isomer trans-1-amino-2-[18F]cyclobutane-1-carboxylic acid 
trans-97 as a PET brain tumor imaging agent, a synthetic route toward this compound was also developed 
(Scheme 19).33 Starting from 1,2-di(trimethylsilyloxy)cyclobutene, the intermediate tert-butyl 1-amino-2-
hydroxycyclobutanecarboxylate 93 was prepared in six steps. The key step in the reaction sequence 
toward amino acid trans-97 was the formation of the cyclic sulfamidite cis-94 by reaction of amino alcohol 
93 with thionyl chloride, exclusively yielding the cis derivative cis-94. This sulfamidite cis-94 was oxidized 
toward sulfamidate cis-95, which was subsequently converted into 18F-labelled tert-butyl 
cyclobutanecarboxylate trans-96 by treatment with K18F. Hydrolysis by treatment with trifluoroacetic acid 
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in CH2Cl2 afforded the desired trans-1-amino-2-[18F]cyclobutane-1-carboxylic acid trans-97. Biological 
evaluation of this compound supported its candidacy as a promising PET brain tumor imaging agent. 
 
Scheme 1933 
The synthesis of a difluorinated cyclobutane-containing α-amino acid, more specifically 1-amino-3,3-
difluorocyclobutanecarboxylic acid 102 is depicted in Scheme 20.34 Precursor 99 was synthesized from 
acetone 98 in three steps in 32% yield. Fluorination of cyclobutanone 99 was effectuated using 
morphDAST, leading to diisopropyl 3,3-difluorocyclopropane-1,1-dicarboxylate 100 in quantitative yield. 
The first step in the conversion of dicarboxylate 100 toward the corresponding amino acid comprised a 
monosaponification toward carboxylic acid 101. Subsequently, transformation of the carboxyl group into 
an amino group was achieved by means of a Curtius reaction. In a last step, hydrolysis of the remaining 
isopropyl ester was established using 3M aq. HCl under reflux conditions, furnishing amino acid 102 in 42% 
yield after ion-exchange chromatography. 
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Scheme 2034 
As a last example of a fluorinated α-amino acid containing a cyclobutane core, the synthesis of 4-fluoro-
2,4-methanoproline 109 is described (Scheme 21).35 Methyl 2-fluoroacrylate 103 was reduced toward allyl 
alcohol 104 using AlH3, generated in situ from LiAlH4 and AlCl3, which was subsequently transformed into 
mesylate 105. Coupling of this mesylate 105 with amino ester 106 afforded diene 107, the key 
intermediate of this synthetic pathway. A photochemical intramolecular [2+2]-cycloaddition of diene 107 
led to the formation of bicyclic compound 108 which was hydrolyzed toward 4-fluoro-2,4-methanoproline 
109 in 94% yield. 
 
Scheme 2135 
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2.2.2 Ring fluorinated 2-aminocyclobutanecarboxylic acid derivatives 
An important synthetic methodology for the synthesis of cyclobutanes is a [2+2]-cycloaddition reaction. 
Also for the synthesis of ring fluorinated 2-aminocyclobutanecarboxylic acid derivatives, the [2+2]-
cycloaddition strategy has been applied. In that respect, the photocycloaddition between fluorinated 
nucleic bases and various olefins has been studied extensively, often leading to the formation of polycyclic 
compounds containing a fluorinated cyclobutane moiety.36 Since this exceeds the scope of this literature 
overview, these examples will not be discussed in detail. In one case however, the [2+2]-cycloaddition 
between 5-fluorouracil 110 and ethylene was used for the synthesis of the bicyclic compound 111, which 
was transformed into trans-2-amino-1-fluorocyclobutanecarboxylic acid trans-112 (Scheme 22).37 
 
Scheme 2237 
N-Boc-2-amino-1-fluorocyclobutanecarboxylic acid trans-113 was prepared via the same methodology as 
described above (Scheme 22), starting from 1-Boc-5-fluorouracil (Scheme 23).38 Chiral derivatisation of 
this compound trans-113 by coupling with lithiated oxazolidinone (4S,5R)-114 furnished diastereomers 
115 which were isolated in 47% and 45% yield. Removal of the oxazolidinone moiety was established by 
treatment with LiOOH furnishing enantiopure 1-fluorocyclobutanecarboxylic acids (1R,2R)-113 and 
(1S,2S)-113 in 90% and 75% yield, respectively. 
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Scheme 2338 
The incorporation of the enantiopure fluorinated β-aminocyclobutanecarboxylic acid (1R,2R)-113 in 
homo-oligomers was achieved by using standard peptide coupling techniques.38 The formation of dimer 
(1R,2R,1’R,2’R)-117 is depicted in Scheme 24. The conversion of carboxylic acid (1R,2R)-113 into the 
corresponding benzyl ester (1R,2R)-116 was achieved by reaction with benzyl alcohol in the presence of 
DCC in dichloromethane. In the next step, the Boc-protecting group of cyclobutane (1R,2R)-116 was 
removed and the corresponding amine was coupled with carboxylic acid (1R,2R)-113 to give dipeptide 
(1R,2R,1’R,2’R)-117 in excellent yield. The synthesis of four- and six-membered oligomers proceeded via 
the same methodology. After investigation of their conformational preference, it was concluded that these 
homo-oligomers adopt a strand-like secondary structure. 
 
Scheme 2438 
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Another example of a [2+2]-cycloaddition reaction leading to fluorinated 2-aminocyclobutanecarboxylic 
acid derivatives is presented in Scheme 25.39 The reaction between difluoroketene aminal 118 with 
acrylates 119 in hexane at room temperature or 90 °C, depending on the substrate, afforded methyl 
3,3-difluorocyclobutanecarboxylates 120 as sole end products, which were isolated in very good yields. 
 
Scheme 2539 
Furthermore, an intramolecular [2+2]-photocycloaddition of the trifluorovinyl-containing scaffold 121, 
initiated by radiation at 254 nm, led to the formation of a tricyclic compound 122 as a single diastereomer 
(Scheme 26).40 
 
Scheme 2640 
2.3 Synthesis of ring fluorinated aziridine-2-carboxylates 
Aziridine-2-carboxylates are attractive substrates in synthetic chemistry since they comprise two 
electrophilic centres, the strained aziridine ring and the carboxylate functionality.41 Because they are also 
a member of the class of small-membered ring-containing amino acid derivatives, the synthesis of ring 
fluorinated aziridine-2-carboxylates 123 will be discussed in this section (Figure 7). 
 
Figure 7 
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The first synthesis of a 2-fluoroaziridine-2-carboxylate was reported in 1973 and involves the addition of a 
carbenoid compound onto a C=N double bond (Scheme 27).42 Organomercury compound 124, prepared 
from ethyl bromofluoroacetate and phenylmercuric chloride in the presence of KOtBu, was used as a 
CFCOOEt transfer reagent which added to the C=N bond of N-phenyliminophosgene 125. This reaction led 
to the formation of ethyl N-phenyl-3,3-dichloro-2-fluoroaziridine-2-carboxylate 126 in 50% yield next to 
36% recovery of the starting organomercury compound 124. This reaction could either proceed via the 
intermediate α-fluoro-α-ethoxycarbonylcarbene or via a direct transfer process, but the mechanism was 
not elucidated. 
 
Scheme 2742 
In the second example, depicted in Scheme 28, the fluorinated aziridine was formed by the addition of a 
nitrene across an α-fluoro-α,β-unsaturated ester 127, using the Evans aziridination procedure with 
TsN=IPh as the nitrene source.43 This reaction proceeded sluggishly, affording the aziridines cis-128 and 
trans-128 as a diastereomeric mixture in a varying ratio and with low isolated yields (4-32%). 
 
Scheme 2843 
Additionally, two other nitrene sources were used in the reaction with ethyl 2-fluoro-3-phenylacrylate 127 
(R = Ph), more specifically ethyl N-[(p-nitrobenzenesulfonyl)oxy]carbamate and 3-amino-2-
trifluoromethylquinazolin-4(3H)-one, leading to the corresponding aziridines in similar low yields 
(27-32%). Furthermore, ethyl N-[(p-nitrobenzenesulfonyl)oxy]carbamate was also used as a nitrene source 
in the reaction with methyl 3,3-difluoro-2-trifluoromethylacrylate leading to the formation of the 
corresponding fluorinated aziridine-2-carboxylate in 88% yield.44 
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As a last example, the Reformatsky-type aza-Darzens reaction between ethyl dibromofluoroacetate 53 and 
various aromatic imines 129 was optimized and directed toward the synthesis of fluorinated ethyl 
aziridine-2-carboxylates 130 (Scheme 29).45 In a previous report, 2-fluoroaziridine-2-carboxylates were 
described as side products in a Reformatsky-type synthesis of α-bromo-α-fluoro-β-lactams, starting from 
ethyl dibromofluoroacetate 53 and various imines.46 By changing the solvent from Et2O to CH3CN and using 
unactivated Zn metal in the Reformatsky reaction, the selective formation of aziridines 130 was achieved, 
which were isolated in 60-100% yield with a varying diastereomeric ratio, depending on the substituents 
R1 and R2. 
 
Scheme 2945 
Methyl 1-fluoroaziridine-2-carboxylates 132 have also been synthesized, via fluorination of methyl 
aziridine-2-carboxylate 131 (Scheme 30).47 This fluorination reaction was performed in a 
diastereoselective way, since the selective formation of trans-132 was achieved when the reaction was 
performed in the presence of KF, while a mixture of trans-132 and cis-132 was formed upon reaction in 
the presence of triethylamine. This can be explained by the presence of an intramolecular hydrogen bond 
in aziridine 131, which is broken by triethylamine and subsequent attack of F2 at the nitrogen atom occurs 
cis or trans relative to the ester function. However, in the presence of KF there is retention of the hydrogen 
bond, leading to exclusive trans-attack of F2. No yields were reported for these reactions. Other derivatives 
of 1-fluoroaziridine-2-carboxylates have also been synthesized using the same methodology.48 The 
compounds are of interest since it was shown that aziridines 132 have an extraordinary high barrier to 
nitrogen inversion. Furthermore, alkyl 1-fluoroaziridine-2,2-dicarboxylates react in a stereoselective way 
with nucleophiles since only the acyl group in trans configuration to the fluorine substituent reacts with 
the nucleophile. 
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Scheme 3047 
2.4 Synthesis of ring fluorinated azetidine-2-carboxylates and azetidine-3-
carboxylates 
In this section, the synthesis of fluorinated azetidine-2-carboxylates 133 and azetidine-3-carboxylates 134 
will be described (Figure 8). Since azetidin-2-ones (or β-lactams) can be seen as a separate class of 
compounds, the synthesis of their ring fluorinated analogues will not be discussed in this literature 
overview. 
 
Figure 8 
In a first example, 3-fluoroazetidine-2-carboxylic acid (S)-136 was prepared via a substitutive fluorination 
of L-azetidine-2-carboxylic acid (S)-135 using fluorooxytrifluoromethane gas in liquid HF (Scheme 31).49 
 
Scheme 3149 
Very recently, the synthesis of functionalized optically pure derivatives of 3-fluoroazetidine-2-carboxylic 
acid was reported, as novel peptide building blocks.50 In Scheme 32, only the synthesis of (2S,3R,4R)-3-
fluoro-4-hydroxymethylazetidine-2-carboxylic acid (2S,3R,4R)-144 is presented, the synthesis of the other 
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enantiomer proceeding analogously. First, the diacetonide of 3-fluoroglucose 137 was transformed into 
pyranose ditriflate (2R,3R,4S,5S,6R)-138 in five steps. Subsequently, azetidine-formation was achieved by 
treatment of ditriflate (2R,3R,4S,5S,6R)-138 with an excess of benzylamine. Treatment of bicyclic azetidine 
(1S,2S,4R,5R,7S)-139 with boron(III) fluoride etherate in acetic anhydride gave azetidine (1’S,2S,3S,4R)-140 
in quantitative yield, which was reduced in two steps toward triol (1’S,2S,3R,4R)-141. Next, oxidative 
cleavage of the diol moiety in compound (1’S,2S,3R,4R)-141 followed by treatment with iodine in MeOH 
gave rise to the formation of methyl ester (2S,3R,4R)-142. Hydrolysis of the ester toward carboxylic acid 
(2S,3R,4R)-143 was achieved by treatment with K2CO3, and subsequent removal of the benzyl group via 
hydrogenolysis led to the formation of the unprotected (2S,3S,4R)-3-fluoro-4-hydroxymethylazetidine-2-
carboxylic acid (2S,3R,4R)-144. Both enantiomers were tested as potential inhibitors of glycosidases, but 
no activity was observed. 
 
Scheme 3250 
Furthermore, the formation of the stable dipeptide, consisting of two units of (2R,3S,4S)-3-fluoro-4-
hydroxymethylazetidine-2-carboxylic acid (2R,3S,4S)-144 was described. First, protection of the 
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hydroxymethyl moiety was achieved by treatment of azetidine (2R,3S,4S)-142 with TBDMSCl in DMF, 
leading to tert-butyldimethylsilylether (2R,3S,4S)-145 (Scheme 33). Subsequently, hydrolysis of the methyl 
ester of azetidine (2R,3S,4S)-145 using K2CO3 in aqueous dioxane furnished azetidine-2-carboxylic acid 
(2R,3S,4S)-146. Upon treatment of methyl ester (2R,3S,4S)-145 with methylamine, amide (2R,3S,4S)-147 
was formed, which was subsequently debenzylated to give free amine (2R,3S,4S)-148. Finally, dipeptide 
(2’R,3’S,4’S,2R,3S,4S)-149 was formed by stirring a mixture of azetidine-2-carboxylic acid (2R,3S,4S)-146 
and azetidine (2R,3S,4S)-148 in the presence of HBTU and Et3N in DMF (Scheme 34). 
 
Scheme 33 
 
 
Scheme 3450 
A third example of a ring fluorinated amino acid with an azetidine core comprises the synthesis of N-Boc 
protected β-amino acid 158 (Scheme 35).51 Allylamine 152 was prepared from dichlorinated isobutene 150 
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in two steps via a sequential nucleophilic substitution of the two chlorine atoms. In the next step, 
transimination with diphenylmethylideneamine afforded imine 153, which was used as the substrate for 
a bromofluorination reaction toward imine 154 using Et3N.HF in the presence of NBS. Reduction of imine 
154 and subsequent ring closure was achieved by treatment with NaCNBH3 in MeOH at reflux temperature 
after which hydrogenolysis in the presence of Boc anhydride yielded N-Boc azetidine 156. Subsequently, 
oxidative cleavage of the p-methoxyphenyl ether was achieved by treatment of azetidine 156 with CAN, 
yielding 3-hydroxymethylazetidine 157, which was converted into carboxylic acid 158 in the last step, by 
treatment with NaIO4 in the presence of RuCl3.3H2O. 
 
Scheme 3551 
2.5 Conclusion 
Although fluorinated amino acids can be seen as interesting scaffolds in synthetic and medicinal chemistry, 
the number of synthetic routes toward the small-membered ring analogues remains rather limited.  
In this regard, the class of ring fluorinated cyclopropyl-containing amino acids has been explored the most. 
As can be seen in this literature overview, various examples of mono- and difluorinated α-ACC derivatives 
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have been described in the literature, including diastereoselective and enantioselective synthetic 
pathways. In contrast, only one example of a fluorinated β-ACC derivative has been reported. This is 
probably due to the inherent instability of β-ACC due to its donor-acceptor substituted cyclopropane 
structure. Therefore, the synthesis of fluorinated β-ACC derivatives remains a challenge which should be 
encountered to gain insight in the reactivity of these strained compounds. 
The chemistry of cyclobutyl-containing amino acids has also been explored relatively well. As a member of 
this class of constrained amino acids, the PET tracer trans-1-amino-3-[18F]cyclobutane-1-carboxylic acid is 
a nice example of the application of a non-proteinogenic fluorinated amino acid. Furthermore, the 
stereoselective synthesis of a fluorinated β-ACBC derivative was reported, as well as its incorporation in 
homo-oligomers. 
In contrast, as can be seen in this literature overview, fluorinated amino acids containing an aziridine or 
an azetidine ring have been studied to a very limited extent. However, given the broad applicability of 
aziridines52 and azetidines53 as versatile building blocks, the development of novel synthetic routes toward 
ring fluorinated aziridine- and azetidine-containing amino acids remains a challenge which is of great 
interest. 
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3 Results and discussion 
3.1 Stereoselective synthesis of both enantiomers of trans-2-
(diphenylmethylideneamino)cyclopropanecarboxylic acid using a chiral pool 
approach and their incorporation in dipeptides54 
3.1.1 Introduction 
As described in the introduction, the interest in cyclic β-amino acids has increased significantly in the past 
decades,9e,55 which is due to the ability of β-amino acids to improve the metabolic stability of β-peptides 
in which they are incorporated. Moreover, β-peptides represent an important class of foldamers,7,56 as 
they can adopt various secondary structures including helices, sheets and turns.56,9a,9d,57 The smallest 
carbocyclic β-amino acid is β-aminocyclopropanecarboxylic acid (β-ACC) 159, a carbocyclic analogue of 
β-alanine. β-ACC 159 itself has never been synthesized due to the inherent instability of this small-
membered ring caused by its 1,2-donor-acceptor substituted cyclopropane structure.58 Therefore, a 
suitable stabilizing group at nitrogen is essential to avoid spontaneous ring opening of the cyclopropane 
core, which complicates the synthesis of β-ACC derivatives and their incorporation in peptides.12,59 
Moreover, due to the presence of two stereogenic centres in the cyclopropane ring, 
β-aminocyclopropanecarboxylic acid 159 exists as four stereoisomers (Figure 9). This entails an extra 
challenge in the development of a strategy for the synthesis of enantiopure β-ACC derivatives.  
 
Figure 9 
Although different asymmetric synthetic approaches toward 2-aminocyclopropanecarboxylates have been 
reported,60 the elaboration of synthetic pathways toward β-ACC derivatives with no extra functionalization 
of the cyclopropane core remains rather scarce. An enantiomerically enriched 
cis-2-aminocyclopropanecarboxylic acid derivative (63% ee) was synthesized using a chemoselective 
hydrolysis of a cyclopropane meso-diester with Pig Liver Esterase (PLE) followed by appropriate functional 
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group transformation.61 Enamides have proved to serve as valuable precursors in the synthesis of 
unsubstituted N-stabilized β-ACC derivatives via a cyclopropanation reaction using ethyl diazoacetate as a 
carbene source in the presence of a catalyst.62 An asymmetric cyclopropanation reaction of styrene with 
ethyl diazoacetate afforded an unsubstituted trans-β-ACC derivative (90% ee) in five steps using a chiral 
(salen)Ru(II) cyclopropanation catalyst.63 Noteworthy, only one synthetic route toward an unsubstituted 
chiral β-aminocyclopropanecarboxylic acid using a chiral pool approach has been described in the 
literature, more specifically starting from the expensive chiral building block benzyl (S)-(+)-glycidyl ether.64 
The only other synthesis starting from a chiral building block, D-glyceraldehyde, leads to an 
enantiomerically pure substituted trans-1-methyl-β-ACC derivative in 9 steps.61 
Next to their synthesis, also the incorporation of cis-,60a,9b,65 and to a lesser extent 
trans-β-aminocyclopropanecarboxylates60a in peptides, allowing to influence their structural 
conformation, has received a lot of attention in recent years. The synthesis of a cis-β-ACC-containing 
pseudopeptide, starting from a meso-anhydride and (S)-prolinate is the only example that can be 
mentioned regarding the incorporation of an unsubstituted β-ACC building block in peptides.66 
In view of these important gaps in the chemistry of chiral β-ACCs, in a first part of this PhD thesis, the 
synthesis of a new enantiopure unsubstituted (-)-trans-β-aminocyclopropanecarboxylic acid via a 
stereoselective base-induced ring closure is described, starting from an (S)-aspartic acid derivative as chiral 
building block. The (+)-trans-β-ACC enantiomer was synthesized via the same pathway starting from the 
(R)-aspartic acid derivative. Surprisingly, (S)-aspartic acid, one of the twenty proteinogenic amino acids 
and a naturally occurring β-amino acid, has never been used as a chiral building block in the synthesis of 
enantiopure β-aminocyclopropanecarboxylic acids. Moreover, the incorporation of these new trans-β-
aminocyclopropanecarboxylic acids in dipeptides was studied as well. 
3.1.2 Synthesis of trans-2-(diphenylmethylideneamino)cyclopropanecarboxylic acids 
By using acyclic aspartic acid derivatives 162 as chiral building blocks for the synthesis of β-ACCs 160, the 
introduction of the cyclopropane core was envisaged to proceed via a 1,3-cyclization reaction (Scheme 
36). Therefore, the synthesis of an eligible precursor 161, bearing a leaving group in γ-position and a 
suitably stabilized amino group in β-position, starting from these aspartic acid derivatives 162 had to be 
developed.  
Results and discussion  Chapter 3 
37 
 
 
Scheme 36 
In a previous Master thesis,13 (S)-benzyl 3-diphenylmethylideneamino-4-iodobutanoate (S)-164 was 
synthesized in four steps starting from (S)-β-benzyl N-(tert-butoxycarbonyl)aspartate (S)-163, in 29% total 
yield (Scheme 37). 
 
Scheme 3713 
In this PhD thesis, the same synthetic pathway, presented in detail in Scheme 38, was applied for the 
synthesis of the other enantiomer (R)-benzyl 3-diphenylmethylideneamino-4-iodobutanoate (R)-164. The 
carboxylic acid moiety of aspartate (R)-163 was converted into the corresponding alcohol (R)-165 in 70% 
yield by reduction using NaBH4 after activation with isobutyl chloroformate.67 In a next step, a modified 
Appel reaction using a PPh3/I2 complex was applied for the conversion of β-amino alcohol (R)-165 into 
iodide (R)-166, which was isolated in 86% yield.68 In theory, this N-Boc protected iodide (R)-166 could serve 
as a direct precursor in the synthesis of β-ACCs, although competition with formation of the corresponding 
aziridines could be expected.69 However, it has been demonstrated that the presence of only one electron-
withdrawing group at nitrogen in such type of precursors is not sufficient to allow cyclization to 1,2-donor-
acceptor substituted cyclopropanes.70 Therefore, another group at nitrogen was introduced, more 
specifically a diphenylmethylidene group, which has already been used previously as a stabilizing group in 
the synthesis of donor-acceptor substituted cyclopropanes.12a,70a Therefore, Boc-deprotection of the 
amino group of β-amino ester (R)-166 was achieved under acidic conditions affording β-iodoammonium 
salt (R)-167 in 76% yield. Subsequent transimination of (R)-167 with diphenylmethylideneamine 12 yielded 
enantiopure (R)-benzyl 3-diphenylmethylideneamino-4-iodobutanoate (R)-164, as a direct precursor for 
the synthesis of novel chiral unsubstituted β-aminocyclopropanecarboxylates. 
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Scheme 38 
With γ-iodo β-amino esters (S)-164 and (R)-164 in hand, the base-induced ring closure of these precursors 
toward the envisaged chiral benzyl cyclopropanecarboxylates was investigated and optimized (Table 1). In 
previous research, KOtBu was already evaluated as a base to initiate the ring closure of γ-iodo β-amino 
ester (S)-164. Although treatment of ester (S)-164 with KOtBu gave rise to the formation of the envisaged 
β-aminocyclopropanecarboxylates 8, this reaction proceeded with a low diastereoselectivity (dr trans : cis 
79-61 : 21-39) and also led to the formation of a side product, probably due to a transesterification 
reaction. Following these moderate results, the use of another base, more specifically the stronger 
nitrogen base potassium hexamethyldisilazide (KHMDS), was evaluated in the ring closure reaction. When 
(S)-benzyl 4-iodobutanoate (S)-164 reacted with 1.1 equiv KHMDS in THF for five minutes at -78 °C, 92% 
of the starting product was converted toward cyclopropanes 8, with no formation of side products. 
Moreover, an improvement of the diastereomeric ratio of cyclopropanes 8 was observed (dr trans : cis 88 
: 12) (Table 1, entry 1). Prolongation of the reaction time to ten minutes led to a full conversion of the 
starting material toward cyclopropanes 8 in a good diastereomeric ratio (dr trans : cis 91 : 9) (Table 1, entry 
2). In an attempt to improve the diastereomeric ratio, the reaction time was prolonged toward one and 
two hours, with some improvement of the diastereomeric ratio (up to 99 : 1), but no improvement of the 
yield of cyclopropanecarboxylate (1R,2R)-8 (Table 1, entries 3-4). From these attempts, (1R,2R)-trans-
benzyl cyclopropanecarboxylate (1R,2R)-8 was isolated in a good yield of 81% (resp. 80%) (dr > 99 : 1). 
When (S)-benzyl 4-iodobutanoate (S)-164 reacted with KHMDS at a higher temperature, a similar variable 
diastereomeric ratio was observed (dr trans : cis up to 99 : 1) and (1R,2R)-trans-benzyl 
2-(diphenylmethylideneamino)cyclopropanecarboxylate (1R,2R)-8 was isolated in 74% yield (dr > 99 : 1) 
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after recrystallization (Table 1, entry 5). The use of more equivalents of base was also evaluated but did 
not lead to an improvement of the diastereomeric ratio or the yield (Table 1, entry 6). Noteworthy, 
treatment of pure trans-(1R,2R)-benzyl 2-(diphenylmethylideneamino)cyclopropanecarboxylate (1R,2R)-8 
with KHMDS under similar reaction conditions (THF, -78 °C, 1 h), in an attempt to see whether trans/cis 
isomerisation took place, only led to degradation of this cyclopropane derivative.  
Table 1: Synthesis of 2-(diphenylmethylidenamino)cyclopropanecarboxylate (1R,2R)-8 
 
Entry Reaction conditions dr trans : cisa Yield (1R,2R)-8b 
1 1.1 equiv KHMDS, THF, -78 °C, 5 min 88 : 12c 70% 
2 1.1 equiv KHMDS, THF, -78 °C, 10 min 91 : 9 79% 
3 1.1 equiv KHMDS, THF, -78 °C, 1 h 95 : 5 81% 
4 1.1 equiv KHMDS, THF, -78 °C, 2 h 99 : 1 80% 
5 1.1 equiv KHMDS, THF, 0 °C, 5 min 99 : 1 74% 
6 1.5 equiv KHMDS, THF, -78 °C, 1 h 93 : 7 65% 
a Determined via 1H NMR analysis of the crude reaction mixture. b dr trans : cis > 99 : 1. c 92% conversion. 
 
The relative configuration of cyclopropane (1R,2R)-8 was assigned based on comparison of the coupling 
constants in the 1H NMR signal corresponding to HA with literature values. The literature values of the 
vicinal coupling constants trans-3JHA,HB (= 2.5 Hz), trans-
3JHA,HC (= 4.7 Hz) and cis-
3JHA,HD (= 7.4 Hz) are 
comparable to the values of the observed vicinal coupling constants trans-3JHA,HB (= 3.0-3.2 Hz), trans-
3JHA,H 
(= 4.7-4.9 Hz) and cis-3JHA,HD (= 7.5-7.7 Hz) of the similar racemic trans-β-ACC derivatives 168
12a and 169.71 
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Figure 10 
The reaction of the enantiomeric (R)-benzyl 3-(diphenylmethylideneamino)-4-iodobutanoate (R)-164 with 
KHMDS, performed under similar reaction conditions (1.1 equiv KHMDS, -78 °C, 1 h), afforded 
cyclopropanes 8 in a good diastereomeric ratio (dr trans : cis 97 : 3) from which (1S,2S)-benzyl 
2-(diphenylmethylideneamino)cyclopropanecarboxylate (1S,2S)-8 was isolated in 75% yield after 
recrystallization (dr > 99 : 1) (Table 2, entry 1). Enantiomer (R)-164 was also treated with KHMDS at room 
temperature for one hour, but this resulted in a lower diastereomeric ratio (dr trans : cis 87 : 13) and yield 
(Table 2, entry 2). 
Table 2: Synthesis of 2-(diphenylmethylidenamino)cyclopropanecarboxylate (1S,2S)-8. 
 
Entry Reaction conditions dr trans : cisa Yield (1S,2S)-8b 
1 1.1 equiv KHMDS, THF, -78 °C, 1 h 97 : 3 75% 
2 1.1 equiv KHMDS, THF, r.t., 1 h 87 : 13 56% 
a Determined via 1H NMR analysis of the crude reaction mixture. b dr trans : cis > 99 : 1. 
 
As can be seen in Table 1, the diastereomeric outcome of the ring closure of compound (S)-164 is 
influenced by the reaction time. More specifically, the use of a longer reaction time leads preferably to the 
formation of trans derivative (1R,2R)-8 which is clear from the increasing diastereomeric ratio (dr trans : 
cis up to 99 : 1). Interpretation of these results can lead to the conclusion that trans cyclopropane (1R,2R)-
8 is formed under thermodynamic control. Possibly, cis derivative (1S,2R)-8 is converted into trans 
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derivative (1R,2R)-8 via deprotonation followed by a diastereoselective reprotonation step. However, the 
diastereoselective outcome of this reaction was not completely reproducible since varying diastereomeric 
ratios (dr trans : cis 95 : 5 - 99 : 1) were obtained when the reaction was repeated at -78 °C for two hours. 
Furthermore, the ring closure of the other enantiomer (R)-164 gave a lower diastereomeric ratio (dr trans 
: cis 87 : 13) when this reaction was performed at room temperature (Table 2, entry 2), while these reaction 
conditions should lead to thermodynamic control. In order to elucidate the mechanism of the ring closure 
reaction further, it would be usefull to isolate cis derivatives (1S,2R)-8 and (1R,2S)-8 and investigate 
whether these compounds can be converted into the corresponding trans derivatives via isomerisation. 
In an attempt to isolate (1S,2R)-cis-benzyl 2-(diphenylmethylideneamino)cyclopropanecarboxylate 
(1S,2R)-8, other reaction conditions were evaluated in order to invert the diastereomeric ratio of 
cyclopropanes 8. Addition of 1 equiv of KCl or 1.1 equiv of ZnCl2 to the reaction of (S)-benzyl butanoate 
(S)-164 with KHMDS in THF at -78 °C or 0 °C did not increase the amount of cis-isomer (1S,2R)-8 and 
resulted in a sluggish reaction with the formation of unidentified side products. Also the addition of 
18-crown-6 to the cyclization reaction did not lead to an inversion of the diastereomeric ratio and only 
lowered the conversion of the reaction. By adding these additives to the reaction, it was attempted to 
create a more ‘naked’ anion in the intermediate, so that internal solvation by the 
diphenylmethylideneamine function might take place which could lead to preferential formation of the 
cis-cyclopropane.72 
3.1.3 Saponification and peptide formation 
In a last step toward the synthesis of the unprotected C-terminal β-aminocyclopropanecarboxylic acids, a 
saponification reaction of cyclopropanecarboxylic esters 8 was performed by treatment with aqueous 
NaOH (in methanol). This reaction proceeded smoothly and afforded cyclopropanecarboxylic acids 9 in 
61-77% yield without observation of trans/cis isomerisation (based on detailed analysis of the well-
resolved signals in the 1H NMR spectrum) (Scheme 39 and Scheme 40). Subsequently, the stability of 
cyclopropanecarboxylic acids 9 toward a peptide coupling reaction with methyl glycinate 
hydrochloride 170a was evaluated. In a first attempt, (1R,2R)-cyclopropanecarboxylic acid (1R,2R)-9 was 
reacted with methyl glycinate 170a in the presence of 1.05 equivalents dicyclohexylcarbodiimide (DCC) 
and Et3N in EtOAc. After detailed analysis of the reaction mixture, it was concluded that carboxylic acid 
(1R,2R)-9 had reacted with DCC but the subsequent coupling of the activated acid with methyl glycinate 
failed, and peptide (1R,2R)-171 was not detected. The use of another coupling reagent, more specifically 
1-ethyl-3-(3-N,N-dimethylaminopropyl)carbodiimide (HCl salt) (EDC.HCl), proved to be more successful. 
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Reaction of cyclopropanecarboxylic acid (1R,2R)-9 with 1 equivalent of methyl glycinate (HCl salt) 170a in 
CH2Cl2 for three hours at room temperature in the presence of EDC.HCl and N-methylmorpholine afforded 
dipeptide (1R,2R)-171 which was isolated in 58% yield after column chromatography (Scheme 39). Peptide 
(1S,2S)-171 was formed under similar reaction conditions and was isolated in 68% yield (Scheme 40).  
 
Scheme 39 
 
Scheme 40 
The enantiomeric purity of peptides (1R,2R)-171 and (1S,2S)-171 was confirmed using 1H NMR analysis 
using (R)-Pirkle’s alcohol (R)-172 (Figure 11). When two equivalents of (R)-1-(9-anthryl)-2,2,2-
trifluoroethanol (R)-172 were added to a prepared mixture (1:1) of peptides (1R,2R)-171 and (1S,2S)-171, 
spectral nonequivalences of the signals from the NH-proton and NCH2-protons appeared in the 1H NMR 
spectrum (300 MHz, CDCl3). When two equivalents of (R)-Pirkle’s alcohol (R)-172 were added to peptide 
(1R,2R)-171 or peptide (1S,2S)-171, no chemical shift nonequivalences could be observed in the 1H NMR 
spectrum, confirming the enantiomeric purity of peptides 171. 
 
Figure 11 
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3.1.4 Conclusion 
In conclusion, a stereoselective synthesis of novel trans-β-aminocyclopropanecarboxylic acids 9 was 
developed, using a chiral pool approach. The key step in the reaction sequence, more specifically the base-
induced ring closure was optimized and afforded (1R,2R)- and (1S,2S)-trans-benzyl 
2-(diphenylmethylideneamino)cyclopropanecarboxylates 8 in very good diastereoselectivity and high 
yield. These new unsubstituted N-stabilized β-ACC derivatives were converted into the C-terminal 
unprotected β-ACCs 9 and were incorporated in dipeptides 171 using standard peptide coupling reaction 
conditions. This procedure opens challenges for the synthesis of novel peptides incorporating 
unsubstituted β-ACCs, with possible interesting biological properties. 
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3.2 Synthesis of novel -aminocyclobutanecarboxylic acid derivatives by a 
solvent-free aza-Michael addition and subsequent ring closure73 
3.2.1 Introduction 
2-Aminocyclobutanecarboxylates (β-ACBCs) comprise a second class of β-amino acids with a small-
membered carbocyclic ring as their core structure. The most common way to synthesize -ACBC 
derivatives uses a [2+2]-cycloaddition strategy, for example between an enamine and an acrylate,74 or 
between ethylene and an uracil derivative followed by opening of the heterocyclic ring.37,75 Using the latter 
method, the four enantiomers of -aminocyclobutanecarboxylic acid 173 have been synthesized, each in 
enantiomerically pure form (Figure 12).76 Another approach uses ethylene and maleic anhydride as starting 
compounds for the [2+2]-cycloaddition, followed by an enzymatic desymmetrization of the resulting meso 
diester and Curtius rearrangement.61 
 
Figure 12 
A poorly studied subclass of β-ACBC derivatives are β-aminocyclobutanedicarboxylic acids, which are 
1,2-donor-acceptor (DA) substituted cyclobutanes which are prone to ring opening77 and [4+2]-annulation 
reactions,78 due to the presence of an extra electron-withdrawing ester function. In this part of this PhD 
thesis, the synthesis of new -aminocyclobutanedicarboxylic acid derivatives via an aza-Michael Induced 
Ring Closure (MIRC) reaction was investigated, using 3-halopropylidenemalonate derivatives as substrates. 
This approach was based on previous research, where dialkyl 2-bromoethylidenemalonates and dialkyl 
3-chloropropylidenemalonates proved to be suitable substrates for the MIRC reaction toward a range of 
functionalised cyclopropanes and some cyclobutanes.12c,12d,79 
3.2.2 Synthesis of 3,3-dimethyl-2-aminocyclobutane-1,1-dicarboxylates 
In a previous Master thesis, β-ACBC derivatives 13a and 13b were synthesized in one step via the MIRC 
reaction, by treatment of malonates 11a-d with diphenylmethylideneamine in DMF at 55-65 °C in the 
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presence of K2CO3 as a mild base, albeit in rather low yields after recrystallization from MeOH (Scheme 
41).13 
 
Scheme 4113 
In an attempt to improve the yield of this transformation, other reaction conditions were explored (Table 
3). When tert-butanol was used as solvent in the presence of triethylamine as a base, the Michael addition 
of diphenylmethylideneamine across malonate 11b was observed, but the intramolecular substitution of 
the leaving group in -position did not occur. Thus, acyclic β-amino ester 174b was isolated in 57% yield 
after recrystallization from Et2O (Table 3, entry 1). The use of the solvent mixture t-BuOH/Et2O in a ratio 
of 4/1 increased the yield of the Michael addition of diphenylmethylideneamine across 
alkylidenemalonate 11b to 67% and shortened the reaction time (Table 3, entry 2). The low solubility of 
adduct 174b in Et2O led to a better conversion of the starting product 11b, disfavouring the reverse retro-
Michael reaction. 3-Bromoalkylidenemalonate 11a was treated with diphenylmethylideneamine under 
similar reaction conditions to obtain pure β-amino ester 174a in 56% yield (Table 3, entry 3). 
Unfortunately, the Michael addition of diphenylmethylideneamine leading to dimethyl malonates 174a 
and 174b proved to be poorly reproducible under these conditions. Furthermore, the addition of 
diphenylmethylideneamine across diethyl alkylidenemalonates 11c-d appeared to be even more 
problematic, which is probably due to the steric hindrance caused by the presence of the two geminal 
ethyl esters on the double bond. When diethyl 2-(3-chloro-2,2-dimethylpropylidene)malonate 11d was 
treated with three equivalents of diphenylmethylideneamine, only 66% conversion of the starting product 
to the corresponding β-amino ester 174d was observed after six days of reaction (Table 3, entry 4). In 
addition, the presence of an excess of diphenylmethylideneamine in the crude reaction mixture made 
isolation of the Michael adduct 174d very difficult to virtually impossible. 
Therefore, other conditions for the Michael addition of diphenylmethylideneamine across 3-halo-
alkylidenemalonates 11 had to be explored. Neither altering the solvent (t-BuOH/THF 4/1, Et2O, THF, 
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CH2Cl2, CH3CN) did lead to better results, nor did the use of other bases (NaH, KOtBu) or addition of a Lewis 
acid (MgBr2). The reaction was also conducted under microwave irradiation and in a pressure vial, but 
again no good conversion of substrates 11 to the corresponding acyclic β-amino esters 174 was observed. 
After many attempts, it was found that the Michael-type addition of diphenylmethylideneamine 12 across 
alkylidenemalonates 11, using triethylamine as a base, could be achieved in the absence of a solvent (neat 
conditions). Treatment of alkylidenemalonates 11a,b,d with 1.05 equivalents diphenylmethylideneamine 
in the presence of triethylamine at 60 °C for 4-48 hours led to a full conversion to the corresponding 
Michael adducts 174a,b,d, which were isolated in 67-79% yield after recrystallization from Et2O (Table 3, 
entries 5-7). The reaction of diethyl 2-(3-bromo-2,2-dimethylpropylidene)malonate 11c and 
diphenylmethylideneamine 12, however, gave rise to the formation of an alternative product, more 
specifically diethyl 2-[2,2-dimethyl-3-(diphenylmethylideneamino)propylidene]malonate 175b (Table 3, 
entry 8). The steric hindrance caused by the presence of the two geminal ethyl esters hampered the 
Michael-type addition of the nucleophile across the activated double bond, and in combination with the 
presence of a good leaving group (in this case bromide), a direct substitution of the leaving group by the 
nucleophile was more favorable. Detailed spectroscopic follow-up of the reactions showed that this 
substitution reaction did not occur when malonates 11a, 11b and 11d were used as substrates. The 
reaction of malonate 11c and diphenylmethylideneamine proceeded more selective toward the Michael 
adduct 174c at room temperature but in this case, a longer reaction time was required (Table 3, entry 9). 
In this manner, a very simple, practical and more sustainable method for the Michael-type addition of 
diphenylmethylideneamine across alkylidenemalonates 11a-d, without the use of hazardous and volatile 
solvents, was developed. In the recent literature, other examples of solvent free aza-Michael additions 
across unsaturated substrates have been reported.80 
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Table 3: Michael-type addition of diphenylmethylideneamine 12 across 3-halopropylidenemalonates 11 
 
Entry Substrate Reaction conditions Compound (Yield)a 
1 11b t-BuOH, , 72 h 174b (57%) 
2 11b t-BuOH/Et2O 4/1, , 55 h 174b (67%) 
3 11a t-BuOH/Et2O 4/1, , 24 h 174a (56%) 
4 11d t-BuOH/Et2O 4/1, , 6 db 174d (-)
c 
5 11a neat, 60 °C, 4 h 174a (79%) 
6 11b neat, 60 °C, 24 h 174b (78%) 
7 11d neat, 60 °C, 48 h 174d (67%) 
8 11c neat, 60 °C, 20 h 175b (38%) 
9 11c neat, r.t., 119 h 174c (76%) 
a Isolated yield after recrystallization from Et2O. b Reaction was conducted with 3 equiv diphenyl-
methylideneamine and 3 equiv Et3N. c 66% conversion after 6 days, compound 174d was not isolated. 
 
In order to convert β-amino esters 174a-d into the targeted β-aminocyclobutanecarboxylic acid derivatives 
13a and 13b, they were treated with a base to enable ring closure. Reaction of 2-[3-bromo-2,2-dimethyl-
1-(diphenylmethylideneamino)propyl]malonates 174a and 174c with 1.2 equivalents of KOtBu in THF for 
three hours at reflux temperature afforded β-aminocyclobutanecarboxylic acid derivatives 13a and 13b in 
good to excellent yields (Scheme 42). 
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Scheme 42 
The cyclization of dimethyl 2-[3-chloro-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 
174b to the corresponding cyclobutane 13a was less straightforward. When KOtBu in tert-butanol under 
reflux or KHMDS or LiHMDS in THF at room temperature were used as basic conditions, the cyclization of 
malonate 174b to cyclobutane 13a was sluggish (0-66% conversion) and suffered from competitive 
retro-Michael addition giving rise to dimethyl alkylidenemalonate 11b (up to 50%). The presence of 
chloride as leaving group and the sterically impeding geminal methyl groups prevented a smooth 
cyclobutanation of diester 174b. Fortunately, the addition of a catalytic amount of NaI to achieve an in situ 
substitution of chloride by iodide, to the reaction of malonates 174b and 174d with KOtBu in THF under 
reflux conditions, led to the desired clean cyclization to β-ACBC derivatives 13a and 13b which were 
isolated in 52-62% yield (Scheme 43). 
 
Scheme 43 
3.2.3 Attempted synthesis of 2-aminocyclobutane-1,1-dicarboxylates 
In analogy with 3,3-gem-dimethyl-β-ACBC derivatives 13, the synthesis of the corresponding 3,3-nor-
dimethylderivatives was also attempted. To this end, precursor 179 was synthesized in three steps starting 
from 1,3-propanediol 176. First, diol 176 was converted into tert-butyldimethylsilylether 177 by treatment 
with TBDMSCl in the presence of NaH81 and subsequent oxidation toward aldehyde 178 was achieved 
using Swern oxidation conditions.82 In the next step, the Knoevenagel condensation of aldehyde 178 with 
dimethyl malonate in the presence of titanium(IV) chloride and pyridine afforded propylidenemalonate 
179 in 60% yield (Scheme 44). 
Results and discussion  Chapter 3 
49 
 
 
Scheme 44 
The next step in this synthetic route was the conversion of the tert-butyldimethylsilyloxy group into a good 
leaving group. Therefore, silyl ether 179 was treated with 1.05 equivalents of tetrabutylammonium 
fluoride (TBAF) in THF at 0 °C for 30 minutes, but unfortunately, this reaction led to the formation of a 
complex reaction mixture. Also upon use of tetramethylammonium fluoride (TMAF) as the fluoride source, 
a complex reaction mixture was obtained. It was concluded that the envisioned alcohol 180, comprising 
both nucleophilic and electrophilic sites, is probably an unstable compound. Therefore, it was decided to 
use propylidenemalonate 179 as the Michael acceptor in the next step. While treatment of 
propylidenemalonate 179 with diphenylmethylideneamine 12 in tert-butanol in the presence of Et3N only 
led to a partial conversion, the use of dichloromethane as a solvent gave better results and adduct 181 
was isolated in 64% yield after recrystallization from Et2O (Scheme 45). 
 
Scheme 45 
In the next step, the removal of the tert-butyldimethylsilyl protecting group in compound 181 was 
evaluated. Unfortunately, while treatment of adduct 181 with TBAF or TMAF at 0 °C in THF only led to 
recovery of the starting material, the formation of a complex reaction mixture was observed when the 
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reaction was performed at room temperature. Since the removal of the TBDMS protecting group of 
compounds 179 and 181 could not be achieved, this reaction pathway toward 2-aminocyclobutane-1,1-
dicarboxylates was not further explored.  
3.2.4 Conclusion 
In conclusion, a novel method to synthesize highly substituted β-ACBC derivatives starting from 
3-halopropylidenemalonates was developed, using diphenylmethylideneamine in a solvent-free aza-
Michael addition followed by a base-induced ring closure. The synthesis of the corresponding 3,3-nor-
dimethyl derivatives could not be effectuated due to the troublesome removal of the tert-
butyldimethylsilyl protecting group of the precursors. 
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3.3 Synthesis of dialkyl 2-amino-3,3-difluorocyclopropane-1,1-dicarboxylates 
3.3.1 Introduction 
As is shown in the literature overview, synthetic pathways toward ring fluorinated α-ACC derivatives have 
been relatively well studied.17,21-26 In contrast, the chemistry of the corresponding ring fluorinated β-ACC 
derivatives comprises a very scarcely investigated field.22 This can be attributed to the inherent instability 
of β-ACC caused by the 1,2-donor-acceptor substituted cyclopropane structure.83 Furthermore, 
fluorinated cyclopropanes in general show an enhanced reactivity, resulting in a decreased stability.84 
Since the synthesis of 2-amino-3,3-difluorocyclopropanecarboxylates has never been described in the 
literature, in the third part of this PhD thesis, a synthetic route toward these elusive compounds was 
developed. 
3.3.2 Synthesis of dialkyl 2-amino-3,3-difluorocyclopropane-1,1-dicarboxylates 
Analogously to the synthesis of β-ACBC derivatives 13, which was achieved via the addition of a nitrogen 
nucleophile to a Michael acceptor followed by a base-induced ring closure, the synthesis of fluorinated 
β-ACC derivatives was envisioned using dialkyl 2-(2-bromo-2,2-difluoroethylidene)malonates 16 as 
substrates. This work is also based on previous research in our group, in which the synthesis of dialkyl 3,3-
dialkyl-2-aminocyclopropane-1,1-dicarboxylates was developed, via a Michael Induced Ring Closure 
(MIRC) reaction starting from dialkyl 2-(2-bromo-2,2-dialkylethylidene)malonates.12c,12d 
Dialkyl 2-(2-bromo-2,2-difluoroethylidene)malonates 16 were synthesized using ethyl 
bromodifluoroacetate 14 as a building block (Scheme 46). Treatment of ester 14 with DIBAL led to the 
formation of an intermediate aluminium hemiacetal, which was used without work-up in the reaction with 
the sodium enolates derived from malonates 15,85 affording alcohols 182. In the next step, alcohols 182 
were treated with acetyl chloride in the presence of Et3N, resulting in acetylation of the alcohol and 
subsequent elimination to give dialkyl 2-(2-bromo-2,2-difluoroethylidene)malonates 16. 
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Scheme 46 
3.3.2.1 Aza-Michael addition of diphenylmethylideneamine 
In a first part, the aza-Michael addition of diphenylmethylideneamine 12 across ethylidenemalonates 16 
was evaluated. Based on the results in the previous section,73 compound 16a (R = Me) was treated with 
1.05 equivalents of diphenylmethylideneamine 12 in the presence of 1.05 equivalents Et3N, under neat 
reaction conditions at room temperature. This led to the formation of adduct 183a, which was isolated in 
75% yield after column chromatography and recrystallization from MeOH to remove residual 
benzophenone. The aza-Michael addition of diphenylmethylideneamine across ethylidenemalonates 16 
also proceeded smoothly in absence of Et3N and adducts 183 were isolated in excellent yields after 
recrystallization (Scheme 47). Dialkyl 2-(2-bromo-2,2-difluoroethylidene)malonates 16 are excellent 
Michael acceptors due to the activation by the two electron-withdrawing ester groups and the two fluorine 
atoms. 
 
Scheme 47 
Having adducts 183 in hand, their base-induced ring closure toward the corresponding cyclopropanes was 
evaluated (Table 4). In a first attempt, adduct 183a was treated with NaOMe (2M in MeOH) at 0 °C, but 
after work-up only starting material was recovered (Table 4, entry 1). In contrast, when this reaction was 
conducted at room temperature, degradation of the starting compound was observed, affording a mixture 
in which only benzophenone and diphenylmethylideneamine were detected (Table 4, entry 2). 
Results and discussion  Chapter 3 
53 
 
Subsequently, compound 183a reacted with 1.2 equivalents KOtBu in THF for one hour at room 
temperature, but no reaction was observed (Table 4, entry 3). By increasing the reaction temperature to 
reflux temperature, a full conversion of the starting compound was observed after two hours. LC-MS 
analysis of the reaction mixture revealed the presence of two products with the same molecular weight, 
corresponding to the molecular weight of the envisioned cyclopropanedicarboxylate 184a. After detailed 
analysis of the 1H NMR spectrum of the reaction mixture, the two compounds in the reaction mixture were 
identified as cyclopropane 184a and pyrroline 185a, in a ratio of 13 : 87 (Table 4, entry 4). The latter 
compound is formed as the result of a rearrangement of cyclopropane 184a. In previous research, 
rearrangement of the related dimethyl 3,3-dimethyl-2-(diphenylmethylideneamino)cyclopropane-1,1-
dicarboxylate, in which the cyclopropane ring is substituted by two methyl groups instead of two fluorine 
atoms, toward the corresponding pyrroline was also observed. In that case however, prolonged heating in 
DMF at reflux temperature86 or treatment with NaCl in a DMSO/H2O mixture at reflux temperature for 23 
hours12c were necessary to initiate this rearrangement. Apparently, due to the presence of the two fluorine 
atoms, difluorinated cyclopropane 184a is more prone to ring expansion than its dimethylated analogue. 
In an attempt to obtain cyclopropane 184a in a higher amount, the reaction of adduct 183a with KOtBu at 
reflux temperature was repeated and after 45 minutes a sample was taken and analysed via 1H NMR. At 
that moment, a reaction conversion of 62% was observed and cyclopropane 184a and pyrroline 185a were 
present in almost equal amounts (Table 4, entry 5). The reaction was stopped after an additional 15 
minutes and 1H NMR analysis of the reaction mixture revealed no further progress of the reaction, but a 
change in the ratio cyclopropane 184a : pyrroline 185a, with pyrroline 185a being the major product (Table 
4, entry 6). It was found that a small change in the reaction conditions had a large effect on the ring 
transformation of cyclopropane 184a toward pyrroline 185a. For example, when the reaction was 
conducted using 1.1 equivalents of KOtBu instead of 1.2 equivalents, leaving the other reaction conditions 
unaltered, a different ratio of reaction products was obtained, with a higher reaction conversion and a 
higher amount of pyrroline in the case of 1.2 equivalents (Table 4, entries 6,7). In a next attempt, two 
equivalents of base were used at reflux temperature in an attempt to achieve a high conversion of the 
starting material in a shorter reaction time, possibly reducing the amount of pyrroline 185a. Indeed, under 
these reaction conditions cyclopropane 184a was found to be the major reaction product (Table 4, entry 
8). However, a large amount of benzophenone was present, indicating degradation of the starting material 
or the reaction products under these reaction conditions. An extra increase of the number of equivalents 
of base gave no better results since treatment of adduct 183a with three equivalents of KOtBu in THF for 
15 minutes at reflux temperature led to the formation of a complex reaction mixture (Table 4, entry 9). 
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Other reaction conditions, for example adding the base portionwise or using Et2O as the solvent, also did 
not lead to better results. It was concluded that the reaction of adduct 183a with 1.1 equivalents of KOtBu 
in THF under reflux conditions for one hour were the best reaction conditions to obtain cyclopropane 184a, 
albeit in a low yield of 20% (Table 4, entry 7). The selective formation of pyrroline 185a was effectuated 
by reacting adduct 183a with 1.1 equivalents of KOtBu in THF under reflux conditions for four hours, and 
pyrroline 185a was isolated in 73% yield (Table 4, entry 10). In all cases, a fourth reaction product was 
present after work-up, based on analysis of the 19F NMR spectrum, in which a small singlet was present at 
-152.12 ppm. Unfortunately, this compound could not be isolated and thus not identified. 
Table 4: Ring closure of dimethyl 2-[(2-bromo-2,2-difluoro-1-diphenylmethylideneamino)ethyl]malonate 183a 
 
Entry Reaction conditions 
Ratioa  
183a : 184a : 185a 
Compound  
(Yield)b 
1 1.05 equiv NaOMe,c MeOH, 0 °C, 1 h 100 : 0 : 0 - 
2 1.05 equiv NaOMe,c MeOH, r.t., 2 h -d - 
3 1.2 equiv KOtBu,e THF, r.t., 1 h 100 : 0 : 0 - 
4 1.2 equiv KOtBu,e THF , Δ, 2 h 0 : 13 : 87 185a (45%) 
5 1.2 equiv KOtBu,e THF, Δ, 45 min 38 : 27 : 34 - 
6 1.2 equiv KOtBu,e THF, Δ, 1 h 37 : 10 : 53 - 
7 1.1 equiv KOtBu,e THF, Δ, 1 h 45 : 24 : 31 184a (20%) 
8 2 equiv KOtBu,e THF, Δ, 15 min 21 : 56 : 23f - 
9 3 equiv KOtBu,e THF, Δ, 15 min -g - 
10 1.1 equiv KOtBu,e THF, Δ, 4 h 9 : 4 : 87 185a (73%) 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. c 2M in MeOH. d Only 
benzophenone and diphenylmethylideneamine were distinguished in the reaction mixture.e 1M in THF. f 
A large amount of benzophenone was present in the reaction mixture. g Complex reaction mixture. 
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Subsequently, the base-induced ring closure of diethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylidene-
amino)]malonate 183b was evaluated. Applying the reaction conditions which gave the best conversion 
toward cyclopropane 184a (1.1 equiv KOtBu, THF, Δ, 1 h) led to the formation of cyclopropane 184b as the 
major reaction product, with a reaction conversion of 94% (Table 5, entry 1). However, next to 
cyclopropane 184b and pyrroline 185b, a third reaction product was present in the reaction mixture. After 
purification of the reaction mixture, this compound was identified as fluorinated diethyl 
cyclopropenedicarboxylate 186b, which was isolated in 10% yield.  
Fluorinated aminocyclopropenes and fluorinated alkyl cyclopropenecarboxylates have never been 
described in the literature before. The synthesis of fluorinated cyclopropenes has been reported and also 
a lot of attention has been devoted to calculation studies regarding the structure of these small-membered 
strained rings.84,87 However, the majority of attention has been devoted to the synthesis of cyclopropenes 
which are substituted by fluorine at the C3 carbon, while less examples are known of cyclopropenes in 
which the fluorine atom is attached to the double bond.88 While cyclopropane 184b was not stable and 
rearranged readily toward pyrroline 185b upon storage at room temperature, diethyl 
cyclopropenedicarboxylate 186b was more stable and could be stored at room temperature for several 
days. Possibly, this higher stability is due to the reduced Pitzer strain in this more planar cyclopropene. In 
diethyl cyclopropanedicarboxylate 184b, the two fluorine atoms are eclipsed with the two ester functions, 
leading to a substantial electronic repulsion, while this interaction is not present in diethyl 
cyclopropenedicarboxylate 186b. 
The 19F NMR spectrum of cyclopropene 186b showed a singlet at -151.97 ppm, and thus it was concluded 
that the unknown compound which was formed upon reaction of dimethyl ethylidenemalonate 183a with 
KOtBu (see discussion Table 4) was the corresponding dimethyl cyclopropenedicarboxylate. But as 
mentioned before, this compound was never isolated. Furthermore, from this first attempt (Table 5, 
entry 1), cyclopropane 184b was isolated in 15% yield. Prolonging the reaction time to two hours led to a 
higher conversion of the starting material and also a higher amount of pyrroline 185b, which was isolated 
in 26% yield (Table 5, entry 2). In this case, cyclopropene 186b was again present in a trace amount and 
was isolated in 1% yield. To achieve the highest conversion of adduct 183b toward pyrroline 185b, the 
reaction time was prolonged to five hours and pyrroline 185b was isolated in 39% yield (Table 5, entry 3). 
In a last attempt, adduct 183b was treated with 1.5 equivalents of KOtBu for 30 minutes, leading to a 
mixture with cyclopropane 184b being the major compound which was isolated in 22% yield (Table 5,  
entry 4).  
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Table 5: Ring closure of diethyl 2-[(2-bromo-2,2-difluoro-1-diphenylmethylideneamino)ethyl]malonate 183b 
 
Entry Reaction conditions 
Ratioa  
183b : 184b : 186b : 185b 
Compound  
(Yield)b 
1 1.1 equiv KOtBu,c THF, Δ, 1 h 6 : 51 : 18 : 25 184b (15%) + 186b (10%) 
2 1.1 equiv KOtBu,c THF, Δ, 2 h 0 : 41 : trace: 59 186b (1%) + 185b (26%)  
3 1.2 equiv KOtBu,c THF, Δ, 5 h 0 : 0 : 17 : 83 185b (39%) 
4 1.5 equiv KOtBu,c THF, Δ, 30 min 0 : 66 : 3 : 31 184b (22%) + 185b (11%) 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. c 1M in THF. 
 
As a last substrate, the base-induced ring closure of diisopropyl malonate 183c was investigated (Table 6). 
In a first attempt, adduct 183c reacted with 1.5 equivalents of KOtBu for 30 minutes at reflux temperature 
in THF (Table 6, entry 1), since under these reaction conditions the best conversion toward diethyl 
cyclopropanedicarboxylate 184b was obtained (Table 5, entry 4). Satisfyingly, full conversion of the 
starting material was observed, with cyclopropane 184c being the major reaction product which was 
isolated in a good yield of 56% (Table 6, entry 1). Next, the synthesis of pyrroline 185c was envisioned. 
Therefore, the reaction time was prolonged to three hours. After work-up, cyclopropane 184c was again 
the major reaction product, despite the long reaction time of three hours. Also, a larger amount of 
cyclopropene 186c was present, which was isolated in 10% yield after purification of the reaction mixture 
(Table 6, entry 2). In a next attempt, adduct 183c reacted with 1.2 equivalents of KOtBu in THF at reflux 
temperature for three hours (Table 6, entry 3). In an attempt to convert cyclopropane 184c, which was 
the major reaction product, into pyrroline 185c, the reaction mixture was redissolved in THF and stirred 
at reflux temperature for four hours. After evaporation of the solvent, a change in the ratio 184c : 185c 
was observed and both products were present in almost equal amounts (Table 6, entry 4). To obtain a full 
conversion toward pyrroline 185c, this reaction mixture was stirred in CH3CN for two hours at reflux 
temperature, leading to an almost full conversion toward pyrroline 185c (Table 6, entry 4). Unfortunately, 
pyrroline 185c could not be isolated in pure form, since this compound could not be separated from 
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benzophenone. Although the rearrangement of cyclopropane 184c toward pyrroline 185c was effectuated 
by heating in THF or CH3CN, this was also accompanied by degradation of the reaction products since the 
amount of benzophenone in the reaction mixture increased after each step. 
Table 6: Ring closure of diisopropyl 2-[(2-bromo-2,2-difluoro-1-diphenylmethylideneamino)ethyl]malonate 183c 
 
Entry Reaction conditions 
Ratioa 
183c : 184c : 186c : 185c 
Compound 
(Yield)b 
1 1.5 equiv KOtBu,c THF, Δ, 30 min 0 : 80 : 6: 14 184c (56%) 
2 1.5 equiv KOtBu,c THF, Δ, 3 h 0 : 74 : 14 : 13 186c (10%) 
3 1.2 equiv KOtBu,c THF, Δ, 3 h 0 : 69 : 4 : 27 - 
4 Reaction mixture entry 3, THF, Δ, 4 h 0 : 52 : 2 : 46 - 
5 Reaction mixture entry 4, CH3CN, Δ, 2 h 0 : 0 : 7 : 93  185c (45%)d 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. c 1M in THF. d 66% 
purity, mixture with benzophenone. 
 
The low yields of cyclopropanes 184, cyclopropenes 186 and pyrrolines 185 are due to their instability 
during their synthesis, work-up, purification and storage. Cyclopropane 184a for example, already 
converts into pyrroline 185a upon storage at -18 °C. Therefore, the temperature of the water bath during 
evaporation was always kept as low as possible and purification using flash chromatography was always 
performed by applying pressure to the column, keeping the contact time with SiO2 as short as possible. 
In the next step, the reduction of pyrrolines 185 toward the corresponding fluorinated pyrrolidines was 
attempted. Fluorinated pyrrolidines belong to a class of fluorinated azaheterocycles that has been studied 
previously in our research group.89 This reduction would give an entry toward fluorinated β-proline 
derivatives, a class of fluorinated β-amino acids that has received only limited attention.90 
In a first attempt, pyrroline 185a was treated with 2.5 equivalents of NaCNBH3 in the presence of acetic 
acid (1.2 equiv) in methanol at room temperature for 15 hours. However, after work-up, a complex 
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reaction mixture was obtained. Next, pyrroline 185a was reacted with NaCNBH3 in the presence of a 
catalytic amount of p-toluenesulfonic acid in THF for 22 hours, which led to a full conversion of the starting 
material.91 After analysis of the crude reaction mixture, it was concluded that instead of the envisaged 
pyrrolidine, a mixture of acyclic amino esters 187a and 188a (ratio 187a : 188a = 3: 1) was formed (Table 
7, entry 1). The formation of amino ester 187a can be rationalized as follows (Scheme 48). Initial reduction 
of the imine function in pyrroline 185a leads to the formation of pyrrolidine 189a, which appears to be 
unstable under the reaction conditions and undergoes ring opening to give acyclic imine 190a. 
Subsequently, under these reductive reaction conditions, imine 190a is converted into amino ester 187a. 
Upon basic work-up, amino ester 187a is converted into amino ester 188a via an E1cb-type elimination 
reaction. Unfortunately, when the purification of the reaction mixture was attempted, compounds 187a 
and 188a were not recovered. Furthermore, the formation of amino esters 187a and 188a under these 
reaction conditions was not reproducible, since repeating this reaction (2 equiv NaCNBH3, 0.1 equiv 
p-TsOH, THF, r.t., 22 h) only led to the formation of a complex reaction mixture. In a next attempt, pyrroline 
185a was treated with NaCNBH3 in the presence of acetic acid in acetonitrile for 30 minutes at 0 °C.92 After 
work-up, a mixture of amino esters 187a and 188a was obtained, in a ratio 187a : 188a = 68 : 32 but again, 
the purification of this mixture failed (Table 7, entry 2). In an attempt to trap pyrrolidine 189a, pyrroline 
185a was first stirred in acetonitrile in the presence of acetyl chloride to effectuate N-acetylation, before 
three equivalents of NaCNBH3 were added. Then, the reaction mixture was stirred for three hours at room 
temperature but this resulted in the formation of a complex reaction mixture in which the N-acetyl 
derivatives of amino esters 187a and 188a were not present (Table 7, entry 3). Next, the effect of the 
addition of both acetic acid and acetyl chloride to the reaction mixture was investigated in the reaction of 
pyrroline 185a with NaCNBH3 (Table 7, entry 4). Again a mixture of amino esters 187a and 188a was 
obtained. Purification of this mixture via flash column chromatography afforded amino ester 188a in pure 
form (29% yield) but this compound appeared to be unstable and no full characterization could be 
performed. The instability of compounds 187a and 188a explains why a complex reaction mixture was 
obtained when pyrroline 185a was reacted with NaCNBH3 under the standard reaction conditions using 
acetic acid in methanol and why the reaction using NaCNBH3 in the presence of p-toluenesulfonic acid was 
not reproducible. Compounds 187a and 188a already degrade upon storage at room temperature for one 
hour or when a temperature of 37 °C was applied for the evaporation of the solvent after work-up. Thus, 
the formation of the complex reaction mixture under these reaction conditions was due to the instability 
of compounds 187a and 188a.  
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Table 7: Reduction of pyrroline 185a 
 
Entry Reaction conditions Result 
1 2 equiv NaCNBH3, 0.1 equiv p-TsOH, THF, r.t., 22 h 187a : 188a = 75 : 25a 
2 2 equiv NaCNBH3, 2 equiv AcOH, CH3CN, 0 °C, 30 min 187a : 188a = 68 : 32a 
3 1) 5 equiv AcCl, CH3CN, r.t., 1 h 30 min 
2) 3 equiv NaCNBH3, MeOH, r.t., 3 h 
Complex reaction mixture 
4 2 equiv NaCNBH3, 2 equiv AcOH, 2 equiv AcCl, 
CH3CN, 0 °C, 20 min 
187a : 188a = 65 : 35a 
(29% 188a)b 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. 
 
 
Scheme 48 
The transformation of pyrroline 185a was also attempted via a nucleophilic addition across the C=N double 
bond by NaOMe or 4-methoxyphenol, but this only led to the formation of a complex reaction mixture.  
Reduction of pyrroline 185c using NaCNBH3 in the presence of acetic acid and acetyl chloride afforded 
difluorinated amino ester 187c, while only a trace amount of the corresponding monofluorinated diester 
was present in the reaction mixture. Apparently, due to the steric hindrance caused by the two isopropyl 
esters, the elimination of fluoride is more difficult. Amino ester 187c was isolated in 18% yield but again, 
this compound proved to be unstable and could not be fully characterized. 
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Scheme 49 
Next to the reduction using NaCNBH3, other reducing agents were also evaluated. However, while the use 
of NaBH4, NaBH(OAc)3 or LiAlH(OtBu)3 gave no reaction, reaction with LiAlH4 or H2 in the presence of Pt/C 
led to the formation of a complex reaction mixture.  
3.3.2.2 Aza-Michael addition of imidazole 
In the next part, imidazole 191 was evaluated as another nitrogen nucleophile, and was reacted with 
ethylidenemalonates 16a,c in the presence of Et3N in tert-butanol (Scheme 50). Although this reaction was 
carried out at reflux temperature for several hours, only adducts 192 was isolated from the reaction 
mixture and no subsequent ring closure was observed. 
 
Scheme 50 
In order to convert adduct 192a into the envisioned cyclopropane 193a, this compound was treated with 
1.5 equivalents of KOtBu in THF at reflux temperature for one hour, after which extra KOtBu was added 
(1.5 equiv) and the stirring was continued for another two hours. According to LC-MS analysis of the 
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reaction mixture, one major product was formed, with a molecular weight corresponding to that of 
cyclopropane 193a. However, after purification of this compound via preparative TLC and detailed analysis 
of the 1H NMR, 13C NMR and HSQC spectra, it was concluded that the product of this reaction was not 
cyclopropane 193a but enamine 194a. In the 1H NMR spectrum a doublet (4JH,F = 1.8 Hz) was present at 
4.54 ppm, corresponding to HA (Figure 13). Indeed, the size of this coupling constant indicates an allylic 
coupling between proton and fluorine, which is in accordance with some examples found in literature.93 
Furthermore, via analysis of the HSQC spectrum it can be seen that the carbon atom attached to HA also 
shows a very small allylic coupling with fluorine (3JC,F = 2.4 Hz). In both cases, the coupling with the other 
fluorine atom was not resolved in the spectrum. 
 
Figure 13 
Furthermore, diisopropyl diester 192c was also converted into enamine 194c, which was isolated in 49% 
yield (Scheme 50).The low yields are due to loss of the product during purification via preparative TLC. 
3.3.2.3 Aza-Michael addition of potassium phthalimide 
In a next part, ethylidenemalonates 16b,c reacted with potassium phthalimide 195 in the presence of 
tetramethylammonium bromide in tert-butanol at reflux temperature, affording adducts 196b,c in low 
yields (28-33%) (Scheme 51). When these adducts were treated with base in THF in the next step, at room 
temperature for 196c or at reflux temperature for 196b, this only led to the formation of a complex 
reaction mixture. 
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Scheme 51 
3.3.3 Conclusion 
In conclusion, three different nucleophiles were evaluated for the synthesis of fluorinated β-ACC 
derivatives via a MIRC reaction starting from ethylidenemalonates 16. The use of 
diphenylmethylideneamine gave the best results and led to the formation of unprecedented fluorinated 
β-ACC derivatives 184. However, these compounds were unstable and rearranged toward fluorinated 
pyrrolines 185. Pyrrolines 185 were in turn converted into unstable acyclic γ-amino esters 187 via 
reduction. When imidazole was reacted with ethylidenemalonates 16, Michael adducts 192 were formed, 
but these could not be converted into the corresponding cyclopropanes 193. Instead, formation of 
enamines 194 was observed. Finally, the use of potassium phthalimide 195 only led to complex reaction 
mixtures when cyclization was attempted.  
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3.4 Attempted synthesis of 3-fluoro- and 3,3-difluoroazetidine-2-carboxylates 
3.4.1 Introduction 
As mentioned in the literature overview, only two examples on the synthesis of 3-fluoroazetidine-2-
carboxylic acid derivatives have been reported before. The first method comprises the fluorination of 
azetidine-2-carboxylic acid using the highly toxic trifluoromethyl hypofluorite gas in liquid HF.49 The second 
method was reported only very recently and describes the formation of 4-hydroxymethylated derivatives 
of 3-fluoroazetidine-2-carboxylic acid.50 In this part of this PhD thesis, it was attempted to develop a 
general synthetic route toward these strained fluorinated amino acid derivatives, without the presence of 
an extra substituent at the 4-position. 
3.4.2 Synthesis of amino esters 
Inspired by the work of Couty,14a,14b the synthesis of difluorinated azetidine-2-carboxylates 197 was 
envisioned via cyclisation of bromodifluorinated precursors 198 (Scheme 52). It was believed that these 
precursors could be synthesized starting from ethyl bromodifluoroacetate 14, via sequential amidation by 
reaction with glycine esters 19, selective reduction of the resulting amide moiety of compounds 200 and 
protection of the amine to give precursors 198. 
 
Scheme 52 
In a first step, ethyl bromodifluoroacetate 14 was brought into reaction with the hydrochloric salt of ethyl 
glycinate 170b in dichloromethane in the presence of Et3N, leading to the formation of amide 200a in good 
yield. The next step in this reaction sequence was the selective reduction of the amide moiety toward 
amino ester 199a. Unfortunately, this reduction proved to be not straightforward. First, the use of borane 
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dimethylsulfide complex (BH3.Me2S) in CH2Cl2 was evaluated in the reaction with amide 200a. Independent 
of the number of equivalents (3 - 12 equiv), the reaction temperature (r.t. - Δ) or the reaction time (1.5 - 
20 h), no conversion toward the envisioned amino ester 199a was observed and only the starting 
compound 200a was recovered (Table 8, entries 1-5). Only when the reaction of amide 200a with six 
equivalents of BH3.Me2S was carried out for a prolonged reaction time of 76 h, a reduction was observed, 
but the compound that was obtained was amino alcohol 201, formed by a reduction of all carbonyls in 
compound 200a (Table 8, entry 6). When borane was used as the THF-complex at room temperature, again 
no reaction occurred (Table 8, entry 7) or a complex mixture was obtained when the reaction was 
conducted at reflux temperature using 10 equivalents of BH3.THF (Table 8, entry 8). In a next attempt, the 
use of monochloroalane, prepared in situ from AlCl3 and LiAlH4, was evaluated, but under these reaction 
conditions, amino alcohol 201 was again formed as the end product (Table 8, entry 9). In an attempt to 
avoid the reduction of the ester moiety, the bulkier tert-butyl ester 200b was also prepared and subjected 
to reductive reaction conditions. In this case, treatment of amide 200b with three equivalents of BH3.Me2S 
in dichloromethane under reflux conditions also led to the undesired formation of amino alcohol 201 
(Table 8, entry 10). 
 
Scheme 53 
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Table 8: Attempted selective reduction of amido esters 200 
Entry Substrate Reaction conditions Result 
1 200a 3 equiv BH3.Me2S, CH2Cl2, r.t., 17 h No reaction 
2 200a 10 equiv BH3.Me2S, CH2Cl2, r.t., 2 h No reaction 
3 200a 3 equiv BH3.Me2S, CH2Cl2, Δ, 20 h No reaction 
4 200a 10 equiv BH3.Me2S, CH2Cl2, Δ, 3 h No reaction 
5 200a 12 equiv BH3.Me2S,a CH2Cl2, Δ, 1.5 h No reaction 
6 200a 6 equiv BH3.Me2S, CH2Cl2, Δ, 76 h 201 (31%)b 
7 200a 1 equiv BH3.THF, THF, r.t., 3 h No reaction 
8 200a 10 equiv BH3.THF, THF, r.t., 3 h Complex reaction mixture 
9 200a 1 equiv AlCl3, 3 equiv LiAlH4, Et2O, 0 °C, 2 h 201 (50% crude) 
10 200b 3 equiv BH3.Me2S, CH2Cl2, Δ, 24 h 201 (60% crude) 
a Added in portions of 2 equiv every 10 minutes. b Isolated yield. 
 
Since the selective reduction of the amide moiety of compounds 200 proved to be difficult, another 
strategy was employed. Since the reduction of thioamides in the presence of ester functions has been 
reported, amide 200a was converted into thioamide 202. While treatment of amide 200a with Lawesson’s 
reagent in benzene at reflux temperature for 3.5 hours resulted only in partial conversion toward 
thioamide 202, the use of toluene as the solvent led to full conversion and thioamide 202 was isolated in 
70% yield (Scheme 54). Subsequently, the selective reduction of the thioamide moiety of compound 202 
was investigated. In a first attempt, thioamide 202 was treated with NiCl2.6H2O in the presence of NaBH4, 
in order to form nickel boride in situ,94 but these reaction conditions only led to the formation of a complex 
reaction mixture (Table 9, entry 1). In contrast, treatment of amide 202 with Raney Nickel in a solvent 
mixture containing EtOH, THF and water at room temperature for one hour only led to recovery of the 
starting material (Table 9, entry 2).95 Another attempt for desulfurization comprised the alkylation of the 
thioamide with methyl iodide, followed by reduction. Unfortunately, upon treatment of thioamide 202 
with MeI in the absence or in the presence of a base, no reaction was observed (Table 9, entries 3-4).96 A 
last attempt comprised the addition of BH3.Me2S, but in this case, either no reaction was observed at room 
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temperature, or a complex reaction mixture was obtained when reflux temperature was applied (Table 9, 
entries 5-6). 
 
Scheme 54 
Table 9: Attempted reduction of thioamide 202 
Entry Reaction conditions Result 
1 8 equiv NiCl2.6H2O, 2.4 equiv NaBH4, THF/MeOH 1/1, r.t., 3 h Complex reaction mixture 
2 RaNi (in H2O), THF/EtOH 1/1, r.t., 1 h No reaction 
3 5 equiv MeI, THF, r.t., 17 h No reaction 
4 1.2 equiv NaH, 5 equiv MeI, THF, r.t., 20 h No reaction 
5 3 equiv BH3.Me2S, CH2Cl2, r.t., 1 h No reaction 
6 3 equiv BH3.Me2S, CH2Cl2, Δ, 2 h Complex reaction mixture 
 
Since all attempts to achieve a selective reduction of the amide moiety in the presence of the ester 
functionality failed, this pathway was abandoned and an alternative approach was sought, which 
comprised the synthesis of aldimines 203 starting from hemiacetal 204 and glycine esters 19 (Scheme 55). 
The reduction of aldimines 203 in the presence of an ester function was believed to be more 
straightforward. 
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Scheme 55 
Unfortunately, the synthesis of aldimines 203 could not be effectuated. Treatment of hemiacetal 204, 
prepared via reduction of ethyl bromodifluoroacetate 14,97 with glycine esters 170b and 170a under Dean-
Stark conditions in the presence of triethylamine in toluene led to the formation of a complex reaction 
mixture. Also the use of milder reaction conditions, by using triethylamine and MgSO4 in dichloromethane, 
afforded a complex reaction mixture (Table 10). 
Table 10: Attempted synthesis of aldimines 203 
 
Entry Substrate 170 Reaction conditions Result 
1 170b (R = Et) 1 equiv 170b, 1 equiv Et3N, toluene, 
Dean-Stark, 3 h 
Complex reaction mixture 
2 170a (R = Me) 1 equiv 170a, 1 equiv Et3N, toluene,  
Dean-Stark, 3 h 
Complex reaction mixture 
3 170a (R = Me) 1 equiv 170a, 1 equiv Et3N,  
2 equiv MgSO4, CH2Cl2, r.t., 1 h 
Complex reaction mixture 
 
Because both of the above-mentioned routes toward precursors 198 failed, an alternative pathway was 
evaluated (Scheme 56). It was decided to introduce the ester function of amino esters 198 after reduction 
of amides 205 toward amines 23, thus avoiding the need for a selective reduction. 
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Scheme 56 
To this end, secondary fluorinated amines 23 were synthesized by reacting ethyl bromodifluoroacetate 14 
with different amines leading to amides 205, which in turn were reduced using borane dimethylsulfide 
complex in dichloromethane under reflux (Scheme 57).15 
 
Scheme 57 
To achieve the coupling between amines 23 with methyl bromoacetate 207a, various reaction conditions 
were applied (Table 11). In a first attempt, amine 23a was treated with 1.2 equivalents of methyl 
bromoacetate 207a in the presence of triethylamine, but this reaction gave no conversion, neither at room 
temperature nor at 70 °C (Table 11, entries 1-2). Subsequently, amine 23a was treated with sodium 
hydroxide in dichloromethane using tetrabutylammonium iodide (TBAI) as phase transfer catalyst (Table 
11, entry 3). Unfortunately, also in this case no reaction was observed. The use of NaH as a base either 
gave no conversion when the reaction was performed at 0 °C for one hour (Table 11, entry 4) or led to the 
formation of a complex reaction mixture upon reaction at room temperature for 20 h (Table 11, entry 5). 
Using N-propyl-2-bromo-2,2-difluoroethylamine 23b as substrate, the use of triethylamine in the presence 
of a catalytic amount of DMAP in dichloromethane was evaluated, with or without the addition of sodium 
iodide, but again no conversion toward the corresponding amino ester 198b was observed (Table 11, 
entries 6-7). The use of neat reaction conditions by stirring amine 23b and bromoacetate 207a in the 
presence of triethylamine was also ineffective (Table 11, entry 8). Although the alkylation of secondary 
amines with bromoacetates 207 normally proceeds under mild reaction conditions,98 the reaction with 
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amines 23 proved to be less straightforward. The lower reactivity of amines 23 is due to the decreased 
nucleophilicity of the amine nitrogen, caused by the electron-withdrawing effect of the two fluorine 
atoms. 
Table 11: Attempted synthesis of amino esters 198 starting from amines 23 
 
Entry Substrate Reaction conditions Result 
1 23a 1.2 equiv 207a, 2 equiv Et3N, DMSO, r.t., 4 h No reaction 
2 23a 1.2 equiv 207a, 2 equiv Et3N, DMSO, 70 °C, 24 h No reaction 
3 23a 1.2 equiv 207a, 3.5 equiv NaOHa, 0.2 equiv 
TBAI, CH2Cl2, r.t., 17 h 
No reaction 
4 23a 1.2 equiv 207a, 1 equiv NaH, DMF, 0 °C, 1 h No reaction 
5 23a 1.2 equiv 207a, 1 equiv NaH, DMF, r.t., 20 h Complex reaction mixture 
6 23b 1 equiv 207a, 1 equiv Et3N, 0.1 equiv DMAP, 
CH2Cl2, Δ, 17 h 
No reaction 
7 23b 1.2 equiv 207a, 1.2 equiv Et3N, 0.1 equiv DMAP, 
1 equiv NaI, CH2Cl2, Δ, 24 h 
No reaction 
8 23b 1.2 equiv 207a, 1.2 equiv Et3N, r.t., 18 h No reaction 
a 2M in H2O. 
 
Bearing in mind the disadvantageous effect of fluorine atoms on the nucleophilicity of the amine nitrogen 
atom, amine 208a was prepared, containing only one fluorine substituent at the β-position.15 At the same 
time, more stringent reaction conditions were applied, by the use of LiHMDS as the base (Table 12). In a 
first attempt, amine 208a was treated with 1.1 equivalents LiHMDS and 1.1 equivalents of methyl 
bromoacetate 207a in THF at -78 °C (Table 12, entry 1). Upon analysis of the reaction mixture, the presence 
of aziridine 210 was observed, next to a trace amount of the desired amino ester 209a. The formation of 
aziridine 210 under these reaction conditions is not surprising, since treatment of amine 208a with 1.5 
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equivalents of LiHMDS in THF at -10 °C for three hours has been used as a preparation method for 
2-fluoroaziridine 210.15 The presence of a trace amount of amino ester 209a in the reaction mixture was 
encouraging and the reaction conditions were adapted in an attempt to direct the reaction toward the 
selective formation of amino ester 209a. Increasing the number of equivalents of methyl bromoacetate 
207a led to a higher conversion toward amino ester 209a, but still a significant amount of aziridine 210 
was present in the reaction mixture (Table 12, entries 2-3). Finally, the use of seven equivalents of methyl 
bromoacetate 207a and no addition of extra solvent led to a selective conversion of amine 208a toward 
amino ester 209a, which was isolated in 79% yield (Table 12, entry 4). 
Table 12: Synthesis of amino ester 209a from amine 208a 
 
Entry Reaction conditions 
Ratioa  
208 : 209a : 210 
Yield 209a 
1 1.1 equiv 207a, 1.1 equiv LiHMDS,b THF, -78 °C, 1 h 55 : trace : 45 - 
2 3 equiv 207a, 1.1 equiv LiHMDS,b THF, -78 °C – r.t., 19 h 29 : 20 : 51 - 
3 5 equiv 207a, 1.1 equiv LiHMDS,b THF, -78 °C - r.t., 20 h 14 : 31 : 55 25% 
4 7 equiv 207a, 1.1 equiv LiHMDS,b 0 °C – r.t., 23 h 0 : 100 : 0 79% 
a Determined via 1H NMR analysis of the crude reaction mixture. b 1M in THF. 
 
Subsequently, these optimized reaction conditions were applied to bromodifluorinated amines 23. Due to 
the lower nucleophilicity of these amines, a higher reaction temperature of 70 °C had to be applied, 
achieving a selective conversion of amines 23 toward amino esters 198a,c,d which were isolated in 
moderate to good yields (Scheme 58). 
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Scheme 58 
3.4.3 Attempted ring closure toward 3-fluoro- and 3,3-difluoroazetidine-2-
carboxylates 
Having precursors 198 and 209 in hand, their ring closure toward the envisioned fluorinated azetidines 
was evaluated. In a first attempt, monofluorinated amino ester 209a was treated with 1.1 equivalents of 
KOtBu for two hours at room temperature. After analysis of the reaction mixture, it was concluded that 
KOtBu had reacted as a nucleophile leading to transesterification toward the corresponding tert-butyl 
ester 212 (Scheme 59). This compound 212 was tentatively identified from the crude reaction mixture via 
1H NMR and LC-MS analysis, but was not isolated. 
 
Scheme 59 
To avoid this transesterification reaction, the use of NaOMe was evaluated next. While reaction of amino 
ester 209a with NaOMe in THF at 0 °C or at room temperature for three hours only led to recovery of the 
starting material, increasing the temperature to reflux temperature led to the formation of a complex 
reaction mixture after three hours of reaction.  
Next, the use of the stronger base LiHMDS was assessed, which was a suitable base for the synthesis of 
azetidine-2-carboxylates starting from very similar non-fluorinated amino esters.14b First, precursor 209a 
was treated with 1.2 equivalents of LiHMDS in THF at -78 °C for two hours (Table 13, entry 1). However, 
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no reaction was observed. Surprisingly, after stirring amino ester 209a in the presence of 1.1 equivalents 
of LiHMDS at 0 °C for one hour, 64% conversion toward amine 208a was observed (Table 13, entry 2). 
Apparently, these reaction conditions lead to removal of the methoxycarbonylmethyl group of amino ester 
209a. This conversion is very peculiar and has not been observed in the literature upon treatment of 
alkoxycarbonylmethylamines with LiHMDS. However, the reductive removal of an alkoxycarbonylmethyl 
group has been reported by photoactivated electron transfer from a neutral organic donor or in the 
presence of lithium.99 The addition of 0.2 equivalents KI to the reaction mixture also did not lead to ring 
closure toward the envisioned azetidine 211 and again 60% conversion toward secondary amine 208a was 
observed (Table 13, entry 3). When the reaction of precursor 209a with LiHDMS was performed in a 
THF/HMPA 10/1 mixture,14a no reaction was observed after two hours at 0 °C (Table 13, entry 4). Increasing 
the reaction temperature to room temperature gave no conversion after one hour of reaction, but led to 
the formation of a complex reaction mixture, in which amine 208a was not detected, when the reaction 
time was prolonged to 17 hours (Table 13, entry 5). Apparently, the lithium ion plays a role in the removal 
of the methoxycarbonylmethyl group leading to the formation of amine 208a. To test the influence of the 
cation in this reaction, precursor 209a was reacted with 1.1 equivalents of KHMDS in THF at 0 °C for one 
hour (Table 13, entry 6). After this time, no reaction conversion was observed, neither toward the 
envisioned azetidine 211, nor toward secondary amine 208a. It can be concluded that the lithium cation 
of LiHMDS is essential for the removal of the methoxycarbonylmethyl group from nitrogen, but its specific 
role remains unclear. Since the reaction of precursor 209a with KHMDS at 0 °C gave no conversion at all, 
this reaction was repeated at room temperature for two hours. Follow-up of this reaction also indicated 
no conversion, so to test if deprotonation at the α-position of the ester took place, the mixture was 
quenched with D2O and stirred for 30 minutes at room temperature. After analysis of the reaction mixture, 
it was concluded that no deuterium atom was present in the end product and thus amino ester was not 
deprotonated by KHMDS. This is in contrast to an example in the literature, were very similar glycinates, 
containing a -CH2CF3 substituent at nitrogen, were alkylated at the α-position of the ester function by 
treatment with KHMDS and a suitable alkyl halide. Thus, in that case, deprotonation did occur, although 
the alkylation only proceeded with activated alkyl halides like allyl bromide, while no alkylation occurred 
using allyl chloride or butyl bromide as the electrophile.100 Also when NaHMDS was used, no reaction was 
observed after one hour at 0 °C (Table 13, entry 8), and no deprotonation occurred after stirring the 
reaction mixture at room temperature for 2.5 hours (Table 13, entry 9). As another example of a nitrogen 
base with a litium cation, precursor 209a was treated with LiTMP, freshly prepared from 
tetramethylpiperidine and BuLi, at -78 °C (Table 13, entry 10). This mixture was stirred at the same 
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temperature for one hour and was then allowed to warm to room temperature and stirred for another 17 
hours. However, after work-up, starting compound 209a was present in the reaction mixture, next to some 
unidentified side products. 
Table 13: Attempted ring closure of amino ester 209a 
 
Entry Reaction conditions Result 
1 1.2 equiv LiHMDS, THF, -78 °C, 2 h No reaction 
2 1.1 equiv LiHMDS, THF, 0 °C, 1 h 64% conversiona 
3 1.1 equiv LiHMDS, 0.2 equiv KI, THF, 0 °C, 1 h 60% conversiona 
4 1.2 equiv LiHMDS, THF/HMPA 10/1, 0 °C, 2 h No reaction 
5 1.2 equiv LiHMDS, THF/HMPA 10/1, r.t., 17 h Complex reaction mixture 
6 1.1 equiv KHMDS, THF, 0 °C, 1 h No reaction 
7 1) 1.1 equiv KHMDS, THF, r.t., 2 h 
2) D2O, r.t., 30 min 
No reaction 
8 1.1 equiv NaHMDS, THF, 0 °C, 1 h No reaction 
9 1) 1.1 equiv NaHMDS, THF, r.t., 2.5 h 
2) D2O, r.t., 30 min 
No reaction 
10 1.1 equiv LiTMP, THF, -78 °C, 1 h, then r.t., 17 h 209a + side products 
11 1.1 equiv LDA, 2 equiv TMSCl, THF, -78 °C, 20 min, then r.t., 1 h No reaction  
a Determined via 1H NMR analysis of the crude reaction mixture. 
 
A possible reaction mechanism for the removal of the methoxycarbonylmethyl group could include 
silylation of compound 209a, followed by degradation towards amine 208a. To test this hypothesis, it was 
attempted to silylate amino ester 209a by treatment with LDA, followed by the addition of TMSCl.101 
However, after stirring this reaction mixture at -78 °C for 20 minutes, followed by one hour at room 
temperature, no reaction could be observed (Table 13, entry 11).  
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Alternatively, the formation of amine 208a could be the result of the nucleophilic attack of the base 
LiHMDS at the α-carbon of the amino ester, followed by expulsion of amine 208a as leaving group. In that 
case, methyl bis(trimethylsilyl)glycinate should be formed as a byproduct. The reaction of amino ester 
209a with LiHMDS was repeated using the reaction conditions mentioned in Table 13, entry 2 (1.1 equiv 
LiHMDS, THF, 0 °C, 1 h). The reaction mixture was analysed using GC-MS without work-up, but methyl 
bis(trimethylsilyl)glycinate could not be detected, while amine 208a was again present in the reaction 
mixture. 
Upon treatment of precursor 209a with butyllithium the envisaged azetidine was also not formed. Instead, 
addition of butyllithium across the carbonyl led to formation of ketone 213 and tertiary alcohol 214 in a 
mixture with starting compound 209a (Scheme 60). The purification of this mixture was attempted via 
column chromatography, but this failed since reaction products 209a, 213 and 214 could not be separated. 
 
Scheme 60 
Next, precursor 209a was reacted with 1.2 equivalents of NaH in THF. However, no reaction was observed 
after two hours at 0 °C or at room temperature. To test if deprotonation had occurred, the reaction of 
precursor 209a with NaH at room temperature was repeated and quenched with D2O after two hours. 
Again no incorporation of deuterium was observed, and it was concluded that NaH did not deprotonate 
precursor 209a. 
Next, the reactivity of the difluorinated analogues 198 toward bases was evaluated, to see if similar results 
could be observed (Table 14). Thus, benzyl ester 198c reacted with 1.1 equivalents of LiHMDS in THF at 
0 °C and after one hour, 25% conversion toward secondary amine 23a was observed, without any 
conversion toward the envisaged azetidine. Again, removal of the alkoxycarbonylmethyl group at nitrogen 
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occurred and it was concluded that this reaction was independent of the alcohol part of the ester. Also the 
reaction of methyl ester 198a with 1.1 equivalents of LiHMDS led to the formation of amine 23a (40% 
conversion after one hour). 
Table 14: Attempted ring closure of amino esters 198 
 
Entry Substrate Reaction conditions Resulta 
1 198c (R = Bn) 1.1 equiv LiHMDS, THF, 0 °C, 1 h 25% conversion 
2 198a (R = Me) 1.1 equiv LiHMDS, THF, 0 °C, 1 h 40% conversion 
a Determined via 1H NMR analysis of the crude reaction mixture. 
 
To test the influence of the substituent at nitrogen, the ring closure of N-propyl amino ester 198d was also 
evaluated. Thus, amino ester 198d was treated with 1.1 equivalents of LiHMDS at 0 °C for two hours (Table 
15, entry 1). However, in this case, no formation of the corresponding secondary amine 23b was observed. 
Instead, after work-up a complex mixture was obtained, in which only amino ester 198d was detected. It 
was concluded that the substituent at nitrogen has an influence on the removal of the 
alkoxycarbonylmethyl group leading to the corresponding secondary amines, but the nature of this 
influence remains unclear. Amino ester 198d was also treated with LiHMDS under other reaction 
conditions (1 equiv Ag2CO3, toluene, r.t., 2 h), but again a complex mixture was obtained in which only 
starting compound 198d was detected (Table 15, entry 2). 
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Table 15: Attempted ring closure of amino ester 198d 
 
Entry Reaction conditions Result 
1 1.1 equiv LiHMDS, THF, 0 °C, 2 h 198d in a complex mixture 
2 1.05 equiv LiHMDS, 1 equiv Ag2CO3, toluene, r.t., 2 h 198d in a complex mixture 
 
The removal of the alkoxycarbonylmethyl substituent on nitrogen upon treatment of amino esters 209 
and 198a,c with LiHMDS is interesting and should be investigated more thoroughly. However, in the 
timeframe of this PhD thesis, this was not possible. 
3.4.4 Conclusion 
In this part of this PhD thesis, the synthesis of fluorinated azetidine-2-carboxylates was attempted. The 
synthesis of amino esters 209 and 198 was not straightforward, but after many attempts, a pathway 
toward these precursors 209 and 198 was developed and optimized. However, the ring closure toward the 
envisioned azetidines could not be effectuated. While the use of LiHMDS led to conversion of precursors 
209 and 198a,c to the corresponding secondary amines by removal of the alkoxycarbonylmethyl group, no 
deprotonation of the amino esters was observed upon use of KHMDS, NaHMDS or NaH. Finally, the use of 
KOtBu and BuLi led to a nucleophilic addition across the carbonyl moiety of the ester function. It is clear 
that the presence of the fluorine atoms has an influence on the behavior of these amino esters, since the 
corresponding non-fluorinated analogues are suitable substrates for the synthesis of azetidine-2-
carboxylates. 
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3.5 Synthesis of fluorinated heterocycles by exploring the nucleophilic vinylic 
substitution (SNV) reaction of gem-difluoroenamides 
3.5.1 Introduction 
The class of enamides represents an interesting group of compounds, since they demonstrate an enhanced 
stability as compared to enamines, but still exhibit a rather nucleophilic reactivity.102 A significant amount 
of research has already been devoted to the class of β,β-dihaloenamines and β,β-dihalogenated 
enamides.103 In contrast, while some β,β-difluorinated enamines have been used as building blocks, for 
example, in the synthesis of difluorocysteine and -serine derivatives,104 dipeptides,105 difluoroimines106 and 
various α,α-difluoro-β-hydroxycarbonyl compounds,107 the chemistry of difluoroenamides has received 
only very limited attention. To our knowledge, this reactivity was exploited only twice toward the synthesis 
of fluorinated heterocycles, more specifically toward isoxazolidines and dihydropyrans108 or oxazoles.109 
Furthermore, one example was found in which the intermediacy of a difluoroenamide was postulated in 
the synthesis of morpholino-fused diketopiperazines.110 Also, while gem-difluoroalkenes have been used 
in a nucleophilic vinylic substitution reaction (SNV) for the synthesis of a variety of fluorinated 
heterocycles,111 their nitrogen-substituted analogues have received less attention. This is remarkable since 
the presence of two fluorine atoms at the β-carbon atom of enamide 25 in combination with an electron-
withdrawing acyl or sulfonyl group (R2) at nitrogen, will lead to a highly polarized double bond and an 
electron-deficient difluorinated carbon atom (Figure 14). If this effect could predominate the electron-
donating effect of the enamide nitrogen atom, enamide 25 would be an example of an electrophilic 
enamide readily reacting with nucleophiles. In this way, the introduction of two fluorine atoms at the 
β-position could be seen as an efficient way to induce umpolung of the enamide functionality.112 The 
potential to use this chemistry in a way that fundamentally deviates from the reactivity of Stork enamines 
and enamides 215113 is the basis of this part of this PhD thesis (Figure 14). 
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Figure 14 
3.5.2 Synthesis of β,β-difluorinated enamides 
In the first part of this work, the synthesis of novel β,β-difluoroenamides 218 and 220 was developed 
(Scheme 61). N-Propyl-2-bromo-2,2-difluoroethylamine 23b was used as the starting compound for this 
synthesis while protection of the secondary amine was necessary in order to avoid aziridine formation 
upon treatment of amine 23b with base.15 Therefore, amine 23b was protected as benzamide 217 or 
tosylamide 219 in good yield by treatment with benzoyl chloride or p-toluenesulfonyl chloride, 
respectively, in dichloromethane in the presence of base. In a final step, benzamide 217 and tosylamide 
219 were treated with LiHMDS in THF at 0 °C to room temperature for three hours in order to achieve 
dehydrobromination, smoothly leading to the formation of new difluorinated enamides 218 and 220 
(82-85% yield). 
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Scheme 61 
3.5.3 Reactivity of β,β-difluorinated enamides 218 and 220 toward nucleophiles 
To test the potential electrophilic reactivity of enamides 218 and 220, a reactivity study with different 
nucleophiles was performed. First, tosylated enamide 220 was treated with benzylamine under various 
reaction conditions (in the presence of K2CO3 or LiHMDS, in CH2Cl2, CH3CN or THF, at 0 °C or reflux 
conditions), but no conversion of products was observed. Next, enamide 220 was reacted with thiophenol 
in the presence of Et3N in acetonitrile at reflux temperature, but again only the starting compound 220 
was recovered (Table 16, entry 1). However, when the reaction with thiophenol was conducted using KOH 
as a base, a mixture of the isomeric fluorinated enamides 221a and 222a (ratio 221a : 222a = 8 : 2) was 
obtained, from which enamide 221a was isolated in 69% yield (Table 16, entry 2). β-Fluoroenamides 221a 
and 222a are the products of a nucleophilic substitution at the vinylic CF2 carbon atom of enamide 220, 
most probably via a non-concerted two-step process (SNV reaction),111a,114 i.e. addition of the nucleophile 
across the double bond is followed by elimination of fluoride (Scheme 62, path a). When enamide 220 was 
treated with 1.2 equivalents of phenol in the presence of KOH, four different products were detected in 
the reaction mixture after work-up, i.e. the isomeric enamides 221b and 222b, addition product 223b 
(formed by protonation of intermediate 225 (Scheme 62, path b)) and amino ester 224b, in a ratio of 221b 
: 222b : 223b : 224b = 4 : 2 : 1 : 3. After purification of this mixture (column chromatography, SiO2), only 
two compounds were isolated, more specifically adduct 223b (10%) and amino ester 224b (85%) (Table 
16, entry 3). Apparently, enamides 221b and 222b were not stable upon prolonged exposure to SiO2 and 
hydrolyzed toward amino ester 224b. When the reaction of enamide 220 with phenol was repeated and 
the reaction mixture was purified via flash column chromatography (SiO2), a mixture of isomers 221b and 
222b was isolated in 32% total yield (ratio 221b : 222b = 8 : 2) (Table 16, entry 4). Finally, two additional 
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nucleophiles were evaluated in this addition-elimination reaction (Table 16, entries 5-6). The reaction of 
enamide 220 with both sodium methoxide (in MeOH/THF) and potassium tert-butoxide (in THF) gave a 
smooth conversion toward a mixture of isomers 221 and 222. In the case of NaOMe, compounds 221c and 
222c were separated by column chromatography, whereas only addition product 221d of KOtBu was 
isolated in 46% yield.  
Table 16: Reactivity of enamide 220 toward nucleophiles 
 
Entry 
Nucleophile 
(equiv) 
Reaction conditions 
Ratioa 
221:222:223:224 
Compound (%)b 
1 thiophenol (1) 1 equiv Et3N, CH3CN, 0 °C - Δ, 24 h 1 : 0 : 0 : 0 - 
2 thiophenol (1.2) 1.2 equiv KOH, CH3CN, Δ, 20 h 8 : 2 : 0 : 0 221a (69) 
3 phenol (1.2) 1.2 equiv KOH, CH3CN, Δ, 20 h 4 : 2 : 1 : 3 223b (10) +  
224b (85)c 
4 phenol (1.2) 1.2 equiv KOH, CH3CN, Δ, 20 h 4 : 2 : 1 : 3 221b/222b (32)d 
5 NaOMe (1.1)e THF, r.t., 3 h 8 : 2 : 0 : 0 221c (57) +  
222c (15) 
6 KOtBu (1.1) THF, 0 °C - r.t., 2 h 8 : 2 : 0 : 0 221d (46) 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. c Formed due to hydrolysis 
of 221b/222b upon prolonged exposure to silica. d Ratio 221b : 222b = 8 : 2; the isomers could not be 
separated. e 1M in MeOH. 
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Scheme 62 
The reaction of β,β-difluorinated enamide 218 with phenol under similar reaction conditions (1.2 equiv 
phenol, 1.2 equiv KOH, CH3CN, reflux), also led to the formation of a mixture of (E)-β-fluoro-β-
phenoxyenamide 226 and (Z)-β-fluoro-β-phenoxyenamide 227, which could not be separated via column 
chromatography, in 80% yield (Scheme 63). 
 
Scheme 63 
The differentiation between the isomeric β-fluoroenamides 221 and 222 was made based on comparison 
of the value of the vicinal coupling constant 3JH,F of the signal of the hydrogen atom at the α-position of 
the vinylic double bond. More specifically, in case of the oxygen-substituted monofluorinated enamides 
221b-d and 222b-d, Z-3JH,F (H and F in a Z configuration) has a value of 0.7-1.7 Hz, while E-3JH,F (H and F in 
an E configuration) results in a much larger value of 19-22 Hz. For the sulfur analogues 221a and 222a 
larger coupling constants were observed, with a value of 5.5 Hz for Z-3JH,F and a larger value of 25.0 Hz for 
E-3JH,F. In case of fluoroenamides 226 and 227, a less resolved 1H NMR was obtained due to hindered 
rotation of the amide bond. However, the differentiation between the isomers could still be made since 
the signal of the hydrogen at the α-position of the vinylic double bond appeared as a broad singlet in case 
of isomer 226 and as a doublet with a coupling constant E-3JH,F of 19.7 Hz in case of isomer 227. 
A possible explanation for the moderate stereoselectivity of this addition-elimination reaction toward 
enamides 221 and 226 (H and F in a Z configuration) can be found by evaluating the conformation of the 
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intermediate carbanions after addition of the nucleophile (Figure 15). To allow fluoride elimination, the 
lone pair of the intermediate carbanion and the fluorine atom must adopt antiperiplanar positions, which 
is the case in two possible transition state models TS-A and TS-B. In TS-B, the substituted nitrogen atom is 
situated in a gauche conformation between the two fluorine atoms, generating an important electronic 
repulsion. In TS-A, only one repulsive interaction between the nitrogen atom and fluorine is possible, 
rendering this conformer energetically more favoured. On the other hand, in TS-A a mild steric hindrance 
is present between the nitrogen atom and the nucleophile. The combination of these two factors, more 
specifically electronic repulsion (which is the main factor) and steric hindrance, leads to the moderate 
stereoselectivity.115 
 
Figure 15  
An alternative pathway for the formation of the substituted enamides 221, 222, 226 and 227 comprises 
initial formation of the corresponding ynamide 228 due to a base-promoted elimination of HF from 
enamides 218 and 220, followed by the addition of the nucleophile (Scheme 64). In this case however, 
formation of the ynamide moiety of compound 228 by dehydrofluorination would result in protonation of 
the nucleophile and formation of the conjugated acid. For example, if treatment of enamide 220 with 
NaOMe (Table 16, entry 5), would lead to the corresponding ynamide, MeOH should be a good nucleophile 
to add across the triple bond. However, upon stirring ynamide 266a (vide infra) in MeOH for a prolonged 
time, no addition of MeOH was observed. Therefore, it is believed that these transformations operate 
through an initial addition of the nucleophile, followed by elimination of fluoride. 
 
Scheme 64  
In a next part, the addition-elimination reaction of carbon nucleophiles across enamide 220 was also 
evaluated. As a first nucleophile, KCN was reacted with difluoroenamide 220 in the presence of NaHCO3 in 
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DMSO at room temperature for 45 hours. After work-up, a mixture of three compounds was obtained, 
more specifically the isomeric substituted fluoroenamides 229 and 230 and N-propyl-p-
toluenesulfonamide 231 (Table 17, entry 1).116 Also in this case, a nucleophilic vinylic substitution reaction 
was observed, leading to the formation of two isomers 229 and 230, with a moderate stereoselectivity 
toward monofluoroenamide 229 (ratio 229 : 230 = 2 : 1). Additionally, a significant amount of N-propyl-p-
toluenesulfonamide 231 was present in the reaction mixture, a compound which was never formed upon 
reaction of difluoroenamide 220 with sulfur and oxygen nucleophiles (Table 16). A possible mechanism for 
the formation of compound 231 is presented in Scheme 65. Compounds 229 and 230 could display the 
reactivity of Michael acceptors due to the presence of the electron withdrawing nitrile substituent. Thus, 
Michael-type addition of cyanide across the double bond of 229 or 230 leads to the formation of 
compound 232 after elimination of amide 233. Upon extractive work-up, unsaturated dinitrile 232 is 
probably discarded with the water phase, since this compound was never detected, and potassium salt 
233 is protonated to give N-propyl-p-toluenesulfonamide 231. The use of ten equivalents of NaHCO3 led 
to a similar reaction outcome (Table 17, entry 2). Changing the base to triethylamine and using dry DMF 
as the solvent also did not lead to better results and again a significant amount of tosylated amine 231 
was present in the reaction mixture, albeit in a slightly lower amount (Table 17, entry 3). However, a higher 
selectivity toward enamide 229 was observed (ratio 229 : 230 = 3 : 1). Upon use of NaCN as the cyanide 
source again a higher amount of amine 231 was present in the reaction mixture, with a ratio of 229 : 230 
= 2.5 : 1. After purification, a mixture of isomeric fluoroenamides 229 and 230 was obtained, in a ratio 229 
: 230 = 3 : 1. Performing the reaction at a higher temperature of 40 °C led to the formation of a higher 
amount of sulfonamide 231 while still a long reaction time was needed to achieve a full conversion of the 
starting material. However, a mixture of enamides 229 and 230 was isolated in 30% yield (ratio 229 : 230 
= 3 : 2) (Table 17, entry 5). Changing the solvent to acetone did not lead to better results since no 
conversion was observed after 17 hours of reaction at reflux temperature (Table 17, entry 6). 
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Table 17: Reactivity of enamide 220 toward cyanide nucleophiles 
 
Entry Reaction conditions Ratioa 220 : 229 : 230 : 231 Yield 229+230 
1 2 equiv KCN, 2 equiv NaHCO3, DMSO, r.t., 45 h 0 : 39 : 19 : 42 - 
2 2 equiv KCN, 10 equiv NaHCO3, DMSO, r.t., 24 h  4 : 36 : 17 : 43 - 
3 2 equiv KCN, 2 equiv Et3N, DMF (dry), r.t., 24 h 8 : 43 : 16 : 34 - 
4 2 equiv NaCN, 2 equiv Et3N, DMF (dry), r.t., 7 h 5 : 37 : 14 : 44 40%b 
5 2 equiv KCN, 2 equiv Et3N, DMF, 40 °C, 23 h 0 : 24 : 14 : 64 30%c 
6 1.05 equiv KCN, 2 equiv Et3N, acetone, Δ, 17 h 100 : 0 : 0 : 0 - 
a Determined via 1H NMR analysis of the crude reaction mixture. b Ratio 229 : 230 = 3 : 1. c Ratio 229 : 230 
= 3 : 2. 
 
 
Scheme 65 
 
The reactivity of β,β-difluoroenamide 220 toward dimethyl malonate was also investigated, but no 
reaction was observed under various reaction conditions (Table 18). Also the reaction of enamide 220 with 
the Grignard reagent ethylmagnesium bromide only led to recovery of the starting material. 
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Table 18: Reactivity of enamide 220 toward dimethyl malonate 
 
Entry Reaction conditions Result 
1 1 equiv dimethyl malonate, 1 equiv pyridine, THF, 0 °C - r.t., 21 h No reaction 
2 1 equiv dimethyl malonate, 1.2 equiv K2CO3, acetone, ∆, 18 h No reaction 
3 1.05 equiv dimethyl malonate, 1.05 equiv NaH, THF, ∆, 20 h No reaction 
 
3.5.4 Synthesis of 6-fluoro-3,4-dihydro-2H-1,4-oxazines 
In the next part, the reactivity of β,β-difluorinated enamides 218 and 220 toward oxygen nucleophiles 
(Table 16, Scheme 63) was expanded to the synthesis of novel heterocyclic monofluorinated compounds 
by incorporating the oxygen nucleophile and the electrophilic β,β-difluoroenamide unit in the same 
precursor, thus enabling an intramolecular vinylic nucleophilic substitution. As such, the synthesis of 
precursors 236 was envisioned, with a two-atom containing linker between the nitrogen atom and the 
oxygen nucleophile, which should lead to the formation of fluorinated 2H-3,4-dihydro-1,4-oxazines 235 
after ring closure (Scheme 66). N-Functionalized oxazines have been reported in the literature,117 and 
these compounds exhibit interesting biological activities, for examples as transthyretin amyloid fibril 
inhibitors,118 and they have been described as intermediates for the synthesis of bridged morpholines.119 
However, 6-fluoro-2H-3,4-dihydro-1,4-oxazines 235 have not been reported in the literature up to date. 
 
Scheme 66 
The first step in the synthetic sequence toward fluorinated enamides 236, should be the coupling of ethyl 
bromodifluoroacetate with an amine containing a protected alcohol function, which could then in the last 
step be used as the oxygen nucleophile to achieve ring closure. As such, 2-aminoethanol 237 was protected 
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as trimethylsilylether 238, by reaction with TMSCl in the presence of triethylamine, in 55% yield (Scheme 
67).120 
 
Scheme 67 
Next, amine 238 reacted with ethyl bromodifluoroacetate 14 resulting in the formation of amide 239, 
which was isolated in an excellent yield of 96% (Scheme 68). In the next step, the reduction of amide 239 
toward amine 240 was investigated using borane dimethylsulfide complex as the reducing agent. 
However, despite the use of different reaction times and temperatures (4 - 24 h, r.t. or Δ), removal of the 
trimethylsilyl protecting group toward alcohol 201 was always observed, leading to mixtures of reaction 
products 201 and 240 and starting compound 239, in varying ratios (Scheme 68). Therefore, the use of 
another protecting group had to be evaluated. 
 
Scheme 68 
Thus, 2-aminoethanol 237 was treated with TBDMSCl in the presence of imidazole in dichloromethane for 
two hours at room temperature, giving a smooth conversion toward tert-butyldimethylsilylether 241 
(Scheme 69).121 
 
Scheme 69 
Subsequently, compound 241 reacted with ethyl bromodifluoroacetate 14 to obtain amide 242 in 65% 
yield. The reduction of amide 242 was effectuated by reaction with BH3.Me2S, without concomitant 
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removal of the TBDMS protecting group, affording amine 243 in 89% yield. Next, a tosyl group was 
introduced at the amine nitrogen atom, by reaction with tosyl chloride in dichloromethane in the presence 
of triethylamine and DMAP. However, this reaction proceeded very slowly and after a prolonged reaction 
time of 14 days tosylamide 244 was isolated in a low yield of 25%. This tosylation reaction was also 
attempted in the presence of Ag2O and KI,122 but no better results were obtained. The dehydrobromination 
of tosylamide 244 proceeded smoothly and resulted in the formation of β,β-difluoroenamide 245 in 70% 
yield (Scheme 70). Next, the deprotection of the tert-butyldimethylsilyl ether of compound 245 was 
attempted. However, upon reaction of TBDMS ether 245 with TMAF or TBAF, either no reaction was 
observed at 0 °C, or a complex mixture was obtained when the reaction was performed at higher 
temperature, in which the envisioned oxazine 246 was present based on LC-MS analysis of the reaction 
mixture, but this compound could not be isolated. 
 
Scheme 70 
Based on these moderate results, the introduction of other protecting groups at nitrogen was evaluated. 
In a first attempt, the reaction of amine 243 with para-nitrobenzenesulfonylchloride (p-NsCl) gave no 
conversion toward the corresponding sulfonamide 247 (Table 19, entry 1). The reaction of amine 243 with 
triflic anhydride gave better results and trifluoromethanesulfonamide 248 was isolated in 75% yield after 
reaction in dichloromethane for 17 hours at room temperature (Table 19, entry 2). Also the reaction with 
benzoyl chloride proceeded smoothly toward benzamide 249, which was isolated in a good yield of 71% 
(Table 19, entry 3). 
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Table 19: Protection of amine 243 
 
Entry PG Reaction conditions Result 
1 p-Ns 1 equiv p-NsCl, 3 equiv Et3N, CH2Cl2, r.t. – Δ, 48 h No reaction 
2 Tf 1.1 equiv Tf2O, 1.2 equiv Et3N, CH2Cl2, r.t., 17 h 75% 248a 
3 Bz 1 equiv benzoyl chloride, 1.1 equiv Et3N, CH2Cl2, Δ, 4 h 71% 249a 
a Isolated yield. 
 
In the next step, dehydrobromination of amines 248 and 249 by treatment with LiHMDS in THF led to the 
formation of β,β-difluoroenamides 250 and 251 in low to good yields (Scheme 71). 
 
Scheme 71 
Since the formation of enamide 250 was achieved in the highest overall yield, the TBDMS deprotection of 
this compound was studied in more detail (Table 20). In a first attempt, trifluoromethanesulfonamide 250 
was treated with 1.05 equivalents of TMAF (tetramethylammonium fluoride) in THF at room temperature. 
After stirring this mixture at the same temperature for 20 hours, a reaction conversion of 30% was 
observed (Table 20, entry 1). Encouraged by this result, the reaction time was prolonged to 40 hours, but 
after work-up a complex reaction mixture was obtained and although oxazine 252 was present in this 
mixture, this compound could not be isolated (Table 20, entry 2). Also the reaction of 250 with TMAF at 
reflux conditions led to the formation of a complex reaction mixture (Table 20, entry 3). The reaction of 
enamide 250 with TBAF (tetrabutylammonium fluoride) gave better results since 100% conversion toward 
oxazine 252 was obtained after 30 minutes of reaction at 0 °C and compound 252 was isolated, albeit in a 
very low yield of 4% (Table 20, entry 4). The deprotection of compound 250 was also effectuated using a 
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catalytic amount of TBAF since upon ring closure toward oxazine 252, fluoride is expelled as the leaving 
group. In this case, oxazine 252 was isolated in a slightly higher yield of 10% (Table 20, entry 5). 
Table 20: Synthesis of 6-fluoro-4-(trifluoromethanesulfonyl)-3,4-dihydro-2H-1,4-oxazine 252 
 
Entry Reaction conditions Result 
1 1.05 equiv TMAF, THF, r.t., 20 h 30% conversiona 
2 1.05 equiv TMAF, THF, r.t., 40 h 252 in complex reaction mixtureb 
3 1.1 equiv TMAF, THF, Δ, 17 h Complex reaction mixture 
4 1.1 equiv TBAF, THF, 0 °C, 30 min 4% 252c 
5 0.2 equiv TBAF, THF, r.t., 17 h 10% 252c 
a Determined via 1H NMR analysis of the crude reaction mixture. b Compound 252 could not be isolated.  
c Isolated yield. 
 
The removal of the TBDMS protecting group of benzamide 251 was also attempted using TBAF at room 
temperature, but led to a mixture of compounds. However, LC-MS indicated the presence of the 
envisioned 1,4-oxazine and further optimization of this reaction is necessary. 
3.5.5 Synthesis of 2-fluoro-1,4-benzoxazines123 
Since the synthesis of oxazine 252 proceeded sluggishly, it was decided to change the two atom linker in 
an attempt to improve the stability of the reaction compounds. Thus, the synthesis of benzofused oxazines 
253 was envisaged, with enamides 254 as suitable precursors (Scheme 72). 
 
Scheme 72 
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The class of dihydro-1,4-benzoxazines 255 has been studied extensively during the last decades, because 
compounds containing this scaffold are known to possess a broad range of interesting biological activities 
such as antidiabetic, antibacterial, anti-inflammatory and neuroprotective activity.124 Recently, derivatives 
of 3,4-dihydro-2H-1,4-benzoxazine 255 were also identified as multi-isoform PI3K,125 diacylglycerol 
acyltransferase126 and angiogenesis inhibitors127 and as potential dual antithrombotic compounds.128 On 
the other hand, less research has been devoted to the synthesis of their unsaturated analogues, 
1,4-benzoxazines 256.124a,129 Nevertheless, some of these compounds have also been shown to possess 
interesting biological activities. An example of a natural product containing the 1,4-benzoxazine core is 
cappamensin A 257, isolated from the roots of Capparis sikkimensis (Figure 16). This substituted 
benzoxazine derivative shows a promising antitumor activity.130 The development of analogues of 
cappamensin A, as potential antitumor agents, is therefore of great interest. Although benzoxazines 
containing a CF3-group have already been synthesized,131 examples of compounds carrying the fluorine 
substituent directly attached to the heterocyclic ring are barely known132 and only one example of a 
2-fluoro-1,4-benzoxazine derivative was found in literature.133 
 
Figure 16 
For the synthesis of the precursor enamides 254, 2-aminophenol 258a was chosen as the building block 
(Scheme 73). First, alcohol 258a was protected as its TBDMS ether, by reaction with TBDMSCl in the 
presence of imidazole in dichloromethane, affording compound 259a in quantitative yield.134 Next, the 
condensation of tert-butyldimethylsilyl ether 259a with ethyl bromodifluoroacetate 14 was attempted. 
First, aniline 259a was stirred in dichloromethane in the presence of ethyl bromodifluoroacetate 14 for 16 
hours at room temperature, but no reaction was observed (Table 21, entry 1). Next, aniline 259a was 
reacted with ester 14 in ethyl acetate at reflux temperature for 17 hours, but again only the starting 
compounds were recovered (Table 21, entry 2).135 When aniline 259a was treated with ester 14 under 
solvent-free reaction conditions at 80 °C, 65% conversion of the starting compounds was observed after 
24 hours (Table 21, entry 3). However, upon purification of amide 260a (SiO2), removal of the TBDMS 
protecting group was observed and compound 260a could not be recovered. 
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Scheme 73 
Table 21: Synthesis of amide 260a from aniline 259a and ethyl bromodifluoroacetate 14 
Entry Reaction conditions Result 
1 1 equiv 259a, 1 equiv 14, CH2Cl2, r.t., 16 h No reaction 
2 1 equiv 259a, 1 equiv 14, 1 equiv Et3N, EtOAc, Δ, 17 h No reaction 
3 1 equiv 259a, 1 equiv 14, neat, 80 °C, 24 h 65% conversiona,b 
a Determined via 1H NMR analysis of the crude reaction mixture. b Purification failed. 
 
Because the amide formation by reaction of aniline 259a with ethyl bromodifluoroacetate 14 was not 
straightforward, probably due to steric hindrance caused by the TBDMS protecting group, it was decided 
to change the reaction order. Thus, 2-aminophenol 258a was reacted in the first step with ethyl 
bromodifluoroacetate 14, leading to the selective formation of amide 261a (Scheme 74). In the second 
step, protection of the phenolic oxygen atom was effectuated by treatment of benzamide 261a with 
TBDMSCl in the presence of imidazole, which gave a clean conversion toward compound 260a without the 
need of purification. The same reaction sequence was applied to substituted 2-aminophenol 258b, leading 
to benzamide 260b. Amides 260 were in turn reduced toward the secondary amines 262 using an excess 
of borane dimethylsulfide complex in CH2Cl2. The next step involved the protection of the nitrogen atom 
of amines 262. Because the introduction of a tosyl group proceeded very slowly while the attempt to 
introduce a mesyl group gave no conversion at all, the use of a benzoyl protecting group was evaluated 
instead. Treatment of β-bromo-β,β-difluoroamines 262 with different benzoyl chlorides 263 in the 
presence of Et3N led to the formation of N-(2-bromo-2,2-difluoroethyl)benzamides 264 as suitable 
precursors for the synthesis of fluorinated 1,4-benzoxazines (Scheme 74). 
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Scheme 74 
The key step in the reaction sequence concerned the conversion of precursors 264 toward the envisioned 
1,4-benzoxazines (Table 22). Therefore, benzamide 264a was treated with LiHMDS, which led to the 
formation of a mixture of difluoroenamide 265a and fluorinated ynamide 266a, resulting from the 
LiHMDS-induced elimination of HF from enamide 265a (Table 22, entry 1). Increasing the number of 
equivalents of LiHMDS led to a full conversion of amide 264a toward ynamide 266a, which was isolated in 
an excellent yield of 97% (Table 22, entry 2). The formation of ynamide 266a can be explained by C-F bond 
activation by coordination of fluorine to the silicon atom in the tert-butyldimethylsilyl protecting group, 
enhancing the leaving group capacity of fluoride (Scheme 75).136 This could also explain why amides 218 
and 220 were not converted into the corresponding ynamides upon treatment with LiHMDS. Next, 
benzamide 264a was treated with one equivalent of KOtBu, leading to a selective conversion toward the 
envisioned benzoxazine 267a, which was isolated in 80% yield (Table 22, entry 3). Since the use of LiHMDS 
or KOtBu led to a different reaction outcome, other bases were evaluated in order to investigate the 
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possible reaction pathway. It was remarkable that the cleavage of the silyl ether did not occur upon 
treatment of benzamide 264a with 2.2 equivalents of LiHMDS, even though under these conditions 
fluoride is expelled from the substrate (Table 22, entry 2). To test the influence of the cation, the reaction 
was repeated with NaHMDS and KHMDS (Table 22, entries 4-5). Thus, benzamide 264a was treated with 
one equivalent of NaHMDS. LC-MS analysis of the reaction mixture after 15 minutes indicated the presence 
of four compounds, i.e. benzamide 264a, enamide 265a, ynamide 266a and benzoxazine 267a. Follow-up 
via LC-MS indicated no further progress of the reaction, so an extra equivalent of NaHMDS was added 
after three hours. After stirring for an additional three hours, the reaction was stopped and a mixture of 
enamide 265a and benzoxazine 267a was obtained in a ratio of 4 : 6, which could not be separated via 
column chromatography (Table 22, entry 4). Subsequently, benzamide 264a was treated with one 
equivalent of KHMDS, which also led to the formation of a mixture of compounds 264a, 265a, 266a and 
267a after 15 minutes of reaction at room temperature. Also in this case, an extra equivalent of base was 
added after three hours, and the reaction was stopped after an additional three hours. After work-up, only 
benzoxazine 267a was detected, so it was assumed that both enamide 265a and ynamide 266a were 
intermediates in the formation of benzoxazine 267a. It was concluded that the cation of the base plays an 
important role in the reaction outcome due to the different properties of the corresponding fluoride salts. 
Upon use of LiHMDS as the base, the reaction terminates at the stage of ynamide 266a in which the silyl 
ether is not deprotected, so apparently the fluoride anion in LiF is not available for this reaction. When 
KHMDS is used, KF is formed, in which the fluoride anion is available for the deprotection reaction, since 
this reaction leads to the formation of benzoxazine 267a after ring closure. This reactivity of alkali-metal 
fluorides may be explained by the higher lattice energy of LiF in comparison with NaF and KF.137 Following 
these results, the use of LiOtBu should also lead to the formation of a TBDMS-protected end product. 
Indeed, the reaction of benzamide 264a with one equivalent of LiOtBu afforded enamide 265a as the sole 
end product, which was isolated in 73% yield (Table 22, entry 6). 
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Table 22: Reactivity of benzamide 264a toward different bases 
 
Entry Reaction conditions 
Ratioa 
264a : 265a : 266a : 267a 
Compound (yield)b 
1 1.1 equiv LiHMDS, THF, 0 °C, 3 h 3 : 3 : 4 : 0 - 
2 2.2 equiv LiHMDS, THF, r.t., 2.5 h 0 : 0 : 1 : 0 266a (97%) 
3 1 equiv KOtBu, THF, r.t., 2 h 0 : 0 : 0 : 1 267a (80%) 
4 2 equiv NaHMDSc, THF, r.t., 6 h 0 : 4 : 0 : 6 - 
5 2 equiv KHMDSc, THF, r.t., 6 h 0 : 0 : 0 : 1 267a (54%) 
6 1 equiv LiOtBu, THF, Δ, 1.5 h 0 : 1 : 0 : 0 265a (73%) 
a Determined via 1H NMR analysis of the crude reaction mixture. b Isolated yield. c 2nd equivalent was added 
after 3 h. 
 
Scheme 75 
Subsequently, the optimized reaction conditions were used to convert benzamides 264a-d toward 
benzoxazines 267 and fluorinated ynamides 266 in good to excellent yields (Scheme 76). In an attempt to 
prove the intermediacy of ynamides 266 in the formation of benzoxazines 267, compounds 266 were 
treated with TBAF in THF in order to remove the TBDMS-protecting group, which led directly to the 
formation of benzoxazines 267. The triple bond in ynamides 266 has an electrophilic reactivity which is 
prone to nucleophilic attack by the phenolic oxygen atom, leading to a smooth conversion toward 
benzoxazines 267 (Scheme 76). 
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Scheme 76 
The chemistry of halogenated ynamides has only been explored to a limited extent. While 2-iodoynamides 
have been used in for example cycloaddition138 and benzannulation139 reactions, the synthesis and 
reactivity of fluorinated ynamides is a totally unexplored field in organic chemistry. Only one report has 
been published in which the formation of a fluorinated ynamine was described, albeit in a very low yield 
of 5%.140 Over the last years, the chemistry of ynamides has received much attention.141 Due to the 
polarization of the triple bond, α-addition of nucleophiles across the triple bond is more common than 
β-addition, although a few examples of β-addition have been described.142 Umpolung of the ynamide 
functionality, leading to addition of nucleophiles at the β-position, is usually achieved via a metal-catalyzed 
reaction. In this work, umpolung is achieved by the presence of a fluorine substituent at the β-position of 
the ynamide in combination with the electron-withdrawing group at nitrogen, leading to selective addition 
of the oxygen nucleophile at the β-position without the need of a metal catalyst. 
To further verify the influence of the tert-butyldimethylsilyl ether on the formation of ynamides 266, it 
was attempted to synthesize an ynamide without this silicon-containing substituent on the phenyl ring 
(Scheme 77). To this end, aniline 268 was reacted with ethyl bromodifluoroacetate 14, giving amide 269 
in 65% yield, which was subsequently converted into amine 270 by reduction using borane dimethylsulfide 
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complex in THF. Introduction of the benzoyl protecting group was effectuated by reacting amine 270 with 
benzoyl chloride in the presence of triethylamine, yielding benzamide 271. In the next step, benzamide 
271 was treated with LiHMDS in THF at 0 °C and the reaction was stirred at room temperature. After three 
hours, LC-MS analysis of the reaction mixture revealed the presence of enamide 272 and a trace of the 
starting compound 271, while the corresponding ynamide was not detected. After an additional hour, an 
extra 2.2 equivalents LiHMDS were added to the reaction mixture and the stirring was continued for 
another 68 hours, while it was followed-up using LC-MS analysis. However, the ynamide was never 
observed in the reaction mixture and after work-up, enamide 272 was isolated in a low yield of 31%, 
probably due to the prolonged reaction time. This result is an extra indication of the influence of the tert-
butyldimethylsilyloxy group on the formation of ynamides 266, which most probably proceeds via a silicon-
induced C-F activation. Enamide 272 was synthesized in a higher yield of 63% upon reaction of benzamide 
271 with 2.2 equiv LiHMDS for three hours at room temperature. 
 
Scheme 77 
3.5.6 Synthesis of 2-fluoro-1,4-benzoxazepin-5-ones123 
Another interesting class of benzo-fused heterocyclic compounds comprises 1,4-benzoxazepin-5-ones 
273. An important example of this type of compounds is the chlorinated analogue piclozotan 274, a 
selective 5-HT1A receptor partial agonist, which has shown in vivo neuroprotective effects.143 Recently, it 
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has been reported that piclozotan 274 also has the potency to improve motor complications (for example 
spasms or involuntary movements of muscles) which are associated with levodopa therapy, administered 
to patients suffering from Parkinson’s disease.144 While trifluoromethylated derivatives have been 
described,145 no reports were found in the literature concerning the synthesis of 2-fluoro- or 3-fluoro-1,4-
benzoxazepin-5-ones. 
 
Figure 17 
Therefore, in the next part of this work the synthesis of novel fluorinated benzo-fused seven-membered 
rings was developed. In the precursor, a three-carbon atom-containing linker had to be positioned 
between the enamide nitrogen atom and the oxygen nucleophile, in order to be able to form a seven-
membered ring via the vinylic nucleophilic substitution reaction. In the synthetic route toward 
benzoxazines 267, the oxygen nucleophile was already incorporated in the fluorinated secondary amines 
262, after which a benzoyl protecting group was introduced at nitrogen (Scheme 74). In the synthetic route 
toward the seven-membered ring analogues, it was chosen to incorporate the oxygen nucleophile in the 
aroyl group attached to nitrogen (Scheme 78). Therefore, a variety of secondary fluorinated amines was 
synthesized by reacting ethyl bromodifluoroacetate 14 with different amines leading to amides 205, which 
in turn were reduced using borane dimethylsulfide complex in dichloromethane or THF under reflux. 
Subsequently, a functionalized benzoyl group was introduced at the nitrogen atom by treatment with  
O-acetylsalicyloyl chloride 275a, leading to the formation of benzamides 276a-c. Benzamides 276 are 
suitable precursors for the synthesis of fluorinated seven-membered rings, since there is a three carbon 
linker in between the nitrogen and oxygen atom. An advantage of this synthetic route is the possibility of 
a late stage functionalization, since various derivatives of 2-acetylsalicylic acid can be used for the 
introduction of the group at nitrogen. For example, acetylsalicyloyl chlorides 275b-c, which were prepared 
from the corresponding carboxylic acids by reaction with thionyl chloride, were reacted with amine 23c, 
leading to the formation of benzamides 276d-e (Scheme 78). 
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Scheme 78 
The final step in the synthesis of the fluorinated seven-membered heterocycles 279 comprised the ring 
closure of precursors 276a-e, which should proceed via the conversion of benzamides 276a-e in the 
corresponding difluorinated enamides, followed by ring closure. In a first attempt, benzamide 276b (R1 = 
Pr, R2 = H) was treated with two equivalents of LiHMDS, which led to the formation of a mixture of three 
reaction products, i.e. deacetylated benzamide 277b, β,β-difluoroenamide 278b and benzoxazepinone 
279b (Scheme 79). The composition of this crude reaction mixture supports the intermediacy of 
β,β-difluoroenamide 278b in the formation of benzoxazepinone 279b. Moreover, it seems that the 
deacetylation of the phenolic oxygen occurs before the formation of the difluoroenamide moiety, since 
the brominated amide 277b was also formed as an intermediate. This deacetylation reaction proceeds 
easily due to the good leaving group properties of the phenolic oxygen atom. This cleavage was also 
observed upon storage of benzamide 276b at room temperature. 
Results and discussion  Chapter 3 
99 
 
 
Scheme 79 
The presence of the envisioned 2-fluoro-1,4-benzoxazepin-5-one 279b in the crude reaction mixture was 
a promising result. Subsequently, the use of potassium tert-butoxide was evaluated for the conversion of 
benzamides 276 into benzoxazepinones 279. In that regard, benzamides 276a-e were stirred in THF under 
reflux in the presence of 2-3 equivalents of KOtBu, which gave a clean conversion toward the envisioned 
2-fluoro-1,4-benzoxazepin-5-ones 279a-e, which were isolated in good yields (Scheme 80). In case of 
2,5-diacetoxybenzamide 276d, three equivalents of KOtBu had to be added to achieve a full conversion 
toward the double deacetylated compound 279d. In a last step, the deprotection of the 4-methoxybenzyl-
substituted benzoxazines 279c,e was attempted. Initially, benzoxazepinone 279c was treated with cerium 
ammonium nitrate in aqueous acetonitrile, but under these reaction conditions either no conversion was 
observed or a complex reaction mixture was formed, depending on the reaction temperature. Finally, the 
removal of the PMB protecting group was achieved by heating benzoxazepine 279c in the presence of five 
equivalents of boron(III) fluoride etherate resulting in 4H-2-fluoro-1,4-benzoxazin-5-one 280a in 51% yield. 
The same procedure was applied to benzoxazepinone 279e, leading to the formation of 
4H-benzoxazepinone 280b. The deprotection of these fluorinated benzoxazepinones enables further 
functionalization of this scaffold. 
 
Scheme 80 
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3.5.7 Reactivity of N-tosyl-β,β-difluoroenamide 220 toward electrophiles 
To test whether N-tosyl-β,β-difluoroenamide 220 displays any nucleophilic reactivity, despite the presence 
of the electron-withdrawing group at nitrogen and the two fluorine atoms at the β-position of the 
enamide, the reaction of this compound with a variety of electrophiles was investigated. 
In a first attempt, the reaction of enamide 220 with isobutyraldehyde in dichloromethane under reflux 
only resulted in recovery of the starting compound 220 (Table 23, entry 1). The reaction of enamide 220 
with allyl bromide under similar reaction conditions gave the same result (Table 23, entry 2). When the 
reaction with allyl bromide was repeated in the presence of aluminium(III) chloride, no reaction took place 
when the reaction was conducted at room temperature, while the formation of degradation compounds 
was observed when this reaction was performed at reflux temperature (Table 23, entries 3-4). In a next 
attempt, difluorinated enamide 220 was first treated with one equivalent n-butyllithium at -78 °C for 30 
minutes, after which allyl bromide was added and the reaction was stirred for another three hours at 0 °C. 
However, this led to the formation of a complex reaction mixture (Table 23, entry 5). To test the stability 
of enamide 220 with respect to n-butyllithium, enamide 220 was stirred in the presence of one equivalent 
of n-BuLi for five hours at 0 °C (Table 23, entry 6). However, this also resulted in the formation of a complex 
reaction mixture. In a next attempt, enamide 220 reacted with LDA in THF at -78 °C for 30 minutes, after 
which allyl bromide was added and the reaction was continued for 30 minutes at 0 °C (Table 23, entry 7). 
Again, a complex reaction mixture was formed. Also upon reaction of enamide 220 with LDA, followed by 
the addition of one equivalent of methyl iodide, a complex reaction mixture was formed (Table 23, entry 
8). Also the gold-catalyzed reaction of enamide 220 with phenylacetylene failed (Table 23, entry 9) since 
no reaction was observed. 
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Table 23: Reactivity of N-tosyl-β,β-difluoroenamide 220 toward electrophiles 
 
Entry Reaction conditions Result 
1 1 equiv isobutyraldehyde, CH2Cl2, Δ, 4 h No reaction 
2 1 equiv allyl bromide, CH2Cl2, Δ, 4 h No reaction 
3 1 equiv allyl bromide, 1 equiv AlCl3, THF, r.t., 15 h No reaction 
4 1 equiv allyl bromide, 1 equiv AlCl3, THF, Δ, 15 h 220 + degradation 
5 1) 1 equiv n-BuLi, THF, -78 °C, 30 min 
2) 1 equiv allyl bromide, THF, 0 °C, 3 h 
Complex reaction 
mixture 
6 1 equiv BuLi, THF, 0 °C, 5 h Complex mixture 
7 1) 1.2 equiv LDA, THF, -78 °C, 30 min 
2) 1 equiv allyl bromide, THF, 0 °C, 30 min 
Complex reaction 
mixture 
8 1) 1.2 equiv LDA, THF, -78 °C, 30 min 
2) 1 equiv MeI, THF, 0 °C, 2 h 
Complex reaction 
mixture 
9 1 equiv PhC≡CH, 5 mol% AuCl3, CH3CN, r.t., 6 h No reaction 
 
Upon treatment of difluoroenamide 220 with one equivalent of N-bromosuccinimide (NBS) in methanol 
at room temperature, the formation of compound 281 was observed, which was isolated in a good yield 
of 60% (Scheme 81). Compound 281 was in turn converted into β,β-difluorinated enamide 282 by 
treatment with LiHMDS in THF at reflux temperature, and enamide 282 was isolated in a low yield of 35%.  
Thus, enamide 220 also shows nucleophilic character since an electrophilic addition reaction across the 
double bond was achieved. However, since all other attempts to react difluoroenamide 220 with 
electrophiles failed (Table 23), it was concluded that the nucleophilic character of difluoroenamide 220 is 
very limited. 
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Scheme 81 
3.5.8 Conclusion 
In conclusion, β,β-difluoroenamides 218 and 220 were synthesized as enamides with an electrophilic 
character. These compounds reacted readily with oxygen and sulfur nucleophiles in an SNV reaction giving 
rise to the formation of substituted monofluorinated enamides. This reactivity was exploited toward the 
synthesis of novel six- and seven-membered heterocycles. While the formation of 6-fluoro-2H-3,4-
dihydro-1,4-oxazines proceeded sluggishly, a straightforward synthesis toward novel 2-fluoro-1,4-
benzoxazines and 2-fluoro-1,4-benzoxazepin-5-ones was developed. In the synthetic pathway toward the 
fluorinated benzoxazines, the formation of fluorinated ynamides was observed, as the first example of an 
efficient route toward this unexplored class of fluorinated compounds. Upon reaction of difluoroenamide 
220 with electrophiles, it was concluded that this enamide shows very limited nucleophilic character since 
it only reacted with NBS in MeOH. 
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3.6 Synthesis of fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones 
3.6.1 Introduction 
Mycobacterium tuberculosis is a pathogenic bacillus which causes the disease tuberculosis (TB), still one 
of the most deadly diseases worldwide, with an estimated number of 9.0 million new cases and 1.5 million 
deaths in 2013.146 Due to the prevalence of multidrug resistant and extensively drug resistant TB, there is 
still a need for the development of new drugs.147 In view of the ongoing interest of our research group in 
the synthesis of annulated phenanthridine-7,12-diones as antimycobacterial compounds,148 and the often 
beneficial effects of the introduction of fluorine in biologically active compounds,3c,149 it was decided to 
synthesize fluorinated derivatives of benzo[j]phenanthridine-7,12-diones. The synthesis of fluorinated 
phenanthridine-7,12-diones, benzo[j]phenanthridine-7,12-diones or 8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine-7,12-diones has not been reported in the literature so far. In previous 
research at our department, it was found that 2,3,4-trimethyl-8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine-7,12-dione 283a possesses a good antimycobacterial activity with a 
MIC50 lower than 0.1 µg/mL (Figure 18).148a,150 However, this compound showed a low specificity since it 
also showed activity toward other gram-positive and gram-negative bacteria as well as activity toward C-
3A, J-774 and MRC-5 human cell lines.151 In an attempt to improve the specificity, it was decided to 
synthesize fluorinated derivatives of annulated phenanthridine-7,12-dione 283a. 
 
Figure 18 
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3.6.2 Synthesis of fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones 
In previous research at our department, the synthesis of substituted benzo[j]phenanthridine-7,12-diones 
285 was developed, with the palladium-catalyzed intramolecular cyclization of methanesulfonamides 284 
as the key step in the reaction sequence (Scheme 82).148b N-Methanesulfonyl-3-bromo-2-
(arylamino)methyl-1,4-naphthoquinones 284 were synthesized starting from 2-bromomethyl-3-bromo-
1,4-naphtoquinone via a nucleophilic substitution with various anilines followed by mesylation. 
 
Scheme 82148b 
Furthermore, the synthesis of 8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-diones 
283, as ‘out of plane derivatives’ was also developed, via the palladium-catalyzed intramolecular 
cyclization of amides 286 toward cyclic amides 287 as the key step (Scheme 83).150 
 
Scheme 83150 
In this PhD thesis, the synthesis of fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones 31 was envisioned, using a combination of the above-mentioned synthetic 
procedures. More specifically, in analogy with the synthetic pathway toward phenanthridines 285, 
methanesulfonamides 30 were believed to be suitable substrates for the palladium-catalyzed ring closure 
toward phenanthridines 288. For the synthesis of precursors 30, aldehyde 28, which was also the starting 
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compound for the synthesis of MOM-protected amides 286, will be transformed into amines 289 via a 
reductive amination with various fluorinated 2-bromoanilines 29. Mesylation of the amines 289 should 
lead to the formation of methanesulfonamides 30 (Scheme 84). 
 
Scheme 84 
3.6.2.1 Synthesis of anilines 289 via reductive amination 
The reductive amination toward amines 289 was believed to be straightforward (Table 24). In a first 
attempt, aldehyde 28 reacted with 2-bromo-5-fluoroaniline 29b in MeOH for one hour at room 
temperature, followed by the addition of one equivalent of NaBH4 at 0 °C and stirring for another 30 
minutes at room temperature.152 However, after work-up, four compounds were present in the reaction 
mixture, more specifically aniline 29b, acetal 290, aldimine 291b and the envisioned amine 289b, which 
was only present in a very small amount (Table 24, entry 1). Since significant amounts of acetal 290 and 
unreduced aldimine 291b were present in the reaction mixture, other reaction conditions were explored. 
In the second attempt, one equivalent of acetic acid was added to the reaction mixture and NaCNBH3 was 
used as the reducing agent (Table 24, entry 2). Although amine 289b was present in a larger amount while 
imine 291b could not be observed, acetal 290 was again formed as a side product in a significant amount.  
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Table 24: Synthesis of aniline 289b starting from aldehyde 28 and aniline 29b 
 
Entry Reaction conditions Ratioa 28 : 290 : 291b : 289b 
1 1) 1 equiv 29b, MeOH, r.t., 1 h 
2) 1 equiv NaBH4, 0 °C - r.t., 30 min 
0 : 47 :47 : 6 
2 1) 1 equiv 29b, 1 equiv AcOH, MeOH, r.t., 7 h 
2) 1 equiv NaCNBH3, MeOH, r.t., 18 h 
0 : 54 : 0 : 46 
a Determined via 1H NMR analysis of the crude reaction mixture. 
 
Since performing the imination reaction in MeOH led to the formation of acetal 290 as a side product, the 
use of isopropanol as a less-nucleophilic solvent was evaluated. Thus, aldehyde 28 was dissolved in iPrOH 
and reacted in a one-pot fashion with aniline 29c in the presence of acetic acid and NaCNBH3. After 
work-up, a mixture of aniline 29c, amine 289c and a compound which was tentatively identified as the 
alcohol resulting from aldehyde reduction, was obtained from which amine 289c was isolated in a low 
yield of 20% (Scheme 85). 
 
Scheme 85 
Since this one-pot reductive amination in iPrOH gave no satisfying results, it was decided to optimize the 
imination step using other non-nucleophilic solvents. Upon treatment of aldehyde 28 with one equivalent 
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of aniline 29c in the presence of two equivalents of MgSO4 in THF at reflux temperature for 17 hours, only 
50% conversion to the imine was achieved. Also the use of Ti(OEt)4 in THF did not lead to better results, 
since an aqueous work-up was needed to remove the titanium salts, resulting in hydrolysis of the imine 
and irreproducible results. 
Subsequently, the imination of aldehyde 28 in 2-methyltetrahydrofuran (2-Me-THF) under microwave 
irradiation was evaluated and the results are presented in Table 25. The conversion of aldehyde 28 toward 
imines 291 was determined based on 1H NMR analysis of the crude reaction mixture. When an acceptable 
conversion was obtained, the reaction mixture was subjected to reductive reaction conditions by 
treatment with NaCNBH3 in the presence of acetic acid in MeOH. In a first attempt, aldehyde 28 reacted 
with one equivalent of 2-bromo-4-fluoroaniline 29a in 2-Me-THF in the presence of two equivalents MgSO4 
for two hours at 60 °C, leading to 50% conversion toward imine 291a (Table 25, entry 1). Increasing the 
number of equivalents of aniline 29a to two or three equivalents led to a higher conversion of 75% and 
97%, respectively (Table 25, entries 2-3). The crude reaction mixture of this last attempt was subjected to 
reductive reaction conditions and amine 289a was isolated in 67% yield starting from aldehyde 28 (Table 
25, entry 3). Unfortunately, when these optimized reaction conditions were applied to the reaction of 
aldehyde 28 with anilines 29b,c,d,e, the conversion toward the corresponding imines was only moderate. 
When aldehyde 28 reacted with 2-bromo-6-fluoroaniline 29c for one hour at 60 °C, a conversion of 60% 
toward the corresponding imine was observed (Table 25, entry 4), while a longer reaction time of three 
hours led to an even lower conversion of 27% (Table 25, entry 5). The reaction of aniline 29b with 
aldehyde 28 gave a higher conversion of 86% after one hour at 60 °C, but amine 289b could only be isolated 
in moderate variable yields (23-53%) (Table 25, entry 6). Also the reaction of aldehyde 28 with 
trifluoromethylated anilines 29d and 29e gave a moderate conversion toward the corresponding imines 
291d,e (Table 25, entries 7-10). 
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Table 25: Synthesis of fluorinated anilines 289 via sequential imination and reduction 
 
Entry Reaction conditions microwave 
Conversion of 28 
toward imine 291a 
Yieldb amine 289 
(from aldehyde 28) 
1 1 equiv 29a (4-F), 2 equiv MgSO4, 60 °C, 2 h 50% - 
2 2 equiv 29a (4-F), 2 equiv MgSO4, 60 °C, 2 h 75% - 
3 3 equiv 29a (4-F), 3 equiv MgSO4, 60 °C, 45 min 97% 289a (67%) 
4 3 equiv 29c (6-F), 3 equiv MgSO4, 60 °C, 1 h 60% - 
5 3 equiv 29c (6-F), 3 equiv MgSO4, 60 °C, 3 h 27% - 
6 3 equiv 29b (5-F), 3 equiv MgSO4, 60 °C, 1 h 86% 289b (23-53%)c 
7 3 equiv 29e (5-CF3), 3 equiv MgSO4, 60 °C, 1 h 70% 289e (13-32%)c 
8 3 equiv 29e (5-CF3), 3 equiv MgSO4, 100 °C, 40 min 56% - 
9 3 equiv 29d (4-CF3), 3 equiv MgSO4, 60 °C, 75 min 79% - 
10 3 equiv 29d (4-CF3), 3 equiv MgSO4, 100 °C, 40 min 38% - 
a Determined via 1H NMR analysis fo the crude reaction mixture. b Isolated yield. c Variable yields were 
obtained from different attempts. 
 
Following these moderate results, dichloromethane was evaluated next as the solvent for the imination 
reaction. Aldehyde 28 was treated with trifluoromethylated anilines 29d-e in the presence of MgSO4 under 
reflux conditions in CH2Cl2. Although a relatively long reaction time was needed (19-48 h), the conversion 
of aldehyde 28 into the corresponding imines 291d,e was very good (96-97%). Eventually, amines 289d,e 
were obtained in good yields (66-71% in two steps) after reduction using NaCNBH3. 
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Table 26: Synthesis of trifluoromethylated anilines 289 via sequential imination and reduction 
 
Entry Reaction conditions  
Conversion of 28 
toward imine 291a 
Yieldb amine 289 
(from aldehyde 28) 
1 3 equiv 29e (5-CF3), 3 equiv MgSO4, Δ, 48 h 96% 289e (71%) 
2 3 equiv 29d (4-CF3), 3 equiv MgSO4, Δ, 19 h 97% 289d (66%) 
a Determined via 1H NMR analysis fo the crude reaction mixture. b Isolated yield. 
 
Additionally, it should be mentioned that the purification of amines 289a-e was not straightforward. Due 
to the low nucleophilicity of anilines 29, caused by the electron-withdrawing fluorine substituents, three 
equivalents of anilines 29 were needed to obtain an acceptable conversion toward the corresponding 
imines. After the reduction step, this excess of anilines 29 needed to be separated from amines 289. 
However, all attempts to separate this mixture via column chromatography (SiO2) using a PE/EtOAc 
mixture as the eluent failed since compounds 29 and 289 eluted simultaneously. Only via preparative TLC 
the separation could be achieved after several runs of the TLC plate. However, preparative TLC can only 
be used on a small scale. Fortunately, the automated flash system (Reveleris Flash Forward), resulted in a 
very good separation when reversed phase conditions were applied using a CH3CN/H2O mixture as the 
eluent. 
3.6.2.2 Protection of anilines 289 
Having anilines 289 in hand, different reaction conditions for their conversion into methanesulfonamides 
30 were evaluated (Table 27). However, reaction of aniline 289b with one or two equivalents 
methanesulfonyl chloride in pyridine at 0 °C or reflux temperature did not lead to the formation of the 
corresponding methanesulfonamide 30b (Table 27, entry 1). Also, upon use of the solvent mixture 
pyridine/CH2Cl2 1/1 at reflux temperature for three hours, no conversion of aniline 289b was observed 
(Table 27, entry 2).148b Similar reaction conditions were also applied to aniline 289e, but again no reaction 
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was observed. (Table 27, entry 3). In a next attempt, aniline 289b first reacted with NaH in THF for 15 
minutes, after which MsCl was added and the reaction mixture was stirred at reflux temperature for 17 h 
(Table 27, entry 4).153 But again, no conversion of the starting material was observed. Following these bad 
results, it was decided to try to protect the amino function as a trifluoromethanesulfonamide group. As 
such, aniline 289b reacted with two equivalents N-phenyl-bis(trifluoromethanesulfinimide) in 
dichloromethane, but again no reaction was observed (Table 27, entry 5).154 Finally, treatment of aniline 
289b with two equivalents of triflic anhydride in the presence of NaH in dichloromethane did lead to the 
formation of trifluoromethanesulfonamide 292b, which was isolated in a low yield of 24% (Table 27, entry 
6).155 Applying these reaction conditions to amines 289c and 289a also gave rise to the formation of the 
corresponding trifluoromethanesulfonamides 292c,a which were isolated in slightly higher yields (50-52%) 
(Table 27, entries 7-8). 
Table 27: Protection of anilines 289 
 
Entry Substrate Reaction conditions Result 
1 289b (5-F) 1-2 equiv MsCl, pyridine, 0 °C - Δ, 17 h No reaction 
2 289b (5-F) 1.3 equiv MsCl, pyridine/CH2Cl2 1/1, Δ, 3 h No reaction 
3 289e (5-CF3) 2 equiv MsCl, pyridine/CH2Cl2 1/1, Δ, 17 h No reaction 
4 289b (5-F) 1) 1.2 equiv NaH, THF, r.t., 15 min  
2) 1.2 equiv MsCl, Δ, 17 h 
No reaction 
5 289b (5-F) 2 equiv N-phenyl-bis(trifluoromethanesulfinimide),  
2 equiv Et3N, CH2Cl2, r.t. - Δ, 3 h 
No reaction 
6 289b (5-F) 2.5 equiv NaH, 2 equiv Tf2O, CH2Cl2, 0 °C - r.t., 3 h 24% 292ba 
7 289c (6-F) 2.5 equiv NaH, 2 equiv Tf2O, CH2Cl2, 0 °C - r.t., 3 h 50% 292ca 
8 289a (4-F) 2.5 equiv NaH, 2 equiv Tf2O, CH2Cl2, 0 °C - r.t., 3 h 52% 292aa 
a Isolated yield. 
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In an attempt to synthesize N-triflyl amides 292 in a higher yield, anilines 289 reacted with triflic anhydride 
in CH2Cl2 instead of using pure triflic anhydride. Satisfyingly, under these reaction conditions, 
trifluoromethanesulfonamides 292a-e were formed and isolated in 60-71% yield (Scheme 86).  
 
Scheme 86 
3.6.2.3 Palladium-catalyzed ring closure towards phenanthridines 288 
The next step in the reaction sequence toward fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones was the palladium-catalyzed ring closure of trifluoromethanesulfonamides 
292. To this end, trifluoromethanesulfonamide 292a was reacted with 12 mol% Pd(OAc)2 using 36 mol% 
triphenylphosphine as the ligand and two equivalents potassium carbonate in toluene at 100 °C under 
nitrogen atmosphere. Follow-up using 1H NMR showed a slow progress of the reaction with only 53% 
conversion of the starting material after 46 hours. Thus, extra Pd(OAc)2 (12 mol%) and PPh3 (36 mol%) 
were added and stirring was continued for another nine hours, after which a conversion of 74% was 
achieved. Again extra Pd(OAc)2 (6 mol%) and PPh3 (18 mol%) were added and the stirring was continued 
for another four days, leading to a conversion of 88%. At this point, the reaction was stopped, leading to 
compound 293a as the end product. Apparently, the aromatization toward phenanthridine 288a did not 
occur under these reaction conditions. In the next step, compound 293a was used without purification 
and treated with KOtBu, leading to the desired aromatization toward phenanthridine 288a, which was 
isolated in 42% yield (Table 28, entry 1). The reaction time and the amount of catalyst used in the first step 
could be strongly reduced by performing the Heck coupling under microwave irradiation, although this 
only led to a slight improvement of the yield (51% over two steps) (Table 28, entry 2). Upon use of 
trifluoromethanesulfonamide 292c as the substrate, again a big catalyst load (24 mol% PdOAc2) and 
extended reaction time in the microwave of 46 hours were necessary to achieve a full conversion (Table 
28, entry 3). After aromatization, phenanthridine 288c was isolated in 43% yield. Finally, the Heck coupling 
of substrate 292b gave no conversion when it was performed under microwave irradiation (Table 28, entry 
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4), but full conversion was achieved in batch (Table 28, entry 5), and eventually phenanthridine 288b was 
isolated in 39% yield. It can be concluded that the conversion of monofluorinated 
trifluoromethanesulfonamides 292a-c into phenanthridines 288a-c proceeds sluggishly and needs further 
optimization. 
Table 28: Synthesis of phenanthridines 288 
 
Entry Substrate 
Reaction conditions 
Step 1 
Reaction conditions 
Step 2 
Yielda 
1 292a (4-F) 0.3 equiv Pd(OAc)2, 0.9 equiv PPh3, 
2 equiv K2CO3, toluene, 100 °C, 7 d 
2 equiv KOtBub, Δ, 2 h 42% 288a 
2 292a (4-F) 0.06 equiv Pd(OAc)2, 0.18 equiv PPh3, 
2 equiv K2CO3, toluene, MW, 125 °C, 3 h 
2 equiv KOtBub, Δ, 2 h 51% 288a 
3 292c (6-F) 0.24 equiv Pd(OAc)2, 0.72 equiv PPh3, 
2 equiv K2CO3, toluene, MW, 125 °C, 46 h 
2 equiv KOtBub, Δ, 3.5 h 43% 288c 
4 292b (5-F) 0.06 equiv Pd(OAc)2, 0.18 equiv PPh3, 
2 equiv K2CO3, toluene, MW, 125 °C, 2 h 
-c -c 
5 292b (5-F) 0.12 equiv Pd(OAc)2, 0.36 equiv PPh3, 
4 equiv K2CO3, toluene, Δ, 38 h 
3 equiv KOtBub, Δ, 3 h 39% 288b 
a Yield over two steps, starting from substrate trifluoromethanesulfonamides 292. b 1M in THF. c No 
reaction in step 1. 
 
In an attempt to achieve a higher yield over the two steps, it was decided to isolate intermediates 293d-e, 
synthesized via the Heck coupling of compounds 292d-e, before performing the aromatization step. Thus, 
trifluoromethanesulfonamide 292d was treated with 6 mol% Pd(OAc)2 in the presence of 18 mol% PPh3 
and 2 equiv K2CO3. After 63 hours of stirring in toluene at reflux temperature, no further progress of the 
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reaction could be noticed and extra Pd(OAc)2 (6 mol%), PPh3 (18 mol%) and K2CO3 (2 equiv) were added. 
After stirring this mixture for another 24 hours, full consumption of the starting compound was achieved 
and tetracyclic compound 293d was isolated in 78% yield. Analogously, intramolecular Heck coupling of 
trifluoromethanesulfonamide 292e led to the formation of compound 293e, in 81% yield. In the next step, 
aromatization by reaction with KOtBu in THF under reflux conditions, led to phenanthridines 288d,e in 
quantitative yield (Scheme 87). 
 
Scheme 87 
3.6.2.4 CAN-mediated oxidation toward compounds 31 
The last step in the reaction sequence comprised the oxidative demethylation of compounds 288a-e, 
which was achieved by treatment with 2.3 equivalents CAN in an acetonitrile/water mixture (1/1) for 45 
minutes at 0 °C. Finally, fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-
diones 31a-e were isolated in moderate to good yields (37-76%). 
 
Scheme 88 
3.6.3 Conclusion 
In conclusion, the synthesis of five fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones 31 was developed using 5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-
Results and discussion  Chapter 3 
114 
 
methanonaphthalene-6-carboxaldehyde and various fluorinated 2-bromoanilines as building blocks. Due 
to the low nucleophilicity of these fluorinated anilines, optimization of the reductive amination was 
necessary. After triflation of the resulting amines, Pd-catalyzed ring closure and aromatization, oxidative 
demethylation using CAN led to the formation of the envisaged 8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine-7,12-diones. These compounds will be tested for their activity against 
M. tuberculosis in collaboration with the University of Antwerp.
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4 Perspectives 
In the literature overview it was shown that only a few examples of ring fluorinated β-ACC derivatives or 
fluorinated azetidine-2-carboxylates were reported to date. Therefore, in this PhD thesis, the (attempted) 
synthesis of fluorinated analogues of these compounds is described. However, this proved to be not 
straightforward and further research concerning the chemistry of these strained fluorinated amino acids 
derivatives is necessary. 
The synthesis of difluorinated β-ACC derivatives 184 demonstrated the negative impact of the two fluorine 
atoms on the stability of these compounds. Therefore, it is useful to evaluate the synthesis of 
monofluorinated derivatives 295, via the MIRC reaction of dialkyl 2-(2-chloro-2-
fluoroethylidene)malonates 294 (Scheme 89). In this reaction, the diastereoselective outcome should also 
be evaluated. 
 
Scheme 89 
Furthermore, the incorporation of fluorinated β-ACC derivatives in peptides is of importance to get insight 
on the influence of these amino acids on the secondary conformation of peptides. However, due to the 
instability of β-ACC derivatives 184, their incorporation in peptides will be a major challenge. A possible 
pathway toward dipeptides incorporating the β-ACC unit is the use of amino acid derivatives 297 as 
nucleophiles in the MIRC reaction. Michael addition of nitrogen nucleophiles 297 across dialkyl 2-(2-
haloethylidene)malonates 296 could lead to the formation of dipeptides 298 after ring closure (Scheme 
90). 
Perspectives  Chapter 4 
116 
 
 
Scheme 90 
In this PhD thesis it was also shown that the reduction of pyrrolines 185 resulted in the formation of acyclic 
amino esters 187, which proved to be unstable. It should be useful to try to convert acyclic amino esters 
187 into 2-pyrrolidinones 299 via ring closure, which are possibly more stable (Scheme 91). Further 
aromatization156 could lead to the formation of fluorinated pyrroles 300, which have only been studied to 
a very limited extent.157 
 
Scheme 91 
In the fourth chapter of this PhD thesis, the synthesis of fluorinated azetidine-2-carboxylates was 
attempted. Unfortunately, this goal could not be achieved. However, there are still some options to be 
explored which could lead to the formation of these constrained fluorinated amino acid derivatives. For 
example, the condensation of amines 23 with bromoacetonitrile 301 should lead to amino nitriles 302 
(Scheme 92). The deprotonation of these compounds 302 should be easier than the deprotonation of the 
corresponding esters, and could possibly be followed by ring closure to give azetidines 303. Subsequent 
hydrolysis of the nitrile moiety could lead to azetidine-2-carboxylic acids 304. 
 
Scheme 92 
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In another part of this PhD thesis, the efficient synthesis of various 2-fluoro-1,4-benzoxazines 267 and 
elusive β-fluoroynamides 266 was developed starting from 2-aminophenols 258. These fluorinated 
compounds are interesting scaffolds with potential applications in medicinal chemistry. As an expansion 
of this work, it should be useful to synthesize analogues of 2-fluoro-1,4-benzoxazines 267 incorporating 
an extra nitrogen atom in the aromatic ring. Thus, applying the same reaction sequence to for example 
2-amino-3-hydroxypyridine 305 should give rise to β-fluoroynamides 307 and 2-fluoropyrido[3,2-b][1,4]-
oxazines 308 (Scheme 93). Although these pyrido[3,2-b][1,4]oxazines are interesting scaffolds, they have 
only been studied to a limited extent,129e,158 while fluorinated analogues have not been described to date. 
 
Scheme 93 
In addition, the synthesis of 2-fluoro-1,4-benzoxazepin-5-ones 279 could also be expanded to the synthesis 
of derivatives incorporating an extra nitrogen atom in the aromatic ring. For example, treatment of 
2-acetoxypyridine-3-carboxylic acid 309 with thionyl chloride should lead to the formation of the 
corresponding acid chloride, which could be coupled with fluorinated amines 23 resulting in the formation 
of amides 310. Subsequent treatment with KOtBu should give rise to the formation of unprecedented 
2-fluoropyrido[3,2-f]-1,4-oxazepin-5-ones 311 (Scheme 94). Pyrido[3,2-f]-1,4-oxazepin-5-ones, which are 
not annelated to another aromatic ring, have never been described in the literature before. 
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Scheme 94 
In the final part of this PhD thesis, 8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-
diones 31 were synthesized as potential anti-mycobacterial compounds. However, these methano-bridged 
benzo[j]phenanthridines are chiral compounds and they were synthesized as a racemic mixture. In 
addition of this research, the synthesis of the non-chiral ethano-bridged derivatives should be evaluated, 
which should proceed via the beforementioned methodology, starting from ethano-bridged aldehyde 312 
(Scheme 95). Reductive amination with fluorinated 2-bromoanilines 29, followed by triflation of the amine 
nitrogen atom should afford trifluoromethanesulfonamides 134. Palladium-catalyzed ring closure and 
subsequent aromatization should give compounds 315, which should be converted into fluorinated 
8,9,10,11-tetrahydro-8,11-ethanobenzo[j]phenanthridine-7,12-diones 316 by CAN-mediated oxidation. 
 
Scheme 95 
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5 Experimental section 
5.1 General methods 
Solvents 
Dry dichloromethane was obtained via distillation over calcium hydride. Dry tetrahydrofuran, dry diethyl 
ether and dry toluene were freshly distilled over sodium/benzophenone ketyl before use. Other solvents 
were used as received from the supplier, unless specified otherwise. 
Microwave irradiation 
All microwave reactions were performed in a CEM Focused MicrowaveTM Synthesis System, Model Discover 
with a continuous power output from 0 to 300 W and a self-adjusting, single mode microwave cavity. 
Reactions were performed in 10 mL thick-walled Pyrex reaction vials, closed with a snap-cap and equipped 
with a small magnetic stirring bar. The temperature was increased from room temperature to the desired 
temperature using a ramp time of maximum 5 minutes. The desired temperature was maintained during 
the course of the reaction. The temperature control system used an external infrared sensor to measure 
the temperature on the bottom of the vessel and was used in a feedback loop with the on-board computer 
to regulate the temperature from 25 to 250 °C by adjusting the power output (1 W increments). The 
pressure control, IntelliVentTM Pressure Control System, used an indirect measurement of the pressure by 
sensing changes in the external deflection of the septa on the top of the sealed pressure vessel. Stirring 
was performed by a rotating magnetic plate located below the bottom of the microwave cavity. After the 
desired reaction time, the vial was cooled down by a stream of air which decreased the temperature of 
the vial from approximately 150 °C to 40 °C in less than 120 s. 
Column chromatography 
The purification of reaction mixtures was performed by column chromatography using a glass column filled 
with silica gel (Acros, particle size 35-70 µm, pore diameter ca. 6 nm). Solvent systems were determined 
via initial TLC analysis on glass plates, coated with silica gel (Merck, Kieselgel 60 F254, precoated 0.25 mm) 
using UV light (254 nm and 366 nm), iodine vapor or KMnO4 oxidation as detection methods. Automated 
flash chromatography was performed on a Reveleris® X2 Flash Chromatography System. 
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Liquid chromatography 
LC and LC-MS analyses were performed on an Agilent 1200 Series liquid chromatograph using a reversed 
phase column (Eclipse plus C18 column, 50 x 4.6 mm, particle size 3.5 µm, or a Supelco Ascentis Express 
C18 column, 30 x 4.6 mm, particle size 2.7 µm) with an UV-VIS detector and an Agilent 1100 series LC/MSD 
type SL mass spectrometer (ESI, 70 eV) using a mass selective single quadrupole detector. Gradient elution 
was used (30% acetonitrile in water to 100% acetonitrile over 6 minutes). 
NMR spectroscopy 
1H NMR spectra were recorded at 300 MHz (JEOL ECLIPSE+) or 400 MHz (Bruker Avance III) with CDCl3 as 
solvent and tetramethylsilane as internal standard. 13C NMR spectra were recorded at 75 MHz (JEOL 
ECLIPSE+) or 100.6 MHz (Bruker Advance III) with CDCl3 as solvent and tetramethylsilane as internal 
standard. 19F NMR spectra were recorded at 282 MHz (JEOL ECLIPSE+) or 376.5 MHz (Bruker Advance III) 
with CDCl3 as solvent and CFCl3 as internal standard. Peak assignments were obtained with the aid of HSQC 
and/or HMBC spectra. 
Infrared spectroscopy 
Infrared spectra were recorded on a Perkin Elmer Spectrum BX FT-IR Spectrometer. All compounds were 
analyzed in neat form with an ATR (Attenuated Total Reflectance) accessory. Only selected absorbances 
(νmax, cm-1) were reported. 
Mass spectrometry 
Low resolution mass spectra were recorded via direct injection on an Agilent 1100 Series LC/MSD type SL 
mass spectrometer with Electron Spray Ionisation Geometry (ESI 70 eV) and using a Mass Selective 
Detector (quadrupole). High resolution mass spectra were obtained with an Agilent Technologies 6210 
Time-of-Flight Mass Spectrometer (TOFMS), equipped with ESI/APCI-multimode source. 
Elementary analysis 
Elementary analyses were obtained by means of a Perkin Elmer series II CHNS/O elementary analyzer 
2400. 
Melting point 
Melting points of crystalline compounds were determined using a Büchi B-540 apparatus or a Kofler bench, 
type WME Heizbank of Wagner & Munz. 
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Optical rotation 
Optical rotations were determined using a JASCO P-2000 Series Polarimeter at a wavelength of 589 nm. 
5.2 Safety 
General safety aspects 
The work in the laboratory of the SynBioC Research group (Department of Sustainable Organic Chemistry 
and Technology) was conducted in full compliance with the ‘Internal Safety Guidelines’. Furthermore, 
upon use of chemicals, the internal safety document ‘Safety instructions: how to work with chemicals’, 
was consulted. 
Specific safety aspects 
A list of the risks associated with each chemical is available in the corresponding material safety data sheet 
(MSDS), which can be found on the website of the supplier. Therein, a classification of the hazards was 
made according to the European Regulation (EC) No 1272/2008 [EU-GHS/CLP], which combines the 
Globally Harmonized System of Classification and Labeling of Chemicals (GHS) and Classification, Labelling 
and Packaging regulations (CLP). A brief overview of the chemicals employed in this work classified as 
category 1, the most severe category, of the respective hazard class will be given below, along with the 
GHS hazards and precautions. 
Acid chlorides (acetyl chloride, 4-methoxybenzoyl chloride, 4-chlorobenzoyl chloride, 2-acetylsalicyloyl 
chloride, oxalyl chloride): Causes severe skin burns and eye damage. Wear protective gloves/ eye 
protection/ face protection. Benzoyl chloride: Causes severe skin burns and eye damage. May cause an 
allergic skin reaction. Wear protective gloves/ eye protection/ face protection. 
AlCl3: Causes severe skin burns and eye damage. Causes damage to organs through prolonged or repeated 
exposure if inhaled. Wear protective gloves/ protective clothing/ eye protection/ face protection. 
Allyl bromide: Causes severe skin burns and eye damage. May cause genetic defects. May cause cancer. 
Very toxic to aquatic life. Obtain special instructions before use. Avoid release to the environment. Wear 
protective gloves/ protective clothing/ eye protection/ face protection. 
Amines (propylamine, benzylamine, 4-methoxybenzylamine, ethanolamine): Causes severe skin burns 
and eye damage. Wear protective gloves/ eye protection/ face protection. 
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Fluorinated 2-bromoanilines, aniline: May cause an allergic skin reaction. Causes serious eye damage. 
Causes damage to organs (blood) through prolonged or repeated exposure. Very toxic to aquatic life with 
long lasting effects. Avoid release to the environment. Wear protective gloves/eye protection/face 
protection. 3-Amino-4-bromobenzotrifluoride: Causes severe skin burns and eye damage. Wear 
protective gloves/eye protection/face protection. 
BF3.Et2O: Causes severe skin burns and eye damage. Causes damage to organs through prolonged or 
repeated exposure if inhaled. Wear protective gloves/protective clothing/eye protection/face protection. 
Borane dimethylsulfide complex: Causes serious eye damage. Wear protective gloves/eye 
protection/face protection. 
Bromoacetates: Causes severe skin burns and eye damage. Wear protective gloves/eye protection/face 
protection. 
Butyllithium: Catches fire spontaneously if exposed to air. May be fatal if swallowed and enters airways. 
Causes severe skin burns and eye damage. Do not allow contact with air. Handle under inert gas. Protect 
from moisture. 
Cyanides (KCN, NaCN): May be corrosive to metals. Fatal if swallowed, in contact with skin or if inhaled. 
Causes damage to organs (heart, testes, brain) if swallowed. Causes damage to organs (thyroid) through 
prolonged or repeated exposure. Very toxic to aquatic life with long lasting effects. Do not breathe 
dust/fume/gas/mist/vapours/spray. Avoid release to the environment. Wear protective gloves/protective 
clothing. 
Diisobutylaluminium hydride: Highly flammable liquid and vapour. Catches fire spontaneously if exposed 
to air. Causes severe skin burns and eye damage. Keep away from heat/sparks/open flames/hot surfaces. 
No smoking. Do not allow contact with air. Wear protective gloves/ protective clothing/eye 
protection/face protection. 
EDC.HCl: Causes serious eye damage. Wear protective gloves/eye protection/face protection. 
Ethyl bromodifluoroacetate, ethyl chlorofluoroacetate: Causes severe skin burns and eye damage. Wear 
protective gloves/eye protection/face protection. 
HMPA: May cause genetic defects. May cause cancer. Obtain special instructions before use. 
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Imidazole: Causes severe skin burns and eye damage. May damage the unborn child. Wear protective 
gloves/eye protection/face protection. 
Inorganic acids (HCl): May be corrosive to metals. Causes severe skin burns and eye damage. Avoid 
breathing vapours. Wear protective gloves/eye protection/face protection. 
Inorganic bases (NaOH, KOH): May be corrosive to metals. Causes severe skin burns and eye damage. 
Wear protective gloves/protective clothing/eye protection/face protection. Sodium hydride: In contact 
with water releases flammable gases which may ignite spontaneously. Do not allow contact with water. 
Iodine: Causes damage to organs (thyroid) through prolonged or repeated exposure if swallowed. Very 
toxic to aquatic life. Avoid breathing dust. Avoid release to the environment 
Isobutyl chloroformate: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
NaBH4: In contact with water releases flammable gases which may ignite spontaneously. Causes severe 
skin burns and eye damage. Wear protective gloves/protective clothing/eye protection/face protection. 
Do not allow contact with water. 
NaCNBH3: Flammable solid. Causes severe skin burns and eye damage. Very toxic to aquatic life with long 
lasting effects. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No 
smoking. Avoid release to the environment. Wear protective gloves/protective clothing/eye 
protection/face protection. 
N-Bromosuccinimide: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
N-methylmorpholine: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
Organic acids (HOAc): Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
Organic bases (KHMDS, LiHMDS, KOtBu, LiOtBu): Causes severe skin burns and eye damage. Wear 
protective gloves/protective clothing/eye protection/face protection. NaOMe: Self-heating: may catch 
fire. Causes severe skin burns and eye damage. Keep cool. Protect from sunlight. Wear protective 
gloves/protective clothing/eye protection/face protection. 
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Pd(OAc)2: Causes serious eye damage. Wear protective gloves/eye protection/face protection. 
Phenol: Causes severe skin burns and eye damage. Wear protective gloves/protective clothing/eye 
protection/face protection. 
Phenylacetylene: May be fatal if swallowed and enters airways. 
p-Toluenesulfonyl chloride, p-nitrobenzenesulfonyl chloride, methanesulfonyl chloride: Causes severe 
skin burns and eye damage. Wear protective gloves/protective clothing/eye protection/face protection. 
Tetrachloromethane: May cause an allergic skin reaction. Causes damage to organs through prolonged or 
repeated exposure. Harms public health and the environment by destroying ozone in the upper 
atmosphere. Avoid release to the environment. Wear protective gloves/protective clothing/eye 
protection/face protection. 
TiCl4: Causes severe skin burns and eye damage. Causes damage to organs through prolonged or repeated 
exposure. Do not breathe dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective 
clothing/eye protection/face protection. 
TMSCl, TBDMSCl: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
Thiophenol: Fatal if swallowed, in contact with skin or if inhaled. Causes serious eye damage. Do not 
breathe dust/fume/gas/mist/vapours/spray. Wear protective gloves/eye protection/face protection. 
Thionyl chloride: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection. 
Triethylamine: Causes severe skin burns and eye damage. Wear protective gloves/protective clothing/eye 
protection/face protection. 
Triflic anhydride: Causes severe skin burns and eye damage. Wear protective gloves/protective 
clothing/eye protection/face protection.  
Triphenylphosphine: May cause an allergic skin reaction. Wear protective gloves. 
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5.3 Stereoselective synthesis of both enantiomers of trans-
2-(diphenylmethylideneamino)cyclopropanecarboxylic acid using a chiral pool 
approach and their incorporation in dipeptides 
5.3.1 Synthesis of (R)-benzyl 4-iodo-3-N-(tert-butoxycarbonyl)butanoate (R)-166 
(R)-4-Iodobutanoate (R)-166 was synthesized in two steps following a slightly modified literature 
procedure starting from (R)-β-benzyl N-(tert-butoxycarbonyl)aspartate using PPh3 instead of polymer 
bound triphenylphosphine.67-68 
5.3.2 Synthesis of (R)-benzyl 3-amino-4-iodobutanoate hydrochloride (R)-167 
(R)-Benzyl 4-iodo-3-N-(tert-butoxycarbonyl)butanoate (R)-166 (0.89 g, 2.12 mmol) was dissolved in 10 mL 
of a saturated solution of HCl in Et2O at 0 °C and stirred for 6 hours at 0 °C. After stirring the reaction 
mixture for another 16 hours at room temperature, the solvent was evaporated in vacuo. Subsequently, 
dry Et2O (20 mL) was added and the solution was filtered. After washing the filter cake with dry Et2O (20 
mL), (R)-benzyl 3-amino-4-iodobutanoate hydrochloride (R)-167 (0.39 g, 1.42 mmol) was obtained as white 
crystals in 76% yield. 
(R)-Benzyl 3-amino-4-iodobutanoate hydrochloride (R)-167 
White crystals. Melting point: 129-130 °C. Yield: 76%. 1H NMR (300 MHz, DMSO-d6):  
2.77-2.92 (2H, m, CH2C=O), 3.46-3.61 (3H, m, CH2I and CH), 5.15 (2H, s, CH2O), 7.32-
7.43 (5H, m, CHarom), 8.51 (3H, br s, NH3). 13C NMR (75 MHz, DMSO-d6):  6.3 (CH2I), 37.3 (CH2C=O), 47.6 
(CH), 66.2 (CH2O), 128.0, 128.1 and 128.4 (5x CHarom), 135.5 (Carom,quat), 169.0 (C=O). IR (ATR, cm−1): νNH3 = 
3028, νC=O = 1731, νmax = 1402, 1173, 1154, 1133, 748, 696. MS (ES+): m/z (%): 320 (M + H+ - HCl, 100), 192 
(M + H+ - HCl - HI, 46). 
Optical rotation could not be determined due to instability of the HCl salt in MeOH. 
5.3.3 Synthesis of (R)-benzyl 3-(diphenylmethylideneamino)-4-iodobutanoate (R)-164 
To a solution of (R)-benzyl 3-amino-4-iodobutanoate hydrochloride (R)-167 (0.53 g, 1.5 mmol) in CH2Cl2 
(20 mL) was added diphenylmethylideneamine 12 (1 equiv, 0.27 g, 1.5 mmol). After stirring the reaction 
mixture for 20 hours at room temperature, the solvent was evaporated in vacuo and the residue was 
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redissolved in dry Et2O (20 mL). Filtration of the solids and subsequent removal of the solvent in vacuo 
afforded (R)-benzyl 3-(diphenylmethylideneamino)-4-iodobutanoate (R)-164 in 85% yield (0.61 g, 1.27 
mmol). 
(R)-Benzyl 3-(diphenylmethylideneamino)-4-iodobutanoate (R)-164 
Yellow crystals. Melting point: 82-83 °C. [α]D -40 ± 1 (c 0.8, CH2Cl2). Yield: 85%. 1H NMR 
(300 MHz, CDCl3):  2.76 (1H, dd, J = 15.2 Hz, 7.2 Hz, CH(H)C=O), 2.81 (1H, dd, J = 15.2 
Hz, 5.5 Hz, CH(H)C=O), 3.26 (1H, dd, J = 9.9 Hz, 6.1 Hz, CH(H)I), 3.32 (1H, dd, J = 9.6 Hz, 
6.1 Hz, CH(H)I), 3.84-3.92 (1H, m, CH), 5.06 (1H, d, J = 12.4 Hz, CH(H)O), 5.10 (1H, d, J = 12.4 Hz, CH(H)O), 
7.15-7.20 (2H, m, 2x CHarom), 7.25-7.51 (11H, m, 11x CHarom), 7.57-7.62 (2H, m, 2x CHarom). 13C NMR (75 
MHz, CDCl3):  10.9 (CH2I), 41.2 (CH2C=O), 58.5 (CH), 66.1 (CH2O), 127.5, 127.9, 128.0, 128.3, 128.5, 128.7 
and 130.3 (15x CHarom), 135.6, 136.0 and 139.3 (3x Carom,quat), 169.6 and 170.6 (C=N and C=O). IR (ATR, cm−1): 
νC=O = 1737, νC=N = 1616, νmax = 1292, 1173, 1155, 1131, 695. MS (ES+): m/z (%): 484 (M + H+, 100). HRMS 
(ES+): calcd for C24H23INO2+: 484.0768, found 484.0764. 
5.3.4 Synthesis of (1S,2S)-benzyl 2-(diphenylmethylideneamino)cyclopropane-
carboxylate (1S,2S)-8 
A solution of (R)-benzyl 3-(diphenylmethylideneamino)-4-iodobutanoate (R)-164 (0.15 g, 0.3 mmol, 1 
equiv) in THF (3 mL) was cooled to -78 °C and KHMDS (1M in THF) (1.1 equiv, 0.33 mmol, 0.33 mL) was 
added dropwise. Subsequently, the reaction mixture was stirred for one hour at -78 °C, after which it was 
quenched with 1 mL NH4Cl(aq, sat). The mixture was poured in 10 mL NaOH (2M in H2O), extracted with Et2O 
(3x 10 mL) and the organic layers were dried with MgSO4. After removal of the drying agent and 
evaporation of the solvent in vacuo, a mixture of trans- and cis-benzyl 2-(diphenylmethylideneamino)-
cyclopropanecarboxylate (1S,2S)-8 and (1R,2S)-8 was obtained (dr 97:3) from which (1S,2S)-benzyl 
2-(diphenylmethylideneamino)cyclopropanecarboxylate (1S,2S)-8 was isolated in 75% yield (0.080 g, 0.23 
mmol) (dr > 99:1) after recrystallization from hexane. 
The diastereomeric ratio was determined based on the well-resolved signal of the benzylic protons in the 
1H NMR spectrum. 
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(1S,2S)-Benzyl 2-(diphenylmethylideneamino)cyclopropanecarboxylate (1S,2S)-8 
White crystals. Melting point: 102-103 °C. [α]D 206 (c 1.6, CH2Cl2). Yield: 75%. 1H NMR (300 
MHz, CDCl3):  1.52-1.63 (2H, m, CH2), 2.29 (1H, ddd, J = 8.6 Hz, 6.1 Hz, 2.5 Hz, CHC=O), 3.37 
(1H, ddd, J = 7.4 Hz, 4.8 Hz, 2.5 Hz, CHN), 5.08 (2H, s, CH2O), 7.20-7.55 (15H, m, 15x CHarom). 
13C NMR (75 MHz, CDCl3):  18.6 (CH2), 25.2 (CHC=O), 45.7 (CHN), 66.4 (CH2O), 128.2, 128.3, 128.40, 
128.43, 128.7, 128.9 and 130.1 (10x CHarom), 136.1, 136.4 and 139.6 (3x Carom,quat), 169.2 and 172.8 (C=N 
and C=O). IR (ATR, cm-1): νC=O = 1714, νC=N 1612, νmax = 1400, 1164, 618. MS (ES+): m/z (%): 356 (M + H+, 
100). HRMS (ES+): calcd for C24H22NO2+: 356.1645, found 356.1644. 
5.3.5 Synthesis of (1R,2R)-2-(diphenylmethylideneamino)cyclopropanecarboxylic acid 
(1R,2R)-9 
To an ice-cooled solution of (1R,2R)-benzyl 2-(diphenylmethylideneamino)cyclopropanecarboxylate 
(1R,2R)-8 (0.21 g, 0.6 mmol, 1 equiv) in MeOH/H2O 5/1 (6 mL), aqueous 2M NaOH (5 equiv, 3 mmol, 1.5 
ml) was added. The reaction mixture was stirred at room temperature for 20 hours. The organic solvent 
was evaporated under reduced pressure and the residual aqueous phase was washed with Et2O (2x 10 
mL). Subsequently, the aqueous layer was carefully acidified with a solution of 2M HCl in H2O to pH 6, 
followed by an extraction with CH2Cl2 (3x 10 mL). After drying (MgSO4), filtration and evaporation, the pure 
carboxylic acid (1R,2R)-9 was obtained in 61% yield and dr > 99:1 (0.097 g, 0.37 mmol). 
(1R,2R)-2-(Diphenylmethylideneamino)cyclopropanecarboxylic acid (1R,2R)-9 
White crystals. Melting point: 194-195 °C. [α]D -256 (c 0.5, MeOH). Yield 61%. 1H NMR (300 
MHz, CDCl3):  1.55 (1H, ddd, J = 7.4 Hz, 5.8 Hz, 4.4 Hz, CH(H)), 1.63 (1H, ddd, J = 8.8 Hz, 4.5 
Hz, 4.4 Hz, CH(H)), 2.23 (1H, ddd, J = 8.5 Hz, 6.1 Hz, 2.5 Hz, CHC=O), 3.38 (1H, ddd, J = 7.3 Hz, 
4.8 Hz, 2.3 Hz, CHN), 7.24-7.55 (10H, m, 10x CHarom). OH: not visible 13C NMR (75 MHz, CD3OD): 
 17.7 (CH2), 24.6 (CHC=O), 45.4 (CHN), 128.3, 128.5, 128.6, 129.0 and 130.5 (10x CHarom), 136.9 and 139.8 
(2x Carom,quat), 170.7 and 175.6 (C=N and C=O). IR (ATR, cm-1): νOH = 2850, νC=O = 1698, νC=N = 1613, νmax = 
1209, 1186, 936, 698. MS (ES+): m/z (%): 266 (M + H+, 100). HRMS (ES+): calcd for C17H16NO2+: 266.1176, 
found 266.1176. 
(1S,2S)-2-(Diphenylmethylideneamino)cyclopropanecarboxylic acid (1S,2S)-9 
[α]D 247 (c 0.4, MeOH). 
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5.3.6 Synthesis of (1’R,2’R)-methyl [(2’-diphenylmethylideneaminocyclopropane)-
carbonyl]aminoacetate (1’R,2’R)-171 
To a stirred solution of (1R,2R)-2-(diphenylmethylideneamino)cyclopropanecarboxylic acid (1R,2R)-9 
(0.053 g, 0.2 mmol) and methyl glycinate hydrochloride 170a (1 equiv, 0.025 g, 0.2 mmol) in dry CH2Cl2 (5 
mL) were added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCl) (1 equiv, 0.038 
g, 0.2 mmol) and N-methylmorpholine (3 equiv, 0.061 g, 0.6 mmol), and the reaction mixture was stirred 
at room temperature for three hours. The reaction mixture was poured into water (10 mL) and extracted 
with CH2Cl2 (3x 5 mL). The combined organic layers were dried with MgSO4. The drying agent was removed 
by filtration and the filtrate was concentrated in vacuo to afford pure (1’R,2’R)-methyl [(2’-
diphenylmethylideneaminocyclopropane)carbonyl]aminoacetate (1’R,2’R)-171 (58% yield, 0.039 g, 0.12 
mmol) after column chromatography on silica gel (petroleum ether/EtOAc 1/1). 
(1’R,2’R)-Methyl [(2’-diphenylmethylideneaminocyclopropane)carbonyl]aminoacetate (1’R,2’R)-171 
Viscous oil. [α]D -168 ± 3 (c 0.1, CH2Cl2). Yield: 58%. 1H NMR (300 MHz, CDCl3):  1.49 
(1H, ddd, J = 8.8 Hz, 4.4 Hz, 4.4 Hz, CH(H)), 1.56 (1H, ddd, J = 7.4 Hz, 5.8 Hz, 4.4 Hz, 
CH(H)), 2.11 (1H, ddd, J = 8.5 Hz, 5.9 Hz, 3.0 Hz, CHC=O), 3.36 (1H, ddd, J = 7.2 Hz, 4.8 
Hz, 2.2 Hz, CHN), 3.75 (3H, s, CH3), 4.03 (2H, d, J = 5.0 Hz, CH2NH), 6.28 (1H, t, J = 5.0 
Hz, NH), 7.23-7.55 (10H, m, 10x CHarom). 13C NMR (75 MHz, CDCl3):  17.5 (CH2CHN), 26.9 (CHC=O), 41.3 
(CH2N), 44.8 (CHN), 52.4 (CH3), 128.1, 128.3, 128.4, 128.6, 128.8 and 129.9 (10x CHarom), 136.3 and 139.7 
(2x Carom,quat), 168.7, 170.5 and 171.6 (C=N and 2x C=O). IR (ATR, cm−1): νNH = 3299, νC=O = 1752, νC=O = 1648, 
νmax = 1542, 1207, 1180, 695. MS (ES+): m/z (%): 337 (M + H+, 100). HRMS (ES+): calcd for C20H21N2O3+: 
337.1547, found 337.1548. 
(1’S,2’S)-Methyl [(2’-diphenylmethylideneaminocyclopropane)carbonyl]aminoacetate (1’S,2’S)-171 
[α]D 151 ± 1 (c 0.3, CH2Cl2). 
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5.4 Synthesis of novel -aminocyclobutanecarboxylic acid derivatives by a 
solvent-free aza-Michael addition and subsequent ring closure 
5.4.1 Synthesis of dialkyl 2-[3-halo-2,2-dimethyl-1-(diphenylmethylideneamino)-
propyl]malonates 174 
As a representative example, the synthesis of dimethyl 2-[3-bromo-2,2-dimethyl-1-
(diphenylmethylideneamino)propyl]malonate 174a is described here. In a flame-dried flask, triethylamine 
(1.05 equiv, 0.180 g, 1.86 mmol) was added to a mixture of dimethyl 2-(3-bromo-2,2-
dimethylpropylidene)malonate 11a (1 equiv, 0.520 g, 1.86 mmol) and diphenylmethylideneamine 12 (1.05 
equiv, 0.350 g, 1.96 mmol). This mixture was stirred at 60 °C under solvent-free conditions for four hours. 
Subsequently, dry diethyl ether was added, the solution was filtered and the filtrate was concentrated in 
vacuo. Pure dimethyl 2-[3-bromo-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 174a was 
obtained after recrystallization from diethyl ether in 79% yield. 
Dimethyl 2-[3-bromo-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 174a 
White crystals. Melting point: 140.6-142.1 °C. Yield: 79%. 1H NMR (300 MHz, CDCl3): 
 0.94 (3H, s, CH3), 1.05 (3H, s, CH3), 3.30 (1H, d, J = 9.9 Hz, CH(H)Br), 3.42 (1H, d, J 
= 9.9 Hz, CH(H)Br), 3.52 (3H, s, OCH3), 3.70 (3H, s, OCH3), 4.02 (1H, d, J = 6.1 Hz, 
CH(COOMe)2), 4.36 (1H, d, J = 6.1 Hz, CHN), 7.27-7.60 (10H, m, 10x CHarom). 13C NMR 
(75 MHz, CDCl3):  22.1 (CCH3(CH3)), 23.4 (CCH3(CH3)), 40.7 (C(CH3)2), 44.2 (BrCH2), 52.4 (OCH3), 52.7 
(OCH3), 53.9 (CH(COOMe)2), 66.0 (CHN), 128.0, 128.1, 128.6, 128.7 and 130.3 (10x CHarom), 135.5 (Carom,quat), 
139.6 (Carom,quat), 168.4, 168.6 and 169.5 (2x C=O and C=N). IR (ATR, cm-1): νC=O = 1732, νC=N = 1626, νmax = 
1224, 1204, 1170, 705, 697. MS (ES+): m/z (%): 460/62 (M + H+, 100). El. Anal. Calcd for C23H26BrNO4: C 
60.01, H 5.69, N 3.04, found C 59.83, H 5.58, N 3.27. 
Diethyl 2-[3-bromo-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 174c 
Prepared at room temperature instead of 60 °C. 
White crystals. Melting point: 96.9-97.4 °C. Yield: 76%. 1H NMR (300 MHz, CDCl3):  
0.93 (3H, s, CH3), 1.04 (3H, t, J = 7.2 Hz, CH2CH3), 1.05 (3H, s, CH3), 1.23 (3H, t, J = 7.2 
Hz, CH2CH3), 3.31 (1H, d, J = 10.2 Hz, CH(H)Br), 3.43 (1H, d, J = 10.2 Hz, CH(H)Br), 3.88-
4.04 (2H, m, OCH2), 3.98 (1H, d, J = 6.6 Hz, CH(COOEt)2), 4.16 (2H, q, J = 7.2 Hz, OCH2), 
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4.38 (1H, d, J = 6.6 Hz, CHN), 7.26-7.60 (10H, m, 10x CHarom). 13C NMR (75 MHz, CDCl3):  13.9 (CH2CH3), 
14.0 (CH2CH3), 22.0 (CCH3(CH3)), 23.4 (CCH3(CH3)), 40.8 (C(CH3)2), 44.3 (CH2Br), 54.3 (CH(COOEt)2), 61.4 
(OCH2), 61.6 (OCH2), 65.9 (CHN), 127.9, 128.1, 128.6, 128.76, 128.82 and 130.2 (10x CHarom), 135.6 
(Carom,quat), 139.7 (Carom,quat), 167.9, 168.2 and 169.3 (2x C=O and C=N). IR (ATR, cm-1): νc=o = 1727, νC=N = 
1626, νmax = 1290, 1222, 1178, 1030, 699. MS (ES+): m/z (%): 488/90 (M + H+, 100). El. Anal. Calcd for 
C25H30BrNO4: C 61.48, H 6.19, N 2.87, found C 61.39, H 6.06, N 2.88. 
Diethyl 2-[3-chloro-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 174d 
White crystals. Melting point: 83.9-84.1 °C. Yield: 67%. 1H NMR (300 MHz, CDCl3):  
0.91 (3H, s, CH3), 1.04 (3H, t, J = 6.9 Hz, CH2CH3), 1.04 (3H, s, CH3), 1.23 (3H, t, J = 6.9 
Hz, CH2CH3), 3.36 (1H, d, J = 11.0 Hz, CH(H)Cl), 3.47 (1H, d, J = 11.0 Hz, CH(H)Cl), 3.94 
(2H, q, J = 6.9 Hz, OCH2), 3.99 (1H, d, J = 6.3 Hz, CH(COOEt)2), 4.16 (2H, q, J = 6.9 Hz, 
OCH2), 4.36 (1H, d, J = 6.3 Hz, CHN), 7.26-7.59 (10H, m, 10x CHarom). 13C NMR (75 MHz, CDCl3):  13.9 
(CH2CH3), 14.0 (CH2CH3), 21.0 (CCH3(CH3)), 22.3 (CCH3(CH3)), 41.4 (C(CH3)2), 53.4 (CH2Cl), 54.2 (CH(COOEt)2), 
61.4 (OCH2), 61.6 (OCH2), 65.8 (CHN), 127.9, 128.0, 128.6, 128.77, 128.85 and 130.2 (10x CHarom), 135.6 
(Carom,quat), 139.8 (Carom,quat), 168.0, 168.2 and 169.3 (2x C=O and C=N). IR (ATR, cm-1): νC=O = 1723, νC=N = 
1627, νmax = 1282, 1221, 1180, 1030, 700. MS (ES+): m/z (%): 444/46 (M + H+, 100). El. Anal. Calcd for 
C25H30ClNO4: C 67.63, H 6.81, N 3.15, found C 67.59, H 6.85, N 3.17. 
The spectral data of dimethyl 2-[3-chloro-2,2-dimethyl-1-(diphenylmethylideneamino)propyl]malonate 
174b were in accordance with the data reported in a previous Master thesis.13 
5.4.2 Synthesis of diethyl 2-[2,2-dimethyl-3-(diphenylmethylideneamino)-
propylidene]malonate 175b 
In a flame-dried flask, triethylamine (1.05 equiv, 0.17 g, 1.7 mmol) was added to a mixture of diethyl 2-(3-
bromo-2,2-dimethylpropylidene)malonate 11c (1 equiv, 0.50 g, 1.63 mmol) and 
diphenylmethylideneamine (1.05 equiv, 0.31 g, 1.71 mmol). The reaction mixture was stirred at 60 °C 
under solvent-free conditions for 20 hours. Subsequently, dry diethyl ether was added, the solution was 
filtered and the solvent was removed in vacuo. Pure diethyl 2-[2,2-dimethyl-3-
(diphenylmethylideneamino)propylidene]malonate 175b was obtained after recrystallization from diethyl 
ether in a yield of 38%. 
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Diethyl 2-[2,2-dimethyl-3-(diphenylmethylideneamino)propylidene]malonate 175b 
White crystals. Melting point: 75.6-77.0 °C. Yield: 38%. 1H NMR (300 MHz, 
CDCl3):  1.18 (6H, s, C(CH3)2), 1.28 (3H, t, J = 7.2 Hz, CH2CH3), 1.31 (3H, t, J = 7.2 
Hz, CH2CH3), 3.31 (2H, s, NCH2), 4.22 (2H, q, J = 7.2 Hz, OCH2), 4.24 (2H, q, J = 7.2 
Hz, OCH2), 7.07 (1H, s, CH=C), 7.11-7.15 (2H, m, 2x CHarom), 7.29-7.50 (6H, m, 6x CHarom), 7.61-7.65 (2H, m, 
2x CHarom). 13C NMR (75 MHz, CDCl3):  14.0 (CH2CH3), 14.1 (CH2CH3), 24.7 (C(CH3)2), 39.4 (C(CH3)2), 61.26 
(OCH2), 61.35 (OCH2), 64.2 (NCH2), 126.4 (C=CH), 127.8, 128.0, 128.4, 128.5, 128.6 and 130.0 (10x CHarom), 
136.8 (Carom,quat), 139.8 (Carom,quat), 153.7 (C=CH), 164.5, 167.0 and 168.7 (2x C=O and C=N). IR (ATR, cm-1): 
νC=O = 1725, νC=C = 1646, νC=N = 1626, νmax = 1226, 1204, 1027, 707, 700. MS (ES+): m/z (%): 408 (M + H+, 
100). El. Anal. Calcd for C25H29NO4: C 73.69, H 7.17, N 3.44, found C 73.28, H 7.17, N 3.41. 
5.4.3 Synthesis of dimethyl 2-{[(3-tert-butyldimethylsilyl)oxy]-propylidene}malonate 
179 
Dimethyl 2-{[(3-tert-butyldimethylsilyl)oxy]propylidene}malonate 179 was synthesized following a 
literature procedure.79a 
Dimethyl 2-[(3-tert-butyldimethylsilyl)oxy]propylidenemalonate 179 
Colorless oil. Rf 0.13 (petroleum ether/EtOAc 10/1). Yield: 60%. 1H NMR (300 
MHz, CDCl3):  0.05 (6H, s, 2x SiCH3), 0.89 (9H, s, SiC(CH3)3), 2.54 (2H, dt, J = 
7.6 Hz, 6.3 Hz, OCH2CH2), 3.74 (2H, t, J = 6.3 Hz, OCH2), 3.79 (3H, s, OCH3), 3.83 (3H, s, OCH3), 7.14 (1H, t, J 
= 7.6 Hz, CH=C). 13C NMR (75 MHz, ref = CDCl3):  -5.3 (2x SiCH3), 18.3 (SiC(CH3)3), 25.9 (SiC(CH3)3), 33.4 
(OCH2CH2), 52.3 (OCH3), 52.4 (OCH3), 61.3 (OCH2), 129.1 (CH=C), 147.7 (CH=C), 164.3 (C=O), 165.8 (C=O). 
IR (ATR, cm-1): νC=O = 1728, νC=C = 1649, νmax = 1250, 1212, 1096, 832, 775. MS (ES+): m/z (%): 303 (M + H+, 
100). HRMS (ES+): calcd. for C14H27O5Si+ (M + H+): 303.1622, found 303.1610.  
5.4.4 Synthesis of dimethyl 2-{1-(diphenylmethylideneamino)-3-[(tert-
butyldimethylsilyl)oxy]propyl}malonate 181 
To a solution of dimethyl 2-{[(3-tert-butyldimethylsilyl)oxy]propylidene}malonate 179 (1.00 g, 3.3 mmol) 
in CH2Cl2 (30 mL), diphenylmethylideneamine (2 equiv, 1.20 g, 6.6 mmol) and Et3N (2 equiv, 0.67 g, 6.6 
mmol) were added and this mixture was stirred at reflux temperature for 30 hours. The solvent was 
removed in vacuo and 30 mL of dry Et2O was added. After filtration of the solids, the solvent was 
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evaporated, affording crude malonate 181 as yellow crystals. After recrystallisation from hexane, pure 
malonate 181 (1.01 g, 2.1 mmol) was obtained as white crystals. 
Dimethyl 2-{1-(diphenylmethylideneamino)-3-[(tert-butyldimethylsilyl)oxy]propyl}malonate 181 
White crystals. Yield: 64%. 1H NMR (300 MHz, CDCl3):  0.01 (3H, s, SiCH3), 
0.02 (3H, s, SiCH3), 0.85 (9H, s, SiC(CH3)3), 1.86-1.93 (2H, m, OCH2CH2), 3.49-
3.57 (2H, m, OCH2), 3.69 (3H, s, OCH3), 3.71 (3H, s, OCH3), 3.94 (1H, d, J = 7.7 
Hz, CH(COOMe)2), 4.22-4.29 (1H, m, CHN), 7.28-7.59 (10H, m, 10x CHarom). 13C 
NMR (75 MHz, CDCl3):  -5.4 (2x SiCH3), 18.2 (SiC(CH3)3), 25.9 (SiC(CH3)3), 37.1 (OCH2CH2), 52.3 (2x OCH3), 
56.8 (CH(COOMe)2), 58.4 (CHN), 59.8 (OCH2), 127.9, 128.1 and 128.3 (6x CHarom), 128.5 (CHarom), 128.6 (2x 
CHarom), 130.0 (CHarom), 136.2 (Carom,quat), 140.1 (Carom,quat), 168.4, 168.5 and 168.7 (2x C=O and C=N). IR (ATR, 
cm-1): νC=O = 1742, νC=O = 1721, νC=N = 1627, νmax = 1264, 1253, 1156, 1083, 839, 780, 694. MS (ES+): m/z (%): 
484 (M + H+, 100). 
5.5 Synthesis of 2-amino-3,3-difluorocyclopropane-1,1-dicarboxylates 
5.5.1 Synthesis of 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonates 182 
The synthesis of dimethyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182a is described as 
representative. To a solution of ethyl bromodifluoroacetate (3.00 g, 14.8 mmol) in dry dichloromethane 
(50 mL), was added a solution of DIBAL (1.2M in toluene, 1.1 equiv, 13.6 mL, 16.3 mmol) at -78 °C under 
nitrogen atmosphere and this mixture was stirred for two hours at the same temperature. In another flask, 
dimethyl malonate (3 equiv, 5.85 g, 44.3 mmol) was dissolved in dry THF (50 mL) and NaH (3.3 equiv, 1.17 
g, 48.8 mmol) was added at 0 °C. This mixture was stirred at 0 °C for 30 minutes and was then transferred 
into the former reaction mixture. Stirring was continued for one hour while the mixture was allowed to 
warm to room temperature, after which HCl (2M in H2O) was added until pH 6 was reached. After filtration 
over Celite® and extraction with EtOAc (3x 40 mL), the combined organic phases were washed with brine 
(40 mL). After drying (MgSO4), filtration and evaporation of the organic phase in vacuo, crude malonate 
182a was purified by means of column chromatography (petroleum ether/EtOAc 9/1) affording pure 
dimethyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182a (2.63 g, 9.03 mmol). 
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Dimethyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182a 
Pale yellow oil. Rf 0.03 (petroleum ether/EtOAc 9/1). Yield: 61%. 1H NMR (300 MHz, 
CDCl3):  3.82 (3H, s, OCH3), 3.84 (3H, s, OCH3), 3.90 (1H, d, J = 3.3 Hz, CH(COOMe)2), 
4.62-4.70 (2H, m, CHOH). 13C NMR (75 MHz, ref = CDCl3):  51.6 (CH(COOMe)2), 53.3 
(OCH3), 53.4 (OCH3), 75.3 (t, J = 26.0 Hz, CHOH), 122.9 (t, J = 309.8 Hz, CF2Br), 160.1 and 167.9 (2x C=O). 
19F NMR (282 MHz, CDCl3, ref = CFCl3):  -57.01 (1F, dd, J = 166.7 Hz, JH,F = 7.2 Hz, CF(F)Br), -59.75 (1F, dd, 
J = 166.7 Hz, JH,F = 10.5 Hz, CF(F)Br). IR (ATR, cm-1): νOH = 3458, νC=O = 1736, νmax = 1197, 1159, 1100, 1023, 
925. MS (ES+): m/z (%): 308/10 (M + NH4+, 100). HRMS (ES-): calcd. for C7H8BrF2O5- (M - H+): 288.9529, 
found 288.9528.  
Diethyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182b 
Pale yellow oil. Rf 0.14 (petroleum ether/EtOAc 9/1). Yield: 62%. 1H NMR (400 MHz, 
CDCl3):  1.30 (3H, t, J = 7.0 Hz, CH2CH3), 1.31 (3H, t, J = 7.0 Hz, CH2CH3), 3.85 (1H, d, J = 
3.9 Hz, CH(COOEt)2), 4.28 (2H, q, J = 7.0 Hz, OCH2CH3), 4.30 (2H, q, J = 7.2 Hz, OCH2CH3), 
4.66 (1H, dddd, JH,F = 11.1 Hz, J = 9.1 Hz, JH,F = 7.9 Hz, J = 3.9 Hz, CHOH), 4.78 (1H, d, J = 9.1 Hz, OH). 13C 
NMR (100.6 MHz, CDCl3):  13.88 and 13.93 (2x CH3), 51.0 (CH(COOEt)2), 62.7 and 62.8 (2x OCH2), 75.9 (dd, 
J = 26.0 Hz, 24.7 Hz, CHOH), 122.8 (t, J = 310.6 Hz, CF2Br), 165.6 and 168.1 (2x C=O). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -57.15 (1F, dd, J = 166.5 Hz, JH,F = 7.9 Hz, CF(F)Br), -59.57 (1F, dd, J = 166.5 Hz, JH,F = 
11.1 Hz, CF(F)Br). IR (ATR, cm-1): νOH = 3456, νC=O = 1736, νmax = 1301, 1177, 1096, 1024, 927. MS (ES+): m/z 
(%): 319/21 (M + H+, 40). HRMS (ES+): calcd for C9H14BrF2O5+: 318.9987, found 318.9988. 
Diisopropyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182c 
Pale yellow oil. Rf 0.12 (petroleum ether/EtOAc 9/1). Yield: 59%. 1H NMR (300 MHz, 
CDCl3):  1.27 (6H, d, J = 6.1 Hz, CH(CH3)2), 1.30 (6H, d, J = 6.1 Hz, CH(CH3)2), 3.85 (1H, 
d, J = 3.9 Hz, CH(COOiPr)2), 4.64 (1H, dddd, JH,F = 11.3 Hz, J = 8.7 Hz, JH,F = 8.1 Hz, J = 3.9 
Hz, CHOH), 4.92 (1H, d, J = 8.7 Hz, OH), 5.15 (2H, septet, J = 6.4 Hz, 2x CH(CH3)2). 13C NMR (75 MHz, ref = 
CDCl3):  21.4, 21.48, 21.51 and 21.7 (4x CH3), 51.5 (CH(COOiPr)2), 70.6 and 70.7 (2x CH(CH3)2), 75.8 (t, J = 
25.4 Hz, CHOH), 123.1 (t, J = 310.4 Hz, CF2Br), 165.2 and 167.7 (2x C=O). 19F NMR (282 MHz, CDCl3, ref = 
CFCl3):  -57.02 (1F, dd, J = 166.1 Hz, JH,F = 8.1 Hz, CF(F)Br), -59.75 (1F, dd, J = 166.1 Hz, JH,F = 11.3 Hz, 
CF(F)Br). IR (ATR, cm-1): νOH = 3458, νC=O = 1737, νmax = 1288, 1179, 1095, 1021, 904. MS (ES+): m/z (%): 
347/49 (M + H+, 40), 364/66 (M + NH4+, 100). HRMS (ES-): calcd for C11H16BrF2O5- (M - H+): 345.0155, found 
345. 
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5.5.2 Synthesis of 2-(2-bromo-2,2-difluoroethylidene)malonates 16 
The synthesis of dimethyl 2-(2-bromo-2,2-difluoroethylidene)malonate 16a is described as representative. 
Dimethyl 2-(2-bromo-2,2-difluoro-1-hydroxyethyl)malonate 182a (2.91 g, 10 mmol) was dissolved in dry 
CH2Cl2 (50 mL) and acetyl chloride (2.2 equiv, 1.73 g, 22.0 mmol) and Et3N (4.5 equiv, 4.55 g, 45.0 mmol) 
were added dropwise at 0 °C. After stirring at 0 °C for an additional five minutes, the reaction mixture was 
stirred at reflux temperature for 2.5 hours. A saturated aqueous solution of NH4Cl (40 mL) was added, the 
mixture was extracted with CH2Cl2 (3x 30 mL) and the combined organic phases were dried over MgSO4. 
After removal of the drying agent through filtration, the solvent was evaporated under reduced pressure 
affording crude ethylidenemalonate 16a. After column chromatography, pure dimethyl 2-(2-bromo-2,2-
difluoroethylidene)malonate 16a (2.20 g, 8.1 mmol) was obtained as a colorless oil. 
Dimethyl 2-(2-bromo-2,2-difluoroethylidene)malonate 16a 
Colorless oil. Rf 0.29 (petroleum ether/EtOAc 9/1). Yield: 81%. 1H NMR (300 MHz, 
CDCl3):  3.87 (3H, s, OCH3), 3.89 (3H, s, OCH3), 7.00 (1H, t, JH,F = 11.6 Hz, CH). 13C NMR 
(75 MHz, ref = CDCl3):  53.2 (OCH3), 53.6 (OCH3), 113.8 (t, J = 302.3 Hz, CBrF2), 129.3 (C(COOMe)2), 134.9 
(t, J = 26.5 Hz, CH), 162.2 and 163.2 (2x C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): δ -49.50 (2F, d, JH,F 
= 11.3 Hz, CF2Br). IR (ATR, cm-1): νC=O = 1737, νC=C = 1665, νmax = 1259, 1220, 1114, 946, 932. MS (ES+): m/z 
(%): 290/92 (M + NH4+, 100). HRMS: the mother ion (M + H+) could not be detected. 
Diethyl 2-(2-bromo-2,2-difluoroethylidene)malonate 16b 
Colorless oil. Rf 0.20 (petroleum ether/EtOAc 8/2). Yield: 76%. 1H NMR (300 MHz, 
CDCl3):  1.33 (3H, t, J = 7.2 Hz, OCH2CH3), 1.35 (3H, t, J = 7.2 Hz, OCH2CH3), 4.32 (2H, q, 
J = 7.2 Hz, OCH2CH3), 4.36 (2H, q, J = 7.2 Hz, OCH2CH3), 6.97 (1H, t, JH,F = 11.8 Hz, CH). 13C NMR (75 MHz, 
ref = CDCl3):  11.5 (2x OCH2CH3), 59.9 (OCH2CH3), 60.5 (OCH2CH3), 111.8 (t, J = 302.3 Hz, CF2Br), 128.0 
(C(COOEt)2), 131.6 (t, J = 26.5 Hz, CH), 159.2 and 160.2 (2x C=O). 19F NMR (282 MHz, CDCl3, ref = CFCl3): δ 
-48.85 (2F, d, JH,F = 11.8 Hz, CF2Br). IR (ATR, cm-1): νC=O = 1736, νC=C = 1666, νmax = 1251, 1218, 1111, 947. 
MS (ES+): m/z (%) = 301/3 (M + H+, 10), 318/20 (M + NH4+, 15). HRMS (ES+) calcd for C9H15BrF2NO4+ 318.0147 
(M + NH4+), found 318.0144. 
Diisopropyl 2-(2-bromo-2,2-difluoroethylidene)malonate 16c 
Colorless oil. Rf 0.34 (petroleum ether/EtOAc 95/5). Yield: 71%. 1H NMR (300 MHz, 
CDCl3):  1.30 (6H, d, J = 6.1 Hz, CH(CH3)2), 1.33 (6H, d, J = 6.1 Hz, CH(CH3)2), 5.13 (1H, 
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septet, J = 6.1 Hz, CH(CH3)2), 5.23 (1H, septet, J = 6.1 Hz, CH(CH3)2), 6.92 (1H, t, JH,F = 11.8 Hz, CH). 13C NMR 
(75 MHz, CDCl3):  21.5 (CH(CH3)2), 21.6 (CH(CH3)2), 70.3 (CH(CH3)2), 70.9 (CH(CH3)2), 114.1 (t, J = 302.3 Hz, 
CF2Br), 130.8 (t, J = 4.6 Hz, C(COOiPr)2), 133.6 (t, J = 12.6 Hz, CH), 161.3 and 162.3 (2x C=O). 19F NMR (376.5 
MHz, CDCl3, ref = CFCl3):  -48.36 (2F, d, JH,F = 11.9 Hz, CF2Br). IR (ATR, cm-1): νC=O = 1730, νC=C = 1666, νmax 
= 1257, 1225, 1096, 952. MS (ES+): m/z (%): 329/31 (M + H+, 40). HRMS (ES+): calcd for C11H16BrF2O4+: 
329.0195, found 329.0194. 
5.5.3 Synthesis of 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]-
malonates 183 
The synthesis of dimethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183a is 
described as representative. Diphenylmethylideneamine (1.05 equiv, 0.14 g, 0.77 mmol) was added to 
dimethyl 2-(2-bromo-2,2-difluoroethylidene)malonate 16a (0.20 g, 0.73 mmol) and this mixture was 
stirred for one hour at room temperature. After recrystallization from MeOH, pure dimethyl 2-[2-bromo-
2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183a (0.30 g, 0.66 mmol) was obtained as 
white crystals. 
Dimethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183a 
White crystals. Melting point: 69.7-70.7 °C. Yield: 90%. 1H NMR (300 MHz, CDCl3):  
3.67 (3H, s, OCH3), 3.72 (3H, s, OCH3), 4.27 (1H, d, J = 8.3 Hz, CH(COOMe)2), 4.77 (1H, 
ddd, J = 8.3 Hz, JH,F = 7.9 Hz, 5.9 Hz, CHN), 7.31-7.65 (10H, m, 10x CHarom). 13C NMR (75 
MHz, CDCl3):  52.9 (OCH3), 53.0 (OCH3), 54.4 (d, J = 3.5 Hz, CH(COOMe)2), 67.6 (t, J = 
23.1 Hz, CHN), 123.4 (t, J = 309.2 Hz, CF2Br), 128.1 (2x CHarom), 128.3 (2x CHarom), 128.4 (2x CHarom), 129.1 
(CHarom), 129.3 (2x CHarom), 131.1 (CHarom), 135.2 (Carom,quat), 139.2 (Carom,quat), 166.3 and 166.5 (2x C=O), 
175.0 (C=N). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): δ -50.63 (1F, dd, J = 164.9 Hz, JH,F = 7.9 Hz, CF(F)Br), 
-53.01 (1F, dd, J = 164.9 Hz, JH,F = 5.9 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1736, νC=N = 1626, νmax = 1284, 1160, 
707, 700. MS (ES+): m/z (%): 454/56 (M + H+, 100). HRMS (ES+): calcd for C20H19BrF2NO4+: 454.0460, found 
454.0442. 
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Diethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183b 
White crystals. Melting point: 62-63 °C. Rf 0.30 (petroleum ether/EtOAc 9/1). Yield: 
92%. 1H NMR (400 MHz, CDCl3):  1.16 (3H, t, J = 7.1 Hz, OCH2CH3), 1.23 (3H, t, J = 7.1 
Hz, OCH2CH3), 4.04-4.21 (4H, m, 2x OCH2CH3), 4.22 (1H, d, J = 8.6 Hz, CH(COOEt)2), 4.79 
(1H, ddd, J = 8.6 Hz, JH,F = 8.1 Hz, 6.4 Hz, CHN), 7.31-7.37 (4H, m, 4x CHarom), 7.39-7.44 
(1H, m, CHarom), 7.46-7.52 (3H, m, 3x CHarom), 7.63-7.65 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  
13.9 (CH3), 14.0 (CH3), 54.7 (d, J = 3.2 Hz, CH(COOEt)2), 61.9 (OCH2), 62.1 (OCH2), 67.6 (t, J = 23.0 Hz, CHN), 
123.5 (t, J = 309.1 Hz, CF2Br), 128.0 (2x CHarom), 128.28 (2x CHarom), 128.32 (2x CHarom), 129.0 (CHarom), 129.3 
(2x CHarom), 131.0 (CHarom), 135.2 (Carom,quat), 139.2 (Carom,quat), 165.9 and 166.1 (2x C=O), 174.7 (C=N). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -50.60 (1F, dd, J = 164.4 Hz, JH,F = 8.1 Hz, CF(F)Br), -52.97 (1F, dd, J 
= 164.4 Hz, JH,F = 6.4 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1759, νC=N = 1625, νmax = 1299, 1270, 1030, 1016, 
697. MS (ES+): m/z (%): 482/84 (M + H+, 100). HRMS (ES+): calcd for C22H23BrF2NO4+: 482.0773, found 
482.0789. El. Anal. Calcd for C22H22BrF2NO4: C 54.79, H 4.60, N 2.90, found C 55.11, H 4.57, N 2.60. 
Diisopropyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183c 
White crystals. Melting point: 87-88 °C. Yield: 86%. 1H NMR (300 MHz, CDCl3):  1.13 
(6H, d, J = 6.6 Hz, CH(CH3)2), 1.20 (3H, d, J = 6.6 Hz, CH(CH3)(CH3)), 1.23 (3H, d, J = 6.6 
Hz, CH(CH3)(CH3)), 4.15 (1H, d, J = 8.3 Hz, CH(COOiPr)2), 4.81 (1H, ddd, J = 8.3 Hz, JH,F = 
8.1 Hz, 6.3 Hz, CHN). 13C NMR (75 MHz, ref = CDCl3): 21.55 (CH3), 21.63 (2x CH3), 21.8 
(CH3), 55.2 (CH(COOiPr)2), 67.6 (t, J = 23.1 Hz, CHN), 69.7 (CH(CH3)2), 69.8 (CH(CH3)2), 123.7 (t, J = 309.2 Hz, 
CF2Br), 128.1 (2x CHarom), 128.4 (2x CHarom), 128.5 (2x CHarom), 129.1 (CHarom), 129.5 (2x CHarom), 131.1 
(CHarom), 135.4 (Carom,quat), 139.4 (Carom,quat), 165.7 and 165.9 (2x C=O), 174.6 (C=N). 19F NMR (282 MHz, 
CDCl3, ref = CFCl3 ):  -50.69 (1F, dd, J = 163.8 Hz, JH,F = 8.1 Hz, CF(F)Br), -53.06 (1F, dd, J = 163.8 Hz, JH,F = 
6.3 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1754, νC=N = 1626, νmax = 1286, 1269, 1094, 1033, 692. MS (ES+): m/z 
(%) = 510/12 (M + H+, 100). HRMS (ES+) calcd for C24H27BrF2NO4+: 510.1086, found 510.1085. El. Anal. Calcd 
for C24H26BrF2NO4: C 56.48, H 5.14, N 2.74, found C 56.58, H 4.96, N 2.69. 
5.5.4 Synthesis of 2,2-difluoro-3-(diphenylmethylideneamino)cyclopropane-1,1-
dicarboxylates 184 
The synthesis of dimethyl 2,2-difluoro-3-(diphenylmethylideneamino)cyclopropane-1,1-dicarboxylate 
184a is described as representative. Dimethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)-
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ethyl]malonate 183a (0.28 g, 1.03 mmol) was dissolved in dry THF (5 mL) and KOtBu (1M in THF, 1.1 equiv, 
1.13 mmol, 1.13 mL) was added. This mixture was stirred at reflux temperature for one hour after which 
it was poured in H2O (5 mL) and extracted with EtOAc (3x 5 mL). The organic fractions were dried (MgSO4), 
filtered and evaporated in vacuo. After flash column chromatography, pure dimethyl 2,2-difluoro-
3-(diphenylmethylideneamino)cyclopropane-1,1-dicarboxylate 184a (0.077 g, 0.22 mmol) was obtained.  
Due to the instability of cyclopropanes 184, no full characterization could be obtained. 
Dimethyl 2,2-difluoro-3-(diphenylmethylideneamino)cyclopropane-1,1-dicarboxylate 184a 
Yellow oil. Rf 0.14 (petroleum ether/EtOAc 8/2). Yield: 20%. 1H NMR (400 MHz, CDCl3):  
3.75 (3H, s, OCH3), 4.09 (3H, s, OCH3), 5.64 (1H, dd, JH,F = 15.1 Hz, 2.7 Hz, CHN), 7.28-7.31 
(2H, m, 2x CHarom), 7.36-7.40 (2H, m, 2x CHarom), 7.46-7.48 (1H, m, 1x CHarom), 7.49-7.52 
(3H, m, 3x CHarom), 7.70-7.72 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  50.9 
(OCH3), 57.2 (OCH3), 95.7 (dd, J = 41.4 Hz, 22.6 Hz, CHN), 125.0 (dd, J = 248.8 Hz, 240.8 Hz, CF2), 129.9 (2x 
CHarom), 128.3 (2x CHarom), 128.7 (2x CHarom), 129.6 (2x CHarom), 129.8 (CHarom), 131.8 (CHarom), 135.1 
(Carom,quat), 138.0 (Carom,quat), 162.7 (t, J = 3.6 Hz, C=O), 170.6 (dd, J = 9.0 Hz, 6.2 Hz, C=O), 175.1 (C=N). 
C(COOMe)2: not visible. 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -81.57 (1F, dd, J = 237.0 Hz, JH,F = 15.1 
Hz, CF(F)), -95.55 (1F, dd, J = 237.0 Hz, JH,F = 2.7 Hz, CF(F)). LC-MS (ES+): m/z (%) = 374 (M + H+, 100). 
Diethyl 2,2-difluoro-3-(diphenylmethylideneamino)cyclopropane-1,1-dicarboxylate 184b 
Yellow oil. Rf 0.36 (petroleum ether/EtOAc 7/3). Yield: 22%. 1H NMR (300 MHz, CDCl3):  
1.27 (3H, t, J = 7.2 Hz, CH3), 1.46 (3H, t, J = 7.2 Hz, CH3), 4.19-4.26 (2H, m, OCH2), 4.41-4.54 
(2H, m, OCH2), 5.61 (1H, dd, JH,F = 15.3 Hz, 2.2 Hz, CHN), 7.26-7.51 (8H, m, 8x CHarom), 7.69-
7.71 (2H, m, 2x CHarom). 13C NMR (75 MHz, CDCl3):  14.5 (CH3), 14.8 (CH3), 59.5 (OCH2), 
67.1 (OCH2), 95.5 (dd, J = 41.5 Hz, 23.1 Hz, CHN), 125.1 (dd, J = 246.9 Hz, 240.0 Hz, CF2), 128.0 (2x CHarom), 
128.3 (2x CHarom), 128.7 (2x CHarom), 129.6 (2x CHarom), 129.8 (CHarom), 131.7 (CHarom), 135.2 (Carom,quat), 138.2 
(Carom,quat), 162.5 (C=O), 170.4 (dd, J = 8.7 Hz, 6.3 Hz, C=O), 174.9 (C=N). C(COOEt)2: not visible. 19F NMR 
(282 MHz, CDCl3, ref = CFCl3):  -80.83 (1F, dd, J = 238.1 Hz, JH,F = 15.3 Hz, CF(F)), -95.42 (1F, d, J = 238.1 Hz, 
CF(F)). LC-MS (ES+): m/z (%) = 402 (M + H+, 100). 
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Diisopropyl 2,2-difluoro-3-(diphenylmethylideneamino)cyclopropane-1,1-dicarboxylate 184c 
Yellow oil. Rf 0.15 (petroleum ether/EtOAc 93/7). Yield: 56%. 1H NMR (400 MHz, CDCl3): 
 1.25 (3H, d, J = 6.2 Hz, CH(CH3)(CH3)), 1.26 (3H, d, J = 6.2 Hz, CH(CH3)(CH3)), 1.41 (3H, d, 
J = 6.2 Hz, CH(CH3)(CH3)), 1.49 (3H, d, J = 6.2 Hz, CH(CH3)(CH3)), 5.05-5.16 (2H, m, 2x 
CH(CH3)2), 5.58 (1H, dd, JH,F = 15.0 Hz, 2.2 Hz, CHN), 7.29-7.32 (2H, m, 2x CHarom), 7.34-
7.39 (2H, m, 2x CHarom), 7.45-7.46 (1H, m, CHarom), 7.50-7.51 (3H, m, 3x CHarom), 7.68-7.71 (2H, m, 2x CHarom). 
13C NMR (100.6 MHz, ref = CDCl3):  22.00, 22.04, 22.3 and 22.4 (4x CH3), 66.6 (OCH), 76.0 (OCH), 95.3 (dd, 
J = 41.3 Hz, 22.5 Hz, CHN), 125.2 (dd, J = 249.8 Hz, 242.5 Hz, CF2), 128.1 (2x CHarom), 128.3 (2x CHarom), 128.7 
(2x CHarom), 129.6 (2x CHarom), 129.8 (CHarom), 131.6 (CHarom), 135.1 (Carom,quat), 138.2 (Carom,quat), 162.2 (t, J = 
3.4 Hz, C=O), 170.0 (dd, J = 8.9 Hz, 6.0 Hz, C=O), 174.6 (C=N). C(COOiPr)2: not visible. 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -81.41 (1F, dd, J = 238.4 Hz, 15.0 Hz, CF(F)), -96.58 (1F, d, J = 238.4 Hz, CF(F)). IR (ATR, 
cm-1): νC=O = 1709, νC=N = 1617, νmax = 1430, 1321, 1069, 983, 697. LC-MS (ES+): m/z (%) = 430 (M + H+, 100). 
5.5.5 Synthesis of 3,3-difluoro-5,5-diphenyl-1-pyrroline-4,4-dicarboxylates 185 
The synthesis of dimethyl 3,3-difluoro-5,5-diphenyl-1-pyrroline-4,4-dicarboxylate 185a is described as 
representative. Dimethyl 2-[2-bromo-2,2-difluoro-1-(diphenylmethylideneamino)ethyl]malonate 183a 
(0.50 g, 1.85 mmol) was dissolved in dry THF (20 mL) and KOtBu (1M in THF, 1.1 equiv, 2.04 mmol, 2.04 
mL) was added. This mixture was stirred at reflux temperature for five hours after which it was poured in 
H2O (20 mL) and extracted with EtOAc (3x 20 mL). The organic fractions were dried (MgSO4), filtered and 
evaporated in vacuo. After flash column chromatography, pure dimethyl 3,3-difluoro-5,5-diphenyl-1-
pyrroline-4,4-dicarboxylate 185a (0.49 g, 1.18 mmol) was obtained. 
Dimethyl 3,3-difluoro-5,5-diphenyl-1-pyrroline-4,4-dicarboxylate 185a 
Pale yellow crystals. Melting point: 93-94 °C. Rf 0.27 (petroleum ether/EtOAc 95/5). 
Yield: 73%. 1H NMR (400 MHz, CDCl3):  3.47 (6H, s, 2x OCH3), 7.22-7.32 (6H, m, 6x 
CHarom), 7.42-7.44 (4H, m, 4x CHarom), 8.01 (1H, t, JH,F = 1.8 Hz, HC=N). 13C NMR (100.6 
MHz, ref = CDCl3):  53.1 (2x OCH3), 73.1 (t, J = 18.6 Hz, C(COOMe)2), 88.7 (C(Ph)2), 126.0 (t, J = 261.8 Hz, 
CF2), 128.0 (2x CHarom), 128.1 (4x CHarom), 128.5 (4x CHarom), 140.4 (2x Carom,quat), 156.2 (t, J = 27.3 Hz, HC=N), 
165.1 (2x C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): not visible. IR (ATR, cm-1): νC=O = 1754, νC=O = 1732, 
νmax = 1255, 1175, 1100, 1068, 759, 694. MS (ES+): m/z (%): 374 (M + H+, 100). HRMS (ES+): calcd. for 
C20H18F2NO4+: 374.1198, found 374.1199. 
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Diethyl 3,3-difluoro-5,5-diphenyl-1-pyrroline-4,4-dicarboxylate 185b 
Pale yellow crystals. Melting point: 63-64 °C. Rf 0.42 (petroleum ether/EtOAc 7/3). Yield: 
39%. 1H NMR (300 MHz, CDCl3): 1.00 (6H, t, J = 7.2 Hz, 2x CH3), 3.82-4.01 (4H, m, 2x 
OCH2), 7.23-7.46 (10H, m, 10x CHarom), 8.01 (1H, t, JH,F = 1.9 Hz, HC=N). 13C NMR (75 MHz, 
CDCl3):  13.4 (2x CH3), 62.4 (2x OCH2), 72.9 (t, J = 18.5 Hz, C(COOEt)2), 88.4 (C(Ph)2), 126.0 (t, J = 261.9 Hz, 
CF2), 127.8 (2x CHarom), 127.9 (4x CHarom), 128.5 (4x CHarom), 140.5 (2x Carom,quat), 156.2 (t, J = 28.3 Hz, HC=N), 
164.4 (2x C=O). 19F NMR (282 MHz, CDCl3). not visible. IR (ATR, cm-1): νC=O = 1734, νmax = 1244, 761, 698. 
MS (ES+): m/z (%): 402 (M + H+, 100). HRMS (ES+): calcd. for C22H22F2NO4+: 402.1511, found 402.1510. 
Diisopropyl 3,3-difluoro-5,5-diphenyl-1-pyrroline-4,4-dicarboxylate 185c 
This compound was obtained in 66% purity (mixture with benzophenone) 
Yellow oil. Rf 0.35 (petroleum ether/EtOAc 9/1). Crude yield: 45% (66% purity). 1H NMR 
(400 MHz, CDCl3): 0.90 (6H, br s, CH(CH3)2), 1.04 (2H, d, J = 6.3 Hz, CH(CH3)2), 4.74-4.83 
(2H, m, 2x CH(CH3)2), 7.24-7.29 (6H, m, 6x CHarom), 7.41-7.48 (4H, m, 4x CHarom), 8.00 (1H, 
br s, HC=N). 13C NMR (100.6 MHz, CDCl3):  20.9 (CH(CH3)2), 21.0 (CH(CH3)2), 70.5 (2x CH(CH3)2), 72.7 (t, J = 
17.8 Hz, C(COOiPr)2), 88.2 (C(Ph)2), 126.0 (t, J = 261.4 Hz, CF2), 127.7 (2x CHarom), 127.9 (4x CHarom), 128.5 
(4x CHarom), 140.7 (2x Carom,quat), 156.3 (t, J = 28.2 Hz, HC=N), 163.8 (2x C=O). 19F NMR (376.5 MHz, CDCl3). 
not visible. 
5.5.6 Synthesis of 2-fluoro-3-(diphenylmethylideneamino)cycloprop-2-ene-1,1-
dicarboxylates 186 
The synthesis of diethyl 2-fluoro-3-(diphenylmethylideneamino)cycloprop-2-ene-1,1-dicarboxylate 186b 
is described as representative. To a solution of diethyl 2-[2-bromo-2,2-difluoro-1-
(diphenylmethylideneamino)ethyl]malonate 183b (0.67 g, 1.38 mmol) in dry THF (30 mL), was added 
KOtBu (1M in THF, 1.1 equiv, 1.52 mmol, 1.52 mL). This mixture was stirred at reflux temperature for one 
hour after which it was poured in H2O (20 mL) and extracted with EtOAc (3x 20 mL). The organic fractions 
were dried (MgSO4), filtered and evaporated in vacuo. After flash column chromatography, pure dimethyl 
2-(diphenylmethylideneamino)-3-fluorocycloprop-2-ene-1,1-dicarboxylate 186b (53 mg, 0.14 mmol) was 
obtained. 
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Diethyl 2-fluoro-3-(diphenylmethylideneamino)cycloprop-2-ene-1,1-dicarboxylate 186b 
White crystals. Rf 0.25 (petroleum ether/EtOAc 9/1). Yield: 10%. 1H NMR (400 MHz, 
CDCl3):  1.09 (3H, t, J = 7.1 Hz, CH3), 1.31 (3H, t, J = 7.1 Hz, CH3), 3.66 (2H, q, J = 7.1 Hz, 
OCH2), 4.27 (2H, q, J = 7.1 Hz, OCH2), 7.28-7.48 (8H, m, 8x CHarom), 7.65-7.72 (2H, m, 2x 
CHarom). 13C NMR (100.6 MHz, CDCl3):  14.3 (CH3), 14.8 (CH3), 60.1 (OCH2), 66.4 (OCH2), 
86.4 (d, J = 15.8 Hz, C(COOEt)2) 128.2, 128.4 and 130.0 (10x CHarom), 129.6 (d, J = 18.3 Hz, C=CF), 139.5 (2x 
Carom,quat), 143.5 (d, J = 269.2 Hz, CF), 154.5 (d, J = 5.9 Hz, C=N), 156.9 (d, J = 10.2 Hz, C=O), 161.1 (d, J = 4.2 
Hz, C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -151.97 (1F, s, CF). IR (ATR, cm-1) νC=O = 1698, νC=N = 
1637, νmax = 1489, 1463, 1109, 1067, 776, 694. MS (ES+): m/z (%): 382 (M + H+, 100). HRMS (ES+): calcd. for 
C22H21FNO4+: 382.1449, found 382.1453. 
Diisopropyl 2-fluoro-3-(diphenylmethylideneamino)cycloprop-2-ene-1,1-dicarboxylate 186c 
White crystals. Rf 0.32 (petroleum ether/EtOAc 93/7). Yield: 10%. 1H NMR (400 MHz, 
CDCl3):  1.06 (6H, d, J = 6.2 Hz, CH(CH3)2), 1.29 (6H, d, J = 6.2 Hz, CH(CH3)2), 3.96 (1H, 
septet, J = 6.2 Hz, CH), 5.13 (1H, septet, J = 6.2 Hz, CH), 7.28-7.47 (8H, m, 8x CHarom), 7.65-
7.71 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  21.9 (C(CH3)2), 22.3 (C(CH3)2), 67.5 
(CH(CH3)2), 75.5 (CH(CH3)2), 87.5 (d, J = 15.3 Hz, C(COOEt)2) 128.2, 128.4 and 139.9 (10x CHarom), 129.5 (d, 
J = 17.9 Hz, C=CF), 139.6 (2x Carom,quat), 143.7 (d, J = 269.1 Hz, CF), 154.1 (d, J = 5.9 Hz, C=N), 156.5 (d, J = 
10.3 Hz, C=O), 160.7 (d, J = 4.1 Hz, C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -152.00 (1F, s, CF). IR 
(ATR, cm-1) νC=O = 1708, νC=N = 1633, νmax = 1450, 1276, 1229, 1100, 1063, 694. MS (ES+): m/z (%): 410 (M + 
H+, 100). HRMS (ES+): calcd. for C24H25FNO4+: 410.1762, found 410.1774. 
5.5.7 Synthesis of dimethyl 2-[2-(diphenylmethyleneamino)-1-fluoroethylidene]-
malonate 188a and diisopropyl 2-[2-(diphenylmethyleneamino)-1,1-difluoroethyl]-
malonate 187c 
The synthesis of dimethyl 2-[2-(diphenylmethyleneamino)-1-fluoroethylidene]malonate 188a is described 
as representative. To a mixture of pyrroline 185a (69 mg, 0.19 mmol) in acetonitrile (5 mL) was added 
NaCNBH3 (2 equiv, 23 mg, 0.37 mmol), acetic acid (2 equiv, 24 mg, 0.37 mmol) and acetyl chloride (2 equiv, 
29 mg, 0.37 mmol), and this mixture was stirred at 0 °C for 20 minutes. Subsequently, it was quenched 
with Na2CO3 (5 mL), extracted with EtOAc (3x 5 mL) and the combined organic layers were dried (MgSO4), 
filtered and evaporated under reduced pressure. After column chromatography (SiO2, PE/EtOAc 9/1), pure 
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dimethyl 2-[2-(diphenylmethyleneamino)-1-fluoroethylidene]malonate 188a (19 mg, 0.055 mmol) was 
obtained. 
Dimethyl 2-[2-(diphenylmethyleneamino)-1-fluoroethylidene]malonate 188a 
Yellow oil. Rf 0.21 (petroleum ether/EtOAc 9/1). Yield: 29%. 1H NMR (400 MHz, 
CDCl3):  2.20 (1H, br s, NH), 3.61 (3H, s, CH3), 3.77 (2H, d, JH,F = 21.4 Hz, CH2), 3.84 
(3H, s, CH3), 4.89 (1H, s, CH), 7.19-7.24 (2H, m, 2x CHarom), 7.26-7.31 (4H, m, 4x 
CHarom), 7.39-7.41 (4H, m, 4x CHarom). 13C NMR (100.6 MHz, CDCl3):  45.6 (d, J = 23.3 Hz, CH2CF), 52.5 (CH3), 
52.8 (CH3), 66.0 (CH), 112.3 (d, J = 19.1 Hz, CF=C), 127.3, 127.4 and 128.6 (10x CHarom), 142.9 (2x Carom,quat), 
162.9 (d, J = 2.2 Hz, C=O), 163.3 (C=O), 172.3 (d, J = 286.5 Hz, CF). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -81.66 (1F, t, JH,F = 21.4 Hz, CF). IR, MS and HRMS data could not be obtained due to instability of 
compound 184. 
Diisopropyl 2-[2-(diphenylmethyleneamino)-1,1-difluoroethyl]malonate 187c 
Yellow oil. Rf 0.12 (petroleum ether/EtOAc 95/5). Yield: 18%. 1H NMR (300 MHz, 
CDCl3):  1.21 (6H, d, J = 6.6 Hz, 2x CHCH3(CH3)), 1.23 (6H, d, J = 6.6 Hz, 2x 
CHCH3(CH3)), 1.92 (1H, s, NH), 3.23 (2H, t, JH,F = 14.6 Hz, CH2), 4.28 (1H, t, JH,F = 
13.2 Hz, CHCF2), 4.88 (1H, s, CHPh2), 5.06 (2H, septet, J = 6.3 Hz, 2x CH(CH3)2), 7.16-7.36 (10H, m, 10x 
CHarom). 19F NMR (282 MHz, CDCl3):  -102.15 (2F, q, JH,F = 14.0 Hz, CF2). IR, MS and HRMS data could not 
be obtained due to instability of compound 187c. 
5.5.8 Synthesis of 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-yl)ethyl]malonates 192 
The synthesis of dimethyl 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-yl)ethyl]malonate 192a is described 
as representative. To a solution of dimethyl 2-bromo-2,2-difluoroethylidenemalonate 16a (0.48 g, 1.76 
mmol) in tert-butanol (25 mL) were added imidazole (1 equiv, 0.12 g, 1.76 mmol) and triethylamine (1 
equiv, 0.18 g, 1.76 mmol), and this mixture was stirred at reflux temperature for three hours. After removal 
of the solvent in vacuo, dichloromethane (20 mL) was added and this mixture was washed with brine (20 
mL). The organic layer was dried with MgSO4, filtered and evaporated under reduced pressure. The crude 
product was recrystallized from Et2O, affording pure dimethyl 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-
yl)ethyl]malonate 192a (0.40 g, 1.18 mmol). 
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Dimethyl 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-yl)ethyl]malonate 192a 
Pale yellow crystals. Melting point: 88-89 °C. Yield: 67%. 1H NMR (300 MHz, CDCl3):  
3.56 (3H, s, OCH3), 3.84 (3H, s, OCH3), 4.24 (1H, d, J = 10.5 Hz, CH(COOMe)2), 5.49 (1H, 
ddd, JH,F = 15.9 Hz, J = 10.5 Hz, JH,F = 3.6 Hz, CHN), 7.01 (1H, d, J = 1.1 Hz, CHarom), 7.10 
(1H, s, CHarom), 7.63 (1H, s, CHarom). 13C NMR (75 MHz, ref = CDCl3):  52.5 (C(COOMe)2), 
53.7 (OCH3), 54.0 (OCH3), 64.3 (dd, J = 28.3 Hz, 23.7 Hz, CHCF2Br), 118.6 (CHarom), 120.4 (t, J = 310.4 Hz, 
CF2Br), 130.4 (CHarom), 138.7 (CHarom), 164.4 (C=O), 165.2 (C=O). 19F NMR (282 MHz, CDCl3):  -52.30 (1F, 
dd, J = 173.6 Hz, JH,F = 3.6 Hz, CF(F)Br), -56.33 (1F, dd, J = 173.6 Hz, JH,F = 15.9 Hz, CF(F)Br). IR (ATR, cm-1): 
νC=O = 1743, νmax = 1285, 1251, 1230. MS (ES+): m/z (%): 341/43 (M + H+, 100). HRMS (ES+): calcd. for 
C10H12BrF2N2O4+: 340.9943, found 340.9933. El. Anal. Calcd for C10H11BrF2N2O4: C 35.21, H 3.25, N 8.21, 
found C 35.19, H 3.10, N 8.12. 
Diisopropyl 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-yl)ethyl]malonate 192b 
White crystals. Melting point: 76-77 °C. Yield: 57%. 1H NMR (300 MHz, CDCl3):  1.05 
(3H, d, J = 6.3 Hz, CHCH3(CH3)), 1.08 (3H, d, J = 6.3 Hz, CHCH3(CH3)), 1.28 (3H, d, J = 6.3 
Hz, CHCH3(CH3)), 1.30 (3H, d, J = 6.3 Hz, CHCH3(CH3)), 4.14 (1H, d, J = 10.5 Hz, 
CH(COOiPr)2), 4.83 (1H, septet, J = 6.3 Hz, CH(CH3)2), 5.12 (1H, septet, J = 6.3 Hz, 
CH(CH3)2), 5.46 (1H, ddd, JH,F = 15.8 Hz, J = 10.5 Hz, JH,F = 3.2 Hz, CHN), 7.02 (1H, s, CHarom), 7.09 (1H, s, 
CHarom), 7.63 (1H, s, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  21.1 (CHCH3(CH3)), 21.2 (CHCH3(CH3)), 
21.39 (CHCH3(CH3)), 21.43 (CHCH3(CH3)), 53.3 (CH(COOiPr)2), 64.0 (dd, J = 27.9 Hz, 24.2 Hz, CHN), 70.9 
(CH(CH3)2), 71.1 (CH(CH3)2), 118.6 (d, J = 1.5 Hz, CHarom), 120.6 (dd, J = 311.1 Hz, 309.8 Hz, CF2Br), 130.1 
(CHarom), 138.6 (CHarom), 163.3 (C=O), 164.1 (C=O). 19F NMR (282 MHz, CDCl3):  -51.75 (1F, dd, J = 172.7 Hz, 
JH,F = 3.2 Hz, CF(F)Br), -56.02 (1F, dd, J = 172.7 Hz, JH,F = 15.8 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1723, νmax = 
1228, 1182, 936, 787, 644. MS (ES+): m/z (%): 397/99 (M + H+, 100). HRMS (ES+): calcd. for C14H20BrF2N2O4+: 
397.0569, found 397.0563. El. Anal. Calcd for C14H19BrF2N2O4: C 42.33, H 4.82, N 7.05, found C 42.43, H 
4.77, N 7.23. 
5.5.9 Synthesis of 2-[2,2-difluoro-1-(1H-imidazol-1-yl)vinyl]malonates 194 
The synthesis of dimethyl 2-[2,2-difluoro-1-(1H-imidazol-1-yl)vinyl]malonate 194a is described as 
representative. To a solution of dimethyl 2-[2-bromo-2,2-difluoro-1-(1H-imidazol-1-yl)ethyl]malonate 
192a (0.138 g, 0.41 mmol) in dry THF (5 mL) was added KOtBu (1M in THF, 1.5 equiv, 0.61 mmol, 0.61 mL). 
This mixture was stirred at reflux temperature for one hour, after which extra KOtBu (1M in THF, 1.5 equiv, 
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0.61 mmol, 0.61 mL) was added and the stirring was continued for another two hours. The reaction 
mixture was poured in a saturated aqueous solution of NH4Cl (10 mL) and extracted with EtOAc (3x 10 mL). 
After drying of the combined organic layers with MgSO4, the drying agent was filtered off and the solvent 
was removed in vacuo. Purification using preparative TLC afforded dimethyl 2-[2,2-difluoro-1-(1H-
imidazol-1-yl)vinyl]malonate 194a (30 mg, 0. 12 mmol) as a colorless oil. 
Dimethyl 2-[2,2-difluoro-1-(1H-imidazol-1-yl)vinyl]malonate 194a 
Colorless oil. Rf 0.35 (petroleum ether/EtOAc 1/1). Yield: 29%. 1H NMR (400 MHz, 
CDCl3):  3.76 (6H, s, 2x OCH3), 4.54 (1H, d, JH,F = 1.8 Hz, CH(COOMe)2), 7.03 (1H, s, 
CHarom), 7.10 (1H, s, CHarom), 7.57 (1H, s, CHarom). 13C NMR (100.6 MHz, CDCl3):  51.2 (d, 
J = 2.4 Hz, CH(COOMe)2), 53.5 (2x OCH3), 91.3 (dd, J = 38.8 Hz, 19.9 Hz, CCF2), 120.7 (CHarom), 129.8 (CHarom), 
138.7 (CHarom), 156.6 (dd, J = 298.0 Hz, 294.0 Hz, CF2), 165.7 (t, J = 2.8 Hz, 2x C=O). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -85.54 (1F, d, J = 23.2 Hz, CF(F)), -90.33 (1F, dd, J = 23.2 Hz, JH,F = 1.8 Hz, CF(F)). IR (ATR, 
cm-1): νC=O = 1737, νmax = 1233, 1155, 1078. 
Diisopropyl 2-[2,2-difluoro-1-(1H-imidazol-1-yl)vinyl]malonate 194c 
Colorless oil. Rf 0.15 (petroleum ether/EtOAc 8/2). Yield: 49%. 1H NMR (400 MHz, 
CDCl3):  1.18 (6H, d, J = 6.3 Hz, 2x CHCH3(CH3)), 1.22 (6H, d, J = 6.3 Hz, 2x CHCH3(CH3)), 
4.45 (1H, d, JH,F = 2.1 Hz, CH(COOiPr)2), 5.04 (2H, septet, J = 6.3 Hz, 2x CH(CH3)2), 7.09 
(2H, s, 2x CHarom), 7.60 (1H, s, CHarom). 13C NMR (100.6 MHz, CDCl3):  21.4 (2x 
CHCH3(CH3)), 21.5 (2x CHCH3(CH3)), 52.0 (d, J = 2.2 Hz, CH(COOiPr)2), 70.8 (2x CH(CH3)2), 91.6 (dd, J = 39.0 
Hz, 19.1 Hz, CCF2), 120.9 (CHarom), 129.5 (CHarom), 138.8 (CHarom), 156.4 (dd, J = 297.5 Hz, 293.3 Hz, CF2), 
164.9 (t, J = 2.9 Hz, 2x C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -86.32 (1F, d, J = 23.1 Hz, CF(F)), -
91.04 (1F, d, J = 23.1 Hz, CF(F)). IR (ATR, cm-1): νC=O = 1728, νmax = 1296, 1240, 1096, 960. MS (ES+): m/z (%): 
317 (M + H+, 100). HRMS (ES+): calcd. for C14H19F2N2O4+: 317.1307, found 317.1317. 
5.5.10 Synthesis of 2-[(2-bromo-2,2-difluoro-1-phthalimido)ethyl]malonates 196 
The synthesis of diisopropyl 2-[(2-bromo-2,2-difluoro-1-phthalimido)ethyl]malonate 196c is described as 
representative. To a solution of diisopropyl 2-bromo-2,2-difluoroethylidenemalonate 16c (0.25 g, 0.76 
mmol) in tert-butanol (20 mL) were added potassium phthalimide (1.1 equiv, 0.16 g, 0.84 mmol) and 
tetramethylammonium bromide (0.05 equiv, 5.8 mg, 0.038 mmol) and this mixture was stirred at reflux 
temperature for three hours. After evaporation of the solvent under reduced pressure, EtOAc (20 mL) was 
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added and this mixture was washed with H2O (3x 20 mL). The organic layer was dried with MgSO4 and after 
filtration, evaporation of the solvent in vacuo afforded crude malonate 196c. Purification via column 
chromatography afforded pure diisopropyl 2-[(2-bromo-2,2-difluoro-1-phthalimido)ethyl]malonate 196c 
(0.25 mmol, 0.12 g). 
Diethyl 2-(2-bromo-2,2-difluoro-1-phthalimidoethyl)malonate 196b 
Colorless oil. Rf 0.38 (petroleum ether/EtOAc 9/1). Yield: 28%. 1H NMR (400 MHz, 
CDCl3):  1.10 (3H, t, J = 7.1 Hz, CH3), 1.33 (3H, t, J = 7.1 Hz, CH3), 3.99-4.13 (2H, m, 
OCH2), 4.25-4.36 (2H, m, OCH2), 4.92 (1H, d, J = 11.4 Hz, CH(COOEt)2), 5.62 (1H, ddd, JH,F 
= 15.9 Hz, J = 11.4 Hz, JH,F = 4.2 Hz, CHN), 7.78-7.80 (2H, m, 2x CHarom), 7.86-7.98 (2H, 
m, 2x CHarom).13C NMR (100.6 MHz, CDCl3):  13.7 (CH3), 13.9 (CH3), 49.4 (CH(COOEt)2), 
57.7 (dd, J = 28.2 Hz, 24.9 Hz, CHN), 62.4 (OCH2), 62.7 (OCH2), 121.0 (dd, J = 315.6 Hz, 310.2 Hz, CF2Br), 
123.9 (CHarom), 124.2 (2x CHarom), 131.1 (Carom,quat), 131.4 (Carom,quat), 134.7 (2x CHarom), 165.0 and 165.6 (2x 
OC=O), 166.5 and 166.8 (2x NC=O) 19F NMR (376.5 MHz, CDCl3):  -49.01 (1F, dd, J = 167.8 Hz, JH,F = 4.2 Hz, 
CF(F)), -50.27 (1F, dd, J = 167.8 Hz, JH,F = 15.9 Hz CF(F)). IR (ATR, cm-1): νC=O = 1726, νmax = 1371, 1281, 1214, 
1072, 1020, 718. MS (ES+): m/z (%): 465/67 (M + NH4+, 100). HRMS (ES+): calcd. for C17H20BrF2N2O6+ (M + 
NH4+): 465.0467, found 465.0465. 
Diisopropyl 2-[(2-bromo-2,2-difluoro-1-phthalimido)ethyl]malonate 196c 
Yellow oil. Rf 0.05 (petroleum ether/EtOAc 9/1). Yield: 33%. 1H NMR (300 MHz, CDCl3): 
 1.05 (3H, d, J = 6.3 Hz, CHCH3(CH3)), 1.10 (3H, d, J = 6.3 Hz, CHCH3(CH3)), 1.30 (6H, d, 
J = 6.3 Hz, CH(CH3)2), 4.85 (1H, d, J = 11.6 Hz, CH(COOiPr)2), 4.86 (1H, septet, J = 6.3 Hz, 
CH(CH3)2), 5.13 (1H, septet, J = 6.3 Hz, CH(CH3)2), 5.60 (1H, ddd, JH,F = 15.6 Hz, J = 11.6 
Hz, JH,F = 4.3 Hz, CHN), 7.76-7.81 (2H, m, 2x CHarom), 7.86-7.97 (2H, m, 2x CHarom).13C 
NMR (100.6 MHz, ref = CDCl3):  21.3 (CHCH3(CH3)), 21.4 (CHCH3(CH3)), 23.5 (CH(CH3)2), 50.0 (CH(COOiPr)2), 
57.7 (dd, J = 28.6 Hz, 25.3 Hz, CHN), 70.2 (CH(CH3)2), 70.6 (CH(CH3)2), 121.2 (dd, J = 315.2 Hz, 310.1 Hz, 
CF2Br), 123.9 and 124.2 (2x CHarom), 131.2 (Carom,quat), 131.6 (Carom,quat), 134.8 (2x CHarom), 164.6 and 165.2 
(2x OC=O), 166.6 and 167.0 (2x NC=O). 19F NMR (282 MHz, CDCl3):  -48.69 (1F, dd, J = 167.1 Hz, JH,F = 4.3 
Hz, CF(F)), -50.07 (1F, dd, J = 167.1 Hz, JH,F = 15.6 Hz, CF(F)). IR (ATR, cm-1): νC=O = 1726, νmax = 1375, 1285, 
1097, 717. MS (ES+): m/z (%): 493/95 (M + NH4+, 100), 476/78 (M + H+, 20). HRMS (ES+): calcd. for 
C19H24BrF2N2O6+ (M + NH4+): 493.0780, found 493.0761. 
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5.6 Attempted synthesis of 3-fluoro- and 3,3-difluoroazetidine-2-carboxylates 
5.6.1 Synthesis of N-(2-bromo-2,2-difluoroacetyl)glycinates 200 
The synthesis of ethyl N-(2-bromo-2,2-difluoroacetyl)glycinate 200a is described as representative. To a 
solution of ethyl bromodifluoroacetate (2.00 g, 9.9 mmol) in CH2Cl2 (50 mL), the hydrochloric acid salt of 
ethyl glycinate (1 equiv, 1.38 g, 9.9 mmol) and Et3N (1 equiv, 1.00 g, 9.9 mmol) were added. This mixture 
was stirred for 17 hours at room temperature after which the solvent was evaporated. Subsequently, Et2O 
(50 mL) was added and the solids were filtered off. After removal of the solvent in vacuo, the crude 
reaction product was purified via column chromatography affording 1.96 g (7.52 mmol) glycinate 200a. 
Ethyl N-(2-bromo-2,2-difluoroacetyl)glycinate 200a 
Yellow oil. Rf 0.30 (petroleum ether/EtOAc 6/4). Yield: 76%. 1H NMR (400 MHz, 
CDCl3):  1.32 (3H, t, J = 7.1 Hz, CH3), 4.12 (2H, d, J = 5.0 Hz, NCH2), 4.12 (2H, q, J = 7.1 
Hz, OCH2), 6.78 (1H, br s, NH). 13C NMR (75 MHz, CDCl3):  14.1 (CH3), 41.6 (NCH2), 
62.2 (OCH2), 111.3 (t, J = 315.0 Hz, CF2Br), 160.3 (t, J = 28.3 Hz, CF2BrC=O), 168.5 (C=O). 19F NMR (376.5 
MHz, CDCl3, ref = CFCl3):  -61.29 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3333, νC=O = 1747, νC=O = 1709, νmax = 
1543, 1213, 1175, 1137, 1018, 918. MS (ES+): m/z (%): 277/79 (M + NH4+, 30). HRMS (ES-): calcd. for 
C6H7BrF2NO3-: 257.9583, found 257.9586. 
Tert-butyl N-(2-bromo-2,2-difluoroacetyl)glycinate 200b 
Yellow oil. Rf 0.15 (petroleum ether/EtOAc 9/1). Yield: 88%. 1H NMR (400 MHz, 
CDCl3):  1.50 (9H, s, C(CH3)3), 4.07 (2H, d, J = 4.9 Hz, NCH2), 6.74 (1H, br s, NH). 13C 
NMR (100.6 MHz, ref = CDCl3):  28.0 (C(CH3)3), 42.3 (CH2), 83.2 (C(CH3)3), 111.6 (t, 
J = 315.5 Hz, CF2Br), 160.3 (t, J = 27.9 Hz, CF2BrC=O), 167.6 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -61.10 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3323, νC=O = 1708, νmax = 1369, 1231, 1137, 1018, 914. MS (ES+): 
305/7 (M + NH4+, 100). 
5.6.2 Synthesis of 2-(2-bromo-2,2-difluoroethyl)amino-1-ethanol 201 
To a solution of ethyl N-(2-bromo-2,2-difluoroacetyl)glycinate 200a (0.50 g, 1.9 mmol) in dry CH2Cl2 (10 
mL) BH3.Me2S (6 equiv, 0.88 g, 11.2 mmol) was added and this mixture was stirred at reflux temperature 
for 76 hours. Subsequently, it was slowly quenched with a mixture of H2O and MeOH (1/1, 15 mL) and 
extracted with CH2Cl2 (3x 10 mL). The combined organic layers were dried (MgSO4), filtered and 
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evaporated in vacuo. The crude reaction product was purified using column chromatography affording 
0.12 g (0.59 mmol) 2-(2-bromo-2,2-difluoroethyl)amino-1-ethanol 201. 
2-(2-Bromo-2,2-difluoroethyl)amino-1-ethanol 201 
Yellow oil. Rf 0.03 (petroleum ether/EtOAc 9/2). Yield: 31%. 1H NMR (400 MHz, CDCl3): 
 2.08 (2H, br s, OH and NH), 2.96 (2H, t, J = 5.1 Hz, CH2CH2NH), 3.43 (2H, t, JH,F = 12.5 
Hz, CH2CF2Br), 3.67 (2H, t, J = 5.1 Hz, CH2OH). 13C NMR (100.6 MHz, ref = CDCl3):  50.7 (CH2CH2NH), 59.06 
(t, J = 23.7 Hz, CH2CF2Br), 61.2 (OCH2), 123.4 (t, J = 308.8 Hz, CF2Br). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -51.98 (2F, t, JH,F = 12.5 Hz, CF2Br). IR (ATR, cm-1): νNH and νOH = 3347, νmax = 1200, 1131, 1079, 913. MS 
(ES+): m/z (%): 204/6 (M + H+, 100). HRMS (ES+): calcd. for C4H9BrF2NO+: 203.9830, found 203.9829. 
5.6.3 Synthesis of ethyl (2-bromo-2,2-difluorothioacetyl)glycinate 202 
To a solution of ethyl N-(2-bromo-2,2-difluoroacetyl)glycinate 200a (3.00 g, 1.15 mmol) in dry toluene (50 
mL) was added Lawesson’s reagent (1.2 equiv, 5.60 g, 13.8 mmol) and this mixture was stirred at reflux 
temperature for two hours. Subsequently, the solvent was removed under reduced pressure and the 
residue was purified using column chromatography (PE/EtOAc 9/1), affording pure ethyl (2-bromo-2,2-
difluorothioacetyl)glycinate 202 (2.22 g, 8.1 mmol). 
Ethyl (2-bromo-2,2-difluorothioacetyl)glycinate 202 
Yellow oil. Rf 0.08 (petroleum ether/EtOAc 9/1). Yield: 70%. 1H NMR (400 MHz, 
CDCl3):  1.34 (3H, t, J = 7.1 Hz, CH3), 4.32 (2H, q, J = 7.1 Hz, OCH2), 4.35 (d, J = 4.3 Hz, 
CH2N), 8.38 (1H, s, NH). 13C NMR (100.6 MHz, ref = CDCl3):  14.1 (CH3), 47.2 (OCH2), 
62.6 (CH2N), 113.2 (t, J = 309.6 Hz, CF2Br), 167.8 (C=O), 188.1 (t, J = 27.6 Hz, C=S). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -52.59 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3303, νC=O = 1732, νC=S = 1201, νmax = 1092, 
1007, 977, 846. MS, HRMS: M+ could not be detected. 
5.6.4 Synthesis of 2-bromo-2,2-difluoroacetamides 205 
The synthesis of N-propyl-2-bromo-2,2-difluoroacetamide 205b is described as representative. To an ice-
cooled solution of ethyl bromodifluoroacetate 14 (5.07 g, 25 mmol) in CH2Cl2 (40 mL), was added a solution 
of propylamine (1.77 g, 30 mmol, 1.2 equiv) in CH2Cl2 (20 mL). This mixture was allowed to warm to room 
temperature and after stirring for 15 hours at this temperature, the solvent and excess propylamine were 
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removed in vacuo, affording N-propyl-2-bromo-2,2-difluoroacetamide 205b (5.39 g, 24.8 mmol) in 99% 
yield. 
N-Propyl-2-bromo-2,2-difluoroacetamide 205b 
Colorless oil. Yield: 99%. 1H NMR (300 MHz, CDCl3):  0.97 (3H, t, J = 7.2 Hz, CH3), 1.63 
(2H, sextet, J = 7.2 Hz, CH2CH2CH3), 3.34 (2H, q, J = 6.8 Hz, NCH2), 6.31 (1H, br s, NH). 13C 
NMR (75 MHz, CDCl3):  11.1 (CH3), 22.3 (CH2CH3), 41.9 (NCH2), 111.9 (t, J = 316.1 Hz, 
CF2Br), 160.3 (t, J = 27.1 Hz, C=O). 19F NMR (282 MHz, CDCl3):  -60.40 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 
3304, νC=O = 1698, νmax = 1542, 1130. MS (ES-): m/z (%): 214/16 (M - H+, 100). 
The spectral data of N-benzyl-2-bromo-2,2-difluoroacetamide 205a were in accordance with those 
reported in the literature.159 
5.6.5 Synthesis of amines 23 
2-Bromo-2,2-difluoroethylamines 23 were synthesized following a literature procedure.15 
N-Benzyl-2-bromo-2,2-difluoroethylamine 23a 
Yellow oil. Rf 0.42 (petroleum ether/EtOAc 9/1). Yield: 85%. 1H NMR (400 MHz, CDCl3): 
 1.86 (1H, br s, NH), 3.36 (2H, t, JH,F = 12.5 Hz, CH2CF2Br), 3.95 (2H, s, Carom,quatCH2), 
7.27-7.37 (5H, m, 5x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  52.8 (Carom,quatCH2), 58.3 (t, J = 23.5 Hz, 
CH2CF2Br), 123.7 (t, J = 308.9 Hz, CF2Br), 127.4 (CHarom), 128.1 and 128.6 (4x CHarom), 139.3 (Carom,quat). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -51.34 (2F, t, JH,F = 12.5 Hz, CF2Br). IR (ATR, cm-1): νNH = 3360, νmax = 
1117, 909, 889, 697. MS (ES+): m/z (%): 250/52 (M + H+, 20), 150 (100). HRMS (ES+): calcd. for C9H11BrF2N+: 
250.0037, found 250.0036. 
N-Propyl-2-bromo-2,2-difluoroethylamine 23b 
Colorless oil. Yield: 89%. 1H NMR (400 MHz, CDCl3):  0.93 (3H, t, J = 7.3 Hz, CH3), 1.47 
(1H, br s, NH), 1.50 (2H, sextet, J = 7.3 Hz, CH2CH2CH3), 2.72 (2H, t, J = 7.3 Hz, NCH2CH2), 
3.36 (2H, t, JH,F = 12.6 Hz, CH2CF2Br). 13C NMR (100.6 MHz, CDCl3):  11.5 (CH3), 23.4 (CH2CH3), 51.2 
(NCH2CH2), 59.4 (t, J = 23.3 Hz, CH2CF2Br), 123.9 (t, J = 309.1 Hz, CF2Br). 19F NMR (376.5 MHz, CDCl3): 
 -51.15 (2F, t, JH,F = 12.6 Hz, CF2Br). IR (ATR, cm-1): νNH = 3216, νmax = 1462, 1195, 1094, 904. MS (ES+): m/z 
(%): 202/4 (M + H+, 100). HRMS (ES+): calcd. for C5H11BrF2N+: 202.0037, found 202.0033. 
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5.6.6 Synthesis of amino esters 209 and 198 
The synthesis of methyl N-benzyl-N-(2-chloro-2-fluoroethyl)glycinate 209a is described as representative. 
To a mixture of N-(2-chloro-2-fluoroethyl)benzylamine 208a (5.00 g, 26.6 mmol) and methyl bromoacetate 
207a (7 equiv, 28.5 g, 187 mmol), was added LiHMDS (1M in THF, 1.1 equiv, 29.3 mL, 29.3 mmol) at 0 °C. 
This mixture was stirred at room temperature for 23 hours, after which dichloromethane (50 mL) and H2O 
(50 mL) were added. After extraction with dichloromethane (2x 30 mL), drying (MgSO4), filtration and 
evaporation of the solvent under reduced pressure, a mixture of methyl N-benzyl-N-(2-chloro-2-
fluoroethyl)glycinate 209a and methyl bromoacetate 207a was obtained. After separation of this mixture 
(Reveleris Flash Forward, reversed phase chromatography, CH3CN/H2O. Gradient: during 2 CV: 20% CH3CN, 
during 3 CV: 20 -> 50% CH3CN, during 8 CV: 50 -> 70% CH3CN, during 1 CV: 70 -> 100% CH3CN, during 2 CV: 
100% CH3CN), pure methyl N-benzyl-N-(2-chloro-2-fluoroethyl)glycinate 209a (5.46 g, 21.0 mmol) was 
obtained as a yellow oil. 
Methyl N-benzyl-N-(2-chloro-2-fluoroethyl)glycinate 209a 
Yellow oil. Yield: 79%. 1H NMR (400 MHz, CDCl3):  3.21 (1H, ddd, JH,F = 26.2 Hz, J = 
15.0 Hz, 3.4 Hz, CH(H)CHClF), 3.37 (1H, ddd, J = 15.0 Hz, JH,F = 14.3 Hz, J = 7.1 Hz, 
CH(H)CHClF), 3.50 (2H, s, CH2C=O), 3.71 (3H, s, OCH3), 3.95 (2H, s, CH2Carom,quat), 6.09 
(1H, ddd, JH,F = 51.6 Hz, J = 7.1 Hz, 3.4 Hz, CHClF), 7.27-7.33 (5H, m, 5x CHarom). 13C NMR (100.6 MHz, ref = 
CDCl3):  51.6 (OCH3), 54.9 (CH2C=O), 59.2 (CH2Carom,quat), 61.0 (d, J = 21.4 Hz, CH2CHClF), 101.6 (d, J = 244.3 
Hz, CHClF), 127.7 (CHarom), 128.7 (2x CHarom), 128.9 (2x CHarom), 138.5 (Carom,quat), 171.9 (C=O). 19F NMR 
(376.5 MHz, CDCl3, ref = CFCl3):  -137.31 (1F, ddd, JH,F = 51.6 Hz, 26.2 Hz, 14.3 Hz, CHClF). IR (ATR, cm-1): 
νC=O = 1739, νmax = 1202, 1164, 1037, 699. MS (ES+): m/z (%): 260 (M + H+, 100). HRMS (ES+): calcd. for 
C12H16ClFNO2+: 260.0848, found 260.0848. 
Methyl N-benzyl-N-(2-bromo-2,2-difluoroethyl)glycinate 198a 
Yellow oil. Rf 0.27 (petroleum ether/EtOAc 95/5). Yield: 70%. 1H NMR (400 MHz, 
CDCl3):  3.47 (2H, s, CH2C=O), 3.59 (2H, t, JH,F = 12.6 Hz, CH2CBrF2), 3.69 (3H, s, OCH3), 
4.03 (2H, s, CH2Carom,quat), 7.23-7.35 (5H, m, 5x CHarom). 13C NMR (100.6 MHz, ref = 
CDCl3):  51.7 (OCH3), 53.4 (CH2C=O), 59.1 (CH2Carom,quat), 64.0 (t, J = 23.1 Hz, CH2CBrF2), 123.8 (t, J = 309.2 
Hz, CBrF2), 127.7 (CHarom), 128.7 (2x CHarom), 128.9 (2x CHarom), 138.2 (Carom,quat), 171.8 (C=O). 19F NMR (376.5 
MHz, CDCl3, ref = CFCl3):  -52.47 (2F, t, JH,F = 12.6 Hz, CBrF2). IR (ATR, cm-1): νC=O = 1737, νmax = 1202, 1165, 
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1084, 1022, 924, 698. MS (ES+): m/z (%): 322/24 (M + H+, 20), 117 (100). HRMS (ES+): calcd. for 
C12H15BrF2NO2+: 322.0249, found 322.0261. 
Benzyl N-benzyl-N-(2-bromo-2,2-difluoroethyl)glycinate 198c 
Yellow oil. Rf 0.48 (petroleum ether/EtOAc 9/1). Yield: 40%. 1H NMR (400 MHz, CDCl3): 
 3.52 (2H, s, CH2C=O), 3.61 (2H, t, JH,F = 12.6 Hz, CH2CBrF2), 4.04 (2H, s, NCH2Carom,quat), 
5.15 (2H, s, C=OCH2Carom,quat), 7.30-7.40 (10H, m, 10x CHarom). 13C NMR (100.6 MHz, ref 
= CDCl3):  53.4 (CH2C=O), 58.7 (NCH2Carom,quat), 63.6 (t, J = 23.1 Hz, CH2CBrF2), 66.2 (C=OCH2Carom,quat), 123.6 
(t, J = 309.1 Hz, CBrF2), 128.2, 128.4, 128.5, 128.7 (8x CHarom), 128.9 (CHarom), 129.6 (CHarom), 134.3 
(Carom,quat), 135.5 (Carom,quat), 137.8 (Carom,quat), 170.8 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -52.38 
(2F, t, JH,F = 12.6 Hz, CBrF2). IR (ATR, cm-1): νC=O = 1738, νmax = 1194, 1088, 1023, 697. MS (ES+): m/z (%): 
398/400 (M + H+, 100). HRMS (ES+): calcd. for C18H19BrF2NO2+: 398.0562, found 398.0549. 
Ethyl N-propyl-N-(2-bromo-2,2-difluoroethyl)glycinate 198d 
Yellow oil. Rf 0.38 (petroleum ether/EtOAc 9/1). Yield: 64%. 1H NMR (400 MHz, CDCl3): 
 0.89 (3H, t, J = 7.4 Hz, CH2CH2CH3), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3), 1.48 (2H, sextet, 
J = 7.4 Hz, CH2CH2CH3), 2.76 (2H, t, J = 7.4 Hz, CH2CH2CH3), 3.50 (2H, t, JH,F = 13.1 Hz, 
CH2CF2Br), 3.56 (2H, s, CH2C=O), 4.17 (2H, q, J = 7.1 Hz, OCH2CH3). 13C NMR (100.6 MHz, ref = CDCl3):  
11.4 (CH2CH2CH3), 14.4 (OCH2CH3), 21.7 (CH2CH2CH3), 55.0 (CH2C=O), 57.4 (CH2CH2CH3), 60.6 (OCH2), 64.5 
(t, J = 22.7 Hz, CH2CF2Br), 123.9 (t, J = 309.1 Hz, CF2Br), 171.5 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -52.76 (2F, t, JH,F = 13.1 Hz, CBrF2). IR (ATR, cm-1): νC=O = 1736, νmax = 1188, 1088, 1016, 926, 903. 
MS (ES+): m/z (%): 288/90 (M + H+, 100). 
5.7 Synthesis of fluorinated heterocycles by exploring the nucleophilic vinylic 
substitution (SNV) reaction of gem-difluoroenamides 
5.7.1 Synthesis of silyl ethers 260 
The synthesis of silyl ether 260a is given as representative. To a mixture of amide 261a (2.00 g, 7.5 mmol) 
and imidazole (1.02 g, 15.0 mmol, 2 equiv) in anhydrous CH2Cl2 (40 mL) under N2 atmosphere, TBDMSCl 
(1.19 g, 7.9 mmol, 1.05 equiv) was added at room temperature. This mixture was stirred for 17 hours at 
room temperature. Subsequently, H2O (40 mL) was added and an extraction was performed with CH2Cl2 
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(3x 30 mL). After drying of the combined organic phases (MgSO4), filtration and evaporation of the solvent 
under reduced pressure, acetamide 260a was obtained as orange crystals in 95% yield (2.71 g, 7.1 mmol).  
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-2-bromo-2,2-difluoroacetamide 260a 
Orange crystals. Melting point: 56-57 °C. Yield: 95%. 1H NMR (300 MHz, CDCl3):  0.30 
(6H, s, 2x SiCH3), 1.03 (9H, s, SiC(CH3)3), 6.88 (1H, dd, J = 7.7 Hz, 1.7 Hz, CHarom), 7.01 (1H, 
ddd, J = 7.7 Hz, 7.7 Hz, 1.7 Hz, CHarom), 7.71 (1H, ddd, J = 7.7 Hz, 7.7 Hz, 2.2 Hz, CHarom), 
8.30 (1H, dd, J = 7.7 Hz, 2.2 Hz, CHarom), 8.55 (1H, br s, NH). 13C NMR (75 MHz, CDCl3):  -4.4 (2x SiCH3), 18.1 
(SiC(CH3)3), 25.6 (SiC(CH3)3), 111.6 (t, J = 316.1 Hz, CF2Br), 117.5, 120.2, 121.9 and 125.7 (4x CHarom), 127.3 
and 144.7 (2x Carom,quat), 156.8 (t, J = 27.7 Hz, C=O). 19F NMR (282 MHz, CDCl3, ref = CFCl3):  -60.87 (2F, s, 
CF2Br). IR (ATR, cm-1): νNH = 3398, νC=O = 1717, νmax = 1458, 1100, 783, 752. MS (ES+): m/z (%): 380/82 (M + 
H+, 100). HRMS (ES+): calcd. for C14H21BrF2NO2Si+: 380.0488, found 380.0478. 
N-{4-Methoxy-2-[(tert-butyldimethylsilyl)oxy]phenyl}-2-bromo-2,2-difluoroacetamide 260b 
Brown crystals. Melting point: 69-70 °C. Rf 0.36 (petroleum ether/EtOAc 9/1). 
Yield: 74%. 1H NMR (400 MHz, CDCl3):  0.30 (6H, s, 2x SiCH3), 1.03 (9H, s, 
SiC(CH3)3), 3.79 (3H, s, OCH3), 6.45 (1H, d, J = 2.7 Hz, CHarom), 6.55 (1H, dd, J = 9.0 
Hz, 2.7 Hz, CHarom), 8.30 (1H, d, J = 9.0 Hz, CHarom), 8.36 (1H, br s, NH). 13C NMR (100.6 MHz, CDCl3):  -4.4 
(2x SiCH3), 18.1 (SiC(CH3)3), 25.6 (SiC(CH3)3), 55.5 (OCH3), 105.1 and 105.5 (2x CHarom), 111.7 (t, J = 316.8 Hz, 
CF2Br), 120.8 (Carom,quat), 120.9 (CHarom), 145.9 (Carom,quat), 156.5 (t, J = 27.2 Hz, C=O), 157.4 (Carom,quat). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -60.61 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3404, νC=O = 1717, νmax = 
1530, 1109, 834. MS (ES+): m/z (%): 410/12 (M + H+, 100). El. Anal. Calcd for C15H22BrF2NO3Si: C 43.91, H 
5.40, N 3.41, found C 44.02, H 5.74, N 3.35. 
5.7.2 Synthesis of amides 239 and 242 
The synthesis of N-{2-[(trimethylsilyl)oxy]ethyl}-2-bromo-2,2-difluoroacetamide 239 is described as 
representative. To a solution of ethyl bromodifluoroacetate 14 (6.92 g, 34.1 mmol) in dry CH2Cl2 (170 mL) 
was added a solution of 2-[(trimethylsilyl)oxy]ethylamine 238 (1.1 equiv, 5.00 g, 37.5 mmol) in dry CH2Cl2 
(20 mL) at 0 °C. After stirring this reaction mixture at room temperature for 16 hours, the solvent was 
removed under reduced pressure, affording N-{2-[(trimethylsilyl)oxy]ethyl}-2-bromo-2,2-
difluoroacetamide 239 (9.51 g, 32.7 mmol). 
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N-{2-[(Trimethylsilyl)oxy]ethyl}-2-bromo-2,2-difluoroacetamide 239 
Yellow oil. Yield: 96%. 1H NMR (300 MHz, CDCl3):  0. 14 (9H, s, Si(CH3)3), 3.49 (2H, 
q, J = 5.3 Hz, CH2NH), 3.71 (2H, t, J = 5.3 Hz, CH2O), 6.62 (1H, br s, NH). 13C NMR 
(100.6 MHz, ref = CDCl3):  -0.6 (SiCH3)3), 42.2 (CH2NH), 60.3 (CH2O), 111.9 (t, J = 
315.9 Hz, CF2Br), 160.7 (t, J = 27.1 Hz, C=O). 19F NMR (282 MHz, CDCl3):  -60.37 (2F, s, CF2Br). IR (ATR, 
cm-1): νNH = 3307, νC=O = 1702, νmax = 1542, 1252, 1135, 1099, 933, 838. MS (ES+): m/z (%): 290/92 (M + H+, 
10), 102 (100). 
N-{2-[(Tert-butyldimethylsilyl)oxy]ethyl}-2-bromo-2,2-difluoroacetamide 242 
Colorless oil. Yield: 65%. 1H NMR (300 MHz, CDCl3):  0.08 (6H, s, 2x SiCH3), 0.90 
(9H, s, SiC(CH3)3), 3.49 (2H, q, J = 5.3 Hz, CH2NH), 3.75 (2H, t, J = 5.3 Hz, CH2O), 
6.63 (1H, br s, NH). 13C NMR (75 MHz, CDCl3):  -5.5 (2x SiCH3), 18.2 (SiC(CH3)3), 
25.8 (SiC(CH3)3), 42.2 (CH2NH), 60.8 (CH2O), 111.9 (t, J = 315.6 Hz, CF2Br), 160.1 (t, J = 27.7 Hz, C=O).19F 
NMR (282 MHz, CDCl3):  -60.34 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3313, νC=O = 1703, νmax = 1104, 935, 831, 
776. 
5.7.3 Synthesis of amides 205c, 261 and 269 
The synthesis of N-(4-methoxybenzyl)-2-bromo-2,2-difluoroacetamide 205c is given as a representative 
example. To a solution of ethyl bromodifluoroacetate 14 (2.23 g, 11 mmol) in EtOAc (50 mL), 
4-methoxybenzylamine (1.51 g, 11 mmol, 1 equiv) and Et3N (1.11 g, 11 mmol, 1 equiv) were added, after 
which the mixture was stirred at reflux temperature for four hours. Subsequently, H2O (30 mL) was added 
and an extraction with EtOAc (3 x 30 mL) was performed. After drying of the organic layer (MgSO4), 
filtration and evaporation of the solvent, yellow crystals were obtained, which were recrystallized from 
Et2O affording pure amide 205c as white crystals in 75% yield. 
N-(4-Methoxybenzyl)-2-bromo-2,2-difluoroacetamide 205c 
White crystals. Melting point: 89-90 °C. Rf 0.05 (petroleum ether/EtOAc 9/1). 
Yield: 75%. 1H NMR (400 MHz, CDCl3):  3.78 (3H, s, OCH3), 4.42 (2H, d, J = 5.8 
Hz, CH2), 6.79 (1H, br s, NH), 6.87 (2H, d, J = 8.7 Hz, 2x CHarom), 7.21 (2H, d, J = 
8.7 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  43.7 (CH2NH), 55.4 (OCH3), 111.9 (t, J = 316.1 Hz, 
CF2Br), 114.4 (2x CHarom), 128.3 (Carom,quat), 129.4 (2x CHarom), 159.6 (Carom,quat), 160.0 (t, J = 27.5 Hz, C=O). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -60.99 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3233, νC=O = 1695, νmax = 
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1514, 1169, 1125, 820. MS (ES+): m/z (%): 311/13 (M + NH4+, 20), 221 (100). HRMS (ES-): calcd. for 
C10H9BrF2NO2-: 291.9790, found 291.9790. 
N-(2-Hydroxy-4-methoxyphenyl)-2-bromo-2,2-difluoroacetamide 261b 
Brown crystals. Melting point: 159-160 °C. Yield: 40%. 1H NMR (400 MHz, CD3CN): 
 3.79 (3H, s, OCH3), 6.53 (1H, dd, J = 8.6 Hz, 2.6 Hz, CHarom), 6.56 (1H, d, J = 2.6 Hz, 
CHarom), 7.52 (1H, d, J = 8.6 Hz, CHarom), 7.60 (1H, br s, NH or OH), 8.62 (1H, br s, NH 
or OH). 13C NMR (100.6 MHz, acetone-d6):  55.6 (OCH3), 102.8 and 105.6 (2x CHarom), 112.9 (t, J = 315.5 
Hz, CF2Br), 117.6 (Carom,quat), 124.9 (CHarom), 150.9 (Carom,quat), 158.5 (t, J = 27.1 Hz, C=O), 159.7 (Carom,quat). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -60.53 (2F, s, CF2Br). IR (ATR, cm-1): νNH = 3386, νOH = 3244, νC=O = 
1685, νmax = 1547, 1151, 1110. MS (ES+): m/z (%): 296/98 (M + H+, 30), 313/15 (M + NH4+, 20). HRMS (ES-): 
calcd. for C9H7BrF2NO3-: 293.9583, found 293.9572. El. Anal. Calcd for C9H8BrF2NO3: C 36.51, H 2.72, N 4.73, 
found C 36.86, H 2.68, N 4.57. 
The spectral data of N-(2-hydroxyphenyl)-2-bromo-2,2-difluoroacetamide 261a160 and N-phenyl-2-bromo-
2,2-difluoroacetamide 269135 were in accordance with those reported in the literature. 
5.7.4 Synthesis of amines 23c, 243, 262 and 270 
The synthesis of amine 23c is given as a representative example. To a solution of N-(4-methoxybenzyl)-2-
bromo-2,2-difluoroacetamide 205c (1.94 g, 6.9 mmol) in anhydrous THF (40 mL), borane dimethylsulfide 
complex (1.58 g, 21 mmol, 3 equiv) was added with a syringe. Subsequently, this mixture was stirred at 
reflux temperature for 17 hours after which it was slowly quenched with a mixture of water and methanol 
(H2O/MeOH : 1/1, 50 mL). After extraction with EtOAc (3x 50 mL), drying (MgSO4), filtration and 
evaporation of the solvent, the residue was redissolved in MeOH and stirred in the presence of Pd/C (0.05 
equiv, 0.35 mmol) at room temperature for two hours. After filtration, the crude amine 23c was purified 
by column chromatography (SiO2, PE/EtOAc 92/8) and obtained in 73% yield (1.41 g, 5.0 mmol). 
N-(4-Methoxybenzyl)-2-bromo-2,2-difluoroethylamine 23c 
Colorless oil. Rf 0.12 (petroleum ether/EtOAc 92/8). Yield: 73%. 1H NMR (400 
MHz, CDCl3):  1.78 (1H, br s, NH), 3.34 (2H, t, JH,F = 12.6 Hz, CH2CF2Br), 3.81 (3H, 
s, OCH3), 3.88 (2H, s, Carom,quatCH2), 6.88 (2H, d, J = 8.8 Hz, 2x CHarom), 7.25 (2H, d, J = 8.8 Hz, 2x CHarom). 13C 
NMR (100.6 MHz, ref = CDCl3):  52.2 (Carom,quatCH2), 55.2 (OCH3), 58.1 (t, J = 23.5 Hz, CH2CF2Br), 113.9 (2x 
CHarom), 123.8 (t, J = 308.8 Hz, CF2Br), 129.3 (2x CHarom), 131.3 and 158.9 (2x Carom,quat). 19F NMR (376.5 MHz, 
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CDCl3, ref = CFCl3):  -51.23 (2F, t, JH,F = 12.7 Hz, CF2Br). IR (ATR, cm-1): νNH = 3362, νmax = 1512, 1246, 1033. 
MS (ES+): m/z (%): 121 (100). 
N-{2-[(Tert-butyldimethylsilyl)oxy]ethyl}-2-bromo-2,2-difluoroethylamine 243 
This compound was synthesized using 6 equivalents BH3.Me2S (2nd portion of three equivalents was added 
after 24 hours) in CH2Cl2 for 44 hours. 
Colorless oil. Yield: 89%. 1H NMR (400 MHz, CDCl3):  0.07 (6H, s, 2x SiCH3), 0.90 
(9H, s, SiC(CH3)3), 1.90 (1H, br s, NH), 2.86 (2H, t, J = 5.2 Hz, CH2NH), 3.39 (2H, t, 
JH,F = 12.6 Hz, CH2CF2), 3.70 (2H, t, J = 5.2 Hz, CH2O). 13C NMR (100.6 MHz, ref = CDCl3):  -5.3 (2x SiCH3), 
18.3 (SiC(CH3)3), 25.9 (SiC(CH3)3), 51.1 (CH2NH), 59.4 (t, J = 23.5 Hz, CH2CF2), 62.6 (CH2O), 123.8 (t, J = 308.8 
Hz, CF2Br). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -51.59 (2F, t, JH,F = 12.6 Hz, CF2Br). IR (ATR, cm-1): νNH 
= 3365, νmax = 1088, 906, 830, 773. MS (ES+): m/z (%): 318/20 (M + H+, 100). HRMS (ES+): calcd. for 
C10H23BrF2NOSi+ (M + H+): 318.0695, found 318.0683.  
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-2-bromo-2,2-difluoroethylamine 262a 
Yellow oil. Rf 0.14 (petroleum ether/EtOAc 99/1). Yield: 90%. 1H NMR (300 MHz, CDCl3): 
 0.25 (6H, s, 2x SiCH3), 1.02 (9H, s, SiC(CH3)3), 3.95 (2H, td, JH,F = 11.8 Hz, J = 3.4 Hz, CH2), 
4.65 (1H, br s, NH), 6.65 (1H, ddd, J = 7.8 Hz, 7.4 Hz, 1.5 Hz, CHarom), 6.70 (1H, d, J = 7.9 
Hz, CHarom), 6.77 (1H, dd, J = 7.8 Hz, 1.4 Hz, CHarom), 6.87 (1H, ddd, J = 7.9 Hz, 7.4 Hz, 1.4 Hz, CHarom). 13C 
NMR (75 MHz, ref = CDCl3):  -4.2 (2x SiCH3), 18.3 (SiC(CH3)3), 25.9 (SiC(CH3)3), 54.3 (t, J = 25.4 Hz, CH2CF2Br), 
110.9, 118.0, 118.3 and 122.0 (4x CHarom), 122.6 (t, J = 309.2 Hz, CF2Br), 138.0 and 142.7 (2x Carom,quat). 19F 
NMR (282 MHz, CDCl3, ref = CFCl3):  -53.30 (t, JH,F = 11.8 Hz, CF2Br). IR (ATR, cm-1): νNH = 3446, νmax = 1514, 
1254, 916, 781. MS (ES+): m/z (%): 366/68 (M + H+, 100). HRMS (ES+): calcd. for C14H23BrF2NOSi+: 366.0695, 
found 366.0702. 
N-{4-Methoxy-2-[(tert-butyldimethylsilyl)oxy]phenyl}-2-bromo-2,2-difluoroethylamine 262b 
Yellow oil. Rf 0.57 (petroleum ether/EtOAc 9/1). Yield: 95%. 1H NMR (400 MHz, 
CDCl3):  0.26 (6H, s, 2x SiCH3), 1.02 (9H, s, SiC(CH3)3), 3.73 (3H, s, OCH3), 3.89 (2H, 
td, JH,F = 12.1 Hz, J = 7.2 Hz, CH2), 4.33 (1H, t, J = 7.2 Hz, NH), 6.42 (1H, d, J = 2.8 Hz, 
CHarom), 6.44 (1H, dd, J = 8.4 Hz, 2.8 Hz, CHarom), 6.62 (1H, d, J = 8.4 Hz, CHarom). 13C NMR (100.6 MHz, CDCl3): 
 -4.3 (2x SiCH3), 18.2 (SiC(CH3)3), 25.8 (SiC(CH3)3), 55.1 (t, J = 24.9 Hz, CH2CF2Br), 55.6 (OCH3), 105.5, 106.2 
and 111.5 (3x CHarom), 122.6 (t, J = 309.2 Hz, CF2Br), 132.1, 143.6 and 152.5 (3x Carom,quat). 19F NMR (376.5 
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MHz, CDCl3, ref = CFCl3):  -53.13 (2F, t, JH,F = 12.1 Hz, CF2Br). IR (ATR, cm-1): νNH = 3442, νmax = 1518, 1163, 
837, 780. MS (ES+): m/z (%): 396/98 (M + H+, 100). HRMS (ES+): calcd. for C15H25BrF2NO2Si+: 396.0801, found 
396.0813. 
N-(2-Bromo-2,2-difluoroethyl)aniline 270 
Colorless oil. Rf 0.35 (petroleum ether/EtOAc 95/5). Yield: 46%. 1H NMR (400 MHz, 
CDCl3):  3.91-3.99 (2H, m, CH2), 4.10 (1H, s, NH), 6.71 (2H, d, J = 7.7 Hz, 2x CHarom), 6.80 
(1H, tt, J = 7.4 Hz, 1.0 Hz, CHarom), 7.19-7.24 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, ref 
= CDCl3):  54.5 (t, J = 25.1 Hz, CH2), 113.2 (2x CHarom), 119.1 (CHarom), 122.6 (t, J = 309.4 Hz, CF2Br), 129.5 
(2x CHarom), 146.1 (Carom,quat). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -53.33 (2F, t, JH,F = 11.9 Hz, CF2Br). 
IR (ATR, cm-1): νNH = 3416, νmax = 1602, 1511, 1100, 909, 747, 690. 
5.7.5 Synthesis of N-(2-bromo-2,2-difluoroethyl)benzamides 217, 249, 264 and 271 
The synthesis of N-(2-bromo-2,2-difluoroethyl)-N-propylbenzamide 217 is described as representative. To 
a mixture of N-propyl-2-bromo-2,2-difluoroethylamine 23b (0.33 g, 1.7 mmol) and Et3N (0.84 g, 8.3 mmol, 
5 equiv) in anhydrous CH2Cl2 (20 mL), a solution of benzoyl chloride (0.23 g, 1.7 mmol, 1 equiv) in 
anhydrous CH2Cl2 (5 mL) was added slowly at 0 °C. After stirring at room temperature for 20 hours, the 
reaction mixture was washed with an aqueous solution of HCl (5%, 10 mL) and NaHCO3 (aq, sat). After 
drying (MgSO4) and filtration, the solvent was evaporated in vacuo. Column chromatography (SiO2, 
PE/EtOAc 8/2) afforded pure benzamide 217 in 90% yield (0.41 g, 1.5 mmol). 
N-(2-Bromo-2,2-difluoroethyl)-N-propylbenzamide 217 
Yellow oil. Rf 0.34 (petroleum ether/EtOAc 8/2). Yield: 90%. 1H NMR (400 MHz, CDCl3, 
50 °C):  0.79 (3H, t, J = 7.2 Hz, CH2CH3), 1.52-1.58 (2H, m, CH2CH2CH3), 3.45 (2H, t, J = 
6.8 Hz, NCH2CH2), 4.33 (2H, t, JH,F = 11.2 Hz, CF2BrCH2), 7.39-7.46 (5H, m, 5x CHarom). 13C 
NMR (100.6 MHz, ref = CDCl3):  10.8 (CH2CH3), 21.1 (CH2CH3), 51.3 (NCH2CH2), 52.1 (CH2CF2Br), 121.2 (t, J 
= 308.8 Hz, CF2Br), 126.8 (2x CHarom), 128.6 (2x CHarom), 129.9 (CHarom), 135.6 (Carom, quat), 172.8 (C=O). 19F 
NMR (376.5 MHz, CDCl3):  -50.02 (2F, br s, CF2Br). IR (ATR, cm-1): νC=O = 1647, νmax = 1407, 1089, 1021, 
935, 699. MS (ES+): m/z (%): 306/8 (M + H+, 100). HRMS (ES+): calcd. for C12H15BrF2NO+: 306.0300, found 
306.0295. 
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N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}benzamine 249 
Colorless oil. Rf 0.07 (petroleum ether/EtOAc 97/3). Yield: 71%. 1H NMR (300 
MHz, CDCl3):  0.01 (3H, s, SiCH3), 0.32 (3H, s, SiCH3), 0.87 (9H, s, SiC(CH3)3), 3.44-
3.90 (4H, m, CH2CH2), 4.24-4.66 (2H, m, CH2CF2), 7.35-7.40 (5H, m, 5x CHarom). 13C 
NMR (75 MHz, CDCl3):  -5.5 (2x SiCH3), 18.1 (SiC(CH3)3), 25.8 (SiC(CH3)3), 51.4 (CH2N), 53.2 (m, CH2CF2), 
61.5 (CH2O), 121.2 (t, J = 309.9 Hz, CF2Br), 127.0 (2x CHarom), 128.6 (2x CHarom), 129.9 (CHarom), 135.5 
(Carom,quat), 172.8 (C=O). 19F NMR (282 MHz, CDCl3, ref = CFCl3):  -50.56 (2F, br s, CF2Br). IR (ATR, cm-1): νC=O 
= 1655, νmax = 1090, 1071, 930, 834, 777. MS (ES+): m/z (%): 422/24 (M + H+, 100). HRMS (ES+): calcd. for 
C17H27BrF2NO2Si+: 422.0957, found 422.0965. 
N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]phenyl}benzamide 264a 
White crystals. Melting point: 89-90 °C. Rf 0.23 (petroleum ether/EtOAc 9/1). Yield: 98%. 
1H NMR (400 MHz, CDCl3):  0.26 (3H, s, SiCH3), 0.32 (3H, s, SiCH3), 1.02 (9H, s, SiC(CH3)3), 
4.00 (1H, ddd, JH,F = 18.5 Hz, J = 14.9 Hz, JH,F = 4.2 Hz, CH(H)CF2Br), 5.44 (1H, ddd, JH,F = 
18.9 Hz, J = 14.9 Hz, JH,F = 10.3 Hz, CH(H)CF2Br), 6.74-6.77 (2H, m, 2x CHarom), 7.06-7.15 
(4H, m, 4x CHarom), 7.21-7.22 (1H, m, CHarom), 7.28-7.30 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3): 
 -4.4 (SiCH3), -3.9 (SiCH3), 18.2 (SiC(CH3)3), 25.7 (SiC(CH3)3), 56.4 (dd, J = 25.0 Hz, 22.4 Hz, CH2CF2Br), 118.6 
(CHarom), 120.7 (dd, J = 311.4 Hz, 308.4 Hz, CF2Br), 121.0 (CHarom), 127.5 (2x CHarom), 128.0 (2x CHarom), 129.3, 
129.9 and 131.7 (3x CHarom), 132.9, 134.9 and 150.7 (3x Carom,quat), 171.3 (C=O). 19F NMR (376.5 MHz, CDCl3, 
ref = CFCl3):  -49.08 (1F, ddd, J = 154.5 Hz, JH,F = 18.9 Hz, 4.2 Hz, CF(F)Br), -50.75 (1F, ddd, J = 154.5, JH,F = 
18.5 Hz, 10.3 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1658, νmax = 1285, 909, 783. MS (ES+): m/z (%): 470/72 (M 
+ H+, 100). HRMS (ES+): calcd. for C21H27BrF2NO2Si+: 470.0957, found 470.0957. El. Anal. Calcd for 
C21H26BrF2NO2Si: C 53.62, H 5.57, N 2.98, found C 53.53, H 5.90, N 2.91. 
N-(2-Bromo-2,2-difluoroethyl)-N-{4-methoxy-2-[(tert-butyldimethylsilyl)oxy]phenyl}benzamide 264b 
White crystals. Melting point: 119-120 °C. Rf 0.13 (petroleum ether/EtOAc 9/1). 
Yield: 52%. 1H NMR (400 MHz, CDCl3):  0.26 (3H, s, SiCH3), 0.31 (3H, s, SiCH3), 1.02 
(9H, s, SiC(CH3)3), 3.70 (3H, s, OCH3), 4.91 (1H, ddd, JH,F = 18.4 Hz, J = 14.9 Hz, JH,F = 
4.3 Hz, CH(H)CF2Br), 5.43 (1H, ddd, JH,F = 18.7 Hz, J = 14.9 Hz, JH,F = 10.5 Hz, 
CH(H)CF2Br), 6.28-6.31 (2H, m, 2x CHarom), 6.99-7.01 (1H, m, CHarom), 7.13-7.17 (2H, m, 2x CHarom), 7.21-7.24 
(1H, m, CHarom), 7.29-7.31 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  -4.4 (SiCH3), -3.9 (SiCH3), 18.2 
(SiC(CH3)3), 25.7 (SiC(CH3)3), 55.3 (OCH3), 56.6 (dd, J = 24.9 Hz, 22.4 Hz, CH2CF2Br), 105.1 and 105.3 (2x 
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CHarom), 120.9 (dd, J = 311.3 Hz, 308.3 Hz, CF2Br), 126.2 (Carom,quat), 127.5 (2x CHarom), 127.9 (2x CHarom), 129.8 
and 132.0 (2x CHarom), 135.1, 151.6 and 160.0 (3x Carom,quat), 171.6 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -49.12 (1F, ddd, J = 154.5 Hz, JH,F = 18.7 Hz, 4.3 Hz, CF(F)Br), -50.71 (1F, ddd, J = 154.5, JH,F = 18.4 
Hz, 10.5 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1652, νmax = 1509, 1171, 833. MS (ES+): m/z (%): 500/2 (M + H+, 
100). HRMS (ES+): calcd. for C22H29BrF2NO3Si+: 500.1063, found 500.1067. 
N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]phenyl}-4-methoxybenzamide 264c 
Colorless oil. Rf 0.29 (petroleum ether/EtOAc 95/5). Yield: 76%. 1H NMR (400 MHz, 
CDCl3):  0.19 (3H, s, SiCH3), 0.27 (3H, s, SiCH3), 0.97 (9H, s, SiC(CH3)3), 3.60 (3H, s, 
OCH3), 4.00 (1H, ddd, JH,F = 19.0 Hz, J = 15.0 Hz, JH,F = 3.8 Hz, CH(H)CF2Br), 5.40 (1H, 
ddd, JH,F = 19.3 Hz, J = 15.0 Hz, JH,F = 9.6 Hz, CH(H)CF2Br), 6.58 (2H, d, J = 8.7 Hz, 2x 
CHarom), 6.72-6.76 (1H, m, CHarom), 6.76 (1H, d, J = 8.2 Hz, CHarom), 7.05 (1H, ddd, J = 8.2 Hz, 7.6 Hz, 1.6 Hz, 
CHarom), 7.11 (1H, d, J = 7.6 Hz, CHarom), 7.26 (2H, d, J = 8.7 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3): 
 -4.6 (SiCH3), -4.1 (SiCH3), 18.0 (SiC(CH3)3), 25.5 (SiC(CH3)3), 54.9 (OCH3), 56.6 (dd, J = 23.7 Hz, 23.1 Hz, 
CH2CF2Br), 112.6 (2x CHarom), 118.7 (CHarom), 120.8 (dd, J = 311.1 Hz, 308.9 Hz, CF2Br), 121.1 (CHarom), 126.6 
(Carom,quat), 129.1 (CHarom), 130.3 (2x CHarom), 131.2 (CHarom), 133.3, 150.5 and 160.8 (3x Carom,quat), 170.4 
(C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -48.91 (1F, ddd, J = 153.2 Hz, JH,F = 19.3 Hz, 3.8 Hz, CF(F)Br), 
-50.74 (1F, ddd, J = 153.2 Hz, JH,F = 19.0 Hz, 9.6 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1657, νmax = 1497, 1253, 
909, 782. MS (ES+): m/z (%): 500/2 (M + H+, 100). HRMS (ES+): calcd. for C22H29BrF2NO3Si+: 500.1063, found 
500.1070. 
N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]phenyl}-4-bromobenzamide 264d 
White crystals. Melting point: 83-84 °C. Rf 0.57 (petroleum ether/EtOAc 9/1). Yield: 
75%. 1H NMR (400 MHz, CDCl3):  0.24 (3H, s, SiCH3), 0.31 (3H, s, SiCH3), 1.01 (9H, s, 
SiC(CH3)3), 4.00 (1H, ddd, JH,F = 18.7 Hz, J = 15.0 Hz, JH,F = 4.2 Hz, CH(H)CF2Br), 5.43 
(1H, ddd, JH,F = 19.0 Hz, J = 15.0 Hz, JH,F = 10.1 Hz, CH(H)CF2Br), 6.75-6.79 (2H, m, 2x 
CHarom), 7.07-7.14 (2H, m, 2x CHarom), 7.20 (2H, d, J = 8.5 Hz, 2x CHarom), 7.26 (2H, d, J = 8.5 Hz, 2x CHarom). 
13C NMR (100.6 MHz, ref = CDCl3):  -4.4 (SiCH3), -4.0 (SiCH3), 18.0 (SiC(CH3)3), 25.6 (SiC(CH3)3), 56.5 (dd, J 
= 24.8 Hz, 22.6 Hz, CH2CF2Br), 118.7 (CHarom), 120.5 (dd, J = 311.2 Hz, 308.4 Hz, CF2Br), 121.2 (CHarom), 124.4 
(Carom,quat), 129.5 (CHarom), 129.7 (2x CHarom), 130.6 (2x CHarom), 131.3 (CHarom), 132.6, 133.6 and 150.6 (3x 
Carom,quat), 171.1 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -49.27 (1F, ddd, J = 154.4 Hz, 19.0 Hz, 4.2 
Hz, CF(F)Br), -50.85 (1F, ddd, J = 154.4 Hz, 18.7 Hz, 10.1 Hz, CF(F)Br). IR (ATR, cm-1): νC=O = 1664, νmax = 1479, 
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1282, 1100, 908, 732. MS (ES+): m/z (%): 548/50/52 (M + H+, 100). HRMS (ES+): calcd. for C21H26Br2F2NO2Si+: 
548.0062, found 548.0063. 
N-(2-Bromo-2,2-difluoro)-N-phenylbenzamide 271 
Colorless oil. Rf 0.10 (petroleum ether/EtOAc 9/1). Yield: 63%. 1H NMR (400 MHz, 
CDCl3):  4.81 (2H, t, JH,F = 12.8 Hz, CH2), 7.08-7.11 (2H, m, 2x CHarom), 7.14-7.20 (3H, m, 
3x CHarom), 7.21-7.25 (3H, m, 3x CHarom), 7.29-3.31 (2H, m, 2x CHarom). 13C NMR (100.6 
MHz, ref = CDCl3):  57.9 (t, J = 24.0 Hz, CH2), 120.4 (t, J = 310.1 Hz, CF2), 127.5 (CHarom), 
127.77 and 127.79 (4x CHarom), 128.6 (2x CHarom), 129.3 (2x CHarom), 130.1 (CHarom), 134.7 (Carom,quat), 142.8 
(Carom,quat), 171.0 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -49.97 (2F, t, JH,F = 12.9 Hz, CF2Br). IR 
(ATR, cm-1): νC=O = 1659, νmax = 1370, 1302, 1107, 926, 695. MS (ES+): m/z (%): 340/42 (M + H+, 100). HRMS 
(ES+): calcd. for C15H13BrF2NO+: 340.0143, found 340.0133. 
5.7.6 Synthesis of N-(2-bromo-2,2-difluoroethyl)-4-methylbenzenesulfonamides 219 
and 244 
The synthesis of N-(2-bromo-2,2-difluoroethyl)-N-propyl-4-methylbenzenesulfonamide 219 is described 
as representative. To a mixture of N-propyl-2-bromo-2,2-difluoroethylamine 23b (5.00 g, 25 mmol), Et3N 
(4.00 g, 21 mmol, 0.8 equiv) and DMAP (0.26 g, 2.1 mmol, 0.08 equiv) in anhydrous CH2Cl2 (100 mL), a 
solution of p-toluenesulfonyl chloride (2.12 g, 21 mmol, 0.8 equiv) in anhydrous CH2Cl2 (25 mL) was added 
at 0 °C. The reaction mixture was stirred at reflux temperature for 47 h, poured in 1M HCl (50 mL) and 
extracted with CH2Cl2 (3x 50 mL). After drying of the organic fase (MgSO4), filtration of the drying agent, 
and evaporation of the solvent in vacuo, N-(2-bromo-2,2-difluoroethyl)-N-propyl-4-
methylbenzenesulfonamide 219 was obtained in 78% yield (5.81 g, 19.5 mmol). 
N-(2-Bromo-2,2-difluoroethyl)-N-propyl-4-methylbenzenesulfonamide 219 
White crystals. Melting point: 56-57 °C. Yield: 78%. 1H NMR (400 MHz, CDCl3):  0.82 
(3H, t, J = 7.4 Hz, CH2CH3), 1.58 (2H, sextet, J = 7.6 Hz, CH2CH2CH3), 2.43 (3H, s, 
CH3Carom,quat), 3.18-3.22 (2H, m, NCH2CH2), 4.10 (2H, t, JH,F = 13.3 Hz, CF2BrCH2), 7.31 (2H, d, J = 8.1 Hz, 2x 
CHarom), 7.71 (2H, d, J = 8.1 Hz, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  10.9 (CH2CH3), 20.8 (CH2CH3), 21.5 
(CH3Carom,quat), 50.9 (NCH2CH2), 56.0 (t, J = 24.2 Hz, CH2CF2Br), 120.6 (t, J = 309.5 Hz, CF2Br), 127.3 (2x CHarom), 
129.8 (2x CHarom), 136.6 (Carom, quat), 143.9 (Carom,quat). 19F NMR (376.5 MHz, CDCl3):  -51.47 (2F, t, JH,F = 13.3 
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Hz, CF2Br). IR (ATR, cm-1): νmax = 1345, 1154, 942, 732. MS (ES+): m/z (%): 373/75 (M + NH4+, 100), 356/58 
(M + H+, 80). HRMS (ES+): calcd. for C12H17BrF2NO2S+: 356.0126, found 356.0125. 
N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-4-methylbenzenesulfonamide 
244 
Yellow oil. Rf 0.17 (petroleum ether/EtOAc 17/0.6). Yield: 25%. 1H NMR (300 
MHz, CDCl3):  0.01 (6H, s, 2x SiCH3), 0.85 (9H, s, SiC(CH3)3), 2.39 (3H, s, 
CH3Carom,quat), 3.40 (2H, t, J = 5.5 Hz, NCH2), 3.73 (2H, t, J = 5.5 Hz, OCH2), 4.36 (2H, t, JH,F = 14.0 Hz, CH2CF2), 
7.28 (2H, d, J = 8.0 Hz, 2x CHarom), 7.66 (2H, d, J = 8.0 Hz, 2x CHarom). 13C NMR (75 MHz, CDCl3):  -5.2 (2x 
SiCH3), 18.3 (SiC(CH3)3), 21.5 (CH3Carom,quat), 25.9 (SiC(CH3)3), 50.6 (NCH2), 57.2 (t, J = 23.5 Hz, CH2CF2), 62.4 
(CH2O), 120.9 (t, J = 307.5 Hz, CF2Br), 127.4 (2x CHarom), 129.8 (2x CHarom), 137.0 (Carom,quat), 143.9 (Carom,quat). 
19F NMR (282 MHz, CDCl3):  -51.89 (2F, t, JH,F = 14.0 Hz, CF2Br). IR (ATR, cm-1): νmax = 1158, 1091, 994, 938, 
840, 813, 775, 731. MS (ES+): m/z (%): 472/74 (M + H+, 100). HRMS (ES+): calcd. for C17H29BrF2NO3SSi+: 
472.0783, found 472.0781. 
5.7.7 Synthesis of N-(2-bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]-
ethyl}-1,1,1-trifluoromethanesulfonamide 248 
To a solution of N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-2-bromo-2,2-difluoroethylamine 243 (1.50 g, 4.72 
mmol) and triethylamine (1.2 equiv, 0.57 g, 5.66 mmol) in dry CH2Cl2 (40 mL) was added triflic anhydride 
(1.1 equiv, 0.87 mL, 2.19 mmol) at 0 °C. Subsequently, this reaction mixture was stirred at room 
temperature for 17 hours, after which the mixture was washed with aqueous HCl (1M) and the organic 
phase was dried (MgSO4), filtered and evaporated under reduced pressure. After purification using column 
chromatography, pure N-(2-bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-1,1,1-
trifluoromethanesulfonamide 248 was obtained (1.59 g, 3.54 mmol). 
N-(2-Bromo-2,2-difluoroethyl)-N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-1,1,1-trifluoromethane-
sulfonamide 248 
Colorless oil. Rf 0.47 (petroleum ether/EtOAc 20/1). Yield: 75%. 1H NMR (300 
MHz, CDCl3):  0.09 (6H, s, 2x SiCH3), 0.91 (9H, s, SiC(CH3)3), 3.68 (2H, t, J = 5.0 Hz, 
NCH2), 3.88 (2H, t, J = 5.0 Hz, OCH2), 4.46 (2H, t, JH,F = 13.2 Hz, CH2CF2). 13C NMR (75 MHz, CDCl3):  -2.7 
(SiCH3), 2.9 (SiCH3), 21.0 (SiC(CH3)3), 28.7 (SiC(CH3)3), 53.3 (CH2N), 59.8 (t, J = 23.7 Hz, CH2CF2), 65.0 (CH2O), 
122.1 (t, J = 308.6 Hz, CF2Br), 122.6 (q, J = 322.7 Hz, CF3). 19F NMR (282 MHz, CDCl3):  -52.76 (2F, m, CF2Br), 
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-74.87 (3F, t, J = 5.3 Hz, CF3). IR (ATR, cm-1): νmax = 1192, 1126, 1014, 936, 778. MS (ES+): m/z (%): 450/52 
(M + H+, 100). 
5.7.8 Synthesis of β,β-difluorinated enamides 218, 220, 245, 250, 251 and 272 
The synthesis of benzamide 218 is given as a representative example. To a solution of N-2-bromo-2,2-
difluoroethyl-N-propylbenzamide 217 (1.29 g, 4.2 mmol) in anhydrous THF (40 mL), a solution of LiHMDS 
in THF (1M, 4.4 mL, 1.05 equiv) was added at 0 °C. The reaction mixture was stirred at room temperature 
for three hours, after which it was quenched with NaHCO3 (aq, sat) and extracted with EtOAc (3x 50 mL). 
After drying of the combined organic phases (MgSO4), filtration and evaporation of the solvent, crude 
benzamide 218 was obtained, which was purified via column chromatography (SiO2, PE/EtOAc 9/1) 
affording pure amide 218 in 85% yield (0.80 g, 3.6 mmol). 
N-(2,2-Difluorovinyl)-N-propylbenzamide 218 
Yellow oil. Rf 0.23 (petroleum ether/EtOAc 9/1). Yield: 85%. 1H NMR (400 MHz, CDCl3):  
0.94 (3H, br s, CH2CH3), 1.62-1.68 (2H, m, CH2CH2CH3), 3.57 (2H, br s, NCH2CH2), 5.42 (1H, 
br s, CH=CF2), 7.36-7.46 (5H, m, 5x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  11.2 (CH2CH3), 20.9 
(CH2CH3), 49.4 (NCH2CH2), 89.0-89.5 (m, CH=CF2), 127.5 (2x CHarom), 128.3 (2x CHarom), 130.3 (CHarom), 135.7 
(Carom, quat), 155.5 (t, J = 289.9 Hz, CH=CF2), 171.1 (C=O). 19F NMR (376.5 MHz, CDCl3):  -87.75 (1F, dd, J = 
38.9 Hz, JH,F = 18.2 Hz, CF(F)), -100.56 (1F, d, J = 38.9 Hz, CF(F)). IR (ATR, cm-1): νC=O = 1647, νmax = 1407, 
1089, 1021, 935, 699. MS (ES+): m/z (%): 226 (M + H+, 100). HRMS (ES+): calcd. for C12H14F2NO+: 226.1038, 
found 226.1038. 
N-(2,2-Difluorovinyl)-N-propyl-4-methylbenzenesulfonamide 220 
Yellow crystals. Melting point: 51-52 °C. Rf 0.30 (petroleum ether/EtOAc 10/1). Yield: 
82%. 1H NMR (300 MHz, CDCl3):  0.92 (3H, t, J = 7.2 Hz, CH2CH3), 1.54 (2H, sextet, J = 7.2 
Hz, CH2CH2CH3), 2.44 (3H, s, CH3Carom,quat), 3.10 (2H, t, J = 7.2 Hz, NCH2CH2), 4.87 (1H, dd, JH,F = 18.3 Hz, 2.8 
Hz, CH=CF2), 7.33 (2H, d, J = 8.3 Hz, 2x CHarom), 7.68 (2H, d, J = 8.3 Hz, 2x CHarom). 13C NMR (75 MHz, CDCl3): 
 10.9 (CH2CH3), 21.4 (CH2CH3), 21.6 (CH3Carom,quat), 51.6 (NCH2CH2), 84.9 (dd, J = 49.6 Hz, 13.9 Hz, CH=CF2), 
127.4 (2x CHarom), 129.8 (2x CHarom), 134.8 (Carom,quat), 143.9 (Carom,quat), 159.5 (dd, J = 300.0 Hz, 289.6 Hz, 
CH=CF2). 19F NMR (282 MHz, CDCl3):  -83.20 (1F, dd, J = 28.3 Hz, JH,F = 18.3 Hz, CF(F)), -93.38 (1F, d, J = 
28.3 Hz, CF(F)). IR (ATR, cm-1): νmax = 1749, 1341, 1240, 1164. MS (ES+): m/z (%): 276 (M + H+, 100), 293 (M 
+ NH4+, 33). HRMS (ES+): calcd. for C12H16F2NO2S+: 276.0864, found 276.0863. 
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N-{2-[(Tert-butyldimethylsilyl)oxy]ethyl}-N-(2,2-difluorovinyl)-4-methylbenzenesulfonamine 245 
Colorless oil. Rf 0.37 (petroleum ether/EtOAc 9/1). Yield: 70%. 1H NMR (400 MHz, 
CDCl3):  0.01 (6H, s, 2x SiCH3), 0.84 (9H, s, SiC(CH3)3), 2.41 (3H, s, CH3), 3.29 (2H, 
t, J = 6.0 Hz, CH2N), 3.72 (2H, t, J = 6.0 Hz, CH2O), 5.04 (1H, dd, JH,F = 18.3 Hz, 2.7 Hz, CH=CF2), 7.29 (2H, d, J 
= 8.2 Hz, 2x CHarom), 7.67 (2H, d, J = 8.2 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  -5.5 (2x SiCH3), 
18.3 (SiC(CH3)3), 21.6 (CH3Carom,quat), 25.9 (SiC(CH3)3), 52.3 (CH2N), 61.7 (CH2O), 86.3 (dd, J = 50.0 Hz, 13.8 
Hz, CH=CF2), 127.5 (2x CHarom), 129.9 (2x CHarom), 135.3 (Carom,quat), 144.1 (Carom,quat), 159.1 (dd, J = 299.6 Hz, 
289.1 Hz, CF2). 19F NMR (376.5 MHz, CDCl3):  -83.40 (1F, dd, J = 29.0 Hz, JH,F = 18.3 Hz, CF(F)), -94.60 (1F, 
d, J = 29.0 Hz, CF(F)). IR (ATR, cm-1): νmax = 1165, 1090, 883, 812, 776, 659. MS (ES+): m/z (%): 392 (M + H+, 
100). 
N-{2-[(Tert-butyldimethylsilyl)oxy]ethyl}-N-(2,2-difluorovinyl)-1,1,1-trifluoromethanesulfonamide 250 
Yellow oil. Rf 0.20 (petroleum ether/EtOAc 9/1). Yield: 65%. 1H NMR (400 MHz, 
CDCl3):  0.07 (6H, s, 2x SiCH3), 0.89 (9H, s, SiC(CH3)3), 3.60 (2H, t, J = 5.3 Hz, CH2N), 
3.79 (2H, t, J = 5.3 Hz, CH2O), 5.39 (1H, dd, JH,F = 17.9 Hz, 3.3 Hz, CH=CF2). 13C NMR (75 MHz, CDCl3):  -5.6 
(2x SiCH3), 18.2 (SiC(CH3)3), 25.7 (SiC(CH3)3), 54.0 (CH2N), 60.8 (CH2O), 85.2 (dd, J = 51.9 Hz, 15.0 Hz, 
CH=CF2), 119.9 (q, J = 323.8 Hz, CF3), 159.4 (dd, J = 300.0 Hz, 293.1 Hz, CF2). 19F NMR (376.5 MHz, CDCl3):  
-75.06 (3F, s, CF3), -80.75 to -80.87 (1F, m, CF(F)), -92.43 to -92.50 (1F, m, CF(F)). IR (ATR, cm-1): νmax = 1226, 
1191, 1116, 836, 777. MS (ES+): m/z (%): 370 (M + H+, 55), 361 (100). HRMS: M + H+ could not be detected. 
N-(2,2-Difluorovinyl)-N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}benzamide 251 
Yellow oil. Rf 0.20 (petroleum ether/EtOAc 9/1). Yield: 35%. 1H NMR (300 MHz, 
CDCl3):  0.08 (6H, s, SiCH3), 0.91 (9H, s, 2x SiC(CH3)3), 3.62-3.87 (4H, m, CH2CH2), 
5.52-5.56 (1H, m, CH=CF2), 7.39-7.50 (5H, m, 5x CHarom). 13C NMR (75 MHz, CDCl3): 
 -5.4 (2x SiCH3), 18.2 (SiC(CH3)3), 25.9 (SiC(CH3)3), 50.5 (CH2N), 60.7 (CH2O), 90.3-91.2 (m, CH=CF2), 127.6 
(2x CHarom), 128.2 (2x CHarom), 130.3 (CHarom), 135.6 (Carom,quat), 159.4 (t, J = 298.6 Hz, CF2), 171.2 (C=O). 19F 
NMR (282 MHz, CDCl3, ref = CFCl3):  -85.59 (1F, br s, CF(F)), -101.06 (1F, d, J = 42.1 Hz, CF(F)).  
N-(2,2-Difluorovinyl)-N-phenylbenzamide 272 
Yellow oil. Rf 0.28 (petroleum ether/EtOAc 85/15). Yield: 63%. 1H NMR (400 MHz, CDCl3): 
 6.02 (1H, d, JH,F = 19.5 Hz, CH=CF2), 7.12 (2H, d, J = 7.7 Hz, 2x CHarom), 7.17-7.33 (6H, m, 
6x CHarom), 7.38 (2H, d, J = 7.5 Hz, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  89.9 (dd, J = 
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49.9 Hz, 11.6 Hz, CH=CF2), 126.7 (2x CHarom), 127.1 (CHarom), 128.0 (2x CHarom), 128.8 (2x CHarom), 129.2 (2x 
CHarom), 130.5 (CHarom), 134.7 (Carom,quat), 141.6 (Carom,quat), 155.7 (dd, J = 296.3 Hz, 285.0 Hz, CF2), 169.9 
(C=O). 19F NMR (282 MHz, CDCl3):  -86.01 (1F, dd, J = 41.6 Hz, JH,F = 19.5 Hz, CF(F)), -99.89 (1F, d, J = 41.6 
Hz, CF(F)). IR (ATR, cm-1): νC=O = 1660, νmax = 1333, 1305, 1282, 1228, 693. MS (ES+): m/z (%): 260 (M + H+, 
100). HRMS (ES+): calcd. for C15H12F2NO+: 260.0881, found 260.0878. 
5.7.9 Synthesis of enamides 221a, 221b and 222b, amine 223b and glycinate 224b 
The synthesis of enamide 221a is described as a representative example. N-(2,2-Difluorovinyl)-N-propyl-
4-methylbenzenesulfonamide 220 (0.21 g, 0.78 mmol) was dissolved in acetonitrile (5 mL) and 
subsequently, thiophenol (0.103 g, 0.93 mmol, 1.2 equiv) and KOH (0.052 g, 0.93 mmol, 1.2 equiv) were 
added. After stirring the reaction mixture for 20 hours at reflux temperature, an aqueous solution of HCl 
(1N, 10 mL) was added and an extraction with EtOAc (3x 10 mL) was performed. The combined organic 
layers were dried (MgSO4), filtered and the solvent was removed in vacuo. After column chromatography 
(SiO2, PE/EtOAc 24/1), enamide 221a was isolated in 69% yield (0.20 g, 0.54 mmol). 
(Z)-N-[2-Fluoro-2-(phenylthio)vinyl]-N-propyl-4-methylbenzenesulfonamide 221a 
White crystals. Melting point: 85-86 °C. Rf 0.13 (petroleum ether/EtOAc 24/1). Yield: 
69%. 1H NMR (400 MHz, CDCl3):  0.96 (3H, t, J = 7.4 Hz, CH2CH3), 1.58 (2H, sextet, J = 7.2 
Hz, CH2CH2CH3), 2.43 (3H, s, CH3Carom,quat), 3.19 (2H, t, J = 7.2 Hz, NCH2), 5.89 (1H, d, JH,F = 5.5 Hz, CH=CFS), 
7.30-7.33 (5H, m, 5x CHarom), 7.38-7.40 (2H, m, 2x CHarom), 7.69 (2H, d, J = 8.3 Hz, 2x CHarom). 13C NMR (100.6 
MHz, CDCl3):  11.2 (CH2CH3), 21.6 (CH2CH3 and CH3Carom,quat), 52.0 (NCH2CH2), 115.1 (d, J = 52.2 Hz, 
CH=CFS), 127.5 (2x CHarom), 128.2 (CHarom), 129.2 (2x CHarom), 129.77 (2x CHarom), 129.85 (Carom,quat), 131.5 
(2x CHarom), 134.8 (Carom,quat), 143.9 (Carom,quat), 158.9 (d, J = 297.3 Hz, CH=CFS). 19F NMR (282 MHz, CDCl3):  
-98.83 (1F, d, JH,F = 5.5 Hz, CH=CFS). IR (ATR, cm-1): νmax = 1344, 1161, 1145, 672. MS (ES+): m/z (%): 366 (M 
+ H+, 100). HRMS (ES+): calcd. for C18H21FNO2S2+: 366.0992, found 366.0989. El. Anal. Calcd for 
C18H20FNO2S2: C 59.15, H 5.52, N 3.83, found C 59.35, H 5.72, N 3.73. 
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Enamides 221b (major) and 222b (minor) were obtained as an inseparable mixture (ratio 221b : 222b = 8 
: 2). 
(E)-N-(2-Fluoro-2-phenoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 221b and (Z)-N-(2-fluoro-2-
phenoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 222b 
Yellow oil. Rf 0.13 (petroleum ether/EtOAc 95/5). Yield: 32%. 1H NMR (400 MHz, 
CDCl3):  0.87 (2.4H, t, J = 7.4 Hz, CH2CH3 (major)), 0.94 (0.6H, t, J = 7.4 Hz, CH2CH3 
(minor)), 1.56 (2H, sextet, J = 7.3 Hz, CH2CH2CH3), 2.36 (2.4H, s, CH3Carom,quat (major)), 
2.39 (0.6H, s, CH3Carom,quat (minor)), 3.15 (0.4H, t, J = 7.1 Hz, NCH2CH2 (minor)), 3.21 
(1.6H, t, J = 7.0 Hz, NCH2CH2 (major)), 4.88 (0.2H, d, JH,F = 19.3 Hz, CH=CFO (minor)), 5.33 (0.8H, d, JH,F = 1.0 
Hz, CH=CFO (major)), 6.91-6.93 (1.6H, m, 2x CHarom (major)), 7.07-7.37 (4H, m, 5x CHarom (major)), 7.07-7.37 
(1.4H, m, 7x CHarom (minor)), 7.64-7.67 (1.6H, m, 2x CHarom (major)), 7.69 (0.4H, d, J = 8.4 Hz, 2x CHarom 
(minor)). 13C NMR (100.6 MHz, ref = CDCl3):  11.0 (CH2CH3), 21.48 (CH3Carom,quat (major)), 21.50 
(CH3Carom,quat (minor)), 21.53 (CH2CH3 (major)), 21.6 (CH2CH3 (minor)), 51.5 (NCH2), 91.9 (d, J = 20.7 Hz, 
CH=CFO (minor)), 92.8 (d, J = 60.3 Hz, CH=CFO (major)), 116.8 (2x CHarom (minor)), 116.9 (2x CHarom (major)), 
124.5 (CHarom (major)), 124.8 (CHarom (minor)), 127.4 (2x CHarom (major) and 2x CHarom (minor)), 129.60 (2x 
CHarom (major)), 129.62 (2x CHarom (major)), 129.7 (2x CHarom (minor)), 130.0 (2x CHarom (minor)), 135.1 
(Carom,quat (minor)), 135.4 (Carom,quat (major)), 143.6 (Carom,quat (major)), 143.7 (Carom,quat (minor)), 153.5 (d, J = 
1.2 Hz, OCarom,quat (major)), 154.6 (d, J = 1.5 Hz, OCarom,quat (minor)), 156.5 (d, J = 283.9 Hz, CH=CFO (major)), 
157.5 (d, J = 290.0 Hz, CH=CFO (minor)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -84.57 (0.2F, d, JH,F = 
19.3 Hz, CH=CFO (minor)), -95.80 (0.8F, s, CH=CFO (major)). IR (ATR, cm-1): νmax = 1341, 1190, 1163, 748, 
658. MS (ES+): m/z (%): 350 (M + H+, 100). HRMS (ES+): calcd. for C18H21FNO3S+: 350.1221, found 350.1224. 
N-(2,2-Difluoro-2-phenoxyethyl)-N-propyl-4-methylbenzenesulfonamide 223b 
White crystals. Melting point: 77-78 °C. Rf 0.08 (petroleum ether/EtOAc 95/5). Yield: 
10%. 1H NMR (400 MHz, CDCl3):  0.86 (3H, t, J = 7.4 Hz, CH2CH3), 1.67 (2H, sextet, J = 
7.5 Hz, CH2CH2CH3), 2.41 (3H, s, CH3Carom,quat), 3.27-3.31 (2H, m, NCH2CH2), 3.96 (2H, t, JH,F = 9.3 Hz, 
CH2CF2O), 7.03-7.06 (2H, m, 2x CHarom), 7.18-7.22 (1H, m, CHarom), 7.27-7.33 (4H, m, 4x CHarom), 7.76 (2H, d, 
J = 8.3 Hz, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  11.0 (CH2CH3), 20.9 (CH2CH3), 21.5 (CH3Carom,quat), 49.5 
(t, J = 34.5 Hz, CH2CF2), 50.4 (NCH2), 121.7 (2x CHarom), 122.2 (t, J = 270.2 Hz, CH2CF2), 125.8 (CHarom), 127.4 
(2x CHarom), 129.4 (2x CHarom), 129.6 (2x CHarom), 137.3, 143.4 and 149.7 (3x Carom,quat). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -73.49 (2F, t, JH,F = 9.3 Hz, CF2). IR (ATR, cm-1): νmax = 1336, 1264, 1146, 994. MS (ES+): 
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m/z (%): 370 (M + H+, 100), 387 (M + NH4+, 12). HRMS (ES+): calcd. for C18H22F2NO3S+: 370.1283, found 
370.1279. El. Anal. Calcd for C18H21F2NO3S: C 58.52, H 5.73, N 3.79, found C 58.53, H 5.32, N 3.66. 
Phenyl N-propyl-N-tosylglycinate 224b 
White crystals. Melting point: 88-89 °C. Rf 0.03 (petroleum ether/EtOAc 95/5). Yield: 
85%. 1H NMR (400 MHz, CDCl3):  0.89 (3H, t, J = 7.4 Hz, CH2CH3), 1.61 (2H, sextet, J = 
7.4 Hz, CH2CH2CH3), 2.38 (3H, s, CH3Carom,quat), 3.24-3.28 (2H, m, NCH2CH2), 4.27 (2H, s, NCH2CO), 6.98-7.01 
(2H, m, 2x CHarom), 7.18-7.22 (1H, m, CHarom), 7.27 (2H, d, J = 8.1 Hz, 2x CHarom), 7.31-7.36 (2H, m, 2x CHarom), 
7.77 (2H, d, J = 8.3 Hz, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  11.1 (CH2CH3), 21.3 (CH2CH3), 21.5 
(CH3Carom,quat), 48.1 (NCH2CO), 50.2 (NCH2CH2), 121.2 (2x CHarom), 126.1 (CHarom), 127.4 (2x CHarom), 129.4 
(2x CHarom) and 129.6 (2x CHarom), 136.6, 143.5 and 150.2 (3x Carom,quat), 167.7 (C=O). IR (ATR, cm-1): νC=O = 
1769, νmax = 1334, 1148, 656. MS (ES+): m/z (%): 348 (M + H+, 100), 365 (M + NH4+, 58). HRMS (ES+): calcd. 
for C18H22NO4S+: 348.1264, found 348.1273. 
5.7.10 Synthesis of enamides 221c and 222c. 
To a solution of enamide 220 (0.15 g, 0.55 mmol) in anhydrous THF (10 mL), a solution of NaOMe in MeOH 
(1M, 0.55 mL, 1 equiv) was added. This mixture was stirred for three hours at room temperature. 
Subsequently, aqueous NH4Cl (10 mL) was added, followed by an extraction with EtOAc (3x 10 mL). After 
drying of the combined organic phases (MgSO4), filtration and evaporation of the solvent under reduced 
pressure, a mixture of two isomers 221c and 222c was obtained. After column chromatography (SiO2, 
PE/EtOAc 9/1), enamides 221c and 222c were isolated in 57% (0.090 g, 0.31 mmol) and 15% (0.024 g, 0.08 
mmol) yield, respectively. 
(E)-N-(2-Fluoro-2-methoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 221c 
Yellow oil. Rf 0.31 (petroleum ether/EtOAc 9/1). Yield: 57%. 1H NMR (400 MHz, CDCl3):  
0.91 (3H, t, J = 7.4 Hz, CH2CH3), 1.53 (2H, sextet, J = 7.3 Hz, CH2CH2CH3), 2.42 (3H, s, 
CH3Carom,quat), 3.10 (2H, td, J = 7.2 Hz, 0.8 Hz, NCH2CH2), 3.71 (3H, d, J = 1.0 Hz, OCH3), 4.63 (1H, d, JH,F = 0.7 
Hz, CH=CFO), 7.30 (2H, d, J = 8.1 Hz, 2x CHarom), 7.68 (2H, d, J = 8.1 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref 
= CDCl3):  10.9 (CH2CH3), 21.3 and 21.4 (CH2CH3 and CH3Carom,quat), 51.9 (d, J = 1.2 Hz, NCH2CH2), 57.4 (d, J 
= 6.0 Hz, OCH3), 86.5 (d, J = 64.1 Hz, CH=CFO), 127.4 (2x CHarom), 129.4 (2x CHarom), 135.1 and 143.4 (2x 
Carom,quat), 161.7 (d, J = 280.1 Hz, CH=CFO). 19F NMR (282 MHz, CDCl3):  -97.22 (1F, s, CH=CFO). IR (ATR, 
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cm-1): νmax = 1339, 1161, 732. MS (ES+): m/z (%): 288 (M + H+, 25). HRMS (ES+): calcd. for C13H19FNO3S+: 
288.1064, found 288.1068. 
(Z)-N-(2-Fluoro-2-methoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 222c 
Yellow oil. Rf 0.12 (petroleum ether/EtOAc 9/1). Yield: 15%. 1H NMR (400 MHz, CDCl3): 
 0.92 (3H, t, J = 7.4 Hz, CH2CH3), 1.54 (2H, sextet, J = 7.4 Hz, CH2CH2CH3), 2.42 (3H, s, 
CH3Carom,quat), 3.14 (2H, t, J = 7.2 Hz, NCH2CH2), 3.69 (3H, s, OCH3), 4.39 (1H, d, JH,F = 21.6 Hz, CH=CFO), 7.29 
(2H, d, J = 8.3 Hz, 2x CHarom), 7.69 (2H, d, J = 8.3 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  11.0 
(CH2CH3), 21.4 and 21.5 (CH2CH3 and CH3Carom,quat), 52.1 (d, J = 1.8 Hz, NCH2CH2), 57.0 (d, J = 3.6 Hz, OCH3), 
81.6 (d, J = 20.4 Hz, CH=CFO), 127.4 (2x CHarom), 129.5 (2x CHarom), 135.4 (Carom,quat), 143.4 (Carom,quat) 162.5 
(d, J = 268.9 Hz, CH=CFOCH3). 19F NMR (282 MHz, CDCl3):  -85.13 (1F, d, JH,F = 21.6 Hz, CH=CFO). IR (ATR, 
cm-1): νmax = 1348, 1166, 998, 665. MS (ES+): m/z (%): 288 (M + H+, 25). HRMS (ES+): calcd. for C13H19FNO3S+: 
288.1064, found 288.1059. 
5.7.11 Synthesis of enamide 221d 
To a solution of enamide 220 (0.36 g, 1.3 mmol) in anhydrous THF (20 mL), a solution of KOtBu in THF (1M, 
1.44 mL, 1.1 equiv) was added at 0 °C. After stirring this reaction mixture for two hours at room 
temperature, a saturated solution of NH4Cl in H2O (20 mL) was added. Upon subsequent extraction with 
EtOAc (3x 20 mL), drying of the organic layers (MgSO4), filtration and evaporation of the solvent in vacuo, 
a mixture of enamides 221d and 222d was obtained (221d : 222d = 8 : 2), from which enamide 221d was 
isolated in 46% (0.20 g, 0.60 mmol) yield via column chromatography (SiO2, PE/EtOAc 97/3). 
(E)-N-[2-Fluoro-2-(tert-butoxy)vinyl]-N-propyl-4-methylbenzenesulfonamide 221d 
White crystals. Melting point: 91-92 °C. Rf 0.24 (petroleum ether/EtOAc 97/3). Yield: 
46%. 1H NMR (400 MHz, CDCl3):  0.89 (3H, t, J = 7.4 Hz, CH2CH3), 1.34 (9H, d, J = 0.8 Hz, 
C(CH3)3), 1.52 (2H, sextet, J = 7.3 Hz, CH2CH2CH3), 2.42 (3H, s, CH3Carom,quat), 3.14 (2H, td, J = 7.2 Hz, JH,F = 0.8 
Hz, NCH2CH2), 4.88 (1H, d, JH,F = 1.2 Hz, CH=CFO), 7.29 (2H, d, J = 8.1 Hz, 2x CHarom), 7.69 (2H, d, J = 8.1 Hz, 
2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3)  11.2 (CH2CH3), 21.3 and 21.5 (CH2CH3 and CH3Carom,quat), 28.6 
(C(CH3)3), 51.8 (NCH2CH2), 84.7 (OC(CH3)3), 90.2 (d, J = 69.9 Hz, CH=CFO), 127.5 (2x CHarom), 129.5 (2x 
CHarom), 135.8 and 143.3 (2x Carom,quat), 159.3 (d, J = 284.9 Hz, CH=CFO). 19F NMR (282 MHz, CDCl3):  -85.62 
(1F, s, CH=CFO). IR (ATR, cm-1): νmax = 1343, 1165, 1151, 1137, 660. MS (ES+): m/z (%): 352 (M + Na+, 10). 
HRMS (ES+): calcd for C16H25FNO3S+: 330.1534, found 330.1542. 
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5.7.12 Synthesis of enamides 226 and 227 
To a solution of enamide 218 (0.045 g, 0.20 mmol) in acetonitrile (5 mL) were added phenol (0.023 g, 0.24 
mmol, 1.2 equiv) and KOH (0.013 g, 0.24 mmol, 1.2 equiv). After stirring this reaction mixture for four 
hours at reflux temperature, a saturated solution of NH4Cl in H2O (5 mL) was added. Upon subsequent 
extraction with EtOAc (3x 10 mL), drying of the organic layers (MgSO4), filtration and evaporation of the 
solvent in vacuo, enamides 226 and 227 were isolated as a mixture (ratio 226 : 227 = 4 : 1) in 80% yield 
(0.048 g, 0.16 mmol) after preparative TLC (SiO2, PE/EtOAc 9/1). 
(E)-N-(2-Fluoro-2-phenoxyvinyl)-N-propylbenzamide 226 and (Z)-(2-fluoro-2-phenoxyvinyl)-N-
propylbenzamide 227 
Yellow oil. Rf 0.18 (petroleum ether/EtOAc 9/1). Yield: 80%. 1H NMR (400 MHz, CDCl3): 
 0.94 (3H, br s, CH2CH3), 1.70 (2H, br s, CH2CH2CH3), 3.63 (2H, br s, NCH2), 5.43 (0.2H, 
d, JH,F = 19.9 Hz, CH=CFO (minor)), 5.76 (0.8H, br s, CH=CFO (major)), 6.81-6.91 (3H, m, 
3x CHarom), 7.13-7.56 (7H, m, 7x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  11.2 
(CH2CH3), 20.8 (CH2CH3), 49.4 (NCH2CH2), 96.8 (CH=CFO (minor)), 97.4 (d, J = 57.0 Hz, 
CH=CFO (major)), 115.4, 116.4, 120.0, 124.4, 127.6, 127.9, 128.1, 128.3, 129.4, 129.8, 130.2 and 130.3 (10x 
CHarom (major + minor)), 135.8 (Carom,quat), 152.8 (d, J = 281.0 Hz, CH=CFO (minor)), 154.7 (d, J = 323.4 Hz, 
CH=CFO (major)), 171.3 (C=O). 19F NMR (282 MHz, CDCl3):  -87.11 (1F, d, JH,F = 19.9 Hz, CH=CFO (minor)), 
-100.96 (1F, s, CHCFO (major)). IR (ATR, cm-1): νmax = 1627, 1191, 1164, 751, 691. MS (ES+): m/z (%): 300 (M 
+ H+, 100). HRMS (ES+): calcd for C18H19FNO2+: 300.1394, found 300.1408. 
5.7.13 Synthesis of enamides 229 and 230 
To a solution of enamide 220 (0.152 g, 0.55 mmol) and triethylamine (2 equiv, 0.112 g, 1.10 mmol) in DMF 
(10 mL) was added KCN (2 equiv, 0.072 g, 1.10 mmol) and this mixture was stirred for 23 hours at 40 °C. 
After adding EtOAc (10 mL), the mixture was washed with brine (3x 10 mL). Drying of the organic phase 
(MgSO4), filtration and evaporation of the solvent afforded the crude reaction mixture from which a 
mixture of enamides 229 and 230 was isolated in a ratio of 229 : 230 = 3 : 2 (0.048 g, 0.17 mmol). 
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Enamides 229 (major) and 230 (minor) were obtained as an inseparable mixture (ratio 229 : 230 = 3 : 2). 
(E)-N-(2-Cyano-2-fluorovinyl)-N-propyl-4-methylbenzenesulfonamide 229 and (Z)-(2-cyano-2-
fluorovinyl)-N-propyl-4-methylbenzenesulfonamide 230 
Yellow oil. Rf 0.26 (petroleum ether/EtOAc 10/1). Yield: 30%. 1H NMR (400 MHz, CDCl3): 
 0.87 (1.1H, t, J = 7.4 Hz, CH2CH3 (minor)), 0.92 (1.9H, t, J = 7.4 Hz, CH2CH3 (major)), 
1.56 (0.7H, sextet, J = 7.8 Hz, CH2CH2CH3 (minor)), 1.65 (1.3H, sextet, J = 7.6 Hz, 
CH2CH2CH3 (major)), 2.46 (3H, s, CH3Carom,quat), 3.45-3.49 (2H, m, CH2N), 6.92 (0.4H, d, 
JH,F = 26.6 Hz, CH=CFCN (minor)), 7.38 (2H, d, J = 8.1 Hz, 2x CHarom), 7.66-7.72 (2.6H, m, CH=CFCN (major) 
and 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  10.0 (CH2CH3 (major)), 10.8 (CH2CH3 (minor)), 21.4 
(CH2CH3 (major)), 21.8 (CH3Carom,quat), 22.4 (d, J = 4.0 Hz, CH2CH3 (minor)), 48.1 (CH2N (major)), 49.3 (d, J = 
6.9 Hz, CH2N (minor)), 112.2 (d, J = 42.2 Hz, CN (major)), 113.6 (d, J = 41.4 Hz, CN (minor)), 118.1 (d, J = 
237.1 Hz, CF (minor)), 121.0 (d, J = 213.3 Hz, CF (major)), 121.5 (CH=CFCN (minor)), 127.3 (2x CHarom), 128.1 
(d, J = 48.8 Hz, CH=CFCN (major)), 129.9 (d, J = 13.3 Hz, Carom,quat (major or minor)), 130.5 (2x CHarom), 134.9 
(d, J = 20.6 Hz, Carom,quat (major or minor)), 145.5 (Carom,quat). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -
153.87 (0.4F, d, JH,F = 26.6 Hz, CH=CFCN (minor)), -159.87 (0.6F, d, JH,F = 13.9 Hz, CH=CFCN (major)). IR (ATR, 
cm-1): νCN = 2217, νmax = 1346, 1166, 1137, 990, 813, 662. MS (ES+): m/z (%): 300 (M + NH4+, 100). 
5.7.14 Synthesis of 6-fluoro-4-(trifluoromethanesulfonyl)-3,4-dihydro-2H-1,4-oxazine 
252 
To a solution of N-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-N-(2,2-difluorovinyl)-1,1,1-trifluoromethane-
sulfonamine 250 (0.144 g, 0.39 mmol) in dry THF (5 mL) was added TBAF (1M in THF, 0.2 equiv, 0.08 mmol) 
at 0 °C. After stirring the reaction mixture at room temperature for 17 hours, it was quenched with H2O (5 
mL) and extracted with EtOAc (3x 5 mL). The combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. After purification using column chromatography, pure 6-fluoro-4-
(trifluoromethanesulfonyl)-3,4-dihydro-2H-1,4-oxazine 252 (9 mg, 0.039 mmol) was obtained. 
6-Fluoro-4-(trifluoromethanesulfonyl)-3,4-dihydro-2H-1,4-oxazine 252 
Colorless oil. Rf 0.20 (petroleum ether/EtOAc 9/1). Yield: 10%. 1H NMR (300 MHz, CDCl3):  3.77 
(2H, t, J = 4.4 Hz, CH2N), 4.36 (2H, t, J = 4.4 Hz, CH2O), 5.88 (1H, s, CH=CF). 13C NMR (75 MHz, 
CDCl3):  43.5 (CH2N), 65.9 (CH2O), 83.4 (d, J = 51.9 Hz, CH=CF), 119.9 (q, J = 325.0 Hz, CF3), 153.6 
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(d, J = 248.1 Hz, CH=CF). 19F NMR (282 MHz, CDCl3):  -73.71 (3F, s, CF3), -107.43 (1F, s, CH=CF). IR (ATR, 
cm-1): νmax = 1396, 1304, 1186, 1148, 1088, 1017, 629. 
5.7.15 Synthesis of enamide 265a 
To a solution of benzamide 264a (0.11 g, 0.24 mmol) in anhydrous THF (10 mL), a solution of LiOtBu in THF 
(1M, 0.24 mL, 1 equiv) was added. After stirring this reaction mixture at room temperature for 1.5 hours, 
a saturated solution of NH4Cl in H2O (10 mL) was added. After extraction with EtOAc (3x 10 mL), drying 
(MgSO4), filtration and evaporation of the solvent in vacuo, crude enamide 265a was obtained. Purification 
via preparative TLC (SiO2, PE/EtOAc 95/5) afforded pure enamide 265a in 73% yield (0.067 g, 0.18 mmol). 
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-N-(2,2-difluorovinyl)benzamide 265a 
Colorless oil. Rf 0.43 (petroleum ether/EtOAc 9/1). Yield: 73%. 1H NMR (400 MHz, CDCl3, 
50 °C):  0.23 (6H, s, 2x SiCH3), 0.99 (9H, s, SiC(CH3)3), 6.22 (1H, br s, CH=CF2), 6.75 (1H, 
d, J = 7.4 Hz, CHarom), 6.83 (1H, t, J = 7.5 Hz, CHarom), 7.08-7.18 (4H, m, 4x CHarom), 7.24-
7.28 (1H, m, CHarom), 7.34-7.42 (2H, m, 2x CHarom). 13C NMR (100.6 MHz, CDCl3):  -4.3 (2x 
SiCH3), 18.2 (SiC(CH3)3), 25.7 (SiC(CH3)3), 89.3 (d, J = 53.8 Hz, CH=CF2), 119.1 and 121.2 (2x CHarom), 127.5 
(2x CHarom), 128.3 (2x CHarom), 129.2, 130.0 and 130.2 (3x CHarom), 132.0, 134.7 and 151.2 (3x Carom,quat), 
154.6 (dd, J = 297.3 Hz, 280.2 Hz, CH=CF2), 169.9 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -89.07 
(1F, dd, J = 52.2 Hz, JH,F = 18.2 Hz, CF(F)), -103.03 (1F, d, J = 52.2 Hz, CF(F)). IR (ATR, cm-1): νC=O = 1663, νmax 
= 1327, 1284, 913, 781, 714, 695. MS (ES+): m/z (%): 390 (M + H+, 100). HRMS (ES+): calcd. for 
C21H26F2NO2Si+: 390.1695, found 390.1693.  
5.7.16 Synthesis of ynamides 266a,c,d 
The synthesis of N-{2-[(tert-butyldimethylsilyl)oxy]phenyl}-N-(2-fluoroethynyl)benzamide 266a is given as 
representative. To a solution of benzamide 264a (0.30 g, 0.64 mmol) in anhydrous THF (30 mL), a solution 
of LiHMDS in THF (1M, 1.40 mL, 2.2 equiv) was added at 0 °C. The reaction mixture was allowed to warm 
to room temperature and was stirred at that temperature for 2.5 hours. Subsequently, aqueous NH4Cl (30 
mL) was added and this mixture was extracted with EtOAc (3x 20 mL). Drying of the combined organic 
layers (MgSO4), filtration and evaporation of the solvent under reduced pressure, afforded ynamide 266a 
(0.23 g, 0.62 mmol), which was purified via column chromatography (SiO2, PE/EtOAc 95/5). 
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N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-N-(2-fluoroethynyl)benzamide 266a 
Pale yellow crystals. Melting point: 72-73 °C. Rf 0.21 (petroleum ether/EtOAc 95/5). Yield: 
97%. 1H NMR (300 MHz, CDCl3):  0.18 (6H, s, 2x SiCH3), 0.94 (9H, s, SiC(CH3)3), 6.68-6.80 
(1H, m, CHarom), 6.83-6.92 (1H, m, CHarom), 7.11-7.13 (2H, m, 2x CHarom), 7.24-7.41 (5H, m, 
5x CHarom). 13C NMR (75 MHz, ref = CDCl3):  -4.6 (2x SiCH3), 18.4 (SiC(CH3)3), 27.5 
(SiC(CH3)3), 98.5 (d, J = 55.4 Hz, C≡CF), 116.4, 124.5, 125.0 and 126.6 (4x CHarom), 128.1 (2x CHarom), 128.4 
(2x CHarom), 129.8 (Carom,quat), 130.3 (CHarom), 135.3 and 150.8 (2x Carom,quat), 162.5 (d, J = 274.6 Hz, C≡CF), 
169.5 (C=O). 19F NMR (282 MHz, CDCl3, ref = CFCl3):  -89.78 (1F, s, C≡CF). IR (ATR, cm-1): νC=O = 1657, νmax 
= 1491, 1347, 1244. νC≡C : not visible. MS (ES+): m/z (%): 370 (M + H+, 100). HRMS (ES+): calcd. for 
C21H25FNO2Si+: 370.1633, found 370.1643. 
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-N-(2-fluoroethynyl)-4-methoxybenzamide 266c 
Yellow oil. Rf 0.63 (petroleum ether/EtOAc 9/1). Yield: 94%. 1H NMR (400 MHz, 
CDCl3):  0.14 (6H, s, 2x SiCH3), 0.92 (9H, s, SiC(CH3)3), 3.77 (3H, s, OCH3), 6.77 (2H, 
d, J = 8.5 Hz, 2x CHarom), 6.90-6.94 (2H, m, 2x CHarom), 7.09-7.12 (2H, m, 2x CHarom), 
7.32 (2H, d, J = 8.5 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  -4.70 (SiCH3), 
-4.67 (SiCH3), 18.3 (SiC(CH3)3), 27.3 (SiC(CH3)3), 55.2 (OCH3), 98.7 (d, J = 54.3 Hz, C≡CF), 113.2 (2x CHarom), 
116.2, 124.5, 125.0 and 126.3 (4x CHarom), 127.4 and 130.2 (2x Carom,quat), 130.6 (2x CHarom), 150.8 and 161.1 
(2x Carom,quat), 162.4 (d, J = 274.3 Hz, C≡CF), 168.7 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -89.92 
(1F, s, C≡CF). IR (ATR, cm-1): νC≡C = 2244, νC=O = 1649, νmax = 1245, 732. MS (ES+): m/z (%): 400 (M + H+, 100). 
HRMS (ES+): calcd. for C22H27FNO3Si+: 400.1739, found 400.1748. 
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-N-(2-fluoroethynyl)-4-bromobenzamide 266d 
Yellow crystals. Melting point: 87-88 °C. Rf 0.63 (petroleum ether/EtOAc 9/1). Yield: 
83%. 1H NMR (400 MHz, CDCl3):  0.18 (6H, s, 2x SiCH3), 0.93 (9H, s, SiC(CH3)3), 6.73 
(1H, br s, CHarom), 6.91 (1H, ddd, J = 8.0 Hz, 6.5 Hz, 2.1 Hz, CHarom), 7.11-7.17 (4H, m, 
4x CHarom), 7.41 (2H, d, J = 8.5 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  -4.6 
(SiCH3), -4.5 (SiCH3), 18.4 (SiC(CH3)3), 27.4 (SiC(CH3)3), 89.5 (d, J = 54.9 Hz, C≡CF), 116.6 and 124.7 (2x 
CHarom), 124.8 (Carom,quat), 124.9 and 126.8 (2x CHarom), 129.5 (Carom,quat), 130.1 (2x CHarom), 131.3 (2x CHarom), 
134.1 and 150.7 (2x Carom,quat), 162.5 (d, J = 274.1 Hz, C≡CF), 168.2 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -89.49 (1F, s, C≡CF). IR (ATR, cm-1): νC≡C = 2247, νC=O = 1651, νmax = 1247, 730. MS (ES+): m/z (%): 
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448/50 (M + H+, 100). HRMS (ES+): calcd. for C21H24BrFNO2Si+: 448.0738, found 448.0734. El. Anal. Calcd 
for C21H23BrFNO2Si: C 56.25, H 5.17, N 3.12, found C 56.30, H 4.73, N 3.02. 
5.7.17 Synthesis of benzoxazines 267a-c 
The synthesis of benzoxazine 267a is described as a representative example. To a solution of benzamide 
264a (0.10 g, 0.21 mmol) in anhydrous THF (10 mL), a solution of KOtBu in THF (1M, 0.21 mL, 1 equiv) was 
added. After stirring this reaction mixture at room temperature for two hours, saturated aqueous NH4Cl 
(10 mL) was added. After extraction with EtOAc (3x 10 mL), drying (MgSO4), filtration and evaporation of 
the solvent in vacuo, crude benzoxazine 267a was obtained. Purification via preparative TLC (SiO2, 
PE/EtOAc 95/5) afforded pure benzoxazine 267a in 80% yield (0.043 g, 0.17 mmol). 
4-Benzoyl-2-fluorobenzo[b][1,4]oxazine 267a 
Yellow oil. Rf 0.33 (petroleum ether/EtOAc 9/1). Yield: 80%. 1H NMR (300 MHz, CDCl3):  
6.16 (1H, br s, CH=CFO), 6.98-7.14 (3H, m, 3x CHarom), 7.40-7.56 (6H, m, 6x CHarom). 13C NMR 
(75 MHz, CDCl3):  89.4 (d, J = 48.5 Hz, CH=CF), 117.1, 123.2, 125.0 and 126.7 (4x CHarom), 
127.7 (Carom,quat), 128.1 (2x CHarom), 128.8 (2x CHarom), 131.1 (CHarom), 134.7 and 147.2 (2x 
Carom,quat), 153.1 (d, J = 259.6 Hz, CH=CF), 167.5 (C=O). 19F NMR (282 MHz, CDCl3, ref = CFCl3):  -112.33 (1F, 
br s, CH=CF). IR (ATR, cm-1): νC=O = 1657, νmax = 1490, 1340, 1243, 748, 697. MS (ES+): m/z (%): 256 (M + H+, 
30). HRMS (ES+): calcd. for C15H11FNO2+: 256.0768, found 256.0780. 
4-Benzoyl-2-fluoro-7-methoxybenzo[b][1,4]oxazine 267b 
Yellow oil. Rf 0.22 (petroleum ether/EtOAc 9/1). Yield: 82%. 1H NMR (400 MHz, CDCl3): 
 3.78 (3H, s, OCH3), 6.12 (1H, br s, CH=CF), 6.57-6.58 (2H, m, 2x CHarom), 7.40-7.54 
(6H, m, 6x CHarom). 13C NMR (100.6 MHz, CDCl3):  55.8 (OCH3), 89.5 (d, J = 47.2 Hz, 
CH=CF), 103.0 and 110.1 (2x CHarom), 120.7 (Carom,quat), 123.7 (CHarom), 128.0 (2x CHarom), 
128.7 (2x CHarom), 130.8 (CHarom), 135.1 and 147.9 (2x Carom,quat), 152.8 (d, J = 258.7 Hz, CH=CF), 158.2 
(Carom,quat), 167.2 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -113.34 (1F, br s, CH=CF). IR (ATR, cm-1): 
νC=O = 1651, νmax = 1503, 1307, 1246, 699. MS (ES+): m/z (%): 286 (M + H+, 100). HRMS (ES+): calcd. for 
C16H13FNO3+: 286.0874, found 286.0879. 
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4-(4-Methoxybenzoyl)-2-fluorobenzo[b][1,4]oxazine 267c 
Yellow crystals. Melting point: 68-69 °C. Rf 0.06 (petroleum ether/EtOAc 9/1). Yield: 
70%. 1H NMR (400 MHz, CDCl3):  3.84 (3H, s, OCH3), 6.22 (1H, d, JH,F = 2.7 Hz, CH=CF), 
6.90 (2H, d, J = 8.9 Hz, 2x CHarom), 6.98 (1H, ddd, J = 9.6 Hz, 7.1 Hz, 1.6 Hz, CHarom), 
6.98-7.00 (1H, m, CHarom), 7.08 (1H, ddd, J = 8.4 Hz, 7.1 Hz, 1.4 Hz, CHarom), 7.51-7.55 
(3H, m, 3x CHarom). 13C NMR (100.6 MHz, CDCl3):  55.4 (OCH3), 89.5 (d, J = 47.6 Hz, CH=CF), 113.8 (2x 
CHarom), 117.0, 123.0, 124.8 and 126.3 (4x CHarom), 126.5 and 128.1 (2x Carom,quat), 130.3 (2x CHarom), 147.1 
(Carom,quat), 153.0 (d, J = 261.6 Hz, CH=CF), 161.8 (Carom,quat), 169.9 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -113.01 (1F, d, JH,F = 2.7 Hz, CH=CF). IR (ATR, cm-1): νC=O = 1652, νmax = 1605, 1238, 1180, 756. MS 
(ES+): m/z (%): 286 (M + H+, 100). HRMS (ES+): calcd. for C16H13FNO3+: 286.0874, found 286.0880. 
Synthesis of benzoxazine 267d 
N-{2-[(Tert-butyldimethylsilyl)oxy]phenyl}-N-(2-fluoroethynyl)-4-bromobenzamide 266d (0.11 g, 0.23 
mmol) was dissolved in anhydrous THF (10 mL) at 0 °C and a solution of TBAF in THF (1M, 0.23 mL, 1 equiv) 
was added. Stirring was continued for one hour at the same temperature. Subsequently, the reaction 
mixture was quenched with H2O (10 mL) and extracted with EtOAc (3x 10 mL). After drying of the organic 
layers (MgSO4), filtration and evaporation of the solvent, crude benzoxazine 267d was obtained. 
Purification by means of preparative TLC (SiO2, PE/EtOAc 9/1) afforded benzoxazine 267d in 86% yield 
(0.067 g, 0.20 mmol). 
4-(4-Bromobenzoyl)-2-fluorobenzo[b][1,4]oxazine 267d 
Yellow oil. Rf 0.40 (petroleum ether/EtOAc 9/1). Yield: 86%. 1H NMR (400 MHz, CDCl3): 
 6.14 (1H, br s, CH=CF), 7.00-7.03 (2H, m, 2x CHarom), 7.13 (1H, ddd, J = 8.1 Hz, 7.4 Hz, 
1.4 Hz, CHarom), 7.41-7.58 (5H, m, 5x CHarom). 13C NMR (100.6 MHz, CDCl3):  89.1 (d, J = 
47.7 Hz, CH=CF), 117.1, 123.0 and 124.9 (3x CHarom), 125.6 (Carom,quat), 126.8 (CHarom), 
127.4 (Carom,quat), 129.7 (2x CHarom), 131.9 (2x CHarom), 133.4 and 147.1 (2x Carom,quat), 153.2 (d, J = 263.2 Hz, 
CH=CF), 166.1 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -111.80 (1F, d, JH,F = 2.6 Hz, CH=CF). IR 
(ATR, cm-1): νC=O = 1654, νmax = 1489, 1345, 1242, 750. MS (ES+): m/z (%): 334/36 (M + H+, 100). HRMS (ES+): 
calcd. for C15H10BrFNO2+: 333.9873, found 333.9875. 
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5.7.18 Synthesis of benzamides 276a-c 
The synthesis of benzamide 276b is described as representative example. To a mixture of N-propyl-2-
bromo-2,2-difluoroethylamine 23b (0.54 g, 2.7 mmol) and O-acetylsalicyloyl chloride 275a (0.53 g, 2.7 
mmol, 1 equiv) in THF (30 mL), triethylamine (1.35 g, 13 mmol, 5 equiv) was slowly added at room 
temperature. After stirring this reaction mixture at the same temperature for two hours, aqueous HCl (1M, 
30 mL) was added and an extraction with Et2O (3x 20 mL) was performed. After drying (MgSO4), filtration 
and evaporation of the solvent, benzamide 276b was purified via column chromatography (SiO2, PE/EtOAc 
85/15) and obtained in 55% yield (0.53 g, 1.49 mmol). 
2-Acetoxy-N-(2-bromo-2,2-difluoroethyl)-N-(benzyl)benzamide 276a 
Yellow oil. Rf 0.15 (petroleum ether/EtOAc 85/15). Yield: 95%. 1H NMR (400 MHz, 
CDCl3):  2.03 (0.7H, s, CH3C=O (minor)), 2.32 (2.3H, s, CH3C=O (major)), 3.57-4.43 (2H, 
br s, CH2CF2), 4.57 (2H, s, CH2N), 7.12 (2H, d, J = 6.8 Hz, 2x CHarom), 7.21-7.46 (7H, m, 7x 
CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  20.6 (CH3C=O (minor)), 20.8 (CH3C=O 
(major)), 47.9 (CH2Carom,quat (minor)), 51.5 (t, J = 23.6 Hz, CH2CF2Br (major)), 53.0 
(CH2Carom,quat (major)), 56.0 (t, J = 23.9 Hz, CH2CF2Br (minor)), 120.4 (t, J = 309.5 Hz, CF2Br), 123.0 (CHarom 
(minor)), 123.3 (CHarom (major)), 126.2 (CHarom), 127.3 (2x CHarom), 127.5 and 128.2 (2x CHarom), 128.4 
(Carom,quat (minor)), 128.5 (Carom,quat (major)), 128.9 (2x CHarom (minor)), 129.1 (2x CHarom (major)), 130.8 
(CHarom), 135.2 and 147.0 (2x Carom,quat (major)), 135.8 and 146.5 (2x Carom,quat (minor)), 168.81, 168.85, 168.9 
and 169.1 (NC=O (major and minor) and OC=O (major and minor)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -49.11 to -52.76 (2F, m, CF2Br). IR (ATR, cm-1): νC=O = 1767, νC=O = 1656, νmax = 1190, 1076, 910, 730. MS 
(ES+): m/z (%): 412/14 (M + H+, 100). HRMS (ES+): calcd. for C18H17BrF2NO3+: 412.0354, found 412.0361. 
2-Acetoxy-N-(2-bromo-2,2-difluoroethyl)-N-(propyl)benzamide 276b 
Colorless oil. Rf 0.29 (petroleum ether/EtOAc 85/15). Yield: 55%. 1H NMR (400 MHz, 
CDCl3):  0.74 (2.3H, t, J = 7.4 Hz, CH2CH3 (major)), 0.98 (0.7H, t, J = 7.3 Hz, CH2CH3 
(minor)), 1.50 (1.5H, sextet, J = 7.4 Hz, CH2CH3 (major)), 1.68 (0.5H, sextet, J = 7.3 Hz, 
CH2CH3 (minor)), 2.26 (3H, s, CH3C=O), 3.28 (2H, t, J = 7.6 Hz, NCH2CH2), 3.83-4.62 (2H, m, CH2CF2Br), 7.20 
(1H, d, J = 8.2 Hz, CHarom), 7.30 (1H, d, J = 7.0 Hz, CHarom), 7.33 (1H, ddd, J = 7.3 Hz, 7.0 Hz, 1.8 Hz, CHarom), 
7.45 (1H, ddd, J = 8.2 Hz, 7.3 Hz, 1.8 Hz, CHarom).13C NMR (100.6 MHz, ref = CDCl3, 50 °C):  10.6 (CH2CH3 
(major)), 11.2 (CH2CH3 (minor)), 19.8 (CH2CH3 (minor)), 20.7 (CH3C=O), 20.9 (CH2CH3 (major)), 47.7 
(NCH2CH2 (minor)), 50.6 (NCH2CH2 (major)), 51.8 (t, J = 23.7 Hz, CH2CF2Br (major)), 57.7 (t, J = 23.3 Hz, 
Experimental section  Chapter 5 
172 
 
CH2CF2Br (minor)), 120.5 (t, J = 309.6 Hz, CF2Br), 123.1, 125.9, 127.4 and 130.4 (4x CHarom (major)), 122.9, 
126.0, 128.0 and 130.6 (4x CHarom (minor)), 128.7 (Carom,quat (minor)), 128.8 (Carom,quat (major)), 146.6 
(Carom,quat), 168.6, 168.7 and 168.9 (NC=O (major and minor) and OC=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -50.86 (2F, br s, CF2Br). IR (ATR, cm-1): νC=O = 1767, νC=O = 1651, νmax = 1192, 1177, 1078. MS (ES+): 
m/z (%): 364/66 (M + H+, 100). HRMS (ES+): calcd. for C14H17BrF2NO3+: 364.0354, found 364.0355. 
2-Acetoxy-N-(2-bromo-2,2-difluoroethyl)-N-(4-methoxybenzyl)benzamide 276c 
White crystals. Melting point: 109-110 °C. Rf 0.11 (petroleum ether/EtOAc 9/2). Yield: 
78%. 1H NMR (400 MHz, CDCl3, 50 °C):  2.04 (0.6H, s, CH3C=O (minor)), 2.30 (2.4H, s, 
CH3C=O (major)), 3.80 (3H, s, OCH3), 3.89 (0.4H, br s, CH2CF2 (minor)), 4.30 (1.6H, br s, 
CH2CF2 (major)), 4.49 (2H, s, CH2Carom,quat), 6.86-6.88 (2H, m, 2x CHarom), 7.02-7.04 (2H, 
m, 2x CHarom), 7.20-7.27 (2H, m, 2x CHarom), 7.38-7.45 (2H, m, 2x CHarom). 13C NMR (100.6 
MHz, ref = CDCl3):  20.6 (CH3C=O (minor)), 20.8 (CH3C=O (major)), 47.2 (CH2Carom,quat 
(minor)), 51.0 (t, J = 23.7 Hz, CH2CF2Br (major)), 52.4 (CH2Carom,quat (major)), 55.2 (OCH3), 55.8 (t, J = 23.5 
Hz, CH2CF2Br (minor)), 114.2 (2x CHarom (minor)), 114.4 (2x CHarom (major)), 120.5 (t, J = 309.5 Hz, CF2Br), 
123.0 (CHarom (minor)), 123.2 (CHarom (major)), 126.2 (CHarom), 126.8 (Carom,quat), 127.6 (CHarom (major)), 127.8 
(CHarom (minor)), 128.26 (Carom,quat (minor)), 128.33 (2x CHarom (minor)), 128.5 (Carom,quat (major)), 128.8 (2x 
CHarom (major)), 130.4 (CHarom (minor)), 130.8 (CHarom (major)), 146.4 (Carom,quat (minor)), 146.9 (Carom,quat 
(major)), 159.5 (Carom,quat), 168.7, 168.8 and 168.9 (NC=O (major and minor) and OC=O). 19F NMR (376.5 
MHz, CDCl3, ref = CFCl3):  -48.54 to -52.33 (2F, m, CF2Br). IR (ATR, cm-1): νC=O = 1765, νC=O = 1654, νmax = 
1188, 1080, 925, 790. MS (ES+): m/z (%): 442/44 (M + H+, 100). HRMS (ES+): calcd. for C19H19BrF2NO4+: 
442.0460, found 442.0458. 
5.7.19 Synthesis of benzamides 276d-e 
The synthesis of benzamide 276d is described as representative example. 2,5-Diacetoxybenzoic acid (0.22 
g, 0.94 mmol) was dissolved in SOCl2 (distilled, 1 mL) and stirred at reflux temperature for 15 minutes. 
Subsequently, the residual SOCl2 was evaporated under reduced pressure. The resulting acid chloride 275b 
was used without purification and redissolved in anhydrous THF (20 mL) and N-(4-methoxybenzyl)-2-
bromo-2,2-difluoroethylamine 23c (0.26 g, 1 equiv) and Et3N (0.19 g, 2 equiv) were added at 0 °C. 
Subsequently, the reaction mixture was stirred at room temperature for 22 hours, after which H2O (20 mL) 
was added and an extraction was performed with EtOAc (3x 20 mL). The combined organic layers were 
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dried (MgSO4), filtered and the solvent was removed in vacuo. Purification via flash chromatography (SiO2, 
PE/EtOAc 7/3) afforded benzamide 276d in 72% yield (0.34 g, 0.68 mmol). 
2,5-Diacetoxy-N-(2-bromo-2,2-difluoroethyl)-N-(4-methoxybenzyl)benzamide 276d 
Yellow oil. Rf 0.17 (petroleum ether/EtOAc 7/3). Yield: 72%. 1H NMR (400 MHz, 
CDCl3, 50 °C):  2.03 (0.9H, br s, CH3C=O (minor)), 2.27 (3H, s, CH3C=O), 2.29 (2.1H, 
br s, CH3C=O (major)), 3.80 (3H, s, OCH3), 3.89 (0.6H, br s, CH2CF2 (minor)), 4.27 
(1.4H, br s, CH2CF2 (major)), 4.50 (2H, br s, CH2Carom,quat), 6.86-6.88 (2H, m, 2x 
CHarom), 7.03-7.05 (2H, m, 2x CHarom), 7.15-7.25 (3H, m, 3x CHarom). 13C NMR (100.6 
MHz, CDCl3):  20.6 (CH3C=O (minor)), 20.8 (CH3C=O (major)), 21.0 (CH3C=O), 47.4 
(CH2Carom,quat (minor)), 51.0 (t, J = 23.6 Hz, CH2CF2Br (major)), 52.6 (CH2Carom,quat (major)), 55.3 (OCH3), 55.8 
(t, J = 24.0 Hz, CH2CF2Br (minor)), 114.3 (2x CHarom (minor)), 114.5 (2x CHarom (major)), 120.5 (t, J = 309.3 
Hz, CF2Br), 120.9 (CHarom (major)), 121.6 (CHarom (minor)), 123.9 (CHarom), 124.0 (CHarom (minor)), 124.2 
(CHarom (major)), 126.6 (Carom,quat), 129.17 (2x CHarom (major)), 129.24 (2x CHarom (minor)), 130.5 (Carom,quat), 
143.8 (Carom,quat (minor)), 144.2 (Carom,quat (major)), 148.0 (Carom,quat), 159.5 (Carom,quat (minor)), 159.6 (Carom,quat 
(major)), 167.6 (NC=O (minor)), 167.8 (NC=O (major)), 168.8 (2x OC=O)). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -48.49 to -51.32 (2F, m, CF2Br). IR (ATR, cm-1): νC=O = 1763, νC=O = 1655, νmax = 1201, 1163. MS (ES+): 
m/z (%): 517/19 (M + NH4+, 100), 500/2 (M + H+, 98). HRMS (ES+): calcd. for C21H21BrF2NO6+: 500.0515, 
found 500.0496. 
2-Acetoxy-5-methoxy-N-(2-bromo-2,2-difluoroethyl)-N-(4-methoxybenzyl)benzamide 276e 
White crystals. Melting point: 94-95 °C. Rf 0.12 (petroleum ether/EtOAc 9/2). Yield: 
67%. 1H NMR (400 MHz, CDCl3):  2.02 (0.7H, s, CH3C=O (minor)), 2.29 (2.3H, s, 
CH3C=O (major)), 3.75 (3H, s, OCH3), 3.80 (3H, s, OCH3), 3.81 (2H, br s, CH2CF2), 4.51 
(2H, br s, CH2Carom,quat), 6.86-6.88 (3H, m, 3x CHarom), 6.95 (1H, dd, J = 9.0 Hz, 2.9 Hz, 
CHarom), 7.04 (2H, d, J = 8.6 Hz, 2x CHarom), 7.12 (1H, d, J = 9.0 Hz, CHarom). 13C NMR 
(100.6 MHz, CDCl3):  18.8 (CH3C=O (minor)), 19.0 (CH3C=O (major)), 49.4 (t, J = 
23.1 Hz, CH2CF2Br), 50.7 (CH2Carom,quat), 53.5 (OCH3), 53.9 (OCH3), 110.5 (CHarom (major)), 110.9 (CHarom 
(minor)), 112.4 (2x CHarom (minor)), 112.6 (2x CHarom (major)), 114.4 (CHarom (major)), 114.8 (CHarom (minor)), 
118.6 (t, J = 309.6 Hz, CF2Br), 122.2 (CHarom (minor)), 122.4 (CHarom (major)), 125.1 (Carom,quat (major)), 125.9 
(Carom,quat (minor)), 127.0 (2x CHarom (major)), 127.4 (2x CHarom (minor)), 128.7 (Carom,quat), 137.9 (Carom,quat 
(minor)), 138.4 (Carom,quat (major)), 155.4 and 157.7 (2x Carom,quat), 166.7 (NC=O (minor)), 166.9 (NC=O 
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(major)), 167.4 (OC=O (minor)), 167.5 (OC=O (major)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -48.56 to 
-52.09 (2F, m, CF2Br). IR (ATR, cm-1): νC=O = 1762, νC=O = 1650, νmax = 1188, 1110, 1029. MS (ES+): m/z (%): 
472/74 (M + H+, 100). HRMS (ES+): calcd. for C20H21BrF2NO5+: 472.0566, found 472.0557. El. Anal. Calcd for 
C20H20BrF2NO5: C 50.86, H 4.27, N 2.97, found C 50.73, H 4.21, N 2.92. 
5.7.20 Synthesis of benzamide 277b, enamide 278b and 2-fluoro-1,4-benzoxazepin-5-
one 279b 
To an ice-cooled solution of benzamide 276b (0.086 g, 0.24 mmol) in anhydrous THF (5 mL), a solution of 
LiHMDS in THF (1M, 0.52 mL, 2.2 equiv) was added, and the resulting mixture was stirred at room 
temperature for 5 hours. Subsequently, the reaction mixture was poured into saturated aqueous NH4Cl 
(5 mL) and extracted with EtOAc (3x 10 mL). Drying (MgSO4), filtration of the drying agent and removal of 
the solvent afforded benzamide 277b, enamide 278b and 2-fluoro-1,4-benzoxazepin-5-one 279b, which 
were further purified in 30% (0.024 g, 0.072 mmol), 17% (0.010 g, 0.041 mmol,) and 31% (0.0.16 g, 0.074 
mmol) yield, respectively, by preparative TLC (PE/EtOAc 9/1). 
N-2-Bromo-2,2-difluoroethyl-N-propyl-(2-hydroxy)benzamide 277b 
Yellow oil. Rf 0.04 (petroleum ether/EtOAc 9/1). Yield: 30%. 1H NMR (400 MHz, CDCl3): 
 0.82 (3H, t, J = 7.4 Hz, CH3), 1.60 (2H, sextet, J = 7.4 Hz, CH2CH3), 3.64 (2H, t, J = 7.4 Hz, 
NCH2CH2), 4.40 (2H, t, JH,F = 12.3 Hz, CH2CF2Br), 6.91 (1H, ddd, J = 7.8 Hz, 7.3 Hz, 0.9 Hz, 
CHarom), 7.03 (1H, dd, J = 8.3 Hz, 0.9 Hz, CHarom), 7.33 (1H, dd, J = 7.8 Hz, 1.6 Hz, CHarom), 7.37 (1H, ddd, J = 
8.3 Hz, 7.3 Hz, 1.6 Hz, CHarom), 8.76 (1H, br s, OH). 13C NMR (100.6 MHz, ref = CDCl3):  10.9 (CH3), 21.1 
(CH2CH3), 51.6 (CH2CF2Br), 53.9 (CH2N), 117.8 (CHarom), 118.7 (Carom,quat), 119.4 (CHarom), 120.9 (t, J = 309.5 
Hz, CF2Br), 128.1 and 132.6 (2x CHarom), 157.0 (Carom,quat), 173.4 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -50.47 (2H, t, JH,F = 12.3 Hz, CF2Br). IR (ATR, cm-1): νOH = 3174, νC=O = 1620, νmax = 1595, 1083, 751. 
MS (ES+): m/z (%): 322/24 (M + H+, 100). HRMS (ES+): calcd. for C12H15BrF2NO2+: 322.0249, found 322.0247. 
N-2,2-Difluorovinyl-N-propyl-(2-hydroxy)benzamide 278b 
White powder. Melting point: 59-60 °C. Rf 0.11 (petroleum ether/EtOAc 9/1). Yield: 17%. 
1H NMR (400 MHz, CDCl3):  0.96 (3H, t, J = 7.5 Hz, CH3), 1.69 (2H, sextet, J = 7.5 Hz, 
CH2CH3), 3.60 (2H, t, J = 7.5 Hz, NCH2), 5.61 (1H, dd, JH,F = 19.3 Hz, 2.1 Hz, CH=CF2), 6.83 
(1H, ddd, J = 7.9 Hz, 7.3 Hz, 1.0 Hz, CHarom), 7.00 (1H, dd, J = 8.3 Hz, 1.0 Hz, CHarom), 7.35 (1H, ddd, J = 8.3 
Hz, 7.3 Hz, 1.5 Hz, CHarom), 7.43 (1H, dd, J = 7.9 Hz, 1.5 Hz, CHarom), 9.95 (1H, br s, OH). 13C NMR (100.6 MHz, 
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CDCl3):  11.2 (CH3), 20.6 (CH2CH3), 50.3 (NCH2), 89.6 (dd, J = 49.4 Hz, 13.3 Hz, CHCF2), 116.3 (Carom,quat), 
118.1, 118.3, 128.7 and 133.5 (4x CHarom), 155.4 (dd, J = 295.9 Hz, 287.7 Hz, CHCF2), 159.8 (Carom,quat), 171.6 
(C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -87.33 (1F, dd, J = 40.8 Hz, JH,F = 19.3 Hz, CH=CF(F), -99.90 
(1F, d, J = 40.8 Hz, CH=CF(F)). IR (ATR, cm-1): νOH = 3159, νC=O = 1616, νmax = 1233, 760. MS (ES+): m/z (%): 
242 (M + H+, 100). HRMS (ES+): calcd. for C12H14F2NO2+: 242.0987, found 242.0987. 
2-Fluoro-4-propylbenzo[f][1,4]oxazepin-5-one 279b 
Pale yellow oil. Rf 0.17 (petroleum ether/EtOAc 9/1). Yield: 31% (67% yield was obtained 
following the procedure described below). 1H NMR (400 MHz, CDCl3):  0.97 (3H, t, J = 7.4 
Hz, CH2CH3), 1.70 (2H, sextet, J = 7.4 Hz, CH2CH3), 3.57-3.61 (2H, m, CH2N), 5.50 (1H, d, JH,F 
= 3.7 Hz, CH=CF), 7.11 (1H, dd, J = 8.2 Hz, 1.1 Hz, CHarom), 7.29 (1H, ddd, J = 7.8 Hz, 7.4 Hz, 
1.1 Hz, CHarom), 7.48 (1H, ddd, J = 8.2 Hz, 7.4 Hz, 1.8 Hz, CHarom), 7.92 (1H, dd, J = 7.8 Hz, 1.8 Hz, CHarom). 13C 
NMR (100.6 MHz, CDCl3):  11.1 (CH3), 21.1 (CH2CH3), 49.9 (NCH2), 95.8 (d, J = 57.7 Hz, CH=CF), 119.4 
(CHarom), 125.98 (Carom,quat), 126.02, 132.6 and 133.3 (3x CHarom), 156.8 (d, J = 279.7 Hz, CH=CF), 159.7 (d, J 
= 4.3 Hz, Carom,quat), 165.1 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -99.24 (1F, d, JH,F = 3.7 Hz, CF). 
IR (ATR, cm-1): νC=O = 1639, νmax = 1453, 1411, 1192, 759. MS (ES+): m/z (%): 222 (M + H+, 100). HRMS (ES+): 
calcd. for C12H13FNO2+: 222.0925, found 222.0930. 
5.7.21 Synthesis of benzo[f][1,4]oxazepin-5-ones 279a-e 
As a representative example, the synthesis of 2-fluoro-4-(4-methoxybenzyl)benzo[f][1,4]oxazepin-5-one 
279c is described here. To a solution of benzamide 276c (1.15 g, 2.6 mmol) in anhydrous THF (30 mL), a 
solution of KOtBu in THF (1M, 5.2 mL, 2 equiv) was added at room temperature. After stirring the reaction 
mixture at reflux temperature for three hours, saturated aqueous NH4Cl (30 mL) was added. After 
extraction (3x 30 mL EtOAc), drying with MgSO4, filtration of the drying agent and evaporation of the 
solvent, crude oxazepin-5-one 279c was obtained. Purification by means of column chromatography (SiO2, 
PE/EtOAc 9/1) afforded pure oxazepin-5-one 279c in 77% yield (0.60 g, 2.0 mmol). 
4-Benzyl-2-fluorobenzo[f][1,4]oxazepin-5-one 279a 
White crystals. Melting point: 65-66 °C. Rf 0.19 (petroleum ether/EtOAc 9/1). Yield: 
62%. 1H NMR (400 MHz, CDCl3):  4.85 (2H, s, CH2N), 5.49 (1H, d, JH,F = 3.7 Hz, CH=CF), 
7.11 (1H, dd, J = 8.2 Hz, 1.1 Hz, CHarom), 7.28-7.38 (5H, m, 5x CHarom), 7.49 (1H, ddd, 
J = 8.2 Hz, 7.4 Hz, 1.8 Hz, CHarom), 7.99 (1H, dd, J = 7.8 Hz, 1.8 Hz, CHarom). 13C NMR 
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(100.6 MHz, CDCl3):  51.5 (NCH2), 95.3 (d, J = 58.1 Hz, CH=CF), 119.5 (CHarom), 125.6 (d, J = 2.1 Hz, Carom,quat), 
126.1 and 127.8 (2x CHarom), 128.0 (2x CHarom), 128.8 (2x CHarom), 132.8 and 133.6 (2x CHarom), 136.0 
(Carom,quat), 156.9 (d, J = 280.1 Hz, CH=CF), 159.7 (d, J = 4.4 Hz, Carom,quat), 165.3 (C=O). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -98.64 (1F, d, JH,F = 3.7 Hz, CF). IR (ATR, cm-1): νC=O = 1627, νmax = 1451, 1420, 1196, 
692. MS (ES+): m/z (%): 270 (M + H+, 100). HRMS (ES+): calcd. for C16H13FNO2+: 270.0925, found 270.0921. 
2-Fluoro-4-(4-methoxybenzyl)benzo[f][1,4]oxazepin-5-one 279c 
Yellow oil. Rf 0.12 (petroleum ether/EtOAc 9/1). Yield: 77%. 1H NMR (400 
MHz, CDCl3):  3.80 (3H, s, OCH3), 4.78 (2H, s, NCH2), 5.48 (1H, d, JH,F = 3.7 Hz, 
CH=CF), 6.88 (2H, d, J = 8.6 Hz, 2x CHarom), 7.11 (1H, dd, J = 8.2 Hz, 1.0 Hz, 
CHarom), 7.27 (2H, d, J = 8.6 Hz, 2x CHarom), 7.31 (1H, ddd, J = 7.8 Hz, 7.4 Hz, 1.0 
Hz, CHarom), 7.49 (1H, ddd, J = 8.2 Hz, 7.4 Hz, 1.8 Hz, CHarom), 7.98 (1H, dd, J = 7.8 Hz, 1.8 Hz, CHarom). 13C 
NMR (100.6 MHz, ref = CDCl3):  50.8 (NCH2), 55.0 (OCH3), 95.2 (d, J = 58.1 Hz, CH=CF), 114.0 (2x CHarom), 
119.3 (CHarom), 125.5 (d, J = 2.1 Hz, Carom,quat), 125.9 (CHarom), 128.0 (Carom,quat), 129.3 (2x CHarom), 132.6 and 
133.4 (2x CHarom), 156.6 (d, J = 279.9 Hz, CH=CF), 159.2 (Carom,quat), 159.5 (d, J = 4.3 Hz, Carom,quat), 165.0 
(C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -98.67 (1F, d, JH,F = 3.7 Hz, CF). IR (ATR, cm-1): νC=O = 1640, 
νmax = 1246, 1218, 1200, 1137, 760. MS (ES+): m/z (%): 300 (M + H+, 100). HRMS (ES+): calcd. for C17H15FNO3+: 
300.1030, found 300.1023. 
2-Fluoro-7-hydroxy-4-(4-methoxybenzyl)benzo[f][1,4]oxazepin-5-one 279d 
Brown crystals. Melting point: 108-109 °C. Yield: 86%. 1H NMR (400 MHz, 
CDCl3):  3.80 (3H, s, OCH3), 4.77 (2H, s, NCH2), 5.39 (1H, br s, OH), 5.44 
(1H, d, JH,F = 3.8 Hz, CH=CF), 6.88 (2H, d, J = 8.7 Hz, 2x CHarom), 6.94-7.00 
(2H, m, 2x CHarom), 7.24-7.26 (2H, m, 2x CHarom), 7.44 (1H, d, J = 2.9 Hz, 
CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  51.5 (NCH2), 55.4 (OCH3), 94.9 (d, J = 60.2 Hz, CH=CF), 114.3 
(2x CHarom), 118.2, 120.7 and 121.4 (3x CHarom), 125.5 and 127.6 (2x Carom,quat), 129.5 (2x CHarom), 153.1 (d, J 
= 4.4 Hz, Carom,quat), 154.8 (Carom,quat), 157.4 (d, J = 282.4 Hz, CH=CF), 159.4 (Carom,quat), 166.1 (C=O). 19F NMR 
(376.5 MHz, CDCl3, ref = CFCl3):  -97.96 (1F, s, CF). IR (ATR, cm-1): νOH = 3336, νC=O = 1634, νmax = 1454, 
1219, 1174, 813. MS (ES+): m/z (%): 316 (M + H+, 100). HRMS (ES+): calcd. for C17H15FNO4+: 316.0980, found 
316.0975. 
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2-Fluoro-7-methoxy-4-(4-methoxybenzyl)benzo[f][1,4]oxazepin-5-one 279e 
Yellow oil. Rf 0.17 (petroleum ether/EtOAc 8/2). Yield: 88%. 1H NMR 
(400 MHz, CDCl3):  3.80 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.78 (2H, s, 
NCH2), 5.44 (1H, d, JH,F = 3.8 Hz, CH=CF), 6.88 (2H, d, J = 8.8 Hz, 2x CHarom), 
7.00-7.01 (2H, m, 2x CHarom), 7.27 (2H, d, J = 8.8 Hz, 2x CHarom), 7.44 (1H, 
dd, J = 2.4 Hz, 1.0 Hz, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  51.2 (NCH2), 55.3 (OCH3), 55.9 (OCH3), 
95.0 (d, J = 58.5 Hz, CH=CF), 114.3 (2x CHarom), 115.4, 120.3 and 120.5 (3x CHarom), 126.2 (d, J = 2.2 Hz, 
Carom,quat), 128.1 (Carom,quat), 129.5 (2x CHarom), 153.6 (d, J = 4.4 Hz, Carom,quat), 157.26 (Carom,quat), 157.28 (d, J = 
281.1 Hz, CH=CF), 159.4 (Carom,quat), 165.2 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -98.49 (1F, d, 
JH,F = 3.8 Hz, CF). IR (ATR, cm-1): νC=O = 1640, νmax = 1429, 1244, 1214, 1174, 1032. MS (ES+): m/z (%): 330 
(M + H+, 100). HRMS (ES+): calcd. for C18H17FNO4+: 330.1136, found 330.1137. 
5.7.22 Synthesis of benzo[f][1,4]oxazepin-5-ones 280a-b 
The synthesis of 2-fluorobenzo[f][1,4]oxazepin-5-one 280a is described as representative example. 
2-Fluoro-4-(4-methoxybenzyl)benzo[f][1,4]oxazepin-5-one 279c (0.12 g, 0.38 mmol) was dissolved in 
BF3.OEt2 (0.27 g, 5 equiv, 0.24 mL) and this mixture was stirred at 128 °C for 6 hours. Subsequently, Et2O 
(10 mL) and NaHCO3 (10 mL) were added and an extraction was performed with EtOAc (3x 10 mL). After 
drying (MgSO4), filtration and evaporation of the organic phase in vacuo, Et2O (10 mL) was added and the 
precipitate was filtered off. After evaporation, crude benzoxazepinone 280a was obtained and 
recrystallized from Et2O, affording pure benzoxazepinone 280a in 51% yield (0.035 g, 0.19 mmol). 
2-Fluorobenzo[f][1,4]oxazepin-5-one 280a 
White crystals. Yield: 51%. 1H NMR (400 MHz, CDCl3):  5.60 (1H, t, JH,F = 4.0 Hz, CH=CF), 
6.46 (1H, br s, NH), 7.15 (1H, d, J = 8.1 Hz, CHarom), 7.32 (1H, ddd, J = 7.8 Hz, 7.4 Hz, 0.7 Hz, 
CHarom), 7.55 (1H, ddd, J = 8.1 Hz, 7.4 Hz, 1.7 Hz, CHarom), 7.95 (1H, dd, J = 7.8 Hz, 1.7 Hz, 
CHarom). 13C NMR (100.6 MHz, CDCl3):  90.6 (d, J = 58.9 Hz, CH=CF), 120.2 (CHarom), 124.6 (d, J = 2.2 Hz, 
Carom,quat), 126.1, 132.4 and 134.4 (3x CHarom), 156.0 (d, J = 275.8 Hz, CH=CF), 158.7 (Carom,quat), 166.3 (C=O). 
19F NMR (376.5 MHz, CDCl3, ref = CFCl3): -100.91 (1F, br s, CH=CF). IR (ATR, cm-1): νC=O = 1675, νmax = 1223, 
1180, 786, 752. MS (ES+): m/z (%): 180 (M + H+, 100). HRMS (ES+): calcd. for C9H7FNO2+: 180.0455, found 
180.0454. 
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2-Fluoro-7-methoxybenzo[f][1,4]oxazepin-5-one 280b 
White crystals. Yield: 54%. 1H NMR (400 MHz, CDCl3):  3.83 (3H, s, OCH3), 5.56 (1H, t, 
JH,F = 4.1 Hz, CH=CF), 6.50 (1H, br s, NH), 7.05-7.06 (2H, m, 2x CHarom), 7.39-7.40 (1H, 
m, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  56.0 (OCH3), 90.6 (d, J = 58.9 Hz, 
CH=CF), 115.0, 121.2 and 121.3 (3x CHarom), 125.3 (d, J = 2.3 Hz, Carom,quat), 152.7 (d, J = 3.7 Hz, Carom,quat), 
156.4 (d, J = 277.7 Hz, CH=CF), 157.3 (Carom,quat), 167.1 (C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -100.65 (1F, d, JH,F = 4.1 Hz, CF). IR (ATR, cm-1): νC=O = 1673, νmax = 1487, 1432, 1216, 1186, 768. MS (ES+): 
m/z (%): 210 (M + H+, 100). HRMS (ES+): calcd. for C10H9FNO3+: 210.0561, found 210.0558. 
5.7.23 Reactivity of β,β-difluoroenamide 220 toward electrophiles 
Synthesis of N-(2-bromo-2,2-difluoro-1-methoxyethyl)-N-propyl-4-methyl-benzenesulfonamide 281 
To a solution of enamide 220 (0.250 g, 0.91 mmol) in methanol (5 mL) was added NBS (1 equiv, 0.160 g, 
0.97 mmol) and this mixture was stirred at room temperature for four hours. The solvent was evaporated 
under reduced pressure after which CCl4 was added and the solids were filtered off. This affored pure N-(2-
bromo-2,2-difluoro-1-methoxyethyl)-N-propyl-4-methylbenzenesulfonamide 281 (0.210 g, 0.545 mmol). 
N-(2-Bromo-2,2-difluoro-1-methoxyethyl)-N-propyl-4-methylbenzenesulfonamide 281 
Yellow oil. Yield: 60%. 1H NMR (400 MHz, CDCl3):  0.78 (2H, t, J = 7.4 Hz, CH2CH3), 1.49-
1.65 (2H, m, CH2CH3), 2.44 (3H, s, CH3Carom,quat), 3.17 (2H, t, J = 8.3 Hz, NCH2), 3.46 (3H, 
s, OCH3), 5.47 (1H, dd, JH,F = 11.5 Hz, 4.5 Hz, CH), 7.31 (2H, d, J = 8.2 Hz, 2x CHarom), 7.75 
(2H, d, J = 8.2 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  11.4 (CH2CH3), 21.6 (CH3Carom,quat), 22.6 
(CH2CH3), 45.0 (NCH2), 57.4 (OCH3), 89.9 (dd, J = 28.8 Hz, 23.4 Hz, CH), 119.6 (dd, J = 316.2 Hz, 309.4 Hz, 
CF2Br), 127.7 (2x CHarom), 129.7 (2x CHarom), 137.0 (Carom,quat), 144.2 (Carom,quat). 19F NMR (376.5 MHz, CDCl3, 
ref = CFCl3):  -56.84 (1F, dd, J = 164.9 Hz, JH,F = 4.5 Hz, CF(F)Br), -61.10 (1F, dd, J = 164.9 Hz, JH,F = 11.5 Hz, 
CF(F)Br). IR (ATR, cm-1): νmax = 1164, 1135, 1095, 946, 659. MS (ES+): m/z (%): 403/5 (M + NH4+, 80), 386/88 
(M + H+, 100). 
Synthesis of N-(2,2-difluoro-1-methoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 282 
To a solution of N-(2-bromo-2,2-difluoro-1-methoxyethyl)-N-propyl-4-methylbenzenesulfonamide 281 
(0.050 g, 0.129 mmol) in dry THF (2 mL) was added LiHMDS (1M in THF, 2 equiv, 0.259 mL, 0.259 mmol) at 
0 °C. Subsequently, this mixture was stirred at reflux temperature for one hour, after which another 
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equivalent of LiHMDS (1M in THF, 0.129 mL, 0.129 mmol) was added and the stirring was continued for 
another two hours. The reaction mixture was poured into aqueous NH4Cl (5 mL) and extracted with EtOAc 
(3x 5 mL). After drying (MgSO4), filtration, evaporation and purification using preparative TLC, pure N-(2,2-
difluoro-1-methoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 282 (0.014 g, 0.0453 mmol) was 
obtained. 
N-(2,2-Difluoro-1-methoxyvinyl)-N-propyl-4-methylbenzenesulfonamide 282 
Colorless oil. Rf 0.30 (petroleum ether/EtOAc 9/1). Yield: 35%. 1H NMR (400 MHz, CDCl3): 
 0.79 (2H, t, J = 7.4 Hz, CH2CH3), 1.48 (2H, sextet, J = 7.4 Hz, CH2CH3), 2.44 (3H, s, 
CH3Carom,quat), 3.18 (2H, t, J = 7.4 Hz, NCH2), 3.66 (3H, s, OCH3), 7.31 (2H, d, J = 8.1 Hz, 2x 
CHarom), 7.77 (2H, d, J = 8.1 Hz, 2x CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  10.9 (CH2CH3), 21.2 (CH2CH3), 
21.6 (CH3Carom,quat), 49.2 (NCH2), 59.0 (dd, J = 3.9 Hz, 2.5 Hz, OCH3), 115.7 (dd, J = 35.5 Hz, 34.1 Hz, 
CF2=COMe), 127.8 (2x CHarom), 129.6 (2x CHarom), 136.3 (Carom,quat), 144.1 (Carom,quat), 153.9 (dd, J = 289.8 Hz, 
285.4 Hz, CF2). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -102.17 (1F, d, J = 55.3 Hz, CF(F)), -107.63 (1F, d, 
J = 55.3 Hz, CF(F)). IR (ATR, cm-1): νmax = 1351, 1289, 1236, 1171, 1154, 669. MS (ES+): m/z (%): 323 (M + 
NH4+, 100), 306 (M + H+, 40). 
5.8 Synthesis of fluorinated 8,9,10,11-tetrahydro-8,11-methanobenzo-
[j]phenanthridine-7,12-diones 
5.8.1 Synthesis of amines 289 
Synthesis of 2-bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-
anilines 289a and 289b 
The synthesis of 2-bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-4-
fluoroaniline 289a is described as representative. A solution of 5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-
methanonaphthalene-6-carbaldehyde 28 (0.22 g, 0.93 mmol), 2-bromo-4-fluoroaniline 29a (3 equiv, 0.53 
g, 2.78 mmol) and MgSO4 (3 equiv, 0.33 g, 2.78 mmol) in 2-methyltetrahydrofuran (4 mL) was stirred under 
microwave irradiation at 60 °C for 45 minutes. Subsequently, the drying agent was filtered off and the 
solvent was removed in vacuo, affording the corresponding imine, which was used without further 
purification in the next step. The imine was dissolved in MeOH (10 mL), and NaCNBH3 (2.5 equiv, 0.15 g, 
2.32 mmol) and acetic acid (1.2 equiv, 0.069 g, 1.11 mmol) were added. After stirring the reaction mixture 
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for 17 hours at room temperature, saturated aqueous Na2CO3 (15 mL) was added and an extraction with 
EtOAc was performed (3x 10 mL). After drying of the combined organic phases (MgSO4), filtration and 
evaporation, crude aniline 289a was obtained, which was purified by reverse phase automated flash 
chromatography (0.26 g, 0.62 mmol).  
2-Bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-4-fluoroaniline 
289a 
Pale yellow crystals. Melting point: 93-94 °C. Rf 0.03 (petroleum ether/EtOAc 
9/1). Gradient used for purification: during 3 CV: 40% CH3CN, during 30 CV: 40 
-> 100% CH3CN, during 3 CV: 100% CH3CN. Yield: 67%. 1H NMR (400 MHz, 
CDCl3):  1.28-1.36 (2H, m, 2x CHXHN), 1.56 (1H, d, J = 8.7 Hz, CHAHS), 1.80 (1H, 
d, J = 8.7 Hz, CHAHS), 1.94-2.07 (2H, m, 2x CHXHN), 3.66 (1H, br s, CH-1 or CH-4), 3.71 (1H, br s, CH-1 or CH-
4), 3.82 (3H, s, OCH3), 3.91 (3H, s, OCH3), 4.37 (2H, br s, CH2NH), 4.60 (1H, br s, NH), 6.69 (1H, s, CHarom), 
6.72 (1H, dd, J = 9.0 Hz, JH,F = 5.2 Hz, CHarom), 6.97 (1H, ddd, J = 9.0 Hz, JH,F = 8.1 Hz, J = 2.9 Hz, CHarom), 7.27 
(1H, dd, JH,F = 8.0 Hz, J = 2.9 Hz, CHarom). 13C NMR (100.6 MHz, CDCl3):  26.5 and 27.0 (CH2CH2), 39.7 (CH-1 
or CH-4), 41.3 (CH-1 or CH-4), 44.1 (CH2NH), 49.1 (CH2), 55.9 (OCH3), 61.4 (OCH3), 108.9 (d, J = 9.8 Hz, 
Carom,quat), 109.6 (CHarom), 111.7 (d, J = 7.5 Hz, CHarom), 115.0 (d, J = 11.6 Hz, CHaromCF), 119.3 (d, J = 25.5 Hz, 
CHaromCF), 128.3, 136.5 and 140.5 (3x Carom,quat), 142.0 (d, J = 2.1 Hz, Carom,quat), 146.1 and 149.1 (2x Carom,quat), 
154.5 (d, J = 238.8 Hz, CFarom). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -127.76 (1F, ddd, JH,F = 8.1 Hz, 8.0 
Hz, 5.2 Hz, CFarom). IR (ATR, cm-1): νmax = 1506, 1490, 1315, 1023, 848, 796. MS (ES+): m/z (%): 217 (100). 
HRMS (ES+): calcd. for C14H17O2+ (M - C6H4BrFN-): 217.1223, found 217.1224. 
2-Bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-5-fluoroaniline 
289b 
Pale yellow crystals. Melting point: 80-81 °C. Gradient used for purification: during 
3 CV: 40% CH3CN, during 30 CV: 40 -> 100% CH3CN, during 3 CV: 100% CH3CN. 
Yield: 53%. 1H NMR (400 MHz, CDCl3):  1.20-1.28 (2H, m, 2x CHXHN), 1.49 (1H, d, 
J = 8.8 Hz, CHAHS), 1.70-1.73 (1H, m, CHAHS), 1.87-1.99 (2H, m, 2x CHXHN), 3.56-
3.59 (1H, m, CH-1 or CH-4), 3.62-3.64 (1H, m, CH-1 or CH-4), 3.76 (3H, s, OCH3), 
3.83 (3H, s, OCH3), 4.29 (2H, br s, CH2NH), 4.78 (1H, br s, NH), 6.28 (1H, ddd, J = 8.5 Hz, JH,F = 8.2 Hz, J = 2.8 
Hz, CHarom), 6.44 (1H, dd, JH,F = 11.3 Hz, J = 2.8 Hz, CHarom), 7.32 (1H, dd, J = 8.5 Hz, JH,F = 6.0 Hz, CHarom). 13C 
NMR (100.6 MHz, ref = CDCl3):  26.5 and 27.1 (CH2CH2), 39.8 (CH-1 or CH-4), 41.4 (CH-1 or CH-4), 43.7 
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(CH2NH), 49.2 (CH2), 56.1 (OCH3), 61.6 (OCH3), 99.1 (d, J = 27.8 Hz, CHaromCF), 103.7 (d, J = 2.5 Hz, Carom,quat), 
104.3 (1H, d, J = 23.1 Hz, CHaromCF), 109.8 (CHarom), 127.8 (Carom,quat), 132.9 (d, J = 9.9 Hz, CHarom), 136.8, 
140.7 and 146.3 (3x Carom,quat), 146.5 (d, J = 11.3 Hz, Carom,quat), 149.2 (Carom,quat), 163.5 (d, J = 243.0 Hz, CFarom). 
19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -113.62 (1F, ddd, JH,F = 11.3 Hz, 8.2 Hz, 6.0 Hz, CFarom). IR (ATR, 
cm-1): νmax = 1613, 1486, 1308, 1170, 1021, 824. MS (ES+): m/z (%): 217 (100). HRMS (ES+): calcd. for 
C14H17O2+ (M - C6H4BrFN-): 217.1223, found 217.1227. 
Synthesis of 2-bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-6-
fluoroaniline 289c 
A mixture of 5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalene-6-carbaldehyde 28 (0.23 g, 0.97 
mmol), 2-bromo-6-fluoroaniline 29c (1 equiv, 0.18 g, 0.97 mmol), NaCNBH3 (2.5 equiv, 0.15 g, 2.4 mmol) 
and acetic acid (2 equiv, 0.12 g, 1.9 mmol) in iso-propanol (20 mL) was stirred at room temperature for 
seven days. After this time, a saturated aqueous solution of Na2CO3 (15 mL) was added and an extraction 
with EtOAc was performed (3x 15 mL). After drying of the combined organic phases (MgSO4), filtration and 
evaporation, crude aniline 289c was obtained, which was purified by reverse phase automated flash 
chromatography (0.080 g, 0.19 mmol). 
2-Bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-6-fluoroaniline 
289c 
Pale yellow oil. Gradient used for purification: during 3 CV: 40% CH3CN, during 30 
CV: 40 -> 100% CH3CN, during 3 CV: 100% CH3CN. Yield: 20%. 1H NMR (400 MHz, 
CDCl3):  1.17-1.28 (2H, m, 2x CHXHN), 1.48 (1H, ddd, J = 8.7 Hz, 1.4 Hz, 1.4 Hz, 
CHAHS), 1.69-1.72 (1H, m, CHAHS), 1.86-1.98 (2H, m, 2x CHXHN), 3.55-3.57 (1H, m, 
CH-1 or CH-4), 3.62-3.64 (1H, m, CH-1 or CH-4), 3.76 (3H, s, OCH3), 3.86 (3H, s, OCH3), 4.38 (1H, br s, NH), 
4.47 (2H, d, J = 4.4 Hz, CH2NH), 6.61 (1H, ddd, J = 8.2 Hz, 8.1 Hz, JH,F = 4.9 Hz, CHarom), 6.95 (1H, ddd, JH,F = 
12.4 Hz, J = 8.2 Hz, 1.4 Hz, CHarom), 7.22 (1H, ddd, J = 8.1 Hz, 1.4 Hz, 1.3 Hz, CHarom). 13C NMR (100.6 MHz, 
ref = CDCl3):  26.6 and 27.1 (CH2CH2), 39.7 (CH-1 or CH-4), 41.5 (CH-1 or CH-4), 46.7 (d, J = 9.6 Hz, CH2NH), 
49.1 (CH2), 56.0 (OCH3), 61.5 (OCH3), 110.2 (CHarom), 113.9 (d, J = 5.5 Hz, Carom,quat), 116.0 (d, J = 21.3 Hz, 
CHaromCF), 119.6 (d, J = 8.5 Hz, CHarom), 128.2 (d, J = 3.1 Hz, CHarom), 129.5 (Carom,quat), 135.4 (d, J = 12.0 Hz, 
Carom,quat), 136.5, 140.3, 146.3 and 148.9 (4x Carom,quat), 153.4 (d, J = 245.0 Hz, CFarom). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -124.10 (1F, dd, JH,F = 12.4 Hz, 4.9 Hz, CFarom). MS (ES+): m/z (%): 217 (100).  
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Synthesis of 2-bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-
anilines 289d and 289e 
The synthesis of 2-bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-5-
(trifluoromethyl)aniline 289e is described as representative. A mixture of 5,8-dimethoxy-1,2,3,4-
tetrahydro-1,4-methanonaphthalene-6-carboxaldehyde 28 (0.67 g, 2.88 mmol), 2-bromo-5-
trifluoromethylaniline 29e (3 equiv, 2.07 g, 8.63 mmol) and MgSO4 (3 equiv, 1.04 g, 8.63 mmol) in dry 
dichloromethane (40 mL) was stirred at reflux temperature for 19 hours. After this time, the drying agent 
was filtered off and the solvent was removed in vacuo, affording the corresponding imine which was used 
without further purification in the next step. The imine was dissolved in MeOH (30 mL) and NaCNBH3 (2.5 
equiv, 0.45 g, 7.2 mmol) and acetic acid (1.2 equiv, 0.21 g, 3.46 mmol) were added. After stirring the 
reaction mixture for 17 hours at room temperature, saturated aqueous Na2CO3 (30 mL) was added and an 
extraction with EtOAc was performed (3x 20 mL). After drying of the combined organic phases (MgSO4), 
filtration and evaporation, crude aniline 289e was obtained, which was purified by reverse phase 
automated flash chromatography (0.86 g, 1.90 mmol). 
2-Bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-4-
(trifluoromethyl)aniline 289d 
Pale yellow oil. Gradient used for purification: during 3 CV: 40% CH3CN, 
during 30 CV: 40 -> 100% CH3CN, during 3 CV: 100% CH3CN. Yield: 71%. 1H 
NMR (400 MHz, CDCl3):  1.19-1.29 (2H, m, 2x CHXHN), 1.50 (1H, d, J = 8.8 Hz, 
CHAHS), 1.72 (1H, d, J = 8.8 Hz, CHAHS), 1.88-2.00 (2H, m, 2x CHXHN), 3.58 (1H, 
br s, CH-1 or CH-4), 3.64 (1H, br s, CH-1 or CH-4), 3.76 (3H, s, OCH3), 3.84 (3H, s, OCH3), 4.36 (2H, d, J = 5.5 
Hz, CH2NH), 5.03 (1H, t, J = 5.5 Hz, NH), 6.58 (1H, s, CHarom), 6.73 (1H, d, J = 8.5 Hz, CHarom), 7.41 (1H, dd, J 
= 8.5 Hz, 1.2 Hz, CHarom), 7.67 (1H, d, J = 1.2 Hz, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  26.5 and 27.0 
(CH2CH2), 39.8 (CH-1 or CH-4), 41.5 (CH-1 or CH-4), 43.5 (CH2NH), 49.2 (CH2), 56.1 (OCH3), 61.5 (OCH3), 
108.7 (Carom,quat), 109.8 and 110.6 (2x CHarom), 119.2 (q, J = 33.3 Hz, CCF3), 124.2 (q, J = 270.7 Hz, CF3), 125.9 
(q, J = 3.6 Hz, CHaromCCF3), 127.5 (Carom,quat), 129.6 (q, J = 3.8 Hz, CHaromCCF3), 137.0, 140.7, 146.3, 147.5 and 
149.2 (5x Carom,quat). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -61.48 (1F, s, CF3). IR (ATR, cm-1): νNH = 3408, 
νmax = 1610, 1319, 1107, 1076, 1056. MS (ES+): m/z (%): 217 (100). HRMS (ES+): calcd. for C14H17O2+ (M - 
C7H4BrF3N-): 217.1223, found 217.1222.  
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2-Bromo-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-5-
(trifluoromethyl)aniline 289e 
Pale yellow oil. Gradient used for purification: during 3 CV: 40% CH3CN, during 30 
CV: 40 -> 100% CH3CN, during 3 CV: 100% CH3CN. Yield: 66%. 1H NMR (400 MHz, 
CDCl3):  1.19-1.28 (2H, m, 2x CHXHN), 1.50 (1H, d, J = 8.8 Hz, CHAHS), 1.71-1.74 
(1H, m, CHAHS), 1.88-2.00 (2H, m, 2x CHXHN), 3.58 (1H, br s, CH-1 or CH-4), 3.64 
(1H, br s, CH-1 or CH-4), 3.77 (3H, s, OCH3), 3.85 (3H, s, OCH3), 4.34 (2H, d, J = 5.3 
Hz, CH2NH), 4.89 (1H, t, J = 5.3 Hz, NH), 6.61 (1H, s, CHarom), 6.80 (1H, dd, J = 8.2 Hz, 1.5 Hz, CHarom), 6.94 
(1H, d, J = 1.5 Hz, CHarom), 7.51 (1H, d, J = 8.2 Hz, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  26.5 and 27.1 
(CH2CH2), 39.8 (CH-1 or CH-4), 41.5 (CH-1 or CH-4), 43.8 (CH2NH), 49.2 (CH2), 56.1 (OCH3), 61.6 (OCH3), 
107.9 (q, J = 3.9 Hz, CHaromCCF3), 110.2 (CHarom), 113.0 (Carom,quat), 114.0 (q, J = 3.9 Hz, CHaromCCF3), 124.3 (q, 
J = 272.4 Hz, CF3), 127.6 (Carom,quat), 131.0 (q, J = 32.1 Hz, CCF3), 132.8 (CHarom), 137.1, 140.7, 145.4, 146.5 
and 149.1 (5x Carom,quat). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.36 (1F, s, CF3). IR (ATR, cm-1): νmax = 
1165, 1119, 1080, 1054, 1019. MS (ES+): m/z (%): 217 (100). HRMS (ES+): calcd. for C14H17O2+ (M – 
C7H4BrF3N-): 217.1223, found 217.1227.  
5.8.2 Synthesis of trifluoromethanesulfonamides 292 
The synthesis of N-(2-bromo-5-fluorophenyl)-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methano-
naphthalen-6-yl)methyl]-1,1,1-trifluoromethanesulfonamide 292b is described as representative. To a 
solution of aniline 289b (0.158 g, 0.39 mmol) in dry CH2Cl2 (10 mL), were added NaH (2.5 equiv, 23 mg, 
0.97 mmol) and Tf2O (1M in CH2Cl2, 2.5 equiv, 0.97 mL, 0.97 mmol) at 0 °C under N2 atmosphere. This 
mixture was stirred at room temperature for seven hours, after which it was quenched with saturated 
aqueous NH4Cl (10 mL) and extracted with EtOAc (3x 10 mL). The combined organic phases were dried 
(MgSO4), filtered and evaporated in vacuo. After purification via column chromatography, pure 
trifluoromethanesulfonamide 292b was obtained in 71% yield (0.149 g, 0.28 mmol). 
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N-(2-Bromo-4-fluorophenyl)-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-
yl)methyl]-1,1,1-trifluoromethanesulfonamide 292a 
This compound exists as two rotamers in a ratio R1/R2 1/1, due to hindered rotation of the sulfonamide 
bond. 
Viscous oil. Rf 0.27 (petroleum ether/EtOAc 95/5). Yield: 61%. 1H NMR (400 
MHz, CDCl3):  1.01-1.14 (2H, m, 2x CHXHN (R1 and R2)), 1.42-1.45 (1H, m, CHAHS 
(R1 and R2)), 1.58-1.62 (1H, m, CHAHS (R1 and R2)), 1.84-1.93 (2H, m, 2x CHXHN 
(R1 and R2)), 3.52 (2H, br s, CH-1 and CH-4 (R1 and R2)), 3.571 and 3.574 (2x 
1.5H, 2x s, OCH3 (R1 and R2)), 3.71 and 3.73 (2x 1.5H, 2x s, OCH3 (R1 and R2)), 4.88-4.99 (2H, m, CH2N (R1 
and R2)), 6.51 and 6.59 (2x 0.5H, 2x s, CHarom (R1 and R2)), 6.79 and 6.81 (2x 0.5H, 2x ddd, 2x J = 8.8 Hz, 7.2 
Hz, 2.8 Hz, CHarom (R1 and R2)), 6.93 and 6.96 (2x 0.5H, 2x dd, 2x J = 8.8 Hz, 5.5 Hz, CHarom (R1 and R2)), 7.31 
and 7.32 (2x 0.5H, 2x dd, 2x J = 7.8 Hz, 2.8 Hz, CHarom (R1 and R2)). 13C NMR (100.6 MHz, ref = CDCl3):  
26.36, 26.41, 26.9 and 27.0 (CH2CH2 (R1 and R2)), 39.7, 39.8, 41.58 and 41.62 (CH-1 and CH-4 (R1 and R2)), 
48.8 and 49.0 (CH2 (R1 and R2)), 51.0 and 51.2 (CH2N (R1 and R2)), 55.9 (OCH3 (R1 and R2)), 60.9 and 61.1 
(OCH3 (R1 and R2)), 111.77 and 111.84 (CHarom (R1 and R2)), 114.7 and 114.8 (2x d, 2x J = 22.2 Hz, CHarom 
(R1 and R2)), 120.2 (q, J = 323.0 Hz, CF3 (R1 and R2)), 120.8 (d, J = 25.5 Hz, CHarom (R1 and R2)), 122.7 (d, J 
= 16.5 Hz, Carom,quat (R1 and R2)), 126.0-126.4 (m, Carom,quat (R1 and R2)), 131.8 and 131.9 (2x d, 2x J = 11.9 
Hz, Carom,quat (R1 and R2)), 134.15 (d, J = 7.5 Hz, CHarom (R1 and R2)), 138.89 and 138.96 (Carom,quat (R1 and 
R2)), 139.6 and 139.7 (Carom,quat (R1 and R2)), 147.0 and 147.1 (Carom,quat (R1 and R2)), 148.7 and 148.9 
(Carom,quat (R1 and R2)), 162.2 (d, J = 254.5 Hz, CFarom (R1 and R2)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3): 
 -75.23 (3F, s, CF3), -109.55 to -109.67 (1F, m, CFarom). IR (ATR, cm-1): νmax = 1485, 1392, 1223, 1185, 1142, 
1040, 1024, 731. MS (ES+): m/z (%): 217 (100). HRMS (ES+): calcd. for C14H17O2+ (M - C7H3BrF4NO2S-): 
217.1223, found 217.1216. 
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N-(2-Bromo-5-fluorophenyl)-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-
yl)methyl]-1,1,1-trifluoromethanesulfonamide 292b 
This compound exists as two rotamers in a ratio R1/R2 1/1, due to hindered rotation of the sulfonamide 
bond. 
Viscous oil. Rf 0.28 (petroleum ether/EtOAc 9/1). Yield: 71%. 1H NMR (400 MHz, 
CDCl3):  1.00-1.18 (2H, m, 2x CHXHN (R1 and R2)), 1.43 (1H, d, J = 8.6 Hz, CHAHS 
(R1 and R2)), 1.58-1.65 (1H, m, CHAHS (R1 and R2)), 1.85-1.91 (2H, m, 2x CHXHN (R1 
and R2)), 3.52 (2H, br s, CH-1 and CH-4 (R1 and R2)), 3.59 and 3.62 (2x 1.5H, 2x s, 
OCH3 (R1 and R2)), 3.708 and 3.711 (2x 1.5H, 2x s, OCH3 (R1 and R2)), 4.95 (2H, s, 
CH2N (R1 and R2)), 6.51 and 6.54 (2x 0.5H, 2x s, CHarom (R1 and R2)), 6.70 and 6.75 (2x 0.5H, 2x dd, 2x J = 
8.9 Hz, 2.9 Hz, CHarom (R1 and R2)), 6.87-6.92 (1H, m, CHarom (R1 and R2)), 7.52 and 7.53 (2x 0.5H, 2x dd, 2x 
J = 8.9 Hz, 5.7 Hz, CHarom (R1 and R2)). 13C NMR (100.6 MHz, ref = CDCl3):  26.3, 26.4, 26.9 and 27.0 (CH2CH2 
(R1 and R2)), 39.7, 39.8, 41.66 and 41.67 (CH-1 and CH-4 (R1 and R2)), 48.8 and 49.0 (CH2 (R1 and R2)), 
51.0 and 51.3 (CH2N (R1 and R2)), 56.0 (OCH3 (R1 and R2)), 60.9 and 61.1 (OCH3 (R1 and R2)), 111.8 and 
112.0 (CHarom (R1 and R2)), 117.99 and 118.04 (2x d, 2x J = 22.1 Hz, CHarom (R1 and R2)), 120.1 (Carom,quat (R1 
and R2)), 120.1 (q, J = 313.1 Hz, CF3 (R1 and R2)), 120.6 (d, J = 21.1 Hz, CHarom (R1 and R2)), 122.5 and 122.6 
(Carom,quat (R1 and R2)), 134.1 (d, J = 8.5 Hz, CHarom (R1 and R2)), 136.6 (d, J = 10.6 Hz, CHarom (R1 or R2)), 
136.8 (d, J = 11.4 Hz, CHarom (R1 or R2)), 139.06 and 139.11 (Carom,quat (R1 and R2)), 139.6 and 139.7 (Carom,quat 
(R1 and R2)), 146.99 and 147.00 (Carom,quat (R1 and R2)), 148.7 and 148.8 (Carom,quat (R1 and R2)), 161.1 and 
161.2 (2x d, 2x J = 249.7 Hz, CFarom (R1 and R2)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -75.35 (3F, s, 
CF3), -113.71 to -113.87 (1F, m, CFarom). MS (ES+) m/z (%): 555/57 (M + NH4+, 25), 217 (100). HRMS (ES+): 
calcd. for C14H17O2+ (M - C7H3BrF4NO2S-): 217.1223, found 217.1218.  
N-(2-Bromo-6-fluorophenyl)-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-
yl)methyl]-1,1,1-trifluoromethanesulfonamide 292c 
This compound exists as two rotamers in a ratio major/minor 0.56/0.44, due to hindered rotation of the 
sulfonamide bond. 
Viscous oil. Rf 0.35 (petroleum ether/EtOAc 9/1). Yield: 61%. 1H NMR (400 MHz, 
CDCl3):  1.01-1.13 (2H, m, 2x CHXHN), 1.41-1.43 (1H, m, CHAHS), 1.60-1.64 (1H, m, 
CHAHS), 1.82-1.90 (2H, m, 2x CHXHN), 3.50 (1H, br s, CH-1 or CH-4), 3.52 (1H, br s, 
CH-1 or CH-4), 3.54 (1.8H, OCH3 (major)), 3.57 (1.2H, OCH3 (minor)), 3.68 (1.2H, 
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OCH3 (minor)), 3.70 (1.8H, OCH3 (major)), 4.82 (0.4H, d, J = 13.3 Hz, CH(H)N (minor)), 4.85 (0.6H, d, J = 13.4 
Hz, CH(H)N (major)), 5.03 (0.6H, d, J = 13.4 Hz, CH(H)N (major)), 5.07 (0.4H, d, J = 13.3 Hz, CH(H)N (minor)), 
6.55 (0.4H, s, CHarom (minor)), 6.61 (0.6H, s, CHarom (major)), 6.97-7.03 (1H, m, CHarom), 7.17 (1H, ddd, J = 8.2 
Hz, 8.2 Hz, 5.5 Hz, CHarom), 7.34-7.37 (1H, m, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  26.4 and 26.9 
(CH2CH2 (minor)), 26.5 and 27.0 (CH2CH2 (major)), 39.7 (CH-1 or CH-4), 41.68 and 41.71 (CH-1 or CH-4 
(minor+major)), 48.8 (CH2 (major)), 48.9 (CH2 (minor)), 50.4 (CH2N (minor)), 50.5 (CH2N (major)), 55.9 
(OCH3 (minor)), 56.0 (OCH3 (major)), 61.0 (OCH3 (major)), 61.1 (OCH3 (minor)), 112.6 (CHarom (minor)), 112.7 
(CHarom (major)), 115.5 (d, J = 21.6 Hz, CHarom (minor)), 115.6 (d, J = 21.6 Hz, CHarom (major)), 120.0 (q, J = 
323.3 Hz, CF3), 122.3 (Carom,quat (minor)), 122.4 (Carom,quat (major)), 124.7 (d, J = 15.1 Hz, Carom,quat (minor)), 
124.9 (d, J = 14.7 Hz, Carom,quat (major)), 127.5 (Carom,quat), 129.1 (d, J = 3.8 Hz, CHarom (major)), 129.2 (d, J = 
4.3 Hz, CHarom (minor)), 131.6 (d, J = 9.4 Hz, CHarom), 139.0 (Carom,quat), 139.1 (Carom,quat (major)), 139.2 
(Carom,quat (minor)), 147.2 (Carom,quat), 148.5 (Carom,quat (minor)), 148.6 (Carom,quat (major)), 160.79 (d, J = 256.1 
Hz, CFarom (minor)), 160.83 (d, J = 256.3 Hz, CFarom (major)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -75.51 
(d, J = 11.4 Hz, CF3 (major or minor)), -75.54 (d, J = 15.5 Hz, CF3 (major or minor), -112.18 (1F, br s, CFarom). 
IR (ATR, cm-1): νmax = 1394, 1187, 1138, 1024, 869, 782. MS (ES+): m/z (%): 217 (100). HRMS (ES+): calcd. 
for C14H17O2+ (M - C7H3BrF4NO2S-): 217.1223, found 217.1210.  
N-[2-Bromo-4-(trifluoromethyl)phenyl]-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-
methanonaphthalen-6-yl)methyl]-1,1,1-trifluoromethanesulfonamide 292d 
This compound exists as two rotamers in a ratio R1/R2 1/1, due to hindered rotation of the sulfonamide 
bond. 
Yellow oil. Rf 0.53 (petroleum ether/EtOAc 9/1). Yield: 62%. 1H NMR (400 
MHz, CDCl3):  0.97-1.06 (2H, m, 2x CHXHN (R1 and R2)), 1.41-1.44 (1H, m, 
CHAHS (R1 and R2)), 1.57-1.61 (1H, m, CHAHS (R1 and R2)), 1.81-1.92 (2H, m, 
2x CHXHN (R1 and R2)), 3.49 and 3.50 (2H, 2x br s, CH-1 and CH-4 (R1 and R2)), 
3.55 and 3.57 (2x 1.5H, 2x s, OCH3 (R1 and R2)), 3.70 and 3.72 (2x 1.5H, 2x s, OCH3 (R1 and R2)), 4.95 (1H, 
d, J = 13.5 Hz, CH(H)N (R1 and R2)), 5.01 (1H, d, J = 13.5 Hz, CH(H)N (R1 and R2)), 6.52 and 6.57 (2x 0.5H, 
2x s, CHarom (R1 and R2)), 7.08 and 7.12 (2x 0.5H, 2x d, 2x J = 8.3 Hz, CHarom (R1 and R2)), 7.33-7.37 (1H, m, 
CHarom (R1 and R2)), 7.83-7.85 (1H, m, CHarom (R1 and R2)). 13C NMR (100.6 MHz, ref = CDCl3):  26.3, 26.8 
and 26.9 (CH2CH2 (R1 and R2)), 39.67, 39.73, 41.6 and 41.7 (CH-1 and CH-4 (R1 and R2)), 48.7 and 48.9 (CH2 
(R1 and R2)), 51.0 and 51.3 (CH2N (R1 and R2)), 55.9 (OCH3 (R1 and R2)), 60.7 and 60.9 (OCH3 (R1 and R2)), 
111.8 and 112.0 (CHarom (R1 and R2)), 120.1 (q, J = 322.9 Hz, SCF3 (R1 and R2)), 122.2 and 122.4 (2x Carom,quat 
Experimental section  Chapter 5 
187 
 
(R1 and R2)), 122.7 (q, J = 273.1 Hz, CaromCF3 (R1 and R2)), 124.4-124.6 (m, CHarom (R1 and R2)), 125.9-126.3 
(m, Carom,quat (R1 and R2)), 130.5-130.7 (m, CHarom (R1 and R2)), 132.5 and 132.6 (2x d, 2x J = 33.5 Hz, 2x 
CaromCF3), 133.7 (m, CHarom (R1 and R2)), 139.0, 139.1, 139.2, 139.3, 139.4 and 139.4 (3x Carom,quat (R1 and 
R2)), 147.0 (Carom,quat (R1 and R2)), 148.7 and 148.8 (Carom,quat (R1 and R2)). 19F NMR (376.5 MHz, CDCl3, ref 
= CFCl3):  -63.50 and -63.53 (2x 1.5F, 2x s, 2x SCF3 (R1 and R2), -75.29 and -75.32 (2x 1.5F, 2x s, 2x CaromCF3 
(R1 and R2)). IR (ATR, cm-1): νmax = 1394, 1319, 1175, 1134, 1025. MS (ES+): m/z (%): 217 (100). HRMS (ES+): 
calcd. for C14H17O2+ (M - C8H3BrF6NO2S-): 217.1223, found 217.1214.  
N-[2-Bromo-5-(trifluoromethyl)phenyl]-N-[(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-
methanonaphthalen-6-yl)methyl]-1,1,1-trifluoromethanesulfonamide 292e 
This compound exists as two rotamers in a ratio R1/R2 1/1, due to hindered rotation of the sulfonamide 
bond. 
Viscous oil. Rf 0.24 (petroleum ether/EtOAc 9/1). Yield: 60%. 1H NMR (400 MHz, 
CDCl3):  1.00-1.12 (2H, m, 2x CHXHN (R1 and R2)), 1.40-1.42 (1H, m, CHAHS (R1 
and R2)), 1.55-1.60 (1H, m , CHAHS (R1 and R2)), 1.81-1.90 (2H, m, 2x CHXHN (R1 
and R2)), 3.47-3.52 (2H, m, CH-1 and CH-4 (R1 and R2)), 3.577 and 3.580 (2x 1.5H, 
2x s, OCH3 (R1 and R2)), 3.708 and 3.715 (2x 1.5H, 2x s, OCH3 (R1 and R2)), 4.91-
5.01 (2H, m, CH2N (R1 and R2)), 6.51 and 6.54 (2x 0.5H, 2x s, CHarom (R1 and R2)), 7.12 and 7.18 (2x 0.5H, 
2x d, 2x J = 1.7 Hz, CHarom (R1 and R2)), 7.36 and 7.40 (2x 0.5H, 2x dd, 2x J = 8.6 Hz, 1.7 Hz, CHarom (R1 and 
R2)), 7.70 and 7.72 (2x 0.5H, 2x d, 2x J = 8.6 Hz, CHarom (R1 and R2)). 13C NMR (100.6 MHz, ref = CDCl3):  
26.2, 26.3, 26.8 and 26.9 (CH2CH2 (R1 and R2)), 39.65, 39.70, 41.68 and 41.70 (CH-1 and CH-4 (R1 and R2)), 
48.8 and 48.9 (CH2 (R1 and R2)), 51.2 and 51.4 (CH2N (R1 and R2)), 56.01 and 56.03 (OCH3 (R1 and R2)), 
60.7 and 60.8 (OCH3 (R1 and R2)), 111.8 and 112.0 (CHarom (R1 and R2)), 120.1 (q, J = 322.8 Hz, SCF3 (R1 
and R2)), 122.08 and 122.11 (2x Carom,quat (R1 and R2)), 123.0 (q, J = 270.2 Hz, CaromCF3 (R1 and R2)), 127.0-
127.2 (m, CHarom (R1 and R2)), 129.8-130.5 (CHarom and Carom,quat (R1 and R2)), 130.3 and 130.4 (2x d, 2x J = 
33.6 Hz, 2x CaromCF3 (R1 and R2)), 134.1 and 134.2 (CHarom (R1 and R2)), 136.3 and 136.8 (Carom,quat (R1 and 
R2)), 139.3, 139.4, 139.5 and 139.6 (2x Carom,quat (R1 and R2)), 146.8 and 147.0 (Carom,quat (R1 and R2)), 148.7 
and 148.8 (Carom,quat (R1 and R2)). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.43 and -63.48 (2x 1.5F, 2x 
s, 2x SCF3 (R1 and R2)), -75.42 and -75.45 (2x 1.5F, 2x s, 2x CaromCF3 (R1 and R2)). IR (ATR, cm-1): νmax = 1395, 
1325, 1225, 1189, 1173, 1133. MS (ES+): m/z (%): 217 (100). 
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5.8.3 Synthesis of 7,12-dimethoxy-8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridines 288a-c 
The synthesis of 7,12-dimethoxy-2-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 
288a is described as representative. To a mixture of N-(2-bromo-4-fluorophenyl)-N-[(5,8-dimethoxy-
1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-yl)methyl]-1,1,1-trifluoromethanesulfonamide 292a (0.250 
g, 0.46 mmol) in dry toluene (4 mL) in a pressure vial under N2-atmosphere, Pd(OAc)2 (0.06 equiv, 6 mg, 
0.027 mmol), triphenylphosphine (0.18 equiv, 22 mg, 0.084 mmol) and K2CO3 (2 equiv, 128 mg, 0.93 mmol) 
were added. This mixture was stirred under microwave irradiation at 125 °C for 3 hours, after which it was 
quenched with H2O (4 mL). Subsequently, this mixture was filtered over Celite® and extracted with EtOAc 
(3x 6 mL). This organic phase was dried (MgSO4), filtered and evaporated in vacuo, affording crude 7,12-
dimethoxy-2-fluoro-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-hexahydro-8,11-methanobenzo[j]-
phenanthridine 293a, which was not purified but used as such in the following reaction. Therefore, crude 
293a was dissolved in dry THF (10 mL) and two equivalents of KOtBu (1M in THF, 0.92 mL) were added and 
this mixture was stirred at reflux temperature for two hours. After the addition of a saturated aqueous 
solution of NH4Cl (10 mL), an extraction with EtOAc was performed (3x 5 mL) and the combined organic 
phases were dried (MgSO4), filtered and evaporated under reduced pressure. Purification using 
preparative TLC afforded pure 7,12-dimethoxy-2-fluoro-8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine 288a (0.077 g, 0.24 mmol). 
7,12-Dimethoxy-2-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 288a 
Yellow oil. Rf 0.06 (petroleum ether/EtOAc 9/1). Yield: 51%. 1H NMR (400 MHz, CDCl3): 
 1.42-1.44 (2H, m, 2x CHXHN), 1.71 (1H, d, J = 9.1 Hz, CHAHS), 1.87-1.90 (1H, m, CHAHS), 
2.11-2.16 (2H, m, 2x CHXHN), 3.89 (2H, br s, CH-8 and CH-11), 3.96 (3H, s, OCH3), 4.10 
(3H, s, OCH3), 7.45 (1H, ddd, J = 9.0 Hz, 7.7 Hz, 2.8 Hz, CHarom), 8.14 (1H, dd, J = 9.0 Hz, 
6.1 Hz, CHarom), 9.07 (1H, dd, J = 12.3 Hz, 2.8 Hz, CHarom), 9.54 (1H, s, CHarom). 13C NMR 
(100.6 MHz, ref = CDCl3):  27.21 and 27.23 (CH2CH2), 41.0 (CH-8 or CH-11), 41.3 (CH-8 or CH-11), 48.8 
(CH2), 61.0 (OCH3), 62.2 (OCH3), 111.6 (d, J = 25.6 Hz, CHarom), 116.9 (d, J = 24.7 Hz, CHarom), 120.6 (Carom,quat), 
124.9 (d, J = 10.7 Hz, Carom,quat), 125.1 (d, J = 4.2 Hz, Carom,quat), 131.6 (d, J = 9.4 Hz, CHarom), 138.0, 142.0, 
145.7, 146.7 and 147.0 (5x Carom,quat), 147.8 (CHarom), 161.0 (d, J = 243.6 Hz, CFarom). 19F NMR (376.5 MHz, 
CDCl3, ref = CFCl3):  -112.89 to -112.96 (1F, m, CFarom). MS (ES+): m/z (%): 324 (M + H+, 100). HRMS (ES+): 
calcd. for C20H19FNO2+: 324.1394, found 324.1408. 
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7,12-Dimethoxy-3-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 288b 
Yellow oil. Rf 0.07 (petroleum ether/EtOAc 9/1). Yield: 39%. 1H NMR (400 MHz, 
CDCl3):  1.40-1.44 (2H, m, 2x CHXHN), 1.69 (1H, d, J = 9.1 Hz, CHAHS), 1.88 (1H, d, J = 
9.1 Hz, CHAHS), 2.10-2.15 (2H, m, 2x CHXHN), 3.89 (2H, br s, CH-8 and CH-11), 3.92 
(3H, s, OCH3), 4.10 (3H, s, OCH3), 7.38 (1H, ddd, J = 9.4 Hz, 8.0 Hz, 2.8 Hz, CHarom), 
7.79 (1H, dd, J = 9.8 Hz, 2.8 Hz, CHarom), 9.41 (1H, dd, J = 9.4 Hz, 6.3 Hz, CHarom), 9.59 (1H, s, CHarom). 13C NMR 
(100.6 MHz, ref = CDCl3):  27.1 and 27.2 (CH2CH2), 40.9 (CH-8 or CH-11), 41.2 (CH-8 or CH-11), 48.6 (CH2), 
60.8 (OCH3), 62.0 (OCH3), 113.9 (d, J = 20.3 Hz, CHarom), 115.7 (d, J = 22.7 Hz, CHarom), 120.1 (Carom,quat), 120.5 
(d, J = 2.1 Hz, Carom,quat), 125.4 (Carom,quat), 128.7 (d, J = 8.8 Hz, CHarom), 136.7, 146.0 and 146.3 (3x Carom,quat), 
146.4 (d, J = 11.3 Hz, Carom,quat), 147.0 (Carom,quat), 149.6 (CHarom), 161.8 (d, J = 248.1 Hz, CFarom). 19F NMR 
(376.5 MHz, CDCl3, ref = CFCl3):  -113.31 to -113.38 (1F, m, CFarom). IR (ATR, cm-1): νmax = 1450, 1314, 1208, 
1049. MS (ES+): m/z (%): 324 (M + H+, 100). HRMS (ES+): calcd. for C20H19FNO2+: 324.1394, found 324.1399. 
7,12-Dimethoxy-4-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 288c 
Yellow oil. Rf 0.07 (petroleum ether/EtOAc 9/1). Yield: 43%. 1H NMR (400 MHz, 
CDCl3):  1.41-1.45 (2H, m, 2x CHXHN), 1.71 (1H, d, J = 9.1 Hz, CHAHS), 1.88-1.91 (1H, 
m, CHAHS), 2.12-2.16 (2H, m, 2x CHXHN), 3.90 (1H, br s, CH-8 or CH-11), 3.91 (1H, br 
s, CH-8 or CH-11), 3.93 (3H, s, OCH3), 4.10 (3H, s, OCH3), 7.42 (1H, ddd, JH,F = 10.0 Hz, 
J = 8.1 Hz, 1.2 Hz, CHarom), 7.56 (1H, ddd, J = 8.4 Hz, 8.1 Hz, JH,F = 5.8 Hz, CHarom), 9.18 (1H, d, J = 8.4 Hz, 
CHarom), 9.63 (1H, s, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  27.06 and 27.10 (CH2CH2), 40.9 (CH-8 or 
CH-11), 41.3 (CH-8 or CH-11), 48.6 (CH2), 60.9 (OCH3), 62.1 (OCH3), 112.9 (d, J = 19.3 Hz, CHarom), 120.7 
(Carom,quat), 122.2 (d, J = 4.5 Hz, CHarom), 124.9 (d, J = 2.6 Hz, Carom,quat), 125.6 (Carom,quat), 126.5 (d, J = 8.6 Hz, 
CHarom), 134.8 (d, J = 10.3 Hz, Carom,quat), 137.7, 146.3, 146.5 and 147.1 (4x Carom,quat), 148.7 (d, J = 1.3 Hz, 
CHarom), 158.4 (d, J = 252.4 Hz, CFarom). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -125.22 (1F, dd, JH,F = 10.0 
Hz, 5.8 Hz, CFarom). IR (ATR, cm-1): νmax = 1316, 1033, 963, 762. MS (ES+): m/z (%): 324 (M + H+, 100). HRMS 
(ES+): calcd. for C20H19FNO2+: 324.1394, found 324.1406. 
5.8.4 Synthesis of 7,12-dimethoxy-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-
hexahydro-8,11-methanobenzo[j]phenanthridines 293d-e 
The synthesis of 7,12-dimethoxy-2-trifluoromethyl-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-
hexahydro-8,11-methanobenzo[j]phenanthridine 293d is described as representative. To a solution of N-
Experimental section  Chapter 5 
190 
 
(2-bromo-4-(trifluoromethyl)phenyl)-N-(5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-6-
yl)methyl)-1,1,1-trifluoromethanesulfonamide 292d (0.32 g, 0.55 mmol) in THF (10 mL) under nitrogen 
atmosphere, were added Pd(OAc)2 (0.06 equiv, 7.4 mg, 0.033 mmol), triphenylphosphine (0.18 equiv, 26 
mg, 0.099 mmol) and K2CO3 (2 equiv, 0.152 g, 1.10 mmol) and this mixture was stirred at reflux 
temperature for 61 hours. After this time, extra Pd(OAc)2 (0.06 equiv, 7.4 mg, 0.033 mmol), 
triphenylphosphine (0.18 equiv, 26 mg, 0.099 mmol) and K2CO3 (2 equiv, 0.152 g, 1.10 mmol) were added 
and stirring was continued for another 25 hours. After the addition of H2O (10 mL), the reaction mixture 
was filtered over Celite® and extracted with EtOAc (3x 10 mL). After drying of the combined organic phases 
(MgSO4), filtration and evaporation in vacuo, the crude product was purified via column chromatography 
yielding 7,12-dimethoxy-2-trifluoromethyl-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-hexahydro-8,11-
methanobenzo-[j]phenanthridine 293d (0.217 g, 0.43 mmol). 
7,12-Dimethoxy-2-trifluoromethyl-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-hexahydro-8,11-
methanobenzo[j]phenanthridine 293d 
Pale yellow crystals. Melting point: 118-119 °C. Rf 0.38 (petroleum ether/EtOAc 9/1). 
Yield: 78%. 1H NMR (400 MHz, CDCl3):  1.29-1.34 (2H, m, 2x CHXHN), 1.59 (1H, d, J = 
9.0 Hz, CHAHS), 1.79 (1H, J = 9.0 Hz, CHAHS), 2.02-2.07 (2H, m, 2x CHXHN), 3.63 (3H, s, 
OCH3), 3.70 (2H, br s, CH-8 and CH-11), 3.90 (3H, s, OCH3), 4.66 (1H, br s, CH(H)N), 
4.97 (1H, br s, CH(H)N), 7.57 (1H, dd, J = 8.5 Hz, 1.6 Hz, CHarom), 7.72 (1H, d, J = 8.5 Hz, 
CHarom), 8.77 (1H, d, J = 1.6 Hz, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  27.0 (CH2CH2), 40.7 (CH-8 or 
CH-11), 41.7 (CH-8 or CH-11), 45.6 (CH2NH), 48.9 (CH2), 60.9 (OCH3), 61.2 (OCH3), 120.0 (q, J = 324.5 Hz, 
SCF3), 120.8 (Carom,quat), 124.0 (q, J = 272.4 Hz, CaromCF3), 124.5 (q, J = 3.5 Hz, CHarom), 125.3 (Carom,quat), 125.55 
(CHarom), 125.61 (q, J = 4.0 Hz, CHarom), 129.7 (q, J = 32.5 Hz, CaromCF3), 130.2, 137.0, 141.2, 142.8, 145.6 and 
147.5 (6x Carom,quat). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.19 (3F, s, SCF3), -75.78 (3F, s, CaromCF3). 
IR (ATR, cm-1): νmax = 1400, 1332, 1195, 1137, 1086. MS (ES+): m/z (%): 374 (M - CHF3SO3 + H+, 100). HRMS 
(ES+): calcd. for C21H19F3NO2+ (M - CHF3SO3 + H+): 374.1362, found 374.1378. 
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7,12-Dimethoxy-3-trifluoromethyl-5-(trifluoromethanesulfonyl)-5,6,8,9,10,11-hexahydro-8,11-
methanobenzo[j]phenanthridine 293e 
Pale yellow crystals. Melting point: 143-144 °C. Rf 0.42 (petroleum ether/EtOAc 
9/1). Yield: 81%. 1H NMR (400 MHz, CDCl3):  1.28-1.35 (2H, m, 2x CHXHN), 1.59 
(1H, d, J = 9.0 Hz, CHAHS), 1.79 (1H, d, J = 9.0 Hz, CHAHS), 2.03-2.07 (2H, m, 2x 
CHXHN), 3.62 (3H, s, OCH3), 3.70 (2H, br s, CH-8 and CH-11), 3.90 (3H, s, OCH3), 4.64 
(1H, br s, CH(H)N), 4.99 (1H, br s, CH(H)N), 7.61 (1H, d, J = 8.5 Hz, CHarom), 7.83 (1H, s, CHarom), 8.55 (1H, d, 
J = 8.5 Hz, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  27.0 (CH2CH2), 40.7 (CH-8 or CH-11), 41.7 (CH-8 or 
CH-11), 45.6 (CH2NH), 48.8 (CH2), 61.0 (OCH3), 61.1 (OCH3), 120.0 (q, J = 324.7 Hz, SCF3), 120.9 (Carom,quat), 
122.5 (q, J = 3.7 Hz, CHarom), 123.7 (q, J = 272.3 Hz, CaromCF3), 124.3 (q, J = 3.5 Hz, CHarom), 125.7 (Carom,quat), 
128.8 (CHarom), 129.6 (q, J = 33.2 Hz, CaromCF3), 133.1, 134.5, 141.5, 142.8, 145.7 and 147.7 (6x Carom,quat). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.20 (3F, s, SCF3), -75.70 (3F, s, CaromCF3). IR (ATR, cm-1): νmax = 
1398, 1327, 1311, 1193, 1121, 1075. MS (ES+): m/z (%): 374 (M - CHF3SO3 + H+, 100). HRMS (ES+): calcd. for 
C21H19F3NO2+ (M - CHF3SO3 + H+): 374.1362, found 374.1368. 
5.8.5 Synthesis of 7,12-dimethoxy-8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridines 288d,e 
The synthesis of 7,12-dimethoxy-2-trifluoromethyl-8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine 288d is described as representative. To a solution of 7,12-dimethoxy-2-trifluoromethyl-5-
(trifluoromethanesulfonyl)-5,6,8,9,10,11-hexahydro-8,11-methanobenzo[j]phenanthridine 293d (0.155 g, 
0.31 mmol) in THF (10 mL), was added KOtBu (1M in THF, 1.2 equiv, 0.37 mmol) and this mixture was 
stirred at reflux temperature for three hours. After the addition of saturated aqueous NH4Cl, the reaction 
mixture was extracted with EtOAc (3x 10 mL), dried (MgSO4), filtered and evaporated under reduced 
pressure. Without the need for purification, 7,12-dimethoxy-2-trifluoromethyl-8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine 288d was obtained in quantitative yield (0.113 g, 0.31 mmol). 
7,12-Dimethoxy-2-trifluoromethyl-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 288d 
Yellow oil. Yield: quant. 1H NMR (400 MHz, CDCl3):  1.39-1.44 (2H, m, 2x CHXHN), 1.70 
(1H, d, J = 9.2 Hz, CHAHS), 1.87-1.90 (1H, m, CHAHS), 2.11-2.16 (2H, m, 2x CHXHN), 3.90 
(2H, br s, CH-8 and CH-11), 3.95 (3H, s, OCH3), 4.11 (3H, s, OCH3), 7.89 (1H, dd, J = 8.5 
Hz, 1.8 Hz, CHarom), 8.24 (1H, d, J = 8.5 Hz, CHarom), 9.67 (1H, s, CHarom), 9.79 (1H, br s, 
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CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  27.0 and 27.1 (CH2CH2), 41.0 (CH-8 or CH-11), 41.4 (CH-8 or 
CH-11), 48.7 (CH2), 60.8 (OCH3), 62.0 (OCH3), 120.6 and 123.4 (2x Carom,quat), 123.9 (q, J = 3.1 Hz, CHarom), 
124.6 (q, J = 271.2 Hz, CF3), 124.7 (q, J = 4.6 Hz, CHarom), 125.0 (Carom,quat), 128.2 (q, J = 31.9 Hz, CCF3), 130.4 
(CHarom), 137.9, 146.2, 146.8 and 147.2 (4x Carom,quat), 150.6 (CHarom). 19F NMR (376.5 MHz, CDCl3, ref = 
CFCl3):  -62.20 (3F, s, CF3). IR (ATR, cm-1): νmax = 1334, 1320, 1161, 1118, 1087. MS (ES+): m/z (%): 374 (M 
+ H+, 100). HRMS (ES+): calcd. for C21H19F3NO2+: 374.1362, found 374.1378. 
7,12-Dimethoxy-3-trifluoromethyl-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine 288e 
Yellow oil. Yield: quant. 1H NMR (400 MHz, CDCl3):  1.41-1.46 (2H, m, 2x CHXHN), 
1.72 (1H, d, J = 9.1 Hz, CHAHS), 1.88-1.92 (1H, m, CHAHS), 2.13-2.18 (2H, m, 2x 
CHXHN), 3.92 (2H, br s, CH-8 and CH-11), 3.95 (3H, s, OCH3), 4.12 (3H, s, OCH3), 7.82 
(1H, dd, J = 8.9 Hz, 1.9 Hz, CHarom), 8.44 (1H, br s, CHarom), 9.52 (1H, d, J = 8.9 Hz, 
CHarom), 9.66 (1H, s, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  26.9 and 27.0 (CH2CH2), 40.9 (CH-8 or CH-
11), 41.4 (CH-8 or CH-11), 48.6 (CH2), 60.7 (OCH3), 61.8 (OCH3), 120.8 (Carom,quat), 122.3 (q, J = 3.1 Hz, CHarom), 
124.2 (q, J = 272.2 Hz, CF3), 125.5 and 126.2 (2x Carom,quat), 127.0 (q, J = 4.1 Hz, CHarom), 127.7 (CHarom), 129.3 
(q, J = 32.6 Hz, CCF3), 138.2, 144.2, 146.4, 146.6 and 146.9 (5x Carom,quat), 149.8 (CHarom). 19F NMR (376.5 
MHz, CDCl3, ref = CFCl3):  -62.82 (3F, s, CF3). IR (ATR, cm-1): νmax = 1332, 1312, 1174, 1116, 1070, 1050. MS 
(ES+): m/z (%): 374 (M + H+, 100). HRMS (ES+): calcd. for C21H19F3NO2+: 374.1362, found 374.1379. 
5.8.6 Synthesis of 8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-
diones 31 
The synthesis of 2-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31a is 
described as representative. To a solution of 7,12-dimethoxy-2-fluoro-8,9,10,11-tetrahydro-8,11-
methanobenzo[j]phenanthridine 288a (0.030 g, 0.093 mmol) in CH3CN (2 mL), was added a solution of CAN 
(2.3 equiv, 0.12 g, 0.21 mmol) in H2O (2 mL) at 0 °C. This mixture was stirred at this temperature for 45 
minutes, after which H2O (4 mL) was added and an extraction was performed with EtOAc (3x 5 mL). The 
combined organic layers were dried (MgSO4), filtered and evaporated under reduced pressure affording 
crude 2-fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31a, which was 
purified via preparative TLC (0.015 g, 0.034 mmol). 
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2-Fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31a 
Orange crystals. Melting point: 198-199 °C. Rf 0.13 (petroleum ether/EtOAc 9/1). Yield: 
37%. 1H NMR (400 MHz, CDCl3):  1.27-1.34 (2H, m, 2x CHXHN), 1.52 (1H, d, J = 9.2 Hz, 
CHAHS), 1.74-1.77 (1H, m, CHAHS), 2.00-2.08 (2H, m, 2x CHXHN), 3.69 (1H, br s, CH-8 or 
CH-11), 3.70 (1H, br s, CH-8 or CH-11), 7.62 (1H, ddd, J = 9.3 Hz, JH,F = 7.5 Hz, J = 2.8 Hz, 
CHarom), 8.17 (1H, dd, J = 9.3 Hz, JH,F = 5.7 Hz, CHarom), 9.15 (1H, dd, JH,F = 11.4 Hz, J = 2.8 
Hz, CHarom), 9.55 (1H, s, CHarom). 13C NMR (100.6 MHz, CDCl3):  25.2 and 25.3 (CH2CH2), 40.9 (CH-8 or CH-
11), 41.4 (CH-8 or CH-11), 47.3 (CH2), 111.3 (d, J = 25.8 Hz, CHarom), 122.1 (d, J = 26.4 Hz, CHarom), 123.7 (d, 
J = 11.8 Hz, Carom,quat), 124.1 (Carom,quat), 132.3 (d, J = 6.7 Hz, Carom,quat), 132.5 (d, J = 9.5 Hz, CHarom), 146.7 (d, 
J = 2.8 Hz, CHarom), 149.4, 152.0 and 155.3 (3x Carom,quat), 163.1 (d, J = 251.1 Hz, CFarom), 182.1 and 185.0 (2x 
C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -107.83 (1F, ddd, JH,F = 11.4 Hz, 7.5 Hz, 5.7 Hz, CFarom). IR 
(ATR, cm-1): νC=O = 1645, νmax = 1320, 1271, 1196, 1006. MS (ES+): m/z (%): 294 (M + H+, 100). HRMS (ES+): 
calcd. for C18H13FNO2+: 294.0925, found 294.0931. 
3-Fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31b 
Orange crystals. Melting point: 154-155 °C. Rf 0.29 (petroleum ether/EtOAc 9/1). 
Yield: 50%. 1H NMR (400 MHz, CDCl3):  1.27-1.34 (2H, m, 2x CHXHN), 1.52 (1H, d, J 
= 9.2 Hz, CHAHS), 1.73-1.77 (1H, m, CHAHS), 2.02-2.08 (2H, m, 2x CHXHN), 3.69 (2H, br 
s, CH-8 and CH-11), 7.54 (1H, ddd, J = 9.6 Hz, 8.0 Hz, 2.6 Hz, CHarom), 7.89 (1H, dd, J 
= 9.4 Hz, 2.6 Hz, CHarom), 9.48 (1H, dd, J = 9.6 Hz, 6.2 Hz, CHarom), 9.60 (1H, s, CHarom). 13C NMR (100.6 MHz, 
CDCl3):  25.3 and 25.4 (CH2CH2), 40.9 (CH-8 or CH-11), 41.4 (CH-8 or CH-11), 47.2 (CH2), 113.8 (d, J = 20.2 
Hz, CHarom), 119.6 (Carom,quat), 120.5 (d, J = 24.5 Hz, CHarom), 123.3 (d, J = 2.7 Hz, Carom,quat), 130.3 (d, J = 9.6 
Hz, CHarom), 133.0 (d, J = 1.8 Hz, Carom,quat), 148.7 (CHarom), 152.0 (Carom,quat), 153.6 (d, J = 12.7 Hz, Carom,quat), 
155.1 (Carom,quat), 164.1 (d, J = 256.5 Hz, CFarom), 182.0 and 185.2 (2x C=O). 19F NMR (376.5 MHz, CDCl3, ref 
= CFCl3):  -105.86 (1F, ddd, J = 9.4 Hz, 8.0 Hz, 6.2 Hz, CFarom). IR (ATR, cm-1): νC=O = 1655, νmax = 1620, 1314, 
1287. MS (ES+): m/z (%): 294 (M + H+, 100). HRMS (ES+): calcd. for C18H13FNO2+ (M + H+): 294.0925, found 
294.0927. 
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4-Fluoro-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31c 
Orange crystals. Melting point: 171-172 °C. Yield: 62%. 1H NMR (400 MHz, CDCl3):  
1.30-1.34 (2H, m, 2x CHXHN), 1.53 (1H, d, J = 9.2 Hz, CHAHS), 1.75-1.78 (1H, m, CHAHS), 
2.04-2.08 (2H, m, 2x CHXHN), 3.70 (2H, br s, CH-8 and CH-11), 7.54 (1H, ddd, JH,F = 9.9 
Hz, J = 7.8 Hz, 1.2 Hz, CHarom), 7.69 (1H, ddd, J = 8.8 Hz, 7.8 Hz, JH,F = 5.4 Hz, CHarom), 
9.20 (1H, d, J = 8.8 Hz, CHarom), 9.62 (1H, s, CHarom). 13C NMR (100.6 MHz, CDCl3):  25.3 and 25.4 (CH2CH2), 
41.0 (CH-8 or CH-11), 41.5 (CH-8 or CH-11), 47.2 (CH2), 115.7 (d, J = 18.5 Hz, CHarom), 123.5 (d, J = 5.3 Hz, 
CHarom), 124.2 and 124.4 (2x Carom,quat), 129.9 (d, J = 8.1 Hz, CHarom), 132.8 (d, J = 2.5 Hz, Carom,quat), 142.1 (d, 
J = 11.3 Hz, Carom,quat), 147.6 (CHarom), 151.9 and 155.4 (2x Carom,quat), 157.8 (d, J = 257.9 Hz, CFarom), 181.9 
and 184.9 (2x C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -123.53 (1F, dd, JH,F = 9.9 Hz, 5.4 Hz, CFarom). 
IR (ATR, cm-1): νC=O = 1655, νmax = 1326, 1287, 1274, 765. MS (ES+): m/z (%): 294 (M + H+, 100). HRMS (ES+): 
calcd. for C18H13FNO2+: 294.0925, found 294.0931. 
2-Trifluoromethyl-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31d 
Orange crystals. Melting point: 151-152 °C. Rf 0.17 (petroleum ether/EtOAc 9/1). Yield: 
76%. 1H NMR (400 MHz, CDCl3):  1.27-1.35 (2H, m, 2x CHXHN), 1.54 (1H, d, J = 9.2 Hz, 
CHAHS), 1.75-1.79 (1H, m, CHAHS), 2.03-2.10 (2H, m, 2x CHXHN), 3.70 (1H, br s, CH-8 or 
CH-11), 3.71 (1H, br s, CH-8 or CH-11), 8.01 (1H, dd, J = 8.9 Hz, 2.0 Hz, CHarom), 8.29 (1H, 
d, J = 8.9 Hz, CHarom), 9.70 (1H, s, CHarom), 9.83 (1H, s, CHarom). 13C NMR (100.6 MHz, ref 
= CDCl3):  25.3 and 25.5 (CH2CH2), 41.1 (CH-8 or CH-11), 41.6 (CH-8 or CH-11), 47.4 (CH2), 121.9 (Carom,quat), 
123.9 (q, J = 272.9 Hz, CF3), 124.4 (Carom,quat), 126.0 (q, J = 4.6 Hz, CHarom), 127.3 (q, J = 3.2 Hz, CHarom), 131.4 
(CHarom), 131.7 (q, J = 32.7 Hz, CCF3), 133.4 (Carom,quat), 149.7 (CHarom), 152.2, 152.6 and 155.4 (3x Carom,quat), 
181.8 and 184.9 (2x C=O). 19F NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.16 (3F, s, CF3). IR (ATR, cm-1): νC=O 
= 1657, νmax = 1303, 1287, 1273, 1130. MS (ES+): m/z (%): 344 (M + H+, 100). HRMS (ES+): calcd. for 
C19H13F3NO2+: 344.0893, found 344.0897. 
3-Trifluoromethyl-8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-dione 31e 
Orange crystals. Melting point: 158-159 °C. Yield: 45%. 1H NMR (400 MHz, CDCl3): 
 1.28-1.35 (2H, m, 2x CHXHN), 1.54 (1H, d, J = 9.2 Hz, CHAHS), 1.76-1.78 (1H, m, 
CHAHS), 2.03-2.10 (2H, m, 2x CHXHN), 3.70 (1H, br s, CH-8 or CH-11), 3.71 (1H, br s, 
CH-8 or CH-11), 7.92 (1H, dd, J = 9.1 Hz, 1.7 Hz, CHarom), 8.47 (1H, s, CHarom), 9.58 
(1H, d, J = 9.1 Hz, CHarom), 9.69 (1H, s, CHarom). 13C NMR (100.6 MHz, ref = CDCl3):  25.2 and 25.3 (CH2CH2), 
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41.0 (CH-8 or CH-11), 41.5 (CH-8 or CH-11), 47.3 (CH2), 123.4 (q, J = 272.9 Hz, CF3), 124.3 and 124.7 (2x 
Carom,quat), 125.3 (q, J = 2.9 Hz, CHarom), 127.6 (q, J = 4.4 Hz, CHarom), 129.1 (CHarom), 132.6 (Carom,quat), 132.9 
(q, J = 33.2 Hz, CCF3), 148.8 (CHarom), 150.9, 152.0 and 155.4 (3x Carom,quat), 181.7 and 184.8 (2x C=O). 19F 
NMR (376.5 MHz, CDCl3, ref = CFCl3):  -63.80 (3F, s, CF3). IR (ATR, cm-1): νC=O = 1655, νmax = 1332, 1286, 
1163, 1131. MS (ES+): m/z (%): 344 (M + H+, 100). HRMS (ES+): calcd. for C19H13F3NO2+: 344.0893, found 
344.0901. 
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6 Summary 
Strained cyclic amino acids, with a small-membered ring as core structure, are of importance as building 
blocks for novel peptidomimetics. More specifically, strained β-amino acid derivatives increase the 
conformational stability and rigidity of peptides, and less units are necessary to obtain peptides which 
adopt a well-defined secondary structure. Therefore, in the first part of this PhD thesis, novel cyclic 
β-amino acid derivatives were synthesized, containing a cyclopropane or a cyclobutane ring as their core 
structure. 
As such, the synthesis of benzyl 2-(diphenylmethylideneamino)cyclopropanecarboxylate (1S,2S)-iii is 
described, employing (R)-β-benzyl N-(tert-butoxycarbonyl)aspartate (R)-i as a chiral building block. To this 
end, aspartate (R)-i was converted into γ-iodo-β-amino ester (R)-ii in four steps in 39% overall yield. The 
diastereoselective ring closure of precursor (R)-ii was effectuated by treatment with KHMDS in THF 
at -78 °C for one hour, leading to a diastereomeric mixture with a diastereomeric ratio trans:cis = 97:3. 
After purification, 2-(diphenylmethylideneamino)cyclopropanecarboxylate (1S,2S)-iii was obtained as a 
single diastereomer in 75% yield (dr > 99:1). 
 
Subsequently, the saponification of both enantiomers of benzyl cyclopropanecarboxylate iii was 
performed by treatment with five equivalents of NaOH in a MeOH/H2O mixture for 20 hours at room 
temperature, leading to the formation of cyclopropanecarboxylic acids (1R,2R)-iv and (1S,2S)-iv in 61% 
and 77% yield, respectively. The coupling of amino acids iv with the hydrochloric salt of methyl glycinate 
v was achieved under standard peptide formation reaction conditions, leading to dipeptides (1R,2R)-vi and 
(1S,2S)-vi in good yields. 
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In the second part of this PhD thesis, the synthesis of dialkyl cyclobutane-1,1-dicarboxylates x starting from 
3-halopropylidenemalonates vii was optimized. After screening various reaction conditions, it was found 
that the addition of diphenylmethylideneamine viii across alkylidenemalonates vii occured under neat 
reaction conditions, giving adducts ix in good yields after recrystallization. The ring closure of adducts ix 
toward the corresponding cyclobutanes x was effectuated by treatment with KOtBu in case of the 
brominated adducts ixa, while a catalytic amount of NaI had to be added to the reaction mixture to achieve 
ring closure of the chlorinated derivatives ixb. 
 
The following parts of this PhD thesis focused on the synthesis of fluorinated compounds. Due to fluorine’s 
unique properties (strong electronegativity, small van der Waals radius), its introduction in organic 
compounds can induce significant changes in their chemical and pharmacological properties. Therefore, 
in the pharmaceutical industry, there is a great interest in the synthesis of fluorinated compounds. 
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The synthesis of fluorinated β-aminocyclopropane-1,1-dicarboxylates xiii was envisaged via the same 
methodology as described above for the synthesis of cyclobutane-,1,-dicarboxylates x, using 
bromodifluorinated ethylidenemalonates xi as Michael acceptors. Michael-type addition of 
diphenylmethylideneamine viii was achieved under neat reaction conditions and afforded adducts xii in 
very good yields. Subsequently, the ring closure of Michael adducts xii toward the envisaged fluorinated 
β-aminocyclopropane-1,1-dicarboxylates xiii was investigated. However, treatment of adducts xii with 
base led to the formation of reaction mixtures containing starting material xii, cyclopropanes xiii, 
pyrrolines xiv, which are the result of a ring transformation of cyclopropanes xiii, and fluorinated 
cyclopropenes xv in varying ratios depending on the reaction conditions. Furthermore, this ring closure 
proved to be sluggish and poorly reproducible due to the instability of the reaction products. 
Cyclopropanes xiii were formed as the major reaction products upon treatment of adducts xii with 1.1-1.5 
equivalents of KOtBu for a short reaction time of 30 minutes to one hour. The synthesis of pyrrolines xiv 
was achieved using a longer reaction time of 4-5 hours, to enable the ring transformation of cyclopropanes 
xiii toward pyrrolines xiv. Under all reaction conditions which were evaluated, fluorinated 
cyclopropenedicarboxylates xv were formed as side products and were isolated in low yields. 
 
The reduction of pyrrolines xiv was evaluated by treatment with NaCNBH3 and led to the formation of 
acyclic amino esters, which proved to be unstable and could not be fully characterized. 
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Furthermore, the synthesis of another class of constrained fluorinated amino acids was envisaged, more 
specifically fluorinated azetidine-2-carboxylates xix and xxii. To this end, several routes toward precursors 
xviii and xxi were evaluated and finally these compounds were synthesized by reacting amines xvi and xx 
with an excess of bromoacetates xvii in the presence of LiHMDS (1M in THF) for 17-23 hours at room 
temperature or 70 °C. However, all attempts to convert amino esters xviii and xxi into the corresponding 
azetidines failed. While treatment with KOtBu and BuLi led to a nucleophilic addition across the ester 
moiety, the use of NaH and KMHDS gave no reaction and only resulted in recovery of the starting material. 
Finally, when amino esters xviii and xxi were treated with LiHMDS, a peculiar reaction was observed, i.e. 
removal of the methoxycarbonylmethyl group, leading to the formation of amines xvi and xx, respectively. 
 
In the next part of this PhD thesis, the synthesis of β,β-difluoroenamides xxv and xxvii was described, as 
new building blocks for the synthesis of azaheterocyclic compounds. Protection of secondary amine xxiiia 
by reaction with benzoyl chloride followed by treatment with LiHMDS led to the formation of enamide 
xxv, while the protection of amine xxiiia as tosylamide xxvi resulted in the formation of enamide xxvii 
after treatment with base. 
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Due to the presence of the electron-withdrawing group at nitrogen in combination with the two fluorine 
atoms on the β-carbon of the enamide functionality, enamides xxv and xxvii showed electrophilic 
reactivity. Indeed, upon treatment of enamides xxv and xxvii with nucleophiles, an SNV reaction was 
observed: addition of the nucleophile across the double bond is followed by elimination of fluoride. This 
reaction led to the formation of two isomers xxviii and xxix, with isomer xxviii being the major reaction 
product in all cases. The selectivity toward isomers xxviii was explained by evaluating the preferred 
conformation of the intermediate carbanions after addition of the nucleophile. 
 
The electrophilic reactivity of enamides xxv and xxvii was exploited toward the synthesis of fluorinated 
heterocycles by incorporating the nucleophile and the electrophilic enamide moiety in the same precursor. 
Whereas the synthesis of 6-fluoro-1,4-oxazines gave poor results, the synthesis of 2-fluoro-1,4-
benzoxazines xxxvi was optimized. Amides xxx, which were synthesized via condensation of the 
corresponding 2-aminophenols with ethyl bromodifluoroacetate, were protected as tert-
butyldimethylsilyl ethers xxxi. Reduction with borane dimethylsulfide complex afforded amines xxxii 
which were converted into amides xxxiv by reaction with different benzoyl chlorides xxxiii. Next, amides 
xxxiv were evaluated as precursors for the synthesis of 2-fluoro-1,4-benzoxazines, by treatment with 
different bases. Treatment of amides xxxiv with 2.2 equivalents LiHMDS led to the formation of ynamides 
xxxv as sole end products, which were isolated in excellent yields. However, upon use of KOtBu, amides 
xxxiv were converted into 2-fluorobenzoxazines xxxvi. After screening different other bases (NaHMDS, 
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KHMDS and LiOtBu), it was concluded that the cation of the base plays an important role in the reaction 
outcome. The use of lithium bases led to the formation of end products in which the tert-butyldimethylsilyl 
ether was still present, while upon use of sodium or potassium bases deprotection was observed. It was 
also demonstrated that ynamides xxxv, a group of compounds which were synthesized in excellent yields 
for the first time, showed electrophilic reactivity since deprotection of the tert-butyldimethylsilyl ether of 
compounds xxxv also resulted in the formation of 2-fluoro-1,4-benzoxazines xxxvi, via addition of the 
phenolic oxygen atom across the triple bond. 
 
The synthesis of fluorinated benzo-fused seven-membered rings could also be achieved, by using amides 
xxxviii as precursors, which were synthesized via condensation of amines xxiii with acid chlorides xxxvii. 
Upon treatment of amides xxxviii with KOtBu, an efficient conversion toward 2-fluoro-1,4-benzoxazepin-
5-ones xxxix was achieved, which were isolated in good yields. Finally, removal of the para-methoxybenzyl 
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group was achieved by reaction of N-PMB substituted benzoxazepinones xxxix with BF3.Et2O, resulting in 
4H-2-fluoro-1,4-benzoxazepin-5-ones xl. 
 
In the last part of this PhD thesis, the synthesis of 8,9,10,11-tetrahydro-8,11-methanobenzo[j]-
phenanthridine-7,12-diones xlvi was developed, as potential antimycobacterial compounds. The synthetic 
route started from aldehyde xli which was converted into different amines xliii via reductive amination 
with various fluorinated 2-bromoanilines xlii. In the next step, amines xliii were treated with triflic 
anhydride resulting in trifluoromethanesulfonamides xliv. Palladium-catalyzed ring closure followed by 
treatment with KOtBu afforded phenanthridines xlv, which were subsequently oxidized toward 8,9,10,11-
tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-diones xlvi. 
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It can be concluded that this PhD thesis resulted in the optimized synthesis of derivatives of two classes of 
carbocyclic amino acids. However, the synthesis of the fluorinated small-membered ring containing amino 
acids proved to be difficult, resulting in the formation of unstable fluorinated β-ACC derivatives, while the 
ring closure toward fluorinated azetidine-2-carboxylates could not be effectuated. The synthesis of novel 
β,β-difluoroenamides as novel building blocks was successful and was exploited toward the synthesis of 
novel fluorinated heterocycles and elusive fluorinated ynamides. Finally, the synthesis of fluorinated 
8,9,10,11-tetrahydro-8,11-methanobenzo[j]phenanthridine-7,12-diones was achieved, as potential 
antimycobacterial compounds. 
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7 Samenvatting 
Cyclische aminozuren bestaande uit een drie- of vierring als basisstructuur zijn belangrijke bouwstenen 
voor de synthese van nieuwe peptidomimetica. Meer specifiek verhogen conformationeel beperkte 
β-aminozuren de conformationele stabiliteit en rigiditeit van peptiden en zijn er minder bouwstenen nodig 
om peptiden te bekomen met een goed gedefinieerde secundaire structuur. In het eerste deel van deze 
doctoraatsthesis werden nieuwe cyclische β-aminozuurderivaten, die een cyclopropaan- of een 
cyclobutaanring bevatten als hun basisstructuur, gesynthetiseerd. 
Zo werd in het eerste deel de synthese van benzyl-2-(difenylmethylideenamino)cyclopropaancarboxylaat 
(1S,2S)-iii beschreven, waarbij (R)-β-benzyl-N-(tert-butoxycarbonyl)aspartaat (R)-i gebruikt werd als 
chirale bouwsteen. Aspartaat (R)-i werd hierbij eerst omgezet in γ-iood-β-amino ester (R)-ii in vier stappen, 
in een totaalrendement van 39%. De diastereoselective ringsluiting van deze precursor (R)-i werd 
bewerkstelligd door reactie met KHMDS in THF bij -78 °C gedurende één uur, waarbij een diastereomeer 
mengsel werd bekomen met een diastereomere ratio trans:cis = 97:3. Na opzuivering werd diastereomeer 
zuiver benzyl-2-(difenylmethylideenamino)cyclopropaancarboxylaat (1S,2S)-iii bekomen in een 
rendement van 75% (dr > 99:1). 
 
Vervolgens werd de verzeping van de beide enantiomeren van cyclopropaancarboxylaat iii bewerkstelligd 
door reactie met vijf equivalenten NaOH in een MeOH/H2O mengsel gedurende 20 uur bij 
kamertemperatuur, waarna cyclopropaancarbonzuren (1R,2R)-iv en (1S,2S)-iv geïsoleerd werden in 
respectievelijk 61% en 77% rendement. De koppeling van aminozuren iv met het hydrochloride zout van 
methylglycinaat v werd bewerkstelligd onder standaard reactieomstandigheden voor peptidevorming, 
waarbij dipeptiden (1R,2R)-vi en (1S,2S)-vi bekomen werden in goede rendementen. 
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In het tweede deel van deze doctoraatsthesis werd de synthese van dialkylcyclobutaan-1,1-dicarboxylaten 
x geoptimaliseerd, waarbij vertrokken werd van 3-halogeenpropylideenmalonaten vii. Nadat verschillende 
reactieomstandigheden geëvalueerd werden, bleek dat de additie van difenylmethylideenamine viii aan 
alkylideenmalonaten vii gerealiseerd werd onder solvent-vrije reactieomstandigheden, waarbij adducten 
ix bekomen werden in goede rendementen na omkristallisatie. De ringsluiting van adducten ix naar de 
overeenkomstige cyclobutanen x werd tenslotte verwezenlijkt door behandeling met KOtBu in het geval 
van de gebromeerde adducten ixa, terwijl de additie van een katalytische hoeveelheid NaI aan het 
reactiemengsel nodig was om ringsluiting van de gechloreerde derivaten ixb te bewerkstelligen. 
 
In de volgende hoofdstukken van deze doctoraatsthesis lag de focus op de synthese van gefluoreerde 
verbindingen. Door zijn unieke eigenschappen (hoge elektronegativiteit, kleine van der Waals straal) leidt 
de introductie van fluor in verbindingen tot een verandering in de chemische en farmacologische 
eigenschappen van deze verbindingen. Hierdoor bestaat er vanuit de farmaceutische industrie een grote 
interesse in de synthese van gefluoreerde verbindingen. 
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De synthese van gefluoreerde dialkyl-β-aminocyclopropaan-1,1-dicarboxylaten xiii werd beoogd via 
dezelfde methodologie als diegene die hierboven beschreven werd voor de synthese van 
dialkylcyclobutaan-1,1-dicarboxylaten x, waarbij gefluoreerde ethylideenmalonaten xi gebruikt werden 
als Michaël acceptoren. De Michaël-type additie van difenylmethylideenamine viii werd bewerkstelligd 
onder solvent-vrije reactieomstandigheden en leverde adducten xii in goede rendementen. Vervolgens 
werd de ringsluiting van deze Michaël adducten naar de beoogde β-aminocyclopropaan-1,1-
dicarboxylaten xiii onderzocht. Wanneer adducten xii in reactie gebracht werden met een base, werden 
reactiemengsels bekomen waarin zowel beginproduct xii, cyclopropanen xiii, pyrrolinen xiv (gevormd 
door ring-transformatie van cyclopropanen xiii) en gefluoreerde cyclopropenen xv werden 
teruggevonden, in wisselende verhoudingen afhankelijk van de reactieomstandigheden. Deze 
ringsluitingsreactie bleek moeilijk te verlopen en weinig reproduceerbaar te zijn door de onstabiliteit van 
de reactieproducten. Wanneer adducten xii werden behandeld met 1,1 tot 1,5 equivalenten KOtBu 
gedurende een korte reactietijd van 30 minuten tot één uur, werden cyclopropanen xiii bekomen als de 
hoofdproducten. Door een langere reactietijd (4 - 5 uur) toe te passen, werden pyrrolinen xiv bekomen 
als hoofdproduct door de ringtransformatie van cyclopropanen xiii naar pyrrolinen xiv onder deze 
omstandigheden. Onder alle reactieomstandigheden werden ook gefluoreerde 
cyclopropeendicarboxylaten xv gevormd als bijproducten, die konden geïsoleerd worden in lage 
rendementen. 
 
Samenvatting  Chapter 7 
208 
 
Vervolgens werd de reductie van pyrrolinen xiv geëvalueerd door reactie met NaCNBH3, maar dit leidde 
tot de vorming van acyclische amino esters die onstabiel waren en dus niet volledig gekarakteriseerd 
konden worden. 
Verder werd ook de synthese van een andere klasse conformationeel beperkte gefluoreerde aminozuren 
beoogd, meer specifiek de gefluoreerde azetidine-2-carboxylaten xix en xxii. Hiervoor werden 
verschillende routes geëvalueerd naar precursoren xviii en xxi en uiteindelijk werden deze verbindingen 
gesynthetiseerd door reactie van aminen xvi en xx met een overmaat broomacetaten xvii in de 
aanwezigheid van LiHMDS (1M in THF) gedurende 17-23 uur bij kamertemperatuur of 70 °C. Jammer 
genoeg faalden alle pogingen om amino esters xviii en xxi om te zetten in de overeenkomstige azetidinen. 
Terwijl reactie met KOtBu en BuLi aanleiding gaf tot een nucleofiele additie aan de ester functie, trad geen 
reactie op wanneer NaH en KHMDS gebruikt werden als base. Wanneer amino esters xviii en xxi behandeld 
werden met LiHMDS tenslotte, werd een eigenaardige reactie waargenomen, namelijk de afsplitsing van 
de alkoxycarbonylmethyl groep, waarbij aminen xvi en xx gevormd werden. 
 
In het volgende deel van deze doctoraatsthesis werd de synthese van β,β-gedifluoreerde enamiden xxv 
en xxviia beschreven, als bouwstenen voor de synthese van azaheterocyclische verbindingen. 
Bescherming van het secundaire amine xxiiia door reactie met benzoylchloride, gevolgd door behandeling 
met LiHMDS leverde enamide xxv, terwijl bescherming van amine xxiiia als tosylamide xxvi, gevolgd door 
behandeling met base resulteerde in de vorming van enamide xxxvii. 
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Door de aanwezigheid van de elektronenzuigende groep op het stikstofatoom, in combinatie met de twee 
fluoratomen op het β-koolstofatoom van de enamide eenheid, vertonen enamiden xxv en xxvii een 
elektrofiele reactiviteit. Inderdaad, wanneer enamiden xxv en xxvii behandeld werden met nucleofielen 
werd een SNV reactie waargenomen: additie van het nucleofiel aan de dubbele binding werd gevolgd door 
eliminatie van fluor. Deze reactie resulteerde in de vorming van twee isomeren xxviii en xxix, waarbij 
isomeer xxviii in alle gevallen bekomen werd als het hoofdisomeer. Deze selectiviteit voor isomeer xxviii 
werd verklaard door evaluatie van de conformatie van de intermediaire carbanionen, bekomen na additie 
van het nucleofiel aan de dubbele binding. 
 
De elektrofiele reactiviteit van enamiden xxv en xxvii werd vervolgens uitgewerkt tot de synthese van 
gefluoreerde heterocyclische verbindingen, door het nucleofiel en de elektrofiele enamide-eenheid te 
incorporeren in één precursor. Terwijl de synthese van 6-fluor-1,4-oxazinen enkel slechte resultaten gaf, 
kon de synthese van 2-fluor-1,4-benzoxazinen xxxvi geoptimaliseerd worden. Amiden xxx, die 
gesynthetiseerd werden via de condensatie van de overeenkomstige 2-aminofenolen met 
ethylbroomdifluoracetaat, werden vervolgens beschermd als tert-butyldimethylsilyl ethers xxxi. Reductie 
van deze verbindingen door behandeling met boraan dimethylsulfide complex resulteerde in aminen xxxii, 
die vervolgens werden omgezet in amiden xxxiv door reactie met verschillende benzoylchloriden xxxiii. 
Vervolgens werden amiden xxxiv geëvalueerd als precursoren voor de synthese van 2-fluor-1,4-
benzoxazinen door behandeling met verschillende basen. De reactie van amiden xxxiv met 2,2 
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equivalenten LiHMDS resulteerde in de selectieve vorming van ynamiden xxxv, die geïsoleerd werden in 
excellente rendementen. Wanneer KOtBu werd gebruikt als base werden amiden xxxiv omgezet in 
2-fluorbenzoxazinen xxxvi. Nadat nog verschillende andere basen (NaHMDS, KHMDS en LiOtBu) getest 
werden, werd geconcludeerd dat het kation van de base een zeer belangrijke rol speelde in het resultaat 
van de reactie. Met lithium basen werden eindproducten bekomen waarin het tert-butyldimethylsilylether 
nog aanwezig was, terwijl bij het gebruik van natrium of kalium basen de ontscherming van deze groep 
werd vastgesteld. Verder kon ook aangetoond worden dat ynamiden xxxv, die in dit onderzoek voor het 
eerst werden gesynthetiseerd in uitstekende rendementen, een elektrofiele reactiviteit vertonen 
aangezien ontscherming van de tert-butyldimethylsilyl groep van deze verbindingen aanleiding gaf tot de 
vorming van 2-fluor-1,4-benzoxazinen xxxvi, via additie van de fenolische zuurstof aan de drievoudige 
binding. 
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De synthese van gefluoreerde benzo-gefuseerde zevenringen kon gerealiseerd worden met het gebruik 
van amiden xxxviii als precursoren. Deze amiden werden bekomen via condensatie van aminen xxiii met 
zuurchloriden xxxvii. Wanneer amiden xxxviii behandeld werden met KOtBu werd een efficiënte conversie 
naar 2-fluor-1,4-benzoxazepin-5-onen xxxix waargenomen, die geïsoleerd werden in goede rendementen. 
De verwijdering van de para-methoxybenzyl groep werd tenslotte bewerkstelligd door reactie van de 
N-PMB gesubstitueerde benzoxazepinonen met BF3.Et2O, waarbij 4H-2-fluor-1,4-benzoxazepin-5-onen xl 
gevormd werden. 
 
In het laatste deel van deze doctoraatsthesis werd de synthese van 8,9,10,11-tetrahydro-8,11-
methanobenzo[j]fenantridine-7,12-dionen xlvi ontwikkeld, als potentieel antimycobacteriële 
verbindingen. De synthetische route vertrok van aldehyde xli, dat omgezet werd in aminen xliii via een 
reductieve aminering met gefluoreerde 2-broomanilinen xlii. In de volgende stap werden aminen xliii 
behandeld met trifluormethaansulfonzuuranhydride, wat resulteerde in de vorming van 
trifluormethaansulfonamiden xliv. Na de palladium-gekatalyseerde ringsluiting, gevolgd door behandeling 
met KOtBu, werden fenantridinen xlv bekomen, die vervolgens geoxideerd werden tot 8,9,10,11-
tetrahydro-8,11-methanobenzo[j]fenantridine-7,12-dionen xlvi. 
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Als algemeen besluit kan gesteld worden dat deze doctoraatsthesis resulteerde in de geoptimaliseerde 
synthese van derivaten uit twee klassen van carbocyclische aminozuren. Echter, de synthese van 
gefluoreerde aminozuren met een drie- of een vierring als basisstructuur bleek moeilijker te verlopen. De 
synthese van gefluoreerde β-ACC derivaten leverde onstabiele eindproducten, terwijl de ringsluiting tot 
gefluoreerde azetidine-2-carboxylaten niet kon gerealiseerd worden. De synthese van nieuwe 
β,β-difluorenamiden was wel succesvol en werd uitgewerkt tot de synthese van nieuwe gefluoreerde 
heterocyclische verbindingen en tot nu toe onbekende gefluoreerde ynamiden. Tenslotte kon de synthese 
van gefluoreerde 8,9,10,11-tetrahydro-8,11-methanobenzo[j]fenantridine-7,12-dionen, als potentieel 
antimycobacteriële verbindingen, met succes verwezenlijkt worden.
References  Chapter 8 
213 
 
8 References 
(1) a) O’Hagan, D.; Harper, D. B. J. Fluorine Chem. 1999, 100, 127; b) O’Hagan, D.; Deng, H. Chem. Rev. 
2015, 115, 634. 
(2) a) Sanada, M.; Miyano, T.; Iwadare, S.; Williamson, J. M.; Arison, B. H.; Smith, J. L.; Douglas, A. W.; 
Liesch, J. M.; Inamine, E. J. Antibiot. 1986, 39, 259; b) Murphy, C. D.; O'Hagan, D.; Schaffrath, C. 
Angew. Chem. Int. Ed. 2001, 40, 4479. 
(3) a) O'Hagan, D. Chem. Soc. Rev. 2008, 37, 308; b) Smart, B. E. J. Fluorine Chem. 2001, 109, 3; c) 
Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320. 
(4) a) Wang, J.; Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; 
Soloshonok, V. A.; Liu, H. Chem. Rev. 2014, 114, 2432; b) O'Hagan, D. J. Fluorine Chem. 2010, 131, 
1071. 
(5) a) Kaspar, A. A.; Reichert, J. M. Drug. Discov. Today 2013, 18, 807; b) Vlieghe, P.; Lisowski, V.; 
Martinez, J.; Khrestchatisky, M. Drug. Discov. Today 2010, 15, 40; c) Uhlig, T.; Kyprianou, T.; 
Martinelli, F. G.; Oppici, C. A.; Heiligers, D.; Hills, D.; Calvo, X. R.; Verhaert, P. EuPa Open Proteom. 
2014, 4, 58; d) Craik, D. J.; Fairlie, D. P.; Liras, S.; Price, D. Chem. Biol. Drug Des. 2013, 81, 136. 
(6) Hintermann, T.; Seebach, D. Chimia 1997, 51, 244. 
(7) Frackenpohl, J.; Arvidsson, P. I.; Schreiber, J. V.; Seebach, D. ChemBioChem 2001, 2, 445. 
(8) Cabrele, C.; Martinek, T. A.; Reiser, O.; Berlicki, Ł. J. Med. Chem. 2014, 57, 9718. 
(9) a) Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. Biodivers. 2004, 1, 1111; b) Pilsl, L. K. A.; Reiser, 
O. Amino Acids 2011, 41, 709; c) Vasudev, P. G.; Chatterjee, S.; Shamala, N.; Balaram, P. Chem. 
Rev. 2011, 111, 657; d) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173; e) Fülöp, F.; Martinek, T. A.; 
Tóth, G. K. Chem. Soc. Rev. 2006, 35, 323. 
(10) a) Buer, B. C.; Levin, B. J.; Marsh, E. N. G. J. Am. Chem. Soc. 2012, 134, 13027; b) Jäckel, C.; Koksch, 
B. Eur. J. Org. Chem. 2005, 4483; c) Buer, B. C.; Marsh, E. N. G. Protein Sci. 2012, 21, 453. 
(11) a) Mathad, R. I.; Jaun, B.; Flögel, O.; Gardiner, J.; Löweneck, M.; Codée, J. D. C.; Seeberger, P. H.; 
Seebach, D.; Edmonds, M. K.; Graichen, F. H. M.; Abell, A. D. Helv. Chim. Acta 2007, 90, 2251; b) 
Mathad, R. I.; Gessier, F.; Seebach, D.; Jaun, B. Helv. Chim. Acta 2005, 88, 266; c) Salwiczek, M.; 
Nyakatura, E. K.; Gerling, U. I. M.; Ye, S.; Koksch, B. Chem. Soc. Rev. 2012, 41, 2135. 
References  Chapter 8 
214 
 
(12) a) Mangelinckx, S.; D'hooghe, M.; Peeters, S.; De Kimpe, N. Synthesis 2009, 1105; b) Mangelinckx, 
S.; De Kimpe, N. Tetrahedron Lett. 2003, 44, 1771; c) Mangelinckx, S.; De Kimpe, N. Synlett 2005, 
1521; d) Mangelinckx, S.; De Kimpe, N. Synlett 2006, 369. 
(13) Meiresonne, T., Synthese van nieuwe carbocyclische beta-aminozuurderivaten en studie van hun 
reactiviteit. Master Thesis, Ghent University 2009. 
(14) a) Sivaprakasam, M.; Couty, F.; Evano, G.; Srinivas, B.; Sridhar, R.; Rao, K. R. Synlett 2006, 781; b) 
Couty, F.; Evano, G.; Vargas-Sanchez, M.; Bouzas, G. J. Org. Chem. 2005, 70, 9028; c) 
Sivaprakasham, M.; Couty, F.; Evano, G.; Srinivas, B.; Sridhar, R.; Rao, K. R. Arkivoc 2007, 71. 
(15) Verniest, G.; Colpaert, F.; Van Hende, E.; De Kimpe, N. J. Org. Chem. 2007, 72, 8569. 
(16) a) Sutherland, A.; Willis, C. L. Nat. Prod. Rep. 2000, 17, 621; b) Qiu, X.-L.; Qing, F.-L. Eur. J. Org. 
Chem. 2011, 2011, 3261; c) Qiu, X.-L.; Meng, W.-D.; Qing, F.-L. Tetrahedron 2004, 60, 6711; d) 
March, T. L.; Johnston, M. R.; Duggan, P. J.; Gardiner, J. Chem. Biodivers. 2012, 9, 2410. 
(17) Sloan, M. J.; Kirk, K. L. Tetrahedron Lett. 1997, 38, 1677. 
(18) Bey, P.; Fozard, J.; Lacoste, J. M.; McDonald, I. A.; Zreika, M.; Palfreyman, M. G. J. Med. Chem. 
1984, 27, 9. 
(19) a) Skolnick, P.; Marvizon, J. C. G.; Jackson, B. W.; Monn, J. A.; Rice, K. C.; Lewin, A. H. Life Sci. 1989, 
45, 1647; b) Von Lubitz, D.; Lin, R. C. S.; McKenzie, R. J.; Devlin, T. M.; McCabe, R. T.; Skolnick, P. 
Eur. J. Pharmacol. 1992, 219, 153. 
(20) Riedel, G.; Platt, B.; Micheau, J. Behav. Brain Res. 2003, 140, 1. 
(21) a) Kirihara, M.; Takuwa, T.; Kawasaki, M.; Kakuda, H.; Hirokami, S.; Takahata, H. Chem. Lett. 1999, 
28, 405; b) Kirihara, M.; Kawasaki, M.; Takuwa, T.; Kakuda, H.; Wakikawa, T.; Takeuchi, Y.; Kirk, K. 
L. Tetrahedron: Asymmetr. 2003, 14, 1753. 
(22) Lemonnier, G.; Lion, C.; Quirion, J. C.; Pin, J. P.; Goudet, C.; Jubault, P. Bioorg. Med. Chem. 2012, 
20, 4716. 
(23) Ivashkin, P.; Couve-Bonnaire, S.; Jubault, P.; Pannecoucke, X. Org. Lett. 2012, 14, 2270. 
(24) Milanole, G.; Couve-Bonnaire, S.; Bonfanti, J. F.; Jubault, P.; Pannecoucke, X. J. Org. Chem. 2013, 
78, 212. 
(25) Ferrary, T.; David, E.; Milanole, G.; Besset, T.; Jubault, P.; Pannecoucke, X. Org. Lett. 2013, 15, 5598. 
(26) Ivashkin, P.; Couve-Bonnaire, S.; Jubault, P.; Pannecoucke, X. Org. Lett. 2012, 14, 5130. 
(27) a) Artamonov, O. S.; Mykhailiuk, P. K.; Voievoda, N. M.; Volochnyuk, D. M.; Komarov, I. V. Synthesis 
2010, 443; b) Keita, M.; De Bona, R.; Santos, M. D.; Lequin, O.; Ongeri, S.; Milcent, T.; Crousse, B. 
References  Chapter 8 
215 
 
Tetrahedron 2013, 69, 3308; c) Mykhailiuk, P. K.; Afonin, S.; Ulrich, A. S.; Komarov, I. V. Synthesis 
2008, 1757. 
(28) Gambhir, S. S. Nat. Rev. Cancer 2002, 2, 683. 
(29) a) Schuster, D. M.; Nye, J. A.; Nieh, P. T.; Votaw, J. R.; Halkar, R. K.; Issa, M. M.; Yu, W.; Sepulveda, 
J.; Zeng, W.; Young, A.; Goodman, M. M. Mol. Imaging Biol. 2009, 11, 434; b) McParland, B. J.; 
Wall, A.; Johansson, S.; Sorensen, J. Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 1256; c) Kanagawa, 
M.; Doi, Y.; Oka, S.; Kobayashi, R.; Nakata, N.; Toyama, M.; Shirakami, Y. Nucl. Med. Biol. 2014, 41, 
545. 
(30) Shoup, T. M.; Goodman, M. M. J. Labelled Compd. Rad. 1999, 42, 215. 
(31) McConathy, J.; Voll, R. J.; Yu, W.; Crowe, R. J.; Goodman, M. M. Appl. Radiat. Isot. 2003, 58, 657. 
(32) Yu, W.; Williams, L.; Camp, V. M.; Malveaux, E.; Olson, J. J.; Goodman, M. M. Bioorg. Med. Chem. 
2009, 17, 1982. 
(33) Yu, W.; Williams, L.; Camp, V. M.; Olson, J. J.; Goodman, M. M. Bioorg. Med. Chem. Lett. 2010, 20, 
2140. 
(34) Mykhailiuk, P. K.; Radchenko, D. S.; Komarov, I. V. J. Fluorine Chem. 2010, 131, 221. 
(35) Tkachenko, A. N.; Radchenko, D. S.; Mykhailiuk, P. K.; Grygorenko, O. O.; Komarov, I. V. Org. Lett. 
2009, 11, 5674. 
(36) a) Liu, X.-L.; Wang, J.-B.; Tong, Y.; Song, Q.-H. Chem. - Eur. J. 2013, 19, 13216; b) Behrendt, P. J.; 
Kim, H.-C.; Hampp, N. J. Photochem. Photobiol., A 2013, 264, 67; c) Ohkura, K.; Aizawa, K.; 
Mukaida, R.; Akizawa, H.; Seki, K.-i. Heterocycles 2012, 86, 1465; d) Liese, J.; Hampp, N. A. J. 
Photochem. Photobiol., A 2011, 219, 228; e) Sinkel, C.; Greiner, A.; Agarwal, S. Macromolecules 
2008, 41, 3460; f) Ohkura, K.; Ishihara, T.; Nishijima, K.-i.; Diakur, J. M.; Seki, K.-i. Chem. Pharm. 
Bull. 2005, 53, 258; g) Ohkura, K.; Nakamura, H.; Sugaol, T.; Sakushima, A.; Takahashi, H.; Seiki, K.-
I. Heterocycles 2002, 57, 665; h) Sun, X.-L.; Haga, N.; Ogura, H.; Takayanagi, H. Chem. Pharm. Bull. 
1994, 42, 2352; i) Alderfer, J. L.; Soni, S. D.; Arakali, A. V.; Wallace, J. C. Photochem. Photobiol. 
1993, 57, 770. 
(37) Gauzy, C.; Saby, B.; Pereira, E.; Faure, S.; Aitken, D. J. Synlett 2006, 1394. 
(38) Hassoun, A.; Grison, C. M.; Guillot, R.; Boddaert, T.; Aitken, D. J. New J. Chem. 2015, 39, 3270. 
(39) Xu, Y.; Dolbier Jr., W. R. J. Org. Chem. 1997, 62, 6503. 
(40) Fort, D. A.; Woltering, T. J.; Nettekoven, M.; Knust, H.; Bach, T. Angew. Chem. Int. Ed. 2012, 51, 
10169. 
(41) Ishikawa, T. Heterocycles 2012, 85, 2837. 
References  Chapter 8 
216 
 
(42) Seyferth, D.; Woodruff, R. A. J. Org. Chem. 1973, 38, 4031. 
(43) Usuki, Y.; Fukuda, Y.; Iio, H. ITE Lett. Batteries New Technol. Med. 2001, 2, 237. 
(44) Ciganek, E. Organic Reactions (Hoboken, NJ, United States) 2008, 72, 1. 
(45) Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Ando, A. Tetrahedron Lett. 2010, 51, 4246. 
(46) Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Miwa, Y.; Minami, H.; Ando, A. Tetrahedron Lett. 
2010, 51, 2000. 
(47) Kostyanovsky, R. G.; Korepin, A. G.; Galkin, P. V.; El’natanov, Y. I.; Kadorkina, G. K.; Chervin, I. I.; 
Kostyanovsky, V. R. Mendeleev Commun. 1995, 5, 216. 
(48) a) Kostyanovsky, R. G.; Chervin, I. I.; Kadorkina, G. K.; Makarov, K. N.; Lantzeva, L. T.; Rozhkov, V. 
V.; Prosyanik, A. V. Mendeleev Commun. 1997, 7, 54; b) Prati, F.; Forni, A.; Moretti, I.; Torre, G.; 
Rozhkov, V. V.; Makarov, K. N.; Chervin, I. I.; Kostyanovsky, R. G. J. Fluorine Chem. 1998, 89, 177. 
(49) Kollonitsch, J.; Barash, L.; Doldouras, G. A. J. Am. Chem. Soc. 1970, 92, 7494. 
(50) Liu, Z.; Jenkinson, S. F.; Vermaas, T.; Adachi, I.; Wormald, M. R.; Hata, Y.; Kurashima, Y.; Kaji, A.; 
Yu, C.-Y.; Kato, A.; Fleet, G. W. J. J. Org. Chem. 2015, 80, 4244. 
(51) Van Hende, E.; Verniest, G.; Deroose, F.; Thuring, J.-W.; Macdonald, G.; De Kimpe, N. J. Org. Chem. 
2009, 74, 2250. 
(52) a) Hu, X. E. Tetrahedron 2004, 60, 2701; b) Stankovic, S.; D'hooghe, M.; Catak, S.; Eum, H.; 
Waroquier, M.; Van Speybroeck, V.; De Kimpe, N.; Ha, H.-J. Chem. Soc. Rev. 2012, 41, 643; c) 
Callebaut, G.; Meiresonne, T.; De Kimpe, N.; Mangelinckx, S. Chem. Rev. 2014, 114, 7954; d) Singh, 
G. S.; D'hooghe, M.; De Kimpe, N. Chem. Rev. 2007, 107, 2080. 
(53) a) Bott, T. M.; West, F. G. Heterocycles 2012, 84, 223; b) Brandi, A.; Cicchi, S.; Cordero, F. M. Chem. 
Rev. 2008, 108, 3988; c) Couty, F.; Evano, G. Org. Prep. Proced. Int. 2006, 38, 427. 
(54) Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. Tetrahedron 2012, 68, 9566. 
(55) a) Fülöp, F. Chem. Rev. 2001, 101, 2181; b) Kiss, L.; Fülöp, F. Synlett 2010, 1302; c) Palko, M.; Kiss, 
L.; Fülöp, F. Curr. Med. Chem. 2005, 12, 3063. 
(56) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905. 
(57) Foldamers: Structure, Properties, and Applications, S. Hecht, I. Huc. Wiley-VCH, Weinheim, 2007, 
p. 456. 
(58) a) Reissig, H. U.; Zimmer, R. Chem. Rev. 2003, 103, 1151; b) Yu, M.; Pagenkopf, B. L. Tetrahedron 
2005, 61, 321. 
References  Chapter 8 
217 
 
(59) a) D'hooghe, M.; Vervisch, K.; De Kimpe, N. J. Org. Chem. 2007, 72, 7329; b) Mangelinckx, S.; 
Courtheyn, D.; Verhé, R.; Van Speybroeck, V.; Waroquier, M.; De Kimpe, N. Synthesis 2006, 2260; 
c) Paulini, K.; Reissig, H. U. Liebigs Ann. Chem. 1994, 549. 
(60) a) Gnad, F.; Reiser, O. Chem. Rev. 2003, 103, 1603; b) Gu, P.; Su, Y.; Wu, X.-P.; Sun, J.; Liu, W.; Xue, 
P.; Li, R. Org. Lett. 2012, 14, 2246; c) Gharpure, S. J.; Vijayasree, U.; Reddy, S. R. Org. Biomol. Chem. 
2012, 10, 1735; d) De Simone, F.; Gertsch, J.; Waser, J. Angew. Chem. Int. Ed. 2010, 49, 5767; e) 
Voigt, J.; Noltemeyer, M.; Reiser, O. Synlett 1997, 202; f) Bubert, C.; Cabrele, C.; Reiser, O. Synlett 
1997, 827; g) Beumer, R.; Bubert, C.; Cabrele, C.; Vielhauer, O.; Pietzsch, M.; Reiser, O. J. Org. 
Chem. 2000, 65, 8960. 
(61) Martín-Vilà, M.; Muray, E.; Aguado, G. P.; Alvarez-Larena, A.; Branchadell, V.; Minguillón, C.; Giralt, 
E.; Ortuño, R. M. Tetrahedron: Asymmetr. 2000, 11, 3569. 
(62) a) Lu, T.; Song, Z.; Hsung, R. P. Org. Lett. 2008, 10, 541; b) Abu-Elfotoh, A.-M.; Phomkeona, K.; 
Shibatomi, K.; Iwasa, S. Angew. Chem. Int. Ed. 2010, 49, 8439. 
(63) Miller, J. A.; Hennessy, E. J.; Marshall, W. J.; Scialdone, M. A.; Nguyen, S. T. J. Org. Chem. 2003, 68, 
7884. 
(64) a) Armstrong, A.; Scutt, J. N. Org. Lett. 2003, 5, 2331; b) Jain, R. P.; Vederas, J. C. Org. Lett. 2003, 
5, 4669. 
(65) a) De Pol, S.; Zorn, C.; Klein, C. D.; Zerbe, O.; Reiser, O. Angew. Chem. Int. Ed. 2004, 43, 511; b) 
Koglin, N.; Zorn, C.; Beumer, R.; Cabrele, C.; Bubert, C.; Sewald, N.; Reiser, O.; Beck-Sickinger, A. G. 
Angew. Chem. Int. Ed. 2003, 42, 202; c) Zorn, C.; Gnad, F.; Salmen, S.; Herpin, T.; Reiser, O. 
Tetrahedron Lett. 2001, 42, 7049; d) Godier-Marc, E.; Aitken, D. J.; Husson, H.-P. Tetrahedron Lett. 
1997, 38, 4065. 
(66) a) Hibbs, E. D.; Hursthouse, M. B.; Jones, I. G.; Jones, W.; Abdul Malik, K. M.; North, M. Tetrahedron 
1997, 53, 17417; b) Jones, I. G.; Jones, W.; North, M.; Teijeira, M.; Uriarte, E. Tetrahedron Lett. 
1997, 38, 889. 
(67) Rodriguez, M.; Llinares, M.; Doulut, S.; Heitz, A.; Martinez, J. Tetrahedron Lett. 1991, 32, 923. 
(68) a) Caputo, R.; Cassano, E.; Longobardo, L.; Palumbo, G. Tetrahedron 1995, 51, 12337; b) Caputo, 
R.; Cassano, E.; Longobardo, L.; Palumbo, G. Tetrahedron Lett. 1995, 36, 167. 
(69) Kwak, W. Y.; Kim, H. J.; Min, J. P.; Yoon, T. H.; Shim, H. J.; Yoo, M., US20120016126 A1, 2012, 
CAN153:481038  
References  Chapter 8 
218 
 
(70) a) Díez, D.; García, P.; Fernández, P.; Marcos, I. S.; Garrido, N. M.; Basabe, P.; Broughton, H. B.; 
Urones, J. G. Synlett 2005, 158; b) Henniges, H.; Gussetti, C.; Militzer, H. C.; Baird, M. S.; de Meijere, 
A. Synthesis 1994, 1471. 
(71) Prosser, A. R.; Banning, J. E.; Rubina, M.; Rubin, M. Org. Lett. 2010, 12, 3968. 
(72) McCoy, L. L. J. Am. Chem. Soc. 1962, 84, 2246. 
(73) Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. Org. Biomol. Chem. 2011, 9, 7085. 
(74) Brannock, K. C.; Kelly, C. A.; Burpitt, R. D.; Bell, A. J. Org. Chem. 1964, 29, 801. 
(75) a) Aitken, D. J.; Gauzy, C.; Pereira, E. Tetrahedron Lett. 2002, 43, 6177; b) Gauzy, C.; Pereira, E.; 
Faure, S.; Aitken, D. J. Tetrahedron Lett. 2004, 45, 7095. 
(76) a) Fernandes, C.; Pereira, E.; Faure, S.; Aitken, D. J. J. Org. Chem. 2009, 74, 3217; b) Declerck, V.; 
Aitken, D. J. Amino Acids 2011, 41, 587. 
(77) a) Hall, H. K.; Ykman, P. J. Am. Chem. Soc. 1975, 97, 800; b) White, J. D.; He, D. C. Org. Lett. 2006, 
8, 1081. 
(78) Perrotta, D.; Racine, S.; Vuilleumier, J.; de Nanteuil, F.; Waser, J. Org. Lett. 2015, 17, 1030. 
(79) a) Mangelinckx, S.; Vermaut, B.; Verhé, R.; De Kimpe, N. Synlett 2008, 2697; b) Caine, D. 
Tetrahedron 2001, 57, 2643. 
(80) a) Liu, X.-L.; Xue, D.; Zhang, Z.-T. J. Heterocycl. Chem. 2011, 48, 489; b) Choudhary, G.; Peddinti, R. 
K. Green Chemistry 2011, 13, 276; c) Imanzadeh, G.; Ahmadi, F.; Zamanloo, M.; Mansoori, Y. 
Molecules 2010, 15, 7353; d) Imanzadeh, G.; Rezaee-Gatar, S. Arkivoc 2015, 121; e) Huang, C.; Yin, 
Y. Q.; Guo, J. H.; Wang, J.; Fan, B. M.; Yang, L. J. RSC Adv. 2014, 4, 10188. 
(81) McDougal, P. G.; Rico, J. G.; Oh, Y. I.; Condon, B. D. J. Org. Chem. 1986, 51, 3388. 
(82) a) Pearson, W. H.; Kropf, J. E.; Choy, A. L.; Lee, I. Y.; Kampf, J. W. J. Org. Chem. 2007, 72, 4135; b) 
Mollet, K.; Catak, S.; Waroquier, M.; Van Speybroeck, V.; D’hooghe, M.; De Kimpe, N. J. Org. Chem. 
2011, 76, 8364. 
(83) Cavitt, M. A.; Phun, L. H.; France, S. Chem. Soc. Rev. 2014, 43, 804. 
(84) Dolbier, W. R.; Battiste, M. A. Chem. Rev. 2003, 103, 1071. 
(85) Aoki, S.; Kawasaki-Takasuka, T.; Yamazaki, T. Tetrahedron 2011, 67, 4845. 
(86) Mangelinckx, S., New syntheses of beta-aminocyclopropanecarboxylic acid derivatives and study 
of their reactivity. PhD Thesis, Ghent University 2006. 
(87) Li, L.; Wang, F.; Ni, C.; Hu, J. Angew. Chem. Int. Ed. 2013, 52, 12390. 
References  Chapter 8 
219 
 
(88) a) Dolbier, W. R.; Shelton, G. R.; Battiste, M. A.; Stanton, J. F.; Price, D. R. Org. Lett. 2002, 4, 233; 
b) Liu, C.; Ma, H.; Nie, J.; Ma, J. Chin. J. Chem. 2012, 30, 47; c) Sato, T.; Niino, H.; Yabe, A. J. Am. 
Chem. Soc. 2003, 125, 11936; d) Enyo, T.; Nicolaides, A.; Tomioka, H. J. Org. Chem. 2002, 67, 5578. 
(89) a) Verniest, G.; Piron, K.; Van Hende, E.; Thuring, J. W.; Macdonald, G.; Deroose, F.; De Kimpe, N. 
Org. Biomol. Chem. 2010, 8, 2509; b) Piron, K.; Verniest, G.; Van Hende, E.; De Kimpe, N. Arkivoc 
2012, 6. 
(90) a) Yarmolchuk, V. S.; Mykhailiuk, P. K.; Komarov, I. V. Tetrahedron Lett. 2011, 52, 1300; b) Patrick, 
T. B.; Shadmehr, M.; Khan, A. H.; Singh, R. K.; Asmelash, B. J. Fluorine Chem. 2012, 143, 109; c) 
Bonini, B. F.; Boschi, F.; Franchini, M. C.; Fochi, M. A.; Fini, F.; Mazzanti, A.; Ricci, A. Synlett 2006, 
543. 
(91) Buil, M. L.; Esteruelas, M. A.; López, A. M.; Mateo, A. C. Organometallics 2006, 25, 4079. 
(92) Wei, W.-T.; Chen, C.-X.; Lu, R.-J.; Wang, J.-J.; Zhang, X.-J.; Yan, M. Org. Biomol. Chem. 2012, 10, 
5245. 
(93) a) Peng, W.; Zhao, J.; Zhu, S. J. Fluorine Chem. 2006, 127, 360; b) Yokota, M.; Fuchibe, K.; Ueda, 
M.; Mayumi, Y.; Ichikawa, J. Org. Lett. 2009, 11, 3994. 
(94) a) Washburn, D. G., US 20080039517, 2008, CAN148:239027 ; b) Guziec, F. S.; Wasmund, L. M. 
Tetrahedron Lett. 1990, 31, 23. 
(95) Koini, E. N.; Papazafiri, P.; Vassilopoulos, A.; Koufaki, M.; Horvath, Z.; Koncz, I.; Virag, L.; Papp, G. 
J.; Varro, A.; Calogeropoulou, T. J. Med. Chem. 2009, 52, 2328. 
(96) Stapon, A.; Li, R. F.; Townsend, C. A. J. Am. Chem. Soc. 2003, 125, 8486. 
(97) Lin, J.-H.; Xiao, J.-C. Eur. J. Org. Chem. 2011, 4536. 
(98) a) Chang, L. L.; Yang, G. X.; McCauley, E.; Mumford, R. A.; Schmidt, J. A.; Hagmann, W. K. Bioorg. 
Med. Chem. Lett. 2008, 18, 1688; b) Bechara, G.; Leygue, N.; Galaup, C.; Mestre, B.; Picard, C. 
Tetrahedron Lett. 2009, 50, 6522; c) Hockova, D.; Keough, D. T.; Janeba, Z.; Wang, T.-H.; de Jersey, 
J.; Guddat, L. W. J. Med. Chem. 2012, 55, 6209. 
(99) a) Alonso, E.; Ramón, D. J.; Yus, M. Tetrahedron 1997, 53, 14355; b) O'Sullivan, S.; Doni, E.; Tuttle, 
T.; Murphy, J. A. Angew. Chem. Int. Ed. 2014, 53, 474. 
(100) Yamazaki, T.; Kawashita, S.; Kitazume, T.; Kubota, T. Chem.-Eur. J. 2009, 15, 11461. 
(101) Aspin, S.; López-Suárez, L.; Larini, P.; Goutierre, A.-S.; Jazzar, R.; Baudoin, O. Org. Lett. 2013, 15, 
5056. 
(102) Carbery, D. R. Org. Biomol. Chem. 2008, 6, 3455. 
References  Chapter 8 
220 
 
(103) a) De Kimpe, N.; Schamp, N. Org. Prep. Proced. Int. 1983, 15, 71; b) De Kimpe, N.; Schamp, N. Org. 
Prep. Proced. Int. 1981, 13, 241; c) Mangelinckx, S.; Boeykens, M.; De Kimpe, N. Synlett 2008, 1394; 
d) Chai, D. I.; Hoffmeister, L.; Lautens, M. Org. Lett. 2011, 13, 106; e) Couty, S.; Barbazanges, M.; 
Meyer, C.; Cossy, J. Synlett 2005, 905; f) Nubbemeyer, U. Science of Synthesis 2008, 32, 235; g) 
Schantl, J. G. Science of Synthesis 2005, 24, 223; h) Petko, K. I.; Sokolenko, T. M.; Yu Kot, S.; 
Kasyanchuk, T. A.; Yagupol'skii, L. M. Russ. J. Org. Chem. 2011, 47, 563; i) Brückner, D. Synlett 2000, 
1402; j) Brückner, D. Tetrahedron 2006, 62, 3809. 
(104) Mae, M.; Amii, H.; Uneyama, K. Tetrahedron Lett. 2000, 41, 7893. 
(105) a) Guo, Y.; Fujiwara, K.; Uneyama, K. Org. Lett. 2006, 8, 827; b) Guo, Y.; Fujiwara, K.; Amii, H.; 
Uneyama, K. J. Org. Chem. 2007, 72, 8523. 
(106) Kobayashi, T.; Nakagawa, T.; Amii, H.; Uneyama, K. Org. Lett. 2003, 5, 4297. 
(107) Blond, G.; Billard, T.; Langlois, B. R. Chem.-Eur. J. 2002, 8, 2917. 
(108) Nguyen, B. T.; Martel, A.; Dhal, R.; Dujardin, G. Synlett 2009, 2492. 
(109) a) Burger, K.; Geith, K.; Sewald, N. J. Fluorine Chem. 1990, 46, 105; b) DesMarteau, D. D.; Lu, C.; 
Vanderveer, D. Tetrahedron Lett. 2009, 50, 3741. 
(110) Burger, K.; Geith, K.; Huebl, D. Synthesis 1988, 189. 
(111) a) Amii, H.; Uneyama, K. Chem. Rev. 2009, 109, 2119; b) Sakoda, K.; Mihara, J.; Ichikawa, J. Chem. 
Commun. 2005, 4684; c) Fujita, T.; Sakoda, K.; Ikeda, M.; Hattori, M.; Ichikawa, J. Synlett 2013, 24, 
57; d) Ichikawa, J.; Wada, Y.; Miyazaki, H.; Mori, T.; Kuroki, H. Org. Lett. 2003, 5, 1455. 
(112) a) Seebach, D. Angew. Chem. Int. Ed. 1979, 18, 239; b) Miyata, O.; Miyoshi, T.; Ueda, M. Arkivoc 
2013, 60. 
(113) Stork, G.; Dowd, S. R. J. Am. Chem. Soc. 1963, 85, 2178. 
(114) a) Rappoport, Z. Acc. Chem. Res. 1981, 14, 7; b) Ichikawa, J., in Fluorine-Containing Synthons, Vol. 
911 (Ed.: V. Soloshonok), ASC  Symposium Series, ACS, Washington, DC, 2005, pp. 262. 
(115) a) Marciniak, B.; Bilska-Markowska, M.; Grzeszczuk, M.; Rapp, M.; Koroniak, H. J. Fluorine Chem. 
2014, 167, 143; b) Tellier, F.; Audouin, M.; Baudry, M.; Sauvêtre, R. Eur. J. Org. Chem. 2000, 1933; 
c) Funabiki, K.; Ohtsuki, T.; Ishihara, T.; Yamanaka, H. J. Chem. Soc., Perkin Trans. 1 1998, 2413. 
(116) Gibson, S. E.; Kaufmann, K. A. C.; Loch, J. A.; Steed, J. W.; White, A. J. P. Chem.-Eur. J. 2005, 11, 
2566. 
(117) a) Ma, X.; Pan, S.; Wang, H.; Chen, W. Org. Lett. 2014, 16, 4554; b) Mollet, K.; Goossens, H.; Piens, 
N.; Catak, S.; Waroquier, M.; Törnroos, K. W.; Van Speybroeck, V.; D'hooghe, M.; De Kimpe, N. 
References  Chapter 8 
221 
 
Chem.-Eur. J. 2013, 19, 3383; c) Maheswara, M.; Lee, Y. Y.; Kang, E. J. Synlett 2012, 2481; d) Kim, 
S. H.; Lee, S.; Kim, S. H.; Lim, J. W.; Kim, J. N. Tetrahedron Lett. 2012, 53, 4979. 
(118) Li, W.; Duan, X. W.; Yan, H.; Xin, H. X. Org. Biomol. Chem. 2013, 11, 4546. 
(119) Bogacki, R.; Gill, D. M.; Kerr, W. J.; Lamont, S.; Parkinson, J. A.; Paterson, L. C. Chem. Commun. 
2013, 49, 8931. 
(120) Dekeukeleire, S.; D’hooghe, M.; De Kimpe, N. J. Org. Chem. 2009, 74, 1644. 
(121) Inman, M.; Moody, C. J. J. Org. Chem. 2010, 75, 6023. 
(122) Bouzide, A.; LeBerre, N.; Sauvé, G. Tetrahedron Lett. 2001, 42, 8781. 
(123) Meiresonne, T.; Verniest, G.; De Kimpe, N.; Mangelinckx, S. The Journal of Organic Chemistry 2015. 
(124) a) Achari, B.; Mandal, S. B.; Dutta, P. K.; Chowdhury, C. Synlett 2004, 2449; b) Ilas, J.; Anderluh, P. 
S.; Dolenc, M. S.; Kikelj, D. Tetrahedron 2005, 61, 7325. 
(125) Perry, B.; Alexander, R.; Bennett, G.; Buckley, G.; Ceska, T.; Crabbe, T.; Dale, V.; Gowers, L.; Horsley, 
H.; James, L.; Jenkins, K.; Crépy, K.; Kulisa, C.; Lightfoot, H.; Lock, C.; Mack, S.; Morgan, T.; Nicolas, 
A.-L.; Pitt, W.; Sabin, V.; Wright, S. Bioorg. Med. Chem. Lett. 2008, 18, 4700. 
(126) Zhou, G.; Zorn, N.; Ting, P.; Aslanian, R.; Lin, M.; Cook, J.; Lachowicz, J.; Lin, A.; Smith, M.; Hwa, J.; 
van Heek, M.; Walker, S. ACS Med. Chem. Lett. 2014, 5, 544. 
(127) Ilic, M.; Ilas, J.; Dunkel, P.; Mátyus, P.; Bohác, A.; Liekens, S.; Kikelj, D. Eur. J. Med. Chem. 2012, 58, 
160. 
(128) Ilic, M.; Kikelj, D.; Ilas, J. Eur. J. Med. Chem. 2012, 50, 255. 
(129) a) Melkonyan, F.; Topolyan, A.; Karchava, A.; Yurovskaya, M. Tetrahedron 2011, 67, 6826; b) Buon, 
C.; Chacun-Lefèvre, L.; Rabot, R.; Bouyssou, P.; Coudert, G. Tetrahedron 2000, 56, 605; c) Buon, C.; 
Bouyssou, P.; Coudert, G. Tetrahedron Lett. 1999, 40, 701; d) Chacun-Lefèvre, L.; Buon, C.; 
Bouyssou, P.; Coudert, G. Tetrahedron Lett. 1998, 39, 5763; e) Lepifre, F.; Buon, C.; Roger, P.-Y.; 
Bouyssou, P.; Coudert, G. Tetrahedron Lett. 2004, 45, 8257; f) Morgans, G. L.; Ngidi, E. L.; Madeley, 
L. G.; Khanye, S. D.; Michael, J. P.; de Koning, C. B.; van Otterlo, W. A. L. Tetrahedron 2009, 65, 
10650. 
(130) Wu, J.-H.; Chang, F.-R.; Hayashi, K.-i.; Shiraki, H.; Liaw, C.-C.; Nakanishi, Y.; Bastow, K. F.; Yu, D.; 
Chen, I.-S.; Lee, K.-H. Bioorg. Med. Chem. Lett. 2003, 13, 2223. 
(131) a) Bodipati, N.; Peddinti, R. K. Org. Biomol. Chem. 2012, 10, 1958; b) Kenis, S.; D'hooghe, M.; 
Verniest, G.; Reybroeck, M.; Dang Thi, T. A.; The, C. P.; Pham, T. T.; Törnroos, K. W.; Van Tuyen, N.; 
De Kimpe, N. Chem.-Eur. J. 2013, 19, 5966. 
References  Chapter 8 
222 
 
(132) Nosova, E. V.; Lipunova, G. N.; Charushin, V. N.; Chupakhin, O. N. J. Fluorine Chem. 2010, 131, 
1267. 
(133) Kubota, T.; Yamamoto, K.; Tanaka, T. Chem. Lett. 1983, 167. 
(134) Delorme, D.; Vaisburg, A.; Moradei, O.; Leit, S.; Raeppel, S.; Frechette, S.; Bouchain, G.; Zhou, Z.; 
Paquin, I.; Gaudette, F.; Isakovic, L., WO 2005092899, 2005, CAN143:367317. 
(135) Mao, S.; Fang, X.; Ba, L.; Wu, F. J. Fluorine Chem. 2007, 128, 5. 
(136) Uneyama, K., in Organofluorine Chemistry, Blackwell Publishing, 2007, pp. 139. 
(137) a) Lide, D. R., CRC Handbook of Chemistry and Physics, Internet Version, 
http://www.hbcpnetbase.com, CRC Press, Boca Raton, FL, 2005; b) Morris, D. F. C. Acta Cryst. 
1956, 9, 197. 
(138) Wang, Y.-P.; Danheiser, R. L. Tetrahedron Lett. 2011, 52, 2111. 
(139) Lam, T. Y.; Wang, Y.-P.; Danheiser, R. L. J. Org. Chem. 2013, 78, 9396. 
(140) Rüger, A. J.; Nieger, M.; Bräse, S. Tetrahedron 2012, 68, 8823. 
(141) a) Wang, X.-N.; Yeom, H.-S.; Fang, L.-C.; He, S.; Ma, Z.-X.; Kedrowski, B. L.; Hsung, R. P. Acc. Chem. 
Res. 2014, 47, 560; b) Zificsak, C. A.; Mulder, J. A.; Hsung, R. P.; Rameshkumar, C.; Wei, L.-L. 
Tetrahedron 2001, 57, 7575; c) DeKorver, K. A.; Li, H.; Lohse, A. G.; Hayashi, R.; Lu, Z.; Zhang, Y.; 
Hsung, R. P. Chem. Rev. 2010, 110, 5064. 
(142) a) Evano, G.; Coste, A.; Jouvin, K. Angew. Chem. Int. Ed. 2010, 49, 2840; b) DeKorver, K. A.; North, 
T. D.; Hsung, R. P. Synlett 2010, 2397. 
(143) a) Kamei, K.; Maeda, N.; Nomura, K.; Shibata, M.; Katsuragi-Ogino, R.; Koyama, M.; Nakajima, M.; 
Inoue, T.; Ohno, T.; Tatsuoka, T. Bioorg. Med. Chem. 2006, 14, 1978; b) Kamei, K.; Maeda, N.; 
Katsuragi-Ogino, R.; Koyama, M.; Nakajima, M.; Tatsuoka, T.; Ohno, T.; Inoue, T. Bioorg. Med. 
Chem. Lett. 2005, 15, 2990; c) Kamei, K.; Maeda, N.; Ogino, R.; Koyama, M.; Nakajima, M.; 
Tatsuoka, T.; Ohno, T.; Inoue, T. Bioorg. Med. Chem. Lett. 2001, 11, 595. 
(144) Tani, Y.; Ogata, A.; Koyama, M.; Inoue, T. Eur. J. Pharmacol. 2010, 649, 218. 
(145) Cocuzza, A. J.; Chidester, D. R.; Cordova, B. C.; Klabe, R. M.; Jeffrey, S.; Diamond, S.; Weigelt, C. A.; 
Ko, S. S.; Bacheler, L. T.; Erickson-Viitanen, S. K.; Rodgers, J. D. Bioorg. Med. Chem. Lett. 2001, 11, 
1389. 
(146) WHO Global Tuberculosis report 2014. 
(147) a) Zumla, A.; Nahid, P.; Cole, S. T. Nat. Rev. Drug. Discov. 2013, 12, 388; b) Kwon, Y.-S.; Jeong, B.-
H.; Koh, W.-J. Curr. Opin. Pulm. Med. 2014, 20, 280; c) Parida, S. K.; Axelsson-Robertson, R.; Rao, 
References  Chapter 8 
223 
 
M. V.; Singh, N.; Master, I.; Lutckii, A.; Keshavjee, S.; Andersson, J.; Zumla, A.; Maeurer, M. J. Intern. 
Med. 2015, 277, 388. 
(148) a) Claes, P.; Cappoen, D.; Uythethofken, C.; Jacobs, J.; Mertens, B.; Mathys, V.; Verschaeve, L.; 
Huygen, K.; De Kimpe, N. Eur. J. Med. Chem. 2014, 77, 409; b) Cappoen, D.; Jacobs, J.; Nguyen Van, 
T.; Claessens, S.; Diels, G.; Anthonissen, R.; Einarsdottir, T.; Fauville, M.; Verschaeve, L.; Huygen, 
K.; De Kimpe, N. Eur. J. Med. Chem. 2012, 48, 57; c) Cappoen, D.; Claes, P.; Jacobs, J.; Anthonissen, 
R.; Mathys, V.; Verschaeve, L.; Huygen, K.; De Kimpe, N. J. Med. Chem. 2014, 57, 2895. 
(149) Bégué, J.-P.; Bonnet-Delpon, D., Bioorganic and medicinal chemistry of fluorine, John Wiley & Sons, 
Hoboken New Jersey, 2008, p. 365. 
(150) Claes, P., Synthesis of heterocyclic annulated quinones and quinoid compounds. PhD Thesis, Ghent 
Univeristy 2013. 
(151) Cappoen, D., Unpublished results. 
(152) Claes, P.; Jacobs, J.; Kesteleyn, B.; Nguyen Van, T.; De Kimpe, N. J. Org. Chem. 2013, 78, 8330. 
(153) a) Van Baelen, G.; Meyers, C.; Lemière, G. L. F.; Hostyn, S.; Dommisse, R.; Maes, L.; Augustyns, K.; 
Haemers, A.; Pieters, L.; Maes, B. U. W. Tetrahedron 2008, 64, 11802; b) Iwaki, T.; Yasuhara, A.; 
Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 1999, 1505. 
(154) Goto, T.; Shiina, A.; Murata, T.; Tomii, M.; Yamazaki, T.; Yoshida, K.-i.; Yoshino, T.; Suzuki, O.; 
Sogawa, Y.; Mizukami, K.; Takagi, N.; Yoshitomi, T.; Etori, M.; Tsuchida, H.; Mikkaichi, T.; Nakao, 
N.; Takahashi, M.; Takahashi, H.; Sasaki, S. Bioorg. Med. Chem. Lett. 2014, 24, 893. 
(155) Saget, T.; Cramer, N. Angew. Chem. Int. Ed. 2012, 51, 12842. 
(156) Verniest, G.; De Kimpe, N. Synlett 2003, 2013. 
(157) a) Wallace, M. B.; Adams, M. E.; Kanouni, T.; Mol, C. D.; Dougan, D. R.; Feher, V. A.; O’Connell, S. 
M.; Shi, L.; Halkowycz, P.; Dong, Q. Bioorg. Med. Chem. Lett. 2010, 20, 4156; b) Xu, T.; Mu, X.; Peng, 
H.; Liu, G. Angew. Chem. Int. Ed. 2011, 50, 8176. 
(158) a) Henry, N.; Sánchez, I.; Sabatié, A.; Bénéteau, V.; Guillaumet, G.; Pujol, M. D. Tetrahedron 2006, 
62, 2405; b) Arrault, A.; Touzeau, F.; Guillaumet, G.; Léger, J.-M.; Jarry, C.; Mérour, J.-Y. 
Tetrahedron 2002, 58, 8145. 
(159) Annedi, S. C.; Li, W.; Samson, S.; Kotra, L. P. J. Org. Chem. 2003, 68, 1043. 
(160) Dolbier Jr., W. R.; Burkholder, C. R.; Médebielle, M. J. Fluorine Chem. 1999, 95, 127. 
Curriculum Vitae  Chapter 9 
225 
 
9 Curriculum Vitae 
Personalia 
Tamara Meiresonne             °Eeklo, 06.01.1986 
Klaverdries 49 bus 202 
9031 Drongen 
0497/83 35 11 
tamara.meiresonne@hotmail.com 
 
Education 
High school 
1998-2004  College-Onze Lieve Vrouw Ten Doorn, Eeklo 
Science-Mathematics (8) 
University 
2004-2009  Ghent University 
Master of science in bioscience engineering: chemistry and bioprocess technology  
Masterthesis: “Synthesis of novel carbocyclic β-amino acid derivatives and study of 
                             their reactivity“. 
Promoter: Prof. Dr. Ir. Norbert De Kimpe 
2009- 2015 Ghent University, Department of Sustainable Organic Chemistry and Technology  
Doctor of applied biological sciences: chemistry and bioprocess technology  
PhD Thesis: “Synthesis of strained cyclic amino acid derivatives and fluorinated 
                                          heterocyclic compounds”. 
Promoters: Prof. Dr. Ir. Norbert De Kimpe and Prof. Dr. Ir. Sven Mangelinckx 
 
 
Curriculum Vitae  Chapter 9 
226 
 
Scientific publications in international journals with peer-review 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Synthesis of novel β-aminocyclobutanecarboxylic acid 
derivatives by a solvent-free aza-Michael addition and subsequent ring closure’, Org. Biomol. Chem. 2011, 
9, 7085-7091. 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Stereoselective synthesis of both enantiomers of trans-2-
(diphenylmethylideneamino)cyclopropanecarboxylic acid using a chiral pool approach and their 
incorporation in dipeptides’, Tetrahedron 2012, 68, 9566-9571. 
Callebaut, G.; Meiresonne, T.; De Kimpe, N.; Mangelinckx, S. ‘Synthesis and reactivity of 2-(carboxymethyl)-
aziridine derivatives’, Chem. Rev. 2014, 114, 7954-8015. 
Meiresonne, T.; Verniest, G.; De Kimpe, N.; Mangelinckx, S. ‘Synthesis of 2-fluoro-1,4-benzoxazines and 
2-fluoro-1,4-benzoxazepin-5-ones by exploring the nucleophilic vinylic substitution (SNV) reaction of 
gem-difluoroenamides’, J. Org. Chem. 2015, 80, 5111-5124. 
Highlighted in Synfacts 2015, 11, 0703. 
Highlighted in Org. Process Res. Dev. 2015, 19, 950-956. 
 
Active participation at conferences 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Synthesis of new β-aminocyclobutanecarboxylic acid 
derivatives via the MIRC reaction’, (poster presentation) 14th Sigma-Aldrich Organic Synthesis Meeting. 
Spa, Belgium (December 2-3, 2010). 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Synthesis of novel β-aminocyclobutanedicarboxylic acid 
derivatives by a solvent-free aza-Michael addition across homoallylic halides and subsequent ring closure’, 
(oral presentation) COST Action CM803, Foldamers: From synthesis and folding, to function. Leeds, 
England (September 7-9, 2011). 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Synthesis of novel β-aminocyclobutanedicarboxylic acid 
derivatives by a solvent-free aza-Michael addition and subsequent ring closure’, (poster presentation) 15th 
Sigma-Aldrich Organic Synthesis Meeting. Spa, Belgium (December 1-2, 2011). 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Stereoselective synthesis of both enantiomers of trans-2-
(diphenylmethylideneamino)cyclopropanecarboxylic acid using a chiral pool approach and their 
Curriculum Vitae  Chapter 9 
227 
 
incorporation in dipeptides’, (poster presentation) 16th Sigma-Aldrich Organic Synthesis Meeting. Spa, 
Belgium (December 6-7, 2012). 
Meiresonne, T.; Mangelinckx, S.; De Kimpe, N. ‘Synthesis of both enantiomers of a novel unsubstituted 
trans-β-aminocyclopropanecarboxylic acid derivative using a chiral pool approach and their incorporation 
in dipeptides’, (poster presentation) COST Action CM803, Foldamers: From synthesis and folding, to 
function. Paris, France (April 10-12, 2013). 
Meiresonne, T.; Verniest, G.; De Kimpe, N. Mangelinckx, S. ‘Synthesis of novel fluorinated 1,4-benzoxazines 
and 1,4-benzoxazepin-5-ones’, (poster presentation) 14th Belgian Organic Synthesis Symposium. Louvain-
La-Neuve, Belgium (July 13-18, 2014). 
Meiresonne, T.; Verniest, G.; De Kimpe, N. Mangelinckx, S. ‘Exploitation of the fluorine-induced umpolung 
of enamides and ynamides leading to the synthesis of 2-fluoro-1,4-benzoxazines and 2-fluoro-1,4-
benzoxazepin-5-ones’, (poster presentation) 18th Sigma-Aldrich Organic Synthesis Meeting. Blankenberge, 
Belgium (December 4-5, 2014). 
